1 00:00:05,760 --> 00:00:09,200 MY NAME IS MARY GLENSHAW, 2 00:00:09,200 --> 00:00:11,400 DESIGNATED FEDERAL OFFICIAL OR 3 00:00:11,400 --> 00:00:12,920 EXECUTIVE SECRETARY OFFICE OF 4 00:00:12,920 --> 00:00:15,200 AIDS RESEARCH ADVISORY COUNCIL, 5 00:00:15,200 --> 00:00:17,160 OARAC. WELCOME, THANK YOU FOR 6 00:00:17,160 --> 00:00:18,600 YOUR PARTICIPATION TODAY. AS A 7 00:00:18,600 --> 00:00:19,600 REMINDER OUR COUNCIL IS GOVERNED 8 00:00:19,600 --> 00:00:22,560 BY PROVISIONS OF FEDERAL 9 00:00:22,560 --> 00:00:24,360 ADVISORY COMMITTEE ACT OR FACA 10 00:00:24,360 --> 00:00:25,920 AS AMENDED WHICH SETS FORTH 11 00:00:25,920 --> 00:00:27,240 STANDARDS FOR THE FORMATION AND 12 00:00:27,240 --> 00:00:32,320 USE OF ADVISORY COMMITTEES. 13 00:00:32,320 --> 00:00:34,360 TODAY'S MEETING WE WILL FOLLOW 14 00:00:34,360 --> 00:00:37,160 SOME GENERAL GUIDELINES, FIRST 15 00:00:37,160 --> 00:00:39,120 PLEASE STAY MUTED AT ALL TIMES 16 00:00:39,120 --> 00:00:40,600 UNLESS SPEAKING. PLEASE KEEP 17 00:00:40,600 --> 00:00:42,680 YOUR CAMERA ON FOR MOST OF THE 18 00:00:42,680 --> 00:00:44,800 MEETING. FEEL FREE TO HIDE YOUR 19 00:00:44,800 --> 00:00:46,240 CAMERA P IF YOU NEED TO LEAVE 20 00:00:46,240 --> 00:00:49,120 MOMENTARILY AND RETURN. WHEN YOU 21 00:00:49,120 --> 00:00:50,640 WOULD LIKE TO PARTICIPATE IN 22 00:00:50,640 --> 00:00:51,560 DISCUSSION PHYSICALLY RAISE YOUR 23 00:00:51,560 --> 00:00:54,720 HAND OR USE THE ZOOM RAISE HAND 24 00:00:54,720 --> 00:00:56,760 FEATURE. THE CHAIR DR. TOLBERT 25 00:00:56,760 --> 00:00:58,320 AND I WILL NOTE WHO WANTS TO 26 00:00:58,320 --> 00:00:59,760 SPEAK AND CALL ON YOU IN TURN SO 27 00:00:59,760 --> 00:01:01,120 WE CAN AVOID SPEAKING OVER EACH 28 00:01:01,120 --> 00:01:03,680 OTHER. PLEASE DO BE AWARE YOU 29 00:01:03,680 --> 00:01:05,240 WILL NEED TO LOWER THE FEATURE 30 00:01:05,240 --> 00:01:08,880 ONCE YOU MADE YOUR REMARKS. FOR 31 00:01:08,880 --> 00:01:10,680 THIS MEETING THE ZOOM CHAT 32 00:01:10,680 --> 00:01:13,320 FEATURE IS ENABLED ONLY FOR 33 00:01:13,320 --> 00:01:16,040 LOGISTICS MESSAGES TO THE HOSTS. 34 00:01:16,040 --> 00:01:18,280 ANY CONCERNS SEND ME A TEXT 35 00:01:18,280 --> 00:01:20,960 MESSAGE AND YOU CAN ALSO CONTACT 36 00:01:20,960 --> 00:01:23,240 MS. MELISSA OUR INFORMATION IN 37 00:01:23,240 --> 00:01:26,480 YOUR INBOX. FOR EVERYONE ON THE 38 00:01:26,480 --> 00:01:28,480 VIDEOCAST, IF YOU WOULD LIKE TO 39 00:01:28,480 --> 00:01:29,720 SEE THIS PRESENTATION USING 40 00:01:29,720 --> 00:01:31,800 CLOSE CAPTION FEATURE, PLEASE 41 00:01:31,800 --> 00:01:33,640 CLICK THE CC ICON IN THE BOTTOM 42 00:01:33,640 --> 00:01:36,800 RIGHT CORNER OF THE VIDEO. NOW I 43 00:01:36,800 --> 00:01:39,760 WOULD LIKE TO REMIND OUR OARAC 44 00:01:39,760 --> 00:01:40,960 MEMBERS OF POLICIES REGARDING 45 00:01:40,960 --> 00:01:43,160 CONFLICTS OF INTEREST. COUNCIL 46 00:01:43,160 --> 00:01:44,520 MEMBERS MAY NOT PARTICIPATE IN 47 00:01:44,520 --> 00:01:47,000 THE REVIEW OR DISCUSSION OF 48 00:01:47,000 --> 00:01:48,840 SPECIFIC PROGRAM OR PROJECT FOR 49 00:01:48,840 --> 00:01:50,400 WHICH THEY HAVE A REAL OR 50 00:01:50,400 --> 00:01:51,960 APPARENT CONFLICT OF INTEREST. 51 00:01:51,960 --> 00:01:53,880 IF A PROGRAM OR PROJECT IS 52 00:01:53,880 --> 00:01:55,200 DISCUSSED THAT PREVENTS AS 53 00:01:55,200 --> 00:01:56,960 CONFLICT FOR YOU YOU MUST EXCUSE 54 00:01:56,960 --> 00:01:58,880 YOURSELF FROM THE MEETING. TO DO 55 00:01:58,880 --> 00:02:00,360 THIS PLEASE SIGNAL ME AND WE 56 00:02:00,360 --> 00:02:01,840 WILL MOVE YOU TO A SEPARATE 57 00:02:01,840 --> 00:02:03,480 MEETING SPACE IN THE ZOOM. FOR 58 00:02:03,480 --> 00:02:05,480 THE PORTION OF THE DISCUSSION 59 00:02:05,480 --> 00:02:08,680 THAT POSES THE CONFLICT. AT THE 60 00:02:08,680 --> 00:02:11,120 CONCLUSION OF TODAY'S MEETING, 61 00:02:11,120 --> 00:02:13,160 YOU WILL HAVE FORM IN YOUR IN 62 00:02:13,160 --> 00:02:14,640 BOX, PLEASE KINDLY 63 00:02:14,640 --> 00:02:16,560 ELECTRONICALLY SIGN IT TO 64 00:02:16,560 --> 00:02:17,840 CONFIRM THAT NO CONFLICTS WERE 65 00:02:17,840 --> 00:02:20,560 PRESENTED FOR YOU TODAY. ARE 66 00:02:20,560 --> 00:02:22,200 THERE ANY QUESTIONS REGARDING 67 00:02:22,200 --> 00:02:23,680 POTENTIAL CONFLICT OF INTEREST 68 00:02:23,680 --> 00:02:28,680 FOR TODAY'S MEETING? HEARING 69 00:02:28,680 --> 00:02:30,080 NONE, PLEASE DO REMEMBER THAT 70 00:02:30,080 --> 00:02:31,640 TODAY'S MEETING IS OPEN TO THE 71 00:02:31,640 --> 00:02:33,560 GENERAL PUBLIC. AND IS CURRENTLY 72 00:02:33,560 --> 00:02:35,000 BEING RECORDED AND VIDEOCAST 73 00:02:35,000 --> 00:02:38,280 LIVE. I WILL NOW TURN THE 74 00:02:38,280 --> 00:02:40,760 MEETING OVER TO OUR CHAIR, DR. 75 00:02:40,760 --> 00:02:42,200 BLANTON TOLBERT WHO WILL BRING 76 00:02:42,200 --> 00:02:45,200 THE MEETING TO ORDER. THANK YOU 77 00:02:45,200 --> 00:02:47,720 >>THANK YOU, MARY. SO GOOD 78 00:02:47,720 --> 00:02:49,920 AFTERNOON, EVERYONE. THE 62ND 79 00:02:49,920 --> 00:02:52,240 MEETING OF OFFICE OF AIDS 80 00:02:52,240 --> 00:02:53,160 RESEARCH ADVISORY COUNCIL IS IN 81 00:02:53,160 --> 00:02:55,640 SESSION. WELCOME COUNCIL 82 00:02:55,640 --> 00:02:57,480 MEMBERS, INVITED SPEAKERS, NIH 83 00:02:57,480 --> 00:02:58,880 COLLEAGUES AND GUESTS WHO ARE 84 00:02:58,880 --> 00:03:01,480 LISTENING IN. COLLEAGUES I WANT 85 00:03:01,480 --> 00:03:04,480 TO START BY INTRODUCING OUR 86 00:03:04,480 --> 00:03:08,040 OARAC AD HOC ADVISOR, EXCUSE ME, 87 00:03:08,040 --> 00:03:10,280 AD HOC MEMBER, WHO IS JOINING US 88 00:03:10,280 --> 00:03:15,680 TODAY AND THAT IS DR. LOUISE 89 00:03:15,680 --> 00:03:17,920 (INDISCERNIBLE) OF THE WYSTAR 90 00:03:17,920 --> 00:03:19,720 INSTITUTE. AS REMINDER AD HOC 91 00:03:19,720 --> 00:03:21,440 MEMBERS WILL BE FORMALLY 92 00:03:21,440 --> 00:03:27,280 INTRODUCED WHEN THEY JOIN AS 93 00:03:27,280 --> 00:03:29,200 FULL VOTING MEMBERS. WELCOME, 94 00:03:29,200 --> 00:03:30,880 WE LOOK FORWARD TO YOUR INPUT. 95 00:03:30,880 --> 00:03:33,640 WE WILL MOVE WITH THE ROLL CALL. 96 00:03:33,640 --> 00:03:34,840 COLLEAGUES WHEN I CALL YOUR NAME 97 00:03:34,840 --> 00:03:38,040 STATE YOUR POSITION AND 98 00:03:38,040 --> 00:03:42,040 INSTITUTIONAL AFFILIATION. DR. 99 00:03:42,040 --> 00:03:42,920 TABIA AKINTO AKINTOBI. 100 00:03:42,920 --> 00:03:46,680 >>GOOD MORNING. TABIA AKINTOBI, 101 00:03:46,680 --> 00:03:47,680 PROFESSOR AND CHAIR DEPARTMENT 102 00:03:47,680 --> 00:03:49,720 OF COMMUNITY HEALTH AND 103 00:03:49,720 --> 00:03:51,560 PREVENTIVE MEDICINE, AND 104 00:03:51,560 --> 00:03:53,760 PRINCIPLE INVESTIGATOR OF THE 105 00:03:53,760 --> 00:03:55,080 INSTITUTIONS PREVENTION RESEARCH 106 00:03:55,080 --> 00:03:56,880 CENTER. 107 00:03:56,880 --> 00:04:03,040 >>THANK YOU. DR. MARGARET 108 00:04:03,040 --> 00:04:03,440 BRANDEAU. 109 00:04:03,440 --> 00:04:04,840 >>PROFESSOR MANAGEMENT SCIENCE 110 00:04:04,840 --> 00:04:07,920 AND ENGINEERING AND PROFESSOR 111 00:04:07,920 --> 00:04:09,040 HEALTH POLICY STANFORD 112 00:04:09,040 --> 00:04:10,000 UNIVERSITY. 113 00:04:10,000 --> 00:04:11,680 >>DR. KATHLEEN COLLINS. 114 00:04:11,680 --> 00:04:14,080 >>GOOD MORNING. I'M KATHLEEN 115 00:04:14,080 --> 00:04:16,200 COLLINS, PROFESSOR OF INTERNAL 116 00:04:16,200 --> 00:04:17,400 MEDICINE IN THE DIVISION OF 117 00:04:17,400 --> 00:04:18,640 INFECTIOUS DISEASE AND PROFESSOR 118 00:04:18,640 --> 00:04:20,920 OF MICROBIOLOGY IMMUNOLOGY AT 119 00:04:20,920 --> 00:04:23,720 UNIVERSITY OF MICHIGAN. ALSO I'M 120 00:04:23,720 --> 00:04:25,400 DIRECTOR OF MICHIGAN MSTP AND 121 00:04:25,400 --> 00:04:26,560 ASSOCIATE DEAN OF PHYSICIAN 122 00:04:26,560 --> 00:04:28,040 SCIENTISTS EDUCATION AND 123 00:04:28,040 --> 00:04:29,520 TRAINING. I RUN A LABORATORY 124 00:04:29,520 --> 00:04:31,600 THAT STUDIES MOLECULAR 125 00:04:31,600 --> 00:04:32,800 MECHANISMS OF HIV DISEASE 126 00:04:32,800 --> 00:04:34,280 PATHOGENESIS. 127 00:04:34,280 --> 00:04:36,680 >>THANK YOU, DR. COLLINS. DR. 128 00:04:36,680 --> 00:04:40,520 HEIDI CRANE. YOU ARE MUTED DR. 129 00:04:40,520 --> 00:04:41,960 CRANE. 130 00:04:41,960 --> 00:04:44,240 >>MY APOLOGIES, HEIDI CRANE, 131 00:04:44,240 --> 00:04:45,040 UNIVERSITY OF WASHINGTON 132 00:04:45,040 --> 00:04:46,880 PROFESSOR INFECTIOUS DISEASES. 133 00:04:46,880 --> 00:04:51,280 >>THANK Y THANK YOU. DR. SHRUT. 134 00:04:51,280 --> 00:04:54,720 >>GOOD MORNING, EARN, PROFESSOR 135 00:04:54,720 --> 00:04:55,920 AND VICE CHAIR DEPARTMENT OF 136 00:04:55,920 --> 00:04:56,920 EPIDEMIOLOGY JOHNS HOPKINS AND 137 00:04:56,920 --> 00:04:58,720 ALSO CO-DIRECTOR OF THE JOHNS 138 00:04:58,720 --> 00:04:59,800 HOPKINS CFAR. 139 00:04:59,800 --> 00:05:04,680 >>THANK YOU. DR. VERONICA 140 00:05:04,680 --> 00:05:04,960 MILLER. 141 00:05:04,960 --> 00:05:09,840 >>VERONICA MILLER, UNIVERSITY 142 00:05:09,840 --> 00:05:12,680 OF CALIFORNIA BERKELEY SCHOOL OF 143 00:05:12,680 --> 00:05:14,160 PUBLIC HEALTH. WHERE I'M ON 144 00:05:14,160 --> 00:05:16,040 FACULTY AND ALSO THE DIRECTOR OF 145 00:05:16,040 --> 00:05:17,280 THE FORUM FOR COLLABORATIVE 146 00:05:17,280 --> 00:05:18,120 RESEARCH. 147 00:05:18,120 --> 00:05:21,280 >>THANK YOU, DR. MILLER. DR. -- 148 00:05:21,280 --> 00:05:24,320 EXCUSE ME RICARDO RIVERA. 149 00:05:24,320 --> 00:05:27,520 >>GOOD MORNING, EVERYONE. 150 00:05:27,520 --> 00:05:29,800 RICARDO RIVERO, PROFESSOR AT 151 00:05:29,800 --> 00:05:32,240 UNIVERSITY OF ILLINOIS COLLEGE 152 00:05:32,240 --> 00:05:35,280 OF MEDICINE, DEPARTMENT OF 153 00:05:35,280 --> 00:05:36,760 FAMILY MEDICINE AND EXECUTIVE 154 00:05:36,760 --> 00:05:39,520 DIRECTOR OF THE MIDWEST AIDS 155 00:05:39,520 --> 00:05:41,560 (INDISCERNIBLE) CENTER. 156 00:05:41,560 --> 00:05:44,600 >>THANK YOU, DR. RIVERO. DR. 157 00:05:44,600 --> 00:05:47,200 JOHN SLEASMAN. 158 00:05:47,200 --> 00:05:48,800 >>JOHN SLEASMAN, PROFESSOR 159 00:05:48,800 --> 00:05:50,920 CHIEF OF DIVISION OF ALLERGY 160 00:05:50,920 --> 00:05:52,440 IMMUNOLOGY AT DUKE UNIVERSITY 161 00:05:52,440 --> 00:05:53,760 AND MEMBER OF THE SCIENTIFIC 162 00:05:53,760 --> 00:05:56,200 LEADERSHIP GROUP FOR IMPACT. 163 00:05:56,200 --> 00:05:58,880 >>THANK YOU. LAST, OF OUR 164 00:05:58,880 --> 00:06:00,960 VOTING MEMBERS DR. IVY TURN 165 00:06:00,960 --> 00:06:10,520 BUTURNBALL.YOU ARE MUTED DR. TU 166 00:06:10,520 --> 00:06:12,840 >>I'M SORRY. GOOD MORNING, 167 00:06:12,840 --> 00:06:15,560 EVERYONE. IVY TURNBALL, DEPUTY 168 00:06:15,560 --> 00:06:17,200 EXECUTIVE DIRECTOR AIDS ALLIANCE 169 00:06:17,200 --> 00:06:19,000 FOR WOMEN INFANTS CHILDREN 170 00:06:19,000 --> 00:06:20,040 YOUTHND FAMILIES AND CHAIR OF 171 00:06:20,040 --> 00:06:22,000 THE NATIONAL BLACK WOMEN'S HIV 172 00:06:22,000 --> 00:06:22,880 AIDS NETWORK. 173 00:06:22,880 --> 00:06:25,440 >>THANK YOU, DR. TURNBALL. 174 00:06:25,440 --> 00:06:28,840 COLLEAGUES I WILL MOVE ON NOW TO 175 00:06:28,840 --> 00:06:36,360 OARAC EXPO F EX-OFFICIO MEMBERS. 176 00:06:36,360 --> 00:06:37,000 ROBERT EISINGER. 177 00:06:37,000 --> 00:06:38,320 >>I DON'T BELIEVE HE'S JOINING 178 00:06:38,320 --> 00:06:38,520 TODAY. 179 00:06:38,520 --> 00:06:39,680 >>THANK YOU. DR. VICTORIA 180 00:06:39,680 --> 00:06:41,240 DAVIE. 181 00:06:41,240 --> 00:06:43,800 >>UNFORTUNATELY DR. DAVIE IS 182 00:06:43,800 --> 00:06:44,760 UNABLE TO JOIN AS WELL. 183 00:06:44,760 --> 00:06:47,720 >>THANK YOU, MARY. MOVING ON 184 00:06:47,720 --> 00:06:49,440 DR. CARL DIEFFENBACH. 185 00:06:49,440 --> 00:06:52,800 >>GOOD MORNING, EVERYBODY. CARL 186 00:06:52,800 --> 00:06:53,640 DIEFFENBACH, DIRECTOR DIVISION 187 00:06:53,640 --> 00:06:55,760 OF AIDS AND NIAID. 188 00:06:55,760 --> 00:07:00,280 >>THANK YOU. DR. ROHAN HAZRA. 189 00:07:00,280 --> 00:07:04,480 IS DR. HAZRA WITH US? 190 00:07:04,480 --> 00:07:10,120 >>JOINING LATER. REAR ADMIRAL 191 00:07:10,120 --> 00:07:11,280 JONATHAN MERMIN. 192 00:07:11,280 --> 00:07:13,360 >>GOOD MORNING, I'M JONATHAN 193 00:07:13,360 --> 00:07:15,760 MERMIN DIRECTOR OF NATIONAL 194 00:07:15,760 --> 00:07:18,360 CENTER FOR HIV VIRAL HEPATITIS 195 00:07:18,360 --> 00:07:21,000 STD AND TD PREVENTION CDC. LOOK 196 00:07:21,000 --> 00:07:22,000 FORWARD TO THE MEETING. 197 00:07:22,000 --> 00:07:25,320 >>THANK YOU, DR. MERMIN. SO 198 00:07:25,320 --> 00:07:27,760 NEXT I'LL INTRODUCE KNEW NIDA 199 00:07:27,760 --> 00:07:30,280 ADVISORY COUNCIL REPRESENTATIVE. 200 00:07:30,280 --> 00:07:33,680 DR. MELANIE OTT OF THE GLADSTONE 201 00:07:33,680 --> 00:07:35,000 INSTITUTE OF VIROLOGY, 202 00:07:35,000 --> 00:07:36,080 UNIVERSITY OF CALIFORNIA SAN 203 00:07:36,080 --> 00:07:39,320 FRANCISCO. 204 00:07:39,320 --> 00:07:42,080 >>GOOD MORNING, EVERYBODY, 205 00:07:42,080 --> 00:07:44,280 MELANIE OTT DIRECTING THE 206 00:07:44,280 --> 00:07:45,400 GLADSTONE INSTITUTE OF VIROLOGY, 207 00:07:45,400 --> 00:07:46,760 PROFESSOR MEDICINE AT THE UC SAN 208 00:07:46,760 --> 00:07:50,280 FRANCISCO. THANK YOU. DELIGHTED 209 00:07:50,280 --> 00:07:50,560 TO BE HERE. 210 00:07:50,560 --> 00:07:54,040 >>THANK YOU. SO MOVING ON TO 211 00:07:54,040 --> 00:07:55,000 CURRENT ADVISORY COUNCIL 212 00:07:55,000 --> 00:07:57,360 REPRESENTATIVES. FOR THOSE WHO 213 00:07:57,360 --> 00:07:59,840 ARE HERE WITH ME PLEASE 214 00:07:59,840 --> 00:08:00,880 INTRODUCE YOURSELF WHEN I CALL 215 00:08:00,880 --> 00:08:03,960 YOUR NAME. DR. FRANCIS 216 00:08:03,960 --> 00:08:12,160 ALI-OSMAN. DR. MONICA GANDHI. 217 00:08:12,160 --> 00:08:15,920 >>MONICA GANDHI, PROFESSOR 218 00:08:15,920 --> 00:08:18,120 MEDICINE UCS STAFF AND ON NIAID 219 00:08:18,120 --> 00:08:19,120 ADVISORY COUNCIL. THANK YOU. 220 00:08:19,120 --> 00:08:22,200 >>THANK YOU. DR. MARGARITA 221 00:08:22,200 --> 00:08:22,960 LIGHTFOOT. 222 00:08:22,960 --> 00:08:25,800 >>GOOD MORNING, EVERYBO EVERYB. 223 00:08:25,800 --> 00:08:27,120 MARGUERITA LIGHTFOOT ASSOCIATE 224 00:08:27,120 --> 00:08:30,840 DEAN RESEARCH OHSU SCHOOL OF 225 00:08:30,840 --> 00:08:32,720 PUBLIC HEALTH REPRESENTING NIMH 226 00:08:32,720 --> 00:08:33,640 COUNCIL. 227 00:08:33,640 --> 00:08:35,640 >>THANK YOU. NEXT, I WILL MOVE 228 00:08:35,640 --> 00:08:38,080 TO OUR OAR LEADERSHIP AND 229 00:08:38,080 --> 00:08:42,080 SPEAKERS. DR. MAUREEN GOODENOW. 230 00:08:42,080 --> 00:08:42,720 GOOD MORNING. 231 00:08:42,720 --> 00:08:45,240 >>GOOD MORNING. 232 00:08:45,240 --> 00:08:52,840 >>REAR ADMIRAL TIMOTHY HULS. 233 00:08:52,840 --> 00:08:54,680 >>DEPUTY DIRECTOR OAR. 234 00:08:54,680 --> 00:08:57,080 >>CAPTAIN PARI GLENSHAW. 235 00:08:57,080 --> 00:08:59,560 >>GOOD MORNING, -- MARY 236 00:08:59,560 --> 00:08:59,800 GLENSHAW. 237 00:08:59,800 --> 00:09:01,000 >>GOOD MORNING, EVERYBODY. 238 00:09:01,000 --> 00:09:07,840 >>THANK YOU, DR. 239 00:09:07,840 --> 00:09:08,840 (INDISCERNIBLE) 240 00:09:08,840 --> 00:09:12,800 >>I'M GEETANJALI BANSAL. 241 00:09:12,800 --> 00:09:15,520 >>THANK YOU, DR. BANSAL. 242 00:09:15,520 --> 00:09:17,800 LASTLY, I -- I WILL INTRODUCE 243 00:09:17,800 --> 00:09:19,920 INVITED GUESTS WHO WILL LIKELY 244 00:09:19,920 --> 00:09:23,000 JOIN US LATER. SO I WILL START 245 00:09:23,000 --> 00:09:26,960 WITH MR. TIMOTHY WESTMORELAND. 246 00:09:26,960 --> 00:09:28,560 >>GOOD MORNING, TIM 247 00:09:28,560 --> 00:09:30,200 WESTMORELAND, PROFESSOR EMERITUS 248 00:09:30,200 --> 00:09:32,200 AT GEORGETOWN LAW SCHOOL. 249 00:09:32,200 --> 00:09:37,400 >>THANK YOU MR. WESTMORELAND. 250 00:09:37,400 --> 00:09:43,600 DR. RICHARD HODES. DR. STACY 251 00:09:43,600 --> 00:09:44,720 KIERINGTON LAWRENCE. HERE WITH 252 00:09:44,720 --> 00:09:50,640 US? DR. BASAL EL DADA. 253 00:09:50,640 --> 00:09:52,080 >>GOOD MORNING, PROGRAM OFFICER 254 00:09:52,080 --> 00:09:53,360 AT THE NATIONAL INSTITUTE ON 255 00:09:53,360 --> 00:09:54,360 AGING. 256 00:09:54,360 --> 00:10:04,960 >>THANK YOU. DR. JUDY LEVINSON 257 00:10:06,360 --> 00:10:09,400 DR. THEODORE RAUL. 258 00:10:09,400 --> 00:10:11,600 >>HE WILL BE JOINING LATER TOO 259 00:10:11,600 --> 00:10:17,200 >>THANK YOU. DR. ATHENA CURTIS 260 00:10:17,200 --> 00:10:26,320 JOINING LATER. DR. RONALD 261 00:10:26,320 --> 00:10:29,720 WILCOX. DR. RENEE 262 00:10:29,720 --> 00:10:30,680 (INDISCERNIBLE) WHO WILL JOIN 263 00:10:30,680 --> 00:10:39,400 LATER AS WELL. ROY GULICH 264 00:10:39,400 --> 00:10:41,840 (PHONETIC) JOINING LATER. LASTLY 265 00:10:41,840 --> 00:10:45,840 DR. HENRY BASUR (PHONETIC) WHO I 266 00:10:45,840 --> 00:10:47,760 ASSUME IS ALSO JOINING US LATER 267 00:10:47,760 --> 00:10:48,920 >>THAT'S CORRECT. 268 00:10:48,920 --> 00:10:50,920 >>ALL RIGHT. SO COLLEAGUES, IS 269 00:10:50,920 --> 00:10:53,040 THERE ANYONE THAT I DID NOT CALL 270 00:10:53,040 --> 00:10:58,440 OR THAT I MISSED? OKAY. OUR 271 00:10:58,440 --> 00:10:59,720 FIRST ORDER OF BUSINESS IS TO 272 00:10:59,720 --> 00:11:03,080 APPROVE THE MINUTE THE OCTOBER 273 00:11:03,080 --> 00:11:04,320 2022 OARAC MEETING. YOU SHOULD 274 00:11:04,320 --> 00:11:05,800 HAVE RECEIVED THESE MINUTES 275 00:11:05,800 --> 00:11:08,000 ELECTRONICALLY IN YOUR BRIEFING 276 00:11:08,000 --> 00:11:09,560 BOOK. ARE THERE ADDITIONS OR 277 00:11:09,560 --> 00:11:16,040 CORRECTIONS TO THE MINUTES? 278 00:11:16,040 --> 00:11:18,440 HEARING NONE IS THERE A MOTION 279 00:11:18,440 --> 00:11:19,640 TO ACCEPT MINUTES AS THEY STAND? 280 00:11:19,640 --> 00:11:22,160 >>I MOVE WE APPROVE THE MINUTES 281 00:11:22,160 --> 00:11:23,600 AS THEY STAND. 282 00:11:23,600 --> 00:11:26,400 >>THANK YOU, DR. AKINTOBI. IS 283 00:11:26,400 --> 00:11:28,000 THERE A SECOND? 284 00:11:28,000 --> 00:11:30,520 >>I SECOND. 285 00:11:30,520 --> 00:11:33,000 >>THANK YOU. IS ANYONE OPPOSED 286 00:11:33,000 --> 00:11:34,440 TO APPROVING THE MINUTES AS THEY 287 00:11:34,440 --> 00:11:40,000 STAND? HEARING NONE THE MOTION 288 00:11:40,000 --> 00:11:42,000 IS PASSED, MINUTES ARE APPROVED 289 00:11:42,000 --> 00:11:44,920 SO THANK YOU, EVERYONE. AS A 290 00:11:44,920 --> 00:11:47,360 REMINDER, PER OUR CHARTER AND 291 00:11:47,360 --> 00:11:50,760 LEGISLATION, THE OARAC ADVISES 292 00:11:50,760 --> 00:11:52,320 THE OAR DIRECTOR ON BROAD 293 00:11:52,320 --> 00:11:54,600 MATTERS RELATING TO HIV RESEARCH 294 00:11:54,600 --> 00:11:55,200 POLICIES PRIORITIES AND 295 00:11:55,200 --> 00:11:58,560 STRATEGIC PLANNING INCLUDING THE 296 00:11:58,560 --> 00:12:01,360 REVIEW OF NIH AIDS RELATED 297 00:12:01,360 --> 00:12:02,880 PROGRAMS. NOW I WILL PROVIDE A 298 00:12:02,880 --> 00:12:04,920 BRIEF OVERVIEW OF TODAY'S AGENDA 299 00:12:04,920 --> 00:12:07,920 WHICH YOU CAN FIND AGAIN IN YOUR 300 00:12:07,920 --> 00:12:09,560 BRIEFING BOOK. REPORT FIRST BY 301 00:12:09,560 --> 00:12:12,000 OAR DIRECTOR. WE WILL HAVE A 302 00:12:12,000 --> 00:12:14,120 SPECIAL GUEST SPEAKER, 303 00:12:14,120 --> 00:12:16,080 MR. TIMOTHY WESTMORELAND. A 304 00:12:16,080 --> 00:12:16,960 PRESENTATION FROM THE DIRECTOR 305 00:12:16,960 --> 00:12:19,800 OF THE NATIONAL INSTITUTES OF 306 00:12:19,800 --> 00:12:23,280 AGING AND THE PROGRAM LEADERSHIP 307 00:12:23,280 --> 00:12:25,920 FROM NIH. ALSO HAVE A REPORT ON 308 00:12:25,920 --> 00:12:28,080 NIH OAR HIV AND AGING 309 00:12:28,080 --> 00:12:31,000 ACTIVITIES. AND UPDATE ON THE 310 00:12:31,000 --> 00:12:32,680 INFANT FEEDING FOR INDIVIDUALS 311 00:12:32,680 --> 00:12:35,440 WITH HIV IN THE UNITED STATES 312 00:12:35,440 --> 00:12:36,680 RECOMMENDATION. A PRESENTATION 313 00:12:36,680 --> 00:12:39,920 ON EXPANDING INCLUSION IN NIH 314 00:12:39,920 --> 00:12:42,920 TREATMENT TRIALS WORKSHOP. A 315 00:12:42,920 --> 00:12:45,240 PRESENTATION FROM THE DIRECTOR 316 00:12:45,240 --> 00:12:47,240 OF ADVANCE RESEARCH PROJECTS 317 00:12:47,240 --> 00:12:49,960 AGENCY FOR HEALTH ARPA H. 318 00:12:49,960 --> 00:12:53,480 UPDATES FROM THE ADVISORY NIH 319 00:12:53,480 --> 00:12:55,200 ADVISORY COUNCIL. AND UPDATES 320 00:12:55,200 --> 00:12:57,360 FROM THE OARAC HIV CLINICAL 321 00:12:57,360 --> 00:12:59,120 GUIDELINES WORKING GROUP. AS YOU 322 00:12:59,120 --> 00:13:00,880 CAN SEE WE HAVE A VERY BUSY 323 00:13:00,880 --> 00:13:01,960 SCHEDULE, HENCE THE EARLY START 324 00:13:01,960 --> 00:13:05,000 FOR TODAY. SO THE AGENDA WILL 325 00:13:05,000 --> 00:13:07,360 ALSO INCLUDE TIME FOR REGISTERED 326 00:13:07,360 --> 00:13:08,760 PUBLIC COMMENTS. SO ANYONE 327 00:13:08,760 --> 00:13:10,920 LISTENING IN TODAY WHO WISHES TO 328 00:13:10,920 --> 00:13:13,760 MAKE A PUBLIC COMMENT H WAS 329 00:13:13,760 --> 00:13:17,720 THERE A COMMENT? OKAY. SO IF YOU 330 00:13:17,720 --> 00:13:19,880 HAVE A PUBLIC COMMENT YOU SHOULD 331 00:13:19,880 --> 00:13:26,000 EMAIL DR. GLENSHAW AT 332 00:13:26,000 --> 00:13:33,640 OINFO@NIH.GOV. OARACINFO@NIH.GOV 333 00:13:33,640 --> 00:13:34,920 WITH YOUR QUESTION AND COMMENT. 334 00:13:34,920 --> 00:13:36,640 OR VISIT THE WEBSITE OR FEDERAL 335 00:13:36,640 --> 00:13:38,360 REGISTER NOTICE FOR MORE 336 00:13:38,360 --> 00:13:41,240 DETAILS. SO WE WILL NOW HEAR 337 00:13:41,240 --> 00:13:42,880 FROM DR. GOODENOW, DIRECTOR OF 338 00:13:42,880 --> 00:13:44,680 OFFICE OF AIDS RESEARCH WHO WILL 339 00:13:44,680 --> 00:13:45,760 INTRODUCE OUR SPECIAL GUEST 340 00:13:45,760 --> 00:13:48,440 SPEAKER THIS MORNING. DR. 341 00:13:48,440 --> 00:13:51,920 GOODENOW, OVER TO YOU. 342 00:13:51,920 --> 00:13:53,600 >>GREETINGS, AND THANK YOU ALL 343 00:13:53,600 --> 00:13:57,360 FOR JOINING US FOR THE 62ND NIH 344 00:13:57,360 --> 00:13:58,760 OARAC MEETING. THANKS, BLANTON 345 00:13:58,760 --> 00:14:01,160 FOR THE INTRODUCTIONS. THIS 346 00:14:01,160 --> 00:14:02,680 YEAR MARKS THE ANNIVERSARY OF 347 00:14:02,680 --> 00:14:03,880 ORGANIZATIONS THAT PLAY A 348 00:14:03,880 --> 00:14:05,880 CRUCIAL ROLE TO SAVE AND IMPROVE 349 00:14:05,880 --> 00:14:07,680 THE LIVES OF MILLIONS OF PEOPLE 350 00:14:07,680 --> 00:14:11,040 WITH HIV. WE SHOULD RECOGNIZE 351 00:14:11,040 --> 00:14:13,080 THE 20 YEARS OF SERVICE PROVIDED 352 00:14:13,080 --> 00:14:16,560 BY PEPFAR. THE 30TH ANNIVERSARY 353 00:14:16,560 --> 00:14:17,840 OF THE CONFERENCE ON REROW 354 00:14:17,840 --> 00:14:19,400 VIRUSES AND OPPORTUNISTIC 355 00:14:19,400 --> 00:14:21,720 INFECTIONS, CROI. 30 YEARS OF 356 00:14:21,720 --> 00:14:23,720 THE HRSA RYAN WHITE HIV AIDS 357 00:14:23,720 --> 00:14:27,360 PROGRAM. AND THE 35TH 358 00:14:27,360 --> 00:14:29,160 ANNIVERSARY OF THE NIH OFFICE OF 359 00:14:29,160 --> 00:14:33,600 AIDS RESEARCH. I WOULD LIKE TO 360 00:14:33,600 --> 00:14:35,960 START BY THANKING BLANTON 361 00:14:35,960 --> 00:14:37,200 TOLBERT, WHO HAS BEEN A MEMBER 362 00:14:37,200 --> 00:14:38,960 OF OARAC SINCE 2020 AND HAS 363 00:14:38,960 --> 00:14:40,960 SERVED AS THE OARAC CHAIR SINCE 364 00:14:40,960 --> 00:14:44,680 JUNE OF 2021. I ALSO WANT TO 365 00:14:44,680 --> 00:14:46,600 ACKNOWLEDGE THE FOLLOWING OARAC 366 00:14:46,600 --> 00:14:48,440 MEMBERS WHO ALONG WITH BLANTON, 367 00:14:48,440 --> 00:14:51,520 HAVE EXTENDED THEIR SERVICE WITH 368 00:14:51,520 --> 00:14:52,800 OUR THANKS AND WILL COMPLETE 369 00:14:52,800 --> 00:14:55,600 THEIR TURNS ON OARAC AS OF MARCH 370 00:14:55,600 --> 00:14:58,120 29 THIS YEAR. THAT INCLUDES DR. 371 00:14:58,120 --> 00:15:00,760 MARGARET BRANDEAU, DR. HEIDI 372 00:15:00,760 --> 00:15:03,600 CRANE, AND DR. JONAH SACHA. 373 00:15:03,600 --> 00:15:07,080 THANK YOU VERY MUCH FOR YOUR 374 00:15:07,080 --> 00:15:08,080 CONTRIBUTIONS AND YOUR VALUABLE 375 00:15:08,080 --> 00:15:12,520 SERVICE. IT IS A PLEASURE TO 376 00:15:12,520 --> 00:15:15,760 INTRODUCE DR. IVY TURNBULL, NEW 377 00:15:15,760 --> 00:15:17,440 ACTING OARAC CHAIR. SHE WILL 378 00:15:17,440 --> 00:15:19,160 ASSUME HER DUTIES AS ACTING 379 00:15:19,160 --> 00:15:23,040 CHAIR BEGINNING MARCH 30TH. DR. 380 00:15:23,040 --> 00:15:24,880 TURNBULL IS DEPUTY EXECUTIVE 381 00:15:24,880 --> 00:15:26,120 DIRECTOR OF THE AIDS ALLIANCE 382 00:15:26,120 --> 00:15:28,400 FOR WOMEN INFANTS CHILDREN YOUTH 383 00:15:28,400 --> 00:15:29,800 AND FAMILIES AT THE AIDS 384 00:15:29,800 --> 00:15:34,480 INSTITUTE. LOOKING FORWARD TO 385 00:15:34,480 --> 00:15:36,960 WORKING WITH YOU, IVY. THANK YOU 386 00:15:36,960 --> 00:15:38,360 TO THOSE WHO PARTICIPATED IN 387 00:15:38,360 --> 00:15:40,600 YESTERDAY'S ORIENTATION. THE 388 00:15:40,600 --> 00:15:42,400 OARAC ORIENTATION IS AN ANNUAL 389 00:15:42,400 --> 00:15:43,600 EVENT AND THERE WILL BE AN 390 00:15:43,600 --> 00:15:45,840 OPPORTUNITY FOR THOSE WHO MISSED 391 00:15:45,840 --> 00:15:47,840 IT THIS YEAR TO PARTICIPATE NEXT 392 00:15:47,840 --> 00:15:51,240 YEAR. AGAIN, WELCOME TO DR. 393 00:15:51,240 --> 00:15:53,480 LOUISE MONTANA WHO IS WITH US 394 00:15:53,480 --> 00:15:55,280 TODAY FOR HIS FIRST AD HOC 395 00:15:55,280 --> 00:15:59,680 MEETING. SWITCHING GEARS, 396 00:15:59,680 --> 00:16:02,200 RELATED TO THE BUDGET, THE FY 397 00:16:02,200 --> 00:16:04,120 2023 OMNIBUS BILL INCLUDES 398 00:16:04,120 --> 00:16:06,480 INCREASE OF $100 MILLION ABOVE 399 00:16:06,480 --> 00:16:10,360 THE FY 2022 AND ACTIVE LEVEL FOR 400 00:16:10,360 --> 00:16:12,800 E RESEARCH RELATED TO HIV AIDS 401 00:16:12,800 --> 00:16:16,120 ACROSS THE NIH. THIS IS A 3.1% 402 00:16:16,120 --> 00:16:20,240 OVER THE FY 2022 NIH HIV BUDGET 403 00:16:20,240 --> 00:16:24,520 WHICH ALSO INCLUDED INCREASE OF 404 00:16:24,520 --> 00:16:26,880 $104 MILLION. THE FY 2022 405 00:16:26,880 --> 00:16:28,360 INCREASE WAS THE LARGEST SINGLE 406 00:16:28,360 --> 00:16:33,120 YEAR INCREASE SINCE FY 2014. OUR 407 00:16:33,120 --> 00:16:37,000 OVERALL SINCE 2018 THERE'S BEEN 408 00:16:37,000 --> 00:16:39,200 A $299 MILLION INCREASE IN THE 409 00:16:39,200 --> 00:16:41,600 NIH RESEARCH BUDGET FOLLOWING 410 00:16:41,600 --> 00:16:44,560 YEARS OF FLAT FUNDING. WORKING 411 00:16:44,560 --> 00:16:46,240 WITH THE NIH OFFICE OF DIRECTOR, 412 00:16:46,240 --> 00:16:48,280 THESE INCREASES WERE DEPLOYED 413 00:16:48,280 --> 00:16:51,600 ACROSS THE NIH HIV RESEARCH 414 00:16:51,600 --> 00:16:56,400 PROGRAM. THE FY 2022, $104 415 00:16:56,400 --> 00:16:59,120 MILLION INCREASE WAS PRIMARILY 416 00:16:59,120 --> 00:17:00,680 ALLOCATED TO RESEARCH ASSOCIATED 417 00:17:00,680 --> 00:17:03,360 WITH TWO OF THE NIH PRIORITIES 418 00:17:03,360 --> 00:17:05,440 FOR HIV AND HIV RELATED 419 00:17:05,440 --> 00:17:08,600 RESEARCH. NAMELY, ADDRESS HIV 420 00:17:08,600 --> 00:17:10,360 ASSOCIATE T CO-MORBIDITIES, 421 00:17:10,360 --> 00:17:12,360 CO-INFECTIONS AND COMPLICATIONS, 422 00:17:12,360 --> 00:17:14,640 AS WELL AS THE CROSS-CUTTING 423 00:17:14,640 --> 00:17:21,000 RESEARCH PRIORITIES. THE FY 23, 424 00:17:21,000 --> 00:17:22,600 $100 MILLION INCREASE IS 425 00:17:22,600 --> 00:17:24,000 DEPLOYED TO NINE INSTITUTES TO 426 00:17:24,000 --> 00:17:25,720 SUPPORT PROJECTS IN ALIGNMENT 427 00:17:25,720 --> 00:17:27,720 WITH AREAS OF EMPHASIS OUTLINED 428 00:17:27,720 --> 00:17:32,280 IN THE FY 23 PROFESSIONAL 429 00:17:32,280 --> 00:17:37,960 JUDGMENT BUDGET. EACH YEAR OAR 430 00:17:37,960 --> 00:17:39,920 LEGISLATIVELY MANDATED TO 431 00:17:39,920 --> 00:17:42,840 DEVELOP HIV AIDS PROFESSIONAL 432 00:17:42,840 --> 00:17:44,520 JUDGMENT BUDGET WHICH HIGHLIGHTS 433 00:17:44,520 --> 00:17:45,920 ACCOMPLISHMENTS IN HIV AIDS 434 00:17:45,920 --> 00:17:47,640 RESEARCH DURING THE PRIOR YEAR. 435 00:17:47,640 --> 00:17:49,320 AND ESTIMATES THE AMOUNT OF 436 00:17:49,320 --> 00:17:51,560 ADDITIONAL FUNDS NEEDED TO 437 00:17:51,560 --> 00:17:53,440 ADVANCE PROGRESS AND PRIORITY 438 00:17:53,440 --> 00:17:56,200 AREAS OF SCIENCE AS OUTLINED IN 439 00:17:56,200 --> 00:17:58,160 THE CURRENT NIH STRATEGIC PLAN 440 00:17:58,160 --> 00:17:59,440 FOR HIV AND HIV RELATED 441 00:17:59,440 --> 00:18:04,840 RESEARCH. THE FY 2024 442 00:18:04,840 --> 00:18:06,840 PROFESSIONAL JUDGMENT BUDGET FOR 443 00:18:06,840 --> 00:18:11,480 HIV AIDS RESEARCH REQUESTS 444 00:18:11,480 --> 00:18:14,960 $3.673 BILLION, AN INCREASE OF 445 00:18:14,960 --> 00:18:19,920 470 MILLION OR 15% OVER THE FY 446 00:18:19,920 --> 00:18:23,400 2022 ACTIVE BUDGET OF 447 00:18:23,400 --> 00:18:24,680 3.4 MILLION OF AIDS RESEARCH AT 448 00:18:24,680 --> 00:18:26,440 THE NIH. SOME OF THE SCIENCE 449 00:18:26,440 --> 00:18:29,200 OPPORTUNITIES HIGH LIGHT LIGHTEN 450 00:18:29,200 --> 00:18:31,840 THE FY 24 INCLUDE AREAS 451 00:18:31,840 --> 00:18:33,640 EXPANDING BASIC BIOMEDICAL AND 452 00:18:33,640 --> 00:18:35,320 BEHAVIORAL RESEARCH, ALSO 453 00:18:35,320 --> 00:18:36,840 EMPHASIZES THE NEED TO 454 00:18:36,840 --> 00:18:39,520 UNDERSTAND BIOLOGICAL BEHAVIORAL 455 00:18:39,520 --> 00:18:41,200 SOCIAL CONDITIONS ASSOCIATED 456 00:18:41,200 --> 00:18:44,760 WITH EFFECTS OF HIV ACROSS THE 457 00:18:44,760 --> 00:18:48,920 LIFE SPAN. THE FY 24 PJ 458 00:18:48,920 --> 00:18:50,840 DESCRIBES WAYS ALSO TO 459 00:18:50,840 --> 00:18:52,200 STRENGTHEN THE CAPACITY AND 460 00:18:52,200 --> 00:18:54,880 DIVERSITY OF THE HIV AIDS 461 00:18:54,880 --> 00:18:56,520 RESEARCH WORK FORCE SUCH AS 462 00:18:56,520 --> 00:18:58,320 EXPAND POOL OF DIVERSE EARLY 463 00:18:58,320 --> 00:19:03,240 CAREER HIV INVESTIGATORS, AND 464 00:19:03,240 --> 00:19:04,480 IMPROVE AND UPGRADE 465 00:19:04,480 --> 00:19:05,680 INFRASTRUCTURE AND EQUIPMENT AT 466 00:19:05,680 --> 00:19:07,000 INSTITUTIONS CONDUCTING HIV AIDS 467 00:19:07,000 --> 00:19:08,240 RESEARCH PARTICULARLY THOSE WITH 468 00:19:08,240 --> 00:19:11,760 LIMITED RESOURCES. THE FULL 469 00:19:11,760 --> 00:19:16,760 TEXT OF THE FY 2024 NIH HIV AIDS 470 00:19:16,760 --> 00:19:18,000 PROFESSIONAL JUDGMENT BUDGET IS 471 00:19:18,000 --> 00:19:21,280 AVAILABLE ON THE OAR WEBSITE. 472 00:19:21,280 --> 00:19:23,480 IN THE LAST CALENDAR YEAR OAR 473 00:19:23,480 --> 00:19:25,160 HAS ACCELERATED THE DEVELOPMENT 474 00:19:25,160 --> 00:19:29,360 OF THE PJ BUDGETS TO ALIGN MORE 475 00:19:29,360 --> 00:19:31,400 CLOSELY WITH THE US GOVERNMENT 476 00:19:31,400 --> 00:19:34,640 BUDGET PROCESSES OVERALL. AND SO 477 00:19:34,640 --> 00:19:36,480 WHILE WE JUST RECENTLY POSTED 478 00:19:36,480 --> 00:19:39,560 THE FY 2024, WE ARE ALREADY 479 00:19:39,560 --> 00:19:46,280 DEVELOPING THE FY 25 PJ. THIS 480 00:19:46,280 --> 00:19:51,160 YEAR MARKS THE 35 -- 35 YEARS OF 481 00:19:51,160 --> 00:19:52,960 INNOVATIVE INTERDISCIPLINARY AND 482 00:19:52,960 --> 00:19:55,200 GLOBAL HIV AIDS RESEARCH PROGRAM 483 00:19:55,200 --> 00:19:57,680 THAT HAS TRANSFORMED HIV AIDS 484 00:19:57,680 --> 00:20:00,080 FROM A ONCE FATAL DISEASE INTO A 485 00:20:00,080 --> 00:20:01,160 MANAGEABLE CHRONIC CONDITION 486 00:20:01,160 --> 00:20:03,520 WITH TREATMENT. AS WE LOOK 487 00:20:03,520 --> 00:20:06,280 FORWARD TO THE FUTURE OF HIV 488 00:20:06,280 --> 00:20:08,040 AIDS RESEARCH, THE PUBLIC NEEDS 489 00:20:08,040 --> 00:20:10,960 OF THE COMMUNITIES AFFECTED BY 490 00:20:10,960 --> 00:20:11,920 HIV CONTINUE TO CHANGE 491 00:20:11,920 --> 00:20:13,800 ESPECIALLY AS PEOPLE LIVE AND 492 00:20:13,800 --> 00:20:17,840 AGE WITH HIV. OAR AGENDA NEEDS 493 00:20:17,840 --> 00:20:19,480 TO LOOK FORWARD TO WHAT IS 494 00:20:19,480 --> 00:20:21,240 NEEDED TO GET US ACROSS THE 495 00:20:21,240 --> 00:20:25,120 FINISH LINE AND END HIV AS BROAD 496 00:20:25,120 --> 00:20:26,320 EXPERTISE AND EXPANDED 497 00:20:26,320 --> 00:20:30,480 PARTNERSHIPS. IT IS NOW MY 498 00:20:30,480 --> 00:20:31,920 PLEASURE TO INTRODUCE A SPECIAL 499 00:20:31,920 --> 00:20:35,120 GUEST SPEAKER, MR. TIMOTHY 500 00:20:35,120 --> 00:20:37,320 WESTMORELAND. MR. WESTMORELAND 501 00:20:37,320 --> 00:20:38,560 SPENT THE EARLY PART OF HIS 502 00:20:38,560 --> 00:20:40,640 CAREER WORKING FOR THE 503 00:20:40,640 --> 00:20:42,440 SUBCOMMITTEE ON HEALTH AND THE 504 00:20:42,440 --> 00:20:44,400 ENVIRONMENT OF THE U.S. HOUSE OF 505 00:20:44,400 --> 00:20:46,000 REPRESENTATIVES UNDER THE 506 00:20:46,000 --> 00:20:48,240 CHAIRMANSHIP OF CONGRESS HENRY 507 00:20:48,240 --> 00:20:51,240 WAXMAN. WHO IS FROM CALIFORNIA. 508 00:20:51,240 --> 00:20:52,840 THERE HE STAFFED HEARINGS AND 509 00:20:52,840 --> 00:20:55,080 LEGISLATION ON PUBLIC HEALTH, 510 00:20:55,080 --> 00:20:57,320 HIV AIDS, REPRODUCTIVE HEALTH 511 00:20:57,320 --> 00:20:59,960 BIOMEDICAL RESEARCH, BIOMEDICAL 512 00:20:59,960 --> 00:21:01,680 ETHICS AND HEALTH REGULATION AND 513 00:21:01,680 --> 00:21:04,200 IN THIS ROLE HE WAS ONE OF THE 514 00:21:04,200 --> 00:21:06,160 AWE ORS OF THE LEGISLATION THAT 515 00:21:06,160 --> 00:21:11,000 CREATED THE OAR IN 1988. 516 00:21:11,000 --> 00:21:12,960 FOLLOWING HIS TIME IN CONGRESS 517 00:21:12,960 --> 00:21:14,120 MR. WESTMORELAND MOVED TO 518 00:21:14,120 --> 00:21:15,320 GEORGETOWN LAW AND APPOINTED 519 00:21:15,320 --> 00:21:17,200 DIRECTOR OF THE MEDICAID AND 520 00:21:17,200 --> 00:21:18,960 CHIP PROGRAMS IN THE DEPARTMENT 521 00:21:18,960 --> 00:21:20,600 OF HEALTH AND HUMAN SERVICES 522 00:21:20,600 --> 00:21:23,120 UNDER PRESIDENT CLINTON. 523 00:21:23,120 --> 00:21:25,040 MR. WESTMORELAND IS CURRENTLY 524 00:21:25,040 --> 00:21:27,000 PROFESSOR FROM GEORGETOWN 525 00:21:27,000 --> 00:21:28,680 UNIVERSITY LAW CENTER WHERE HE 526 00:21:28,680 --> 00:21:32,960 TAUGHT FROM 2001 TO 2022. HE HAS 527 00:21:32,960 --> 00:21:34,600 TAUGHT HEALTH LAW, IF ED RAIL 528 00:21:34,600 --> 00:21:37,040 BUDGETS AND LEGISLATION, HE 529 00:21:37,040 --> 00:21:39,520 SERVED MANY ADVISORY ROLES 530 00:21:39,520 --> 00:21:41,160 INCLUDING KEISER FAMILY 531 00:21:41,160 --> 00:21:43,360 FOUNDATION AND ELIZABETH GLASER 532 00:21:43,360 --> 00:21:45,920 PEDIATRIC AIDS FOUNDATION WHICH 533 00:21:45,920 --> 00:21:47,760 IS WHERE TIM AND I MET YEARS AGO 534 00:21:47,760 --> 00:21:49,400 MY FIRST GRANT WAS FROM THE 535 00:21:49,400 --> 00:21:53,160 PEDIATRIC AIDS FOUNDATION. AND 536 00:21:53,160 --> 00:21:55,760 SO IT IS GREAT TO HAVE YOU HERE, 537 00:21:55,760 --> 00:21:58,000 TIM. VERY EXCITED TO HEAR SOME 538 00:21:58,000 --> 00:22:03,440 OF YOUR REFLECTIONS ON THE START 539 00:22:03,440 --> 00:22:05,880 OF OAR. WE WILL PUT THE SLIDES 540 00:22:05,880 --> 00:22:07,160 OFF FOR NOW. 541 00:22:07,160 --> 00:22:11,320 >>OKAY. THANK YOU. FIRST I WANT 542 00:22:11,320 --> 00:22:12,600 TO SAY THANK YOU TO MAUREEN AND 543 00:22:12,600 --> 00:22:15,000 OTHERS FOR THE INVITATION. WHEN 544 00:22:15,000 --> 00:22:17,800 I STARTED WORKING ON HIV ISSUES 545 00:22:17,800 --> 00:22:21,480 IN THE FALL OF 1981, THERE WAS A 546 00:22:21,480 --> 00:22:23,800 TIME I FELT LIKE I KNEW EVERY 547 00:22:23,800 --> 00:22:30,040 HIV RESEARCHER BY NAME. THEN THE 548 00:22:30,040 --> 00:22:31,040 FIELD GREW AND IT IS NICE TO BE 549 00:22:31,040 --> 00:22:32,640 BACK. I NEED TO BEGIN WITH 550 00:22:32,640 --> 00:22:35,280 COUPLE OF DISCLAIMERS. I INTEND 551 00:22:35,280 --> 00:22:37,240 THESE TO BE INFORMAL REMARK, 552 00:22:37,240 --> 00:22:38,760 I'LL HAVE NO FOOT NOTES, NO 553 00:22:38,760 --> 00:22:40,400 SLIDES, JUST TALKING. I'M A 554 00:22:40,400 --> 00:22:42,600 SOUTHERN PREACHERS KID. AND THE 555 00:22:42,600 --> 00:22:44,920 VIEWS I EXPRESS ARE MY OWN. THEY 556 00:22:44,920 --> 00:22:46,560 SHOULDN'T BE CONSTRUED TO BE 557 00:22:46,560 --> 00:22:48,480 THOSE OF PAST, PRESENT AND MAYBE 558 00:22:48,480 --> 00:22:51,240 SOME DAY FUTURE EMPLOYERS. THEN 559 00:22:51,240 --> 00:22:52,800 FINALLY, PROBABLY MOST 560 00:22:52,800 --> 00:22:53,840 SIGNIFICANTLY, THESE EVENTS THAT 561 00:22:53,840 --> 00:22:57,400 I'M REMINISCING ABOUT FOR YOU, 562 00:22:57,400 --> 00:22:59,680 TOOK PLACE A LONG TIME AGO AND 563 00:22:59,680 --> 00:23:01,360 MY MEMORY IS AGING SO I'M SURE 564 00:23:01,360 --> 00:23:05,080 SOME OF IT IS FLAWED. BEFORE I 565 00:23:05,080 --> 00:23:07,080 TALK ABOUT OAR FOUNDING, I NEED 566 00:23:07,080 --> 00:23:09,280 TO SET SOME CONTEXT HOW WE WERE 567 00:23:09,280 --> 00:23:11,200 WORKING AT THE TIME. THIS WAS A 568 00:23:11,200 --> 00:23:13,160 LONG TIME AGO AND THINGS WERE 569 00:23:13,160 --> 00:23:15,240 REALLY VERY DIFFERENT. 570 00:23:15,240 --> 00:23:20,160 MR. REGA REAGAN WAS PRESIDENT, 571 00:23:20,160 --> 00:23:21,560 MEMBERS OF CONGRESS WERE QUITE 572 00:23:21,560 --> 00:23:23,760 BLUNT SAYING THEY DIDN'T LIKE 573 00:23:23,760 --> 00:23:25,280 GAY MEN AND DIDN'T CARE WHAT 574 00:23:25,280 --> 00:23:28,240 PARTED TO THEM. THE WHITE HOUSE 575 00:23:28,240 --> 00:23:30,280 PRESS SEC WAS EXCHAINING CRUDE 576 00:23:30,280 --> 00:23:32,800 AIDS JOKES WITH THE PRESS CORP. 577 00:23:32,800 --> 00:23:34,640 THE FIRST LEGISLATION I WORKED 578 00:23:34,640 --> 00:23:37,240 ON FOR AIDS FUNDING FRAMED 579 00:23:37,240 --> 00:23:39,880 GENERICALLY ABOUT PUBLIC HEALTH 580 00:23:39,880 --> 00:23:40,960 EMERGENCIES BECAUSE MY SENATE 581 00:23:40,960 --> 00:23:44,240 REPUBLICAN COUNTER PART WAS 582 00:23:44,240 --> 00:23:45,840 UNSURE WHETHER IT WOULD SHORT 583 00:23:45,840 --> 00:23:46,960 CONVOY VERSEIAL RESEARCH. THEN 584 00:23:46,960 --> 00:23:49,440 OF COURSE AS YOU KNOW THERE WAS 585 00:23:49,440 --> 00:23:51,360 WILD CONFUSION ABOUT WHAT THE 586 00:23:51,360 --> 00:23:53,200 DISEASE WAS. FOR YEARS NO ONE 587 00:23:53,200 --> 00:23:54,760 COULD EVEN IDENTIFY AN 588 00:23:54,760 --> 00:23:56,800 INFECTIOUS AGENT. SOME MEMBERS 589 00:23:56,800 --> 00:23:58,040 OF CONGRESS WHOM I WORKED WITH 590 00:23:58,040 --> 00:23:59,560 WERE CONVINCED THAT IT WAS 591 00:23:59,560 --> 00:24:02,080 SPREAD BY MOSQUITOES AND WE HAD 592 00:24:02,080 --> 00:24:04,120 TO COMMISSION A TECHNICAL REPORT 593 00:24:04,120 --> 00:24:06,200 TO RESPOND TO THAT. A FEW OF 594 00:24:06,200 --> 00:24:08,440 THEM STAYED OUT OF THE HOUSE GYM 595 00:24:08,440 --> 00:24:11,560 BECAUSE THEY WERE AFRAID OF 596 00:24:11,560 --> 00:24:13,680 SWEAT. ONE NEWS MAGAZINE RAN A 597 00:24:13,680 --> 00:24:15,960 COVER, NOW WE ARE ALL AT RISK 598 00:24:15,960 --> 00:24:18,480 FOR AIDS. ANOTHER PREDICTED THE 599 00:24:18,480 --> 00:24:20,120 INSURANCE INDUSTRY WOULD NOT 600 00:24:20,120 --> 00:24:21,720 SURVIVE THE EPIDEMIC. PEOPLE 601 00:24:21,720 --> 00:24:23,240 WITH AIDS LOST THEIR JOBS, THEIR 602 00:24:23,240 --> 00:24:25,720 HOMES, AND THEIR FAMILIES. KIDS 603 00:24:25,720 --> 00:24:29,120 WERE KEPT OUT OF SCHOOL. AND ALL 604 00:24:29,120 --> 00:24:31,680 THIS WITHOUT LEGAL RECOURSE IN 605 00:24:31,680 --> 00:24:35,360 MOST STATES. ACROSS THE BOARD 606 00:24:35,360 --> 00:24:36,920 THE REAGAN ADMINISTRATION WAS 607 00:24:36,920 --> 00:24:38,240 OPPOSING ALL INCREASES IN 608 00:24:38,240 --> 00:24:40,200 FUNDING NOT JUST ON AIDS BUT 609 00:24:40,200 --> 00:24:43,160 EVEN ON POLIO VACCINES AND 610 00:24:43,160 --> 00:24:45,240 TUBERCULOSIS CONTROL. NO NEW 611 00:24:45,240 --> 00:24:47,920 MONEY EXCEPT FOR DEFENSE. THE 612 00:24:47,920 --> 00:24:50,080 WHITE HOUSE THREATENED A VOTE 613 00:24:50,080 --> 00:24:50,840 TOE AN APPROPRIATIONS BILL IN 614 00:24:50,840 --> 00:24:52,040 PART BECAUSE IT HAD TOO MUCH 615 00:24:52,040 --> 00:24:55,120 AIDS RESEARCH MONEY IN IT. WE 616 00:24:55,120 --> 00:24:57,320 HAD IN THE SUBCOMMITTEE ON 617 00:24:57,320 --> 00:25:00,200 HEALTH, HEARING AFTER HEARING ON 618 00:25:00,200 --> 00:25:02,160 WHAT RESEARCHERS AND PUBLIC 619 00:25:02,160 --> 00:25:03,760 HEALTH AUTHORITIES THOUGHT WAS 620 00:25:03,760 --> 00:25:05,280 NEEDED. I HAVE TO ACKNOWLEDGE 621 00:25:05,280 --> 00:25:07,200 THIS WAS ALL BEFORE THE INTERNET 622 00:25:07,200 --> 00:25:11,800 AND EVEN MO BEFORE EMAIL SO I GT 623 00:25:11,800 --> 00:25:13,400 DOCUMENTS AND LEAKS OF INTERNAL 624 00:25:13,400 --> 00:25:15,480 BUDGET PROPOSAL THE PUBLIC 625 00:25:15,480 --> 00:25:17,600 HEALTH SERVICE AND ITS OFFICERS, 626 00:25:17,600 --> 00:25:20,320 IN PLAIN BROWN ENVELOPES. 627 00:25:20,320 --> 00:25:22,080 OFFICIAL WITNESSES LIKE TONY 628 00:25:22,080 --> 00:25:25,680 FAUCI AND JIM KERNS FROM CDC HAD 629 00:25:25,680 --> 00:25:26,840 TO SUPPORT THE OFFICIAL 630 00:25:26,840 --> 00:25:27,760 ADMINISTRATION BUDGET BUT OVER 631 00:25:27,760 --> 00:25:33,160 TIME WE DEVELOPED A MENUETTE OF 632 00:25:33,160 --> 00:25:34,280 QUESTIONS WHERE WE CAN SAY WHAT 633 00:25:34,280 --> 00:25:37,240 PRESIDENT SUPPORTED AND MEMBERS 634 00:25:37,240 --> 00:25:38,720 OF CONGRESS COULD ASK THEM IN 635 00:25:38,720 --> 00:25:40,160 YOUR PERSONAL PROFESSIONAL 636 00:25:40,160 --> 00:25:41,200 JUDGMENT WHAT WOULD BE NEEDED TO 637 00:25:41,200 --> 00:25:43,520 RESPOND. WITH THAT KIND OF 638 00:25:43,520 --> 00:25:44,400 QUESTION OFFICIALS COULD 639 00:25:44,400 --> 00:25:46,640 RESPOND. USUALLY REPEATING WHAT 640 00:25:46,640 --> 00:25:48,880 THE AUTHORITY RECEIVED IN THE 641 00:25:48,880 --> 00:25:50,800 PLAIN BROWN ENVELOPES. 642 00:25:50,800 --> 00:25:52,320 EVENTUALLY THE PRESS AND PUBLIC 643 00:25:52,320 --> 00:25:54,280 BEGAN TO AGREE THAT MORE HAD TO 644 00:25:54,280 --> 00:25:57,560 BE DONE. AND ON A BIPARTISAN 645 00:25:57,560 --> 00:25:59,480 BASIS THE CONGRESS CONTINUED TO 646 00:25:59,480 --> 00:26:01,920 INCREASE NIH AND CDC FUNDING FOR 647 00:26:01,920 --> 00:26:05,760 AIDS WORK. BY 1987 THE HOUSE 648 00:26:05,760 --> 00:26:06,880 BUDGET RESOLUTION PROPOSED 649 00:26:06,880 --> 00:26:08,280 DOUBLING THE AIDS RESEARCH 650 00:26:08,280 --> 00:26:09,600 BUDGET. AFTER ALREADY DOUBLING 651 00:26:09,600 --> 00:26:12,160 IT THE YEAR BEFORE. BUT AT THE 652 00:26:12,160 --> 00:26:14,640 SAME TIME THE OMB AND THE OFFICE 653 00:26:14,640 --> 00:26:17,240 OF PERSONNEL MANAGEMENT WERE 654 00:26:17,240 --> 00:26:18,400 IMPOSING PERSONNEL CEILINGS 655 00:26:18,400 --> 00:26:20,000 MAKING HARDER TO EXPEDITE 656 00:26:20,000 --> 00:26:21,480 RESEARCH AWARDS OR DO INTRAMURAL 657 00:26:21,480 --> 00:26:25,360 WORK. AS YOU NO BETTER THAN I -- 658 00:26:25,360 --> 00:26:27,000 KNOW BETTER THAN I WHEN THE 659 00:26:27,000 --> 00:26:27,960 FUNDING WAS APPROVED AIDS 660 00:26:27,960 --> 00:26:30,680 RESEARCH WAS BEING CONDUCTED IN 661 00:26:30,680 --> 00:26:33,600 EVERY NIH INSTITUTE AND CENTER. 662 00:26:33,600 --> 00:26:35,840 EVEN COUNTING THE GRANTS IN THE 663 00:26:35,840 --> 00:26:37,440 PROJECTS FOR AIDS AND RELATED 664 00:26:37,440 --> 00:26:39,120 RESEARCH WAS DIFFICU DIFFICULT.H 665 00:26:39,120 --> 00:26:41,360 LESS FOLLOWING IT. THERE WAS 666 00:26:41,360 --> 00:26:43,160 DUPLICATION. ALLERGY, CANCER 667 00:26:43,160 --> 00:26:45,800 WERE DOING SOME OF THE SAME 668 00:26:45,800 --> 00:26:47,320 PROJECTS. AND THERE WERE GAPS 669 00:26:47,320 --> 00:26:49,000 AND OMISSIONS OF IMPORTANT 670 00:26:49,000 --> 00:26:50,680 ISSUES THAT PEOPLE SIMPLY 671 00:26:50,680 --> 00:26:53,000 WEREN'T STUDYING. AND THERE WAS 672 00:26:53,000 --> 00:26:54,840 NO OVERALL COORDINATED PLAN FOR 673 00:26:54,840 --> 00:26:59,440 AIDS RESEARCH. SO IN 1988, THE 674 00:26:59,440 --> 00:27:02,600 CONGRESS BEGAN NEW LEGISLATION. 675 00:27:02,600 --> 00:27:04,320 THERE WAS ONE VERY HIGH PROFILE 676 00:27:04,320 --> 00:27:06,520 BILL TO CREATE A FEDERAL GRANTS 677 00:27:06,520 --> 00:27:07,680 PROGRAM FOR HIV COUNSELING AND 678 00:27:07,680 --> 00:27:10,720 TESTING. AND TO PROVIDE FOR 679 00:27:10,720 --> 00:27:11,840 CONFIDENTIALITY AND 680 00:27:11,840 --> 00:27:13,040 NON-DISCRIMINATION TO ENCOURAGE 681 00:27:13,040 --> 00:27:15,440 PEOPLE TO BE TESTED. THERE WAS 682 00:27:15,440 --> 00:27:17,760 A SECOND ONE TO IMPROVE AIDS 683 00:27:17,760 --> 00:27:20,560 RESEARCH AUTHORITIES, INCLUDING 684 00:27:20,560 --> 00:27:22,320 EXPEDITING RESEARCH AWARDS, 685 00:27:22,320 --> 00:27:23,520 INCREASING THE PERSONNEL FOR 686 00:27:23,520 --> 00:27:25,800 AIDS RESEARCH, CREATING AN 687 00:27:25,800 --> 00:27:27,640 ANNUAL REPORT TO THE CONGRESS ON 688 00:27:27,640 --> 00:27:30,160 THE RESEARCH, AND CODIFYING 689 00:27:30,160 --> 00:27:34,120 OFFICE OF AIDS RESEARCH IN ORDER 690 00:27:34,120 --> 00:27:36,480 TO COORDINATE NIH AIDS ACTIVITY 691 00:27:36,480 --> 00:27:38,920 AND REPORT ON THEM. MOST OF THE 692 00:27:38,920 --> 00:27:40,440 CONGRESSIONAL DEBATE AND 693 00:27:40,440 --> 00:27:42,560 CONTROVERSY WERE ABOUT THE FIRST 694 00:27:42,560 --> 00:27:44,120 BILL THOUGH NEW DRUGS FOR 695 00:27:44,120 --> 00:27:45,120 PREVENTING OPPORTUNISTIC 696 00:27:45,120 --> 00:27:47,360 INFECTIONS, NOT ALL OF THE AIDS 697 00:27:47,360 --> 00:27:49,320 ACTIVISTS SUPPORTED FEDERAL 698 00:27:49,320 --> 00:27:52,400 ENCOURAGEMENT OF TESTING. FOR 699 00:27:52,400 --> 00:27:54,200 THE RIGHT WING AMENDMENT AFTER 700 00:27:54,200 --> 00:27:57,240 AMENDMENT WAS PROPOSED TO 701 00:27:57,240 --> 00:27:57,840 REQUIRE MAUNDSTORY TESTING AND 702 00:27:57,840 --> 00:28:00,200 REPORTING OF NAMES. THE PEOPLE 703 00:28:00,200 --> 00:28:01,440 WHO DIDN'T LIKE GAY MEN WERE 704 00:28:01,440 --> 00:28:02,800 OPPOSED TO THE 705 00:28:02,800 --> 00:28:04,040 NON-DISCRIMINATION PROVISIONS, 706 00:28:04,040 --> 00:28:05,480 SAYING THAT THE TESTING BILL WAS 707 00:28:05,480 --> 00:28:07,880 A SECRET GAY RIGHTS BILL. AND 708 00:28:07,880 --> 00:28:10,480 BEFORE THE DEBATE PROTECTIONS -- 709 00:28:10,480 --> 00:28:12,080 BEFORE THE DEBATE, THOSE 710 00:28:12,080 --> 00:28:13,600 PROTECTIONS HAD TO BE DROPPED TO 711 00:28:13,600 --> 00:28:16,600 MAKE THE BILL BIPARTISAN. BUT 712 00:28:16,600 --> 00:28:17,880 THE REAGAN ADMINISTRATION ALSO 713 00:28:17,880 --> 00:28:20,680 OPPOSED RESEARCH PROVISIONS 714 00:28:20,680 --> 00:28:21,840 SAYING THEY WERE ALL 715 00:28:21,840 --> 00:28:22,360 MICROMANAGEMENT THAT WAS 716 00:28:22,360 --> 00:28:26,080 UNNECESSARY. AS ALWAYS THE OMB 717 00:28:26,080 --> 00:28:27,880 SAID ALL THAT COULD BE DONE WAS 718 00:28:27,880 --> 00:28:33,560 BEING DONE. THE SENATE HAS IS 719 00:28:33,560 --> 00:28:35,920 NOT PASSED BILL ON 720 00:28:35,920 --> 00:28:37,040 CONFIDENTIALITY, THEY WERE TOO 721 00:28:37,040 --> 00:28:39,040 CONTROVERSIAL. WE TRIED TO GET 722 00:28:39,040 --> 00:28:40,640 SENATE AGREEMENT IN CONFERENCE 723 00:28:40,640 --> 00:28:42,920 BUT JESSIE HELMS I DESCRIBE IN 724 00:28:42,920 --> 00:28:46,640 MY PERSONAL VIEWS AS THE 80s 725 00:28:46,640 --> 00:28:49,480 EQUIVALENT OF TED CRUZ AND RAND 726 00:28:49,480 --> 00:28:51,360 PAUL WRAPPED INTO ONE, 727 00:28:51,360 --> 00:28:53,760 THREATENED TO VETO THE WHOLE 728 00:28:53,760 --> 00:28:54,560 PACKAGE, THAT WAS TOO MUCH 729 00:28:54,560 --> 00:28:55,560 PROTECTION OF PEOPLE WITH AIDS 730 00:28:55,560 --> 00:28:59,640 FOR HIM TO ACCEPT. AND ANY BOSS, 731 00:28:59,640 --> 00:29:01,600 MR. WAXMAN SAID HE COULDN'T 732 00:29:01,600 --> 00:29:03,600 SUPPORT A FEDERAL TESTING 733 00:29:03,600 --> 00:29:05,960 PROGRAM THAT DIDN'T PROSECT 734 00:29:05,960 --> 00:29:06,800 CONFIDENTIALITY SO THE TESTING 735 00:29:06,800 --> 00:29:08,920 AND TITLE OF THE BILL HAD TO BE 736 00:29:08,920 --> 00:29:12,400 DEVELOPED DROPPED IT CAME BACK 737 00:29:12,400 --> 00:29:14,280 LATER AS THE RYAN WHITE ACT IN 738 00:29:14,280 --> 00:29:16,560 1990 BUT NOT PART OF THE LARGE 739 00:29:16,560 --> 00:29:19,680 LEGISLATION IN 1988. BUT THE OAR 740 00:29:19,680 --> 00:29:21,160 AND OTHER RESEARCH PROVISIONS 741 00:29:21,160 --> 00:29:26,920 WERE PASSED AND ENACTED, ON A 742 00:29:26,920 --> 00:29:28,560 BIPARTISAN BASIS. AS TIME WENT 743 00:29:28,560 --> 00:29:30,760 ON IT BECAME CLEAR THAT OAR 744 00:29:30,760 --> 00:29:33,600 COULD NOT GET THE ATTENTION OF 745 00:29:33,600 --> 00:29:35,280 INSTITUTES WHEN THEIR SPENDING 746 00:29:35,280 --> 00:29:38,400 PLANS. IF I MAY, MONEY TALKS 747 00:29:38,400 --> 00:29:40,120 EVEN WITHIN THE NIH. THERE WAS 748 00:29:40,120 --> 00:29:42,760 DISCUSSION OF CREATING AN AIDS 749 00:29:42,760 --> 00:29:44,440 INSTITUTE IN THE CONGRESS, THE 750 00:29:44,440 --> 00:29:45,600 AIDS BUDGET WAS ALREADY LARGER 751 00:29:45,600 --> 00:29:48,240 THAN A NUMBER OF THE EXISTING 752 00:29:48,240 --> 00:29:49,560 INSTITUTES. AND THERE MIGHT BE 753 00:29:49,560 --> 00:29:50,760 COORDINATING AND PLANNING 754 00:29:50,760 --> 00:29:54,120 BENEFITS FROM WORKING WITHIN ONE 755 00:29:54,120 --> 00:29:55,440 STRUCTURE. THERE ARE ALSO 756 00:29:55,440 --> 00:29:57,520 SIGNIFICANT DISADVANTAGES OF 757 00:29:57,520 --> 00:29:58,720 UPROOTING SCIENCE, SCIENTISTS 758 00:29:58,720 --> 00:30:01,960 AND LABS, AND DISRUPTING 759 00:30:01,960 --> 00:30:03,640 COORDINATION AND COMMUNICATION. 760 00:30:03,640 --> 00:30:06,160 THERE WAS A POLITICAL FEAR, A 761 00:30:06,160 --> 00:30:08,560 POLITICAL FEAR, OF A 762 00:30:08,560 --> 00:30:09,760 PROLIFERATION OF DISEASE 763 00:30:09,760 --> 00:30:12,560 SPECIFIC INSTITUTES AT NIH. SO 764 00:30:12,560 --> 00:30:14,000 BY 1992 THERE WAS HYBRID 765 00:30:14,000 --> 00:30:16,640 STRUCTURE DEBATED IN THE 766 00:30:16,640 --> 00:30:17,600 CONGRESS AND INSTITUTE WITHOUT 767 00:30:17,600 --> 00:30:20,760 WALLSWALLS WAS THE PHRASE. KEEPG 768 00:30:20,760 --> 00:30:22,080 THE WORK AND PEOPLE WITHIN 769 00:30:22,080 --> 00:30:24,320 EXISTING INSTITUTES AND CENTERS, 770 00:30:24,320 --> 00:30:26,720 COORDINATING FUNDING DECISIONS 771 00:30:26,720 --> 00:30:29,120 TO INSTALL GAPS AND OVERLAPS. A 772 00:30:29,120 --> 00:30:32,040 NUMBER OF OUTSIDE SCIENTISTS AND 773 00:30:32,040 --> 00:30:35,040 ADVOCATES WERE SUPPORTIVE. BUT 774 00:30:35,040 --> 00:30:38,440 THE INSTITUTE DIRECTOR HAROLD 775 00:30:38,440 --> 00:30:39,760 VARMUS AND TONY FAUCI WERE 776 00:30:39,760 --> 00:30:41,200 OPPOSED AND THAT MATTERED ON THE 777 00:30:41,200 --> 00:30:43,520 HILL AND PRES PRESS. I TALKED TY 778 00:30:43,520 --> 00:30:44,800 BEING HEAD OF SUCH AN INSTITUTE 779 00:30:44,800 --> 00:30:46,160 WHICH HE DIDN'T WANT. BUT HE 780 00:30:46,160 --> 00:30:47,560 DIDN'T WANT THE OAR TO HAVE ANY 781 00:30:47,560 --> 00:30:50,840 CONTROL OF THE BUDGET EITHER. 782 00:30:50,840 --> 00:30:51,680 NONETHELESS THE STRUCTURE WAS 783 00:30:51,680 --> 00:30:54,680 INCORPORATED INTO THE NIH 784 00:30:54,680 --> 00:30:58,880 REVITALIZATION ACT OF 1982. THAT 785 00:30:58,880 --> 00:31:01,640 ACT, HAD CENTRAL CONTROVERSY, 786 00:31:01,640 --> 00:31:02,880 NOT THE OAR, IT WAS NOT THE 787 00:31:02,880 --> 00:31:05,120 REQUIREMENT TO INCLUDE WOMEN AND 788 00:31:05,120 --> 00:31:07,160 RACIAL ETHNIC MINORITIES IN 789 00:31:07,160 --> 00:31:08,240 CLINICAL TRIALS SUPPORTED BY 790 00:31:08,240 --> 00:31:10,960 NIH. IT WAS LIFTING THE 791 00:31:10,960 --> 00:31:12,520 MORATORIUM ON NIH SUPPORT OF 792 00:31:12,520 --> 00:31:16,920 FETAL TISSUE TRANSPLANTATION 793 00:31:16,920 --> 00:31:20,400 WHICH WAS BANNED BY NIH CELL 794 00:31:20,400 --> 00:31:22,080 TORR HEELEY, THAT WAS THE FRONT 795 00:31:22,080 --> 00:31:24,600 PAGE NEWS WITH PARKINSON AND 796 00:31:24,600 --> 00:31:26,120 DIABETES GROUPS LINED UP AGAINST 797 00:31:26,120 --> 00:31:29,880 ANTI-ABORTION GROUP GROUPS BILLS 798 00:31:29,880 --> 00:31:31,360 VETOED OVER FETAL TISSUE BY 799 00:31:31,360 --> 00:31:33,640 PRESIDENT BPRESIDENT BUSH. THE S 800 00:31:33,640 --> 00:31:34,480 OVERWRITTEN IN THE SENATE, 801 00:31:34,480 --> 00:31:35,920 SOMETHING THAT ALMOST NEVER 802 00:31:35,920 --> 00:31:37,680 HAPPENS AND INCLUDED SIGNIFICANT 803 00:31:37,680 --> 00:31:40,480 SUPPORT FROM REPUBLICANS. WE 804 00:31:40,480 --> 00:31:41,560 FAILED TOOVER RIDE IN THE HOUSE, 805 00:31:41,560 --> 00:31:43,680 HAVING A CLEAR MAJORITY TO DO SO 806 00:31:43,680 --> 00:31:47,080 BUT NOT THE TWO-THIRDS REQUIRED 807 00:31:47,080 --> 00:31:49,800 THEN MR. CLINTON MADE THE BUSH 808 00:31:49,800 --> 00:31:51,560 VETO AN ELECTION ISSUE PROMISING 809 00:31:51,560 --> 00:31:54,160 TO SIGN IT AND LIFTING THE FETAL 810 00:31:54,160 --> 00:31:56,560 TISSUE RESEARCH MORATORIUM BY 811 00:31:56,560 --> 00:31:59,560 EXECUTIVE ORDER. THE BILL -- THE 812 00:31:59,560 --> 00:32:02,080 NIH REVITALIZATION ACT PASSED 813 00:32:02,080 --> 00:32:04,080 INCLUDING STRENGTHENING OAR WITH 814 00:32:04,080 --> 00:32:07,320 BUDGET AUTHORITY. SEEMS A LONG 815 00:32:07,320 --> 00:32:09,480 TIME AGO, AND I'M NOW THOROUGHLY 816 00:32:09,480 --> 00:32:10,920 OUT OF TOUCH WITH THE FIELD THAT 817 00:32:10,920 --> 00:32:14,480 YOU ARE THE LEADERS IN. I DON'T 818 00:32:14,480 --> 00:32:16,160 KNOW EVERY AIDS RESEARCHER BY 819 00:32:16,160 --> 00:32:17,800 NAME ANY MORE. AND I DON'T KNOW 820 00:32:17,800 --> 00:32:20,080 THE ONGOING RESEARCH AND THOSE 821 00:32:20,080 --> 00:32:21,360 PROJECTS THAT ARE WAITING IN THE 822 00:32:21,360 --> 00:32:23,400 WINGS. BUT I ASSUME AND 823 00:32:23,400 --> 00:32:25,600 LISTENING TO YOUR AGENDA, I 824 00:32:25,600 --> 00:32:27,560 KNOW, THAT THE ORGANIZATIONAL 825 00:32:27,560 --> 00:32:30,080 PARADOXES ARE STILL MUCH THE 826 00:32:30,080 --> 00:32:32,880 SAME. HOW TO COORDINATE WORK 827 00:32:32,880 --> 00:32:34,280 OVER MULTIPLE INSTITUTES AND 828 00:32:34,280 --> 00:32:36,160 CENTERINGS WITH MULTIPLE 829 00:32:36,160 --> 00:32:37,680 CONSTITUENCIES AND HOW TO MAKE 830 00:32:37,680 --> 00:32:39,480 SCIENTIFIC PROGRESS OVER SO MUCH 831 00:32:39,480 --> 00:32:41,520 POLITICAL CONTROVERSY. I KNOW 832 00:32:41,520 --> 00:32:43,160 YOU HAVE GOT GOOD LEADERSHIP AND 833 00:32:43,160 --> 00:32:51,520 I WISH YOU LUCK. MAUREEN. 834 00:32:51,520 --> 00:32:55,120 >>THANKS, TIM, THAT WAS GREAT. 835 00:32:55,120 --> 00:32:57,480 REALLY GOOD TO SEE YOU, JUST SO 836 00:32:57,480 --> 00:32:58,640 EVERYONE KNOWS WE WILL HAVE TIME 837 00:32:58,640 --> 00:33:00,520 DURING THE DISCUSSION AFTER I 838 00:33:00,520 --> 00:33:02,840 FINISH MY REMARKS THAT WE CAN -- 839 00:33:02,840 --> 00:33:04,520 IF ANYONE HAS COMMENTS 840 00:33:04,520 --> 00:33:07,480 PARTICULARLY OR QUESTIONS FOR 841 00:33:07,480 --> 00:33:09,840 TIM, HE'S STILL ON LINE WITH US. 842 00:33:09,840 --> 00:33:12,960 SO LOOKING FORWARD, I WANT TO 843 00:33:12,960 --> 00:33:14,080 BRING UP ABOUT LISTENING 844 00:33:14,080 --> 00:33:20,120 SESSIONS, WHICH ARE CRITICAL TO 845 00:33:20,120 --> 00:33:21,800 ACCOMPLISHING THE HIV OAR 846 00:33:21,800 --> 00:33:26,440 MISSION. IF I CAN GET BACK TO MY 847 00:33:26,440 --> 00:33:33,240 RIGHT SCREEN, THERE WE ARE. OAR 848 00:33:33,240 --> 00:33:34,240 LISTENING SESSIONS WITH 849 00:33:34,240 --> 00:33:36,320 COMMUNITY PARTNERS PROVIDE DATA, 850 00:33:36,320 --> 00:33:39,200 USED TO ENSURE THE NIH HIV 851 00:33:39,200 --> 00:33:40,680 RESEARCH PROGRAM IS FLEXIBLE AND 852 00:33:40,680 --> 00:33:42,600 THAT RESEARCH PRIORITIES ARE 853 00:33:42,600 --> 00:33:44,160 RESPONSIVE TO THE EMERGING 854 00:33:44,160 --> 00:33:46,960 CHALLENGES AND NEEDS. OAR IS 855 00:33:46,960 --> 00:33:48,520 FINALIZING A THIRD LISTENING 856 00:33:48,520 --> 00:33:50,720 SESSION REPORT WHICH WILL COVER 857 00:33:50,720 --> 00:33:53,320 SESSIONS HELD BETWEEN AUGUST 858 00:33:53,320 --> 00:33:55,840 2021 AND DECEMBER 2022. THESE 859 00:33:55,840 --> 00:33:58,160 SESSIONS WERE HELD IN D.C. 860 00:33:58,160 --> 00:34:01,240 HOUSTON TEXAS, SAN JUAN PUERTO 861 00:34:01,240 --> 00:34:08,240 RICO AND MON STRE MONTREAL, CANN 862 00:34:08,240 --> 00:34:10,800 PARTICULAR SAN JUAN AND MONTREAL 863 00:34:10,800 --> 00:34:13,040 WAS IN PERSON THE FIRST OUTS OF 864 00:34:13,040 --> 00:34:14,840 DC FOR MOST OF US. MAJOR THEMES 865 00:34:14,840 --> 00:34:15,760 THAT EMERGED DURING THESE 866 00:34:15,760 --> 00:34:18,840 SESSIONS INCLUDE TOPICS DIRECTLY 867 00:34:18,840 --> 00:34:21,480 OR SUPPORTED IN EXPANSION OF HIV 868 00:34:21,480 --> 00:34:23,160 RESEARCH WORK FORCE 869 00:34:23,160 --> 00:34:26,600 INFRASTRUCTURE, AND RESOURCES 870 00:34:26,600 --> 00:34:29,160 OTHER THEMES INCLUDING HIV 871 00:34:29,160 --> 00:34:33,000 ACROSS THE LIFE SPAN, SOCIAL 872 00:34:33,000 --> 00:34:34,800 STRUCTURAL FACTORS THAT IMPACT 873 00:34:34,800 --> 00:34:38,000 HIV RISK AND UPTAKE OF SERVICES, 874 00:34:38,000 --> 00:34:39,120 CULTURAL COMPETENCE AND 875 00:34:39,120 --> 00:34:42,800 COMMUNITY ENGAGEMENT IN HIV 876 00:34:42,800 --> 00:34:44,520 RESEARCH. INFORMATION 877 00:34:44,520 --> 00:34:45,800 DISSEMINATION BOTH FOR HEALTH 878 00:34:45,800 --> 00:34:47,360 EDUCATION AND FOR RESEARCH 879 00:34:47,360 --> 00:34:53,240 FINDINGS. SO I LOOK FORWARD TO 880 00:34:53,240 --> 00:34:55,280 YOUR THOUGHTS REGARDING THE OAR 881 00:34:55,280 --> 00:34:57,360 LISTENING SESSIONS DURING THE 882 00:34:57,360 --> 00:34:58,760 DISCUSSION FOLLOWING THIS 883 00:34:58,760 --> 00:35:01,760 PRESENTATION. LISTENING 884 00:35:01,760 --> 00:35:03,160 SESSIONS WITH FEDERAL ACADEMIC 885 00:35:03,160 --> 00:35:04,920 AND COMMUNITY PARTNERS CONTINUE 886 00:35:04,920 --> 00:35:06,800 TO GUIDE OAR FOCUS ON SPECIAL 887 00:35:06,800 --> 00:35:08,600 AREAS OF INTEREST TIED TO THE 888 00:35:08,600 --> 00:35:10,920 NIH HIV RESEARCH MISSION. IN THE 889 00:35:10,920 --> 00:35:12,800 CURRENT PRIORITIES FOR HIV AND 890 00:35:12,800 --> 00:35:15,120 HIV RELATED RESEARCH. WE CALL 891 00:35:15,120 --> 00:35:17,240 THESE AREAS OF HERSELF SIGNATURE 892 00:35:17,240 --> 00:35:18,320 PROGRAMS AND I'M GOING TO 893 00:35:18,320 --> 00:35:21,280 BRIEFLY HIGHLIGHT A FEW OF THEM 894 00:35:21,280 --> 00:35:23,040 AND SOME OF THE ACTIVITIES SINCE 895 00:35:23,040 --> 00:35:27,520 OUR LAST OARAC MEETING. THE OAR 896 00:35:27,520 --> 00:35:29,680 SIGNATURE PROGRAMS SHOWN IN THIS 897 00:35:29,680 --> 00:35:32,600 SLIDE PLAY A SIGNIFICANT ROLE IN 898 00:35:32,600 --> 00:35:34,760 GUIDING ACTIVITIES AND THEY ARE 899 00:35:34,760 --> 00:35:36,360 MULTI-DISCIPLINARY AND OPEN TO 900 00:35:36,360 --> 00:35:40,200 ALL NIH ICOs. TODAY'S OARAC 901 00:35:40,200 --> 00:35:42,800 AGENDA HIGHLIGHTS THE HIV AGING 902 00:35:42,800 --> 00:35:44,800 SIGNATURE PROGRAM, AND SHORTLY 903 00:35:44,800 --> 00:35:46,520 WE WILL BE HEARING FROM THE 904 00:35:46,520 --> 00:35:48,280 NATIONAL INSTITUTE ON AGING 905 00:35:48,280 --> 00:35:50,480 DIRECTOR DR. RICHARD HODES WHO 906 00:35:50,480 --> 00:35:53,160 WILL REVIEW NIH HIV AGING 907 00:35:53,160 --> 00:35:54,640 RESEARCH PRIORITIES AND PLANS 908 00:35:54,640 --> 00:35:57,720 AND WE WILL ALSO HEAR FROM OAR 909 00:35:57,720 --> 00:36:01,200 HEALTH SCIENTIST ADMINISTRATOR 910 00:36:01,200 --> 00:36:02,520 DR. GEETANJALI BANSAL WHO WILL 911 00:36:02,520 --> 00:36:04,520 REPORT ON THE NIH OAR HIV AND 912 00:36:04,520 --> 00:36:09,200 AGING ACTIVITIES. FUTURE OARAC 913 00:36:09,200 --> 00:36:10,920 MEETINGS WILL FEATURE UPDATES ON 914 00:36:10,920 --> 00:36:12,360 ACTIVITIES ASSOCIATED WITH THE 915 00:36:12,360 --> 00:36:15,800 OTHER THREE SIGNATURE PROGRAMS. 916 00:36:15,800 --> 00:36:17,120 WITH THE GROWING NUMBER OF 917 00:36:17,120 --> 00:36:19,800 PEOPLE AGING WITH HIV, WE 918 00:36:19,800 --> 00:36:21,560 ANTICIPATE THE NEED FOR GREATER 919 00:36:21,560 --> 00:36:24,840 SUPPORT IN THE FUTURE. THE AGING 920 00:36:24,840 --> 00:36:26,120 AND HIV SIGNATURE PROGRAM AIMS 921 00:36:26,120 --> 00:36:28,120 TO CATALYZE COLLABORATION TO 922 00:36:28,120 --> 00:36:30,240 ADDRESS RESEARCH GAPS AND 923 00:36:30,240 --> 00:36:31,280 OPPORTUNITIES AT THE 924 00:36:31,280 --> 00:36:34,760 INTERSECTION OF HIV AND AGING. A 925 00:36:34,760 --> 00:36:36,120 TOTAL OF 17 INSTITUTES CENTERS 926 00:36:36,120 --> 00:36:38,560 AN OFFICES SUPPORT THE 927 00:36:38,560 --> 00:36:40,600 MULTI-FACETED HIV AND AGING 928 00:36:40,600 --> 00:36:43,160 PORTFOLIO. WITH ESTIMATED 929 00:36:43,160 --> 00:36:46,400 FUNDING FOR RESEARCH IN FY 2022, 930 00:36:46,400 --> 00:36:48,760 FOR THIS AREA ABOUT $119 931 00:36:48,760 --> 00:36:54,280 MILLION. IN THE FY 2023 OMNIBUS 932 00:36:54,280 --> 00:36:56,280 BILL REPORT, CONGRESS ENCOURAGED 933 00:36:56,280 --> 00:36:58,240 OAR TO FUND INTERDISCIPLINARY 934 00:36:58,240 --> 00:37:00,720 RESEARCH AND TRAINING PROGRAMS 935 00:37:00,720 --> 00:37:03,080 IN HIV AND AGING. THERE WAS A 936 00:37:03,080 --> 00:37:04,360 DISCUSSION YESTERDAY FOR THOSE 937 00:37:04,360 --> 00:37:08,040 WHO HEARD IT ABOUT THE IMPACT OF 938 00:37:08,040 --> 00:37:09,520 REPORT LANGUAGE ON HOW THE 939 00:37:09,520 --> 00:37:11,800 BUDGET IS SPENT. OAR HAS PARTNER 940 00:37:11,800 --> 00:37:13,840 WITH THE NATIONAL INSTITUTE ON 941 00:37:13,840 --> 00:37:16,960 AGING TO FORM THE NIH HIV AGING 942 00:37:16,960 --> 00:37:20,840 WORKING GROU GROUP. WITH 943 00:37:20,840 --> 00:37:21,800 REPRESENTATION FROM NIH 944 00:37:21,800 --> 00:37:23,880 INSTITUTES CENTERS AND OFFICES 945 00:37:23,880 --> 00:37:28,520 THAT SUPPORT THIS RESEARCH. THIS 946 00:37:28,520 --> 00:37:29,960 GROUP AIMS TO STRENGTH HAD BEEN 947 00:37:29,960 --> 00:37:31,760 STRATEGIC PARTNERS ACROSS 948 00:37:31,760 --> 00:37:33,080 AGENCY, ACADEMIA AND COMMUNITY 949 00:37:33,080 --> 00:37:36,080 ORGANIZATIONS TO ENSURE THAT NIH 950 00:37:36,080 --> 00:37:37,880 RESEARCH IS IN LINE WITH 951 00:37:37,880 --> 00:37:39,040 COMMUNITY NEEDS AND CULTURAL 952 00:37:39,040 --> 00:37:45,040 PREFERENCES. AFTER HEARING MORE 953 00:37:45,040 --> 00:37:47,600 ABOUT HIV AND AGING RESEARCH AND 954 00:37:47,600 --> 00:37:50,240 ACTIVITIES, TODAY'S AGENDA 955 00:37:50,240 --> 00:37:51,880 FEATURES A PRESENTATION ON 956 00:37:51,880 --> 00:37:53,760 UPDATES TO RECOMMENDATIONS ON 957 00:37:53,760 --> 00:37:55,840 INFANT FEEDING FOR INDIVIDUALS 958 00:37:55,840 --> 00:37:58,920 WITH HIV IN THE UNITED STATES 959 00:37:58,920 --> 00:38:01,200 AND OTHER UPDATES TO THE HIV 960 00:38:01,200 --> 00:38:03,840 CLINICAL PRACTICE GUIDELINES. WE 961 00:38:03,840 --> 00:38:07,240 ARE GOING TO BE HEARING ABOUT 962 00:38:07,240 --> 00:38:10,760 EXPANDING INCLUSION IN HIV 963 00:38:10,760 --> 00:38:12,040 TREATMENTS TRIALS, AND ALSO THE 964 00:38:12,040 --> 00:38:13,280 PRESENTATION ON ADVANCE RESEARCH 965 00:38:13,280 --> 00:38:15,120 PROJECTS AGENCY FOR HEALTH OR 966 00:38:15,120 --> 00:38:19,040 ARPA H. THIS IS A NEW 967 00:38:19,040 --> 00:38:20,080 MULTI-DISCIPLINARY PROGRAM 968 00:38:20,080 --> 00:38:21,640 INCLUDED ON THE AGENDA AS PARTS 969 00:38:21,640 --> 00:38:25,600 OF THE OAR ONGOING SERIES TO 970 00:38:25,600 --> 00:38:27,440 HIGHLIGHT EXISTING NIH RESOURCES 971 00:38:27,440 --> 00:38:29,800 THAT CAN BE LEVERAGED TO ADVANCE 972 00:38:29,800 --> 00:38:32,480 HIV RESEARCH. IN PREVIOUS OARAC 973 00:38:32,480 --> 00:38:36,360 MEETINGS, WE FEATURED NIH 974 00:38:36,360 --> 00:38:37,280 RESOURCES SUCH AS THOSE FOUND 975 00:38:37,280 --> 00:38:39,440 WITHIN THE NATIONAL INSTITUTE OF 976 00:38:39,440 --> 00:38:41,960 BIOMEDICAL IMAGING AND 977 00:38:41,960 --> 00:38:43,360 BIOENGINEERING NIBIB, THE 978 00:38:43,360 --> 00:38:46,680 NATIONAL CENTER FOR ADVANCE 979 00:38:46,680 --> 00:38:47,840 TRANSLATION SCIENCES AND THE ALL 980 00:38:47,840 --> 00:38:52,240 OF US RESEARCH PROGRAM. AFTER 981 00:38:52,240 --> 00:38:54,120 ARPA H WE WILL HEAR UPDATES 982 00:38:54,120 --> 00:38:55,760 THROUGH NIH ADVISORY COUNCIL 983 00:38:55,760 --> 00:38:57,200 REPRESENTATIVES AND THE NIH 984 00:38:57,200 --> 00:38:58,000 CLINICAL GUIDELINES WORKING 985 00:38:58,000 --> 00:39:03,640 GROUPS. SO THANK YOU FOR MAKING 986 00:39:03,640 --> 00:39:05,240 THESE MEETINGS A PRIORITY. THE 987 00:39:05,240 --> 00:39:07,160 NEXT MEETING OF OARAC IS 988 00:39:07,160 --> 00:39:10,040 SCHEDULED JUNE 22ND, AND AT THIS 989 00:39:10,040 --> 00:39:11,440 TIME OAR IS PLANNING FOR THIS TO 990 00:39:11,440 --> 00:39:16,000 BE A HYBRID MEETING. SO SOON AS 991 00:39:16,000 --> 00:39:18,240 WE CAN CONFIRM ALL DETAILS FOR 992 00:39:18,240 --> 00:39:19,760 THOSE ARRANGEMENTS WE WILL 993 00:39:19,760 --> 00:39:22,760 INFORM EVERYONE. WE ARE VERY 994 00:39:22,760 --> 00:39:24,720 EXCITED, LOOKING FORWARD TO 995 00:39:24,720 --> 00:39:27,720 HAVING THIS OPPORTUNITY. SO WITH 996 00:39:27,720 --> 00:39:29,080 THAT, I REMIND YOU THAT THERE 997 00:39:29,080 --> 00:39:31,600 ARE MANY WAYS TO STAY CONNECTED 998 00:39:31,600 --> 00:39:36,280 WITH OAR AND ACTIVITIES, AND IF 999 00:39:36,280 --> 00:39:39,160 I COULD SAY A FEW REMARKS IN 1000 00:39:39,160 --> 00:39:42,040 CLOSING BEFORE TURNING THIS BACK 1001 00:39:42,040 --> 00:39:46,840 TO BLANTON. FOR 35 YEARS OAR 1002 00:39:46,840 --> 00:39:49,280 COORDINATED NIH OAR AGENDA 1003 00:39:49,280 --> 00:39:51,480 CONVENING PARTNERS TO CATALYZE 1004 00:39:51,480 --> 00:39:52,760 INTERDISCIPLINARY EFFORTS. OUR 1005 00:39:52,760 --> 00:39:56,200 GOAL REMAINS THE SAME. TO END 1006 00:39:56,200 --> 00:39:58,040 THE HIV PANDEMIC AND IMPROVE THE 1007 00:39:58,040 --> 00:40:00,640 HEALTH OF PEOPLE WITH HIV. WE 1008 00:40:00,640 --> 00:40:02,960 MUST FOCUS ON ACTION TO PREVENT, 1009 00:40:02,960 --> 00:40:06,920 TO TREAT, AND TO CURE HIV. THESE 1010 00:40:06,920 --> 00:40:09,560 ACTIONS WILL REQUIRE CONTINUED 1011 00:40:09,560 --> 00:40:10,600 COMMITMENT INNOVATION AND 1012 00:40:10,600 --> 00:40:13,600 CREATIVITY. TO REDUCE ANY 1013 00:40:13,600 --> 00:40:16,120 EFFORTS NOW INEVITABLY LEAD TO 1014 00:40:16,120 --> 00:40:18,560 RESURGENCE HIV WORLDWIDE. 1015 00:40:18,560 --> 00:40:20,200 COMPROMISING GLOBAL HEALTH IN 1016 00:40:20,200 --> 00:40:23,320 THE 21ST CENTURY. WE MUST REMAIN 1017 00:40:23,320 --> 00:40:26,480 NIMBLE TO RESPOND TO NEW 1018 00:40:26,480 --> 00:40:27,480 CHALLENGES, LEVERAGE NEW AND 1019 00:40:27,480 --> 00:40:30,120 EXISTING PARTNERSHIPS, AND 1020 00:40:30,120 --> 00:40:30,960 ENSURE ALL VOICES CAN 1021 00:40:30,960 --> 00:40:34,560 CONTRIBUTE. THESE ACTIONS 1022 00:40:34,560 --> 00:40:36,960 REQUIRE CONTINUED COMMITMENT 1023 00:40:36,960 --> 00:40:41,000 INNOVATION AND CREATIVITY. TO 1024 00:40:41,000 --> 00:40:42,680 REDUCE -- WE MUST BUILT BILLION 1025 00:40:42,680 --> 00:40:44,360 DOLLAR ON OUR ROBUST REPERTOIRE 1026 00:40:44,360 --> 00:40:45,800 OF OPTIONS TO IMPROVE PREVENTION 1027 00:40:45,800 --> 00:40:48,640 AND TREATMENT STRATEGIES. 1028 00:40:48,640 --> 00:40:49,560 MEANWHILE, THE SCIENTIFIC 1029 00:40:49,560 --> 00:40:51,040 AGENERAL DA WILL CONTINUE -- 1030 00:40:51,040 --> 00:40:53,240 AGENDA WILL CONTINUE, INNOVATIVE 1031 00:40:53,240 --> 00:40:55,240 RESEARCH AND IMMUNOLOGY 1032 00:40:55,240 --> 00:40:56,160 VIROLOGY, BEHAVIORAL AND SOCIAL 1033 00:40:56,160 --> 00:40:59,160 SCIENCES. AS WELL AS 1034 00:40:59,160 --> 00:41:01,280 IMPLEMENTATION SCIENCE RESEARCH 1035 00:41:01,280 --> 00:41:02,600 WHICH IS KEY FOR DISSEMINATION 1036 00:41:02,600 --> 00:41:05,320 OF RESEARCH DISCOVERIES TO THE 1037 00:41:05,320 --> 00:41:07,720 COMMUNITIES WHO BENEFIT THE 1038 00:41:07,720 --> 00:41:10,760 MOST. ENDING THE HIV EPIDEMIC 1039 00:41:10,760 --> 00:41:13,560 PANDEMIC IS AN AMBITIOUS BUT 1040 00:41:13,560 --> 00:41:15,880 FEASIBLE GOAL. THANK YOU. 1041 00:41:15,880 --> 00:41:17,040 BLANTON, BACK OVER TO YOU FOR 1042 00:41:17,040 --> 00:41:20,840 DISCUSSION. 1043 00:41:20,840 --> 00:41:24,560 >>THANK YOU, MAUREEN, FOR A 1044 00:41:24,560 --> 00:41:29,960 WONDERFUL PRESENTATION AND ALSO 1045 00:41:29,960 --> 00:41:33,200 TIM, FOR THE REMARKS IN 1046 00:41:33,200 --> 00:41:35,520 HISTORICAL CONTEXT. COLLEAGUES 1047 00:41:35,520 --> 00:41:38,760 WE HAVE ABOUT 20 MINUTES FOR 1048 00:41:38,760 --> 00:41:39,800 DISCUSSION AND CONVERSATION. I 1049 00:41:39,800 --> 00:41:44,320 ALREADY SEE A HAND UP. BEFORE I 1050 00:41:44,320 --> 00:41:51,600 GO OVER TO YOU, DR. AKINTOBI, I 1051 00:41:51,600 --> 00:41:55,120 WANT TO ASK MR. WESTMORELAND A 1052 00:41:55,120 --> 00:41:57,840 QUESTION JUST A LEAD-OFF 1053 00:41:57,840 --> 00:41:59,360 QUESTION. I ALSO WANT TO SHARE 1054 00:41:59,360 --> 00:42:02,160 THAT I'M ALSO A SOUTHERN 1055 00:42:02,160 --> 00:42:05,240 BRIEFER'S KID SO I APPRECIATE 1056 00:42:05,240 --> 00:42:07,360 YOUR PRESENTATION STYLE -- 1057 00:42:07,360 --> 00:42:10,840 PREACHER'S KID. I APPRECIATE 1058 00:42:10,840 --> 00:42:11,520 YOUR SOUTHERN PRESENTATION 1059 00:42:11,520 --> 00:42:13,000 STYLE. GIVEN YOUR EXPERIENCE, 1060 00:42:13,000 --> 00:42:15,280 ARE THERE ANY LESSONS, BEST 1061 00:42:15,280 --> 00:42:18,760 PRACTICES OR PARALLELS THAT YOU 1062 00:42:18,760 --> 00:42:22,440 LEARNED FROM HIV AIDS AND THE 1063 00:42:22,440 --> 00:42:24,720 CURRENT PANDEMIC THAT YOU MIGHT 1064 00:42:24,720 --> 00:42:30,120 CAN COMMENT ON? 1065 00:42:30,120 --> 00:42:33,160 >>AS ALL OF US KNOW, THE 1066 00:42:33,160 --> 00:42:34,560 CURRENT PANDEMIC AND HIV HAVE A 1067 00:42:34,560 --> 00:42:38,400 LOT OF DIFFERENCES BETWEEN THEM. 1068 00:42:38,400 --> 00:42:39,880 THERE ISN'T THE LEVEL OF STIGMA, 1069 00:42:39,880 --> 00:42:42,080 THERE'S NOT THE LEVEL OF 1070 00:42:42,080 --> 00:42:44,120 IGNORANCE, THERE'S PLENTY OF 1071 00:42:44,120 --> 00:42:46,360 PUBLICITY TO GO AROUND. SO THOSE 1072 00:42:46,360 --> 00:42:49,280 THINGS ARE QUITE DIFFERENT. THE 1073 00:42:49,280 --> 00:42:54,200 THING THAT I THINK THE CONGRESS 1074 00:42:54,200 --> 00:42:55,800 COULD LEARN IS SOMETHING THAT MY 1075 00:42:55,800 --> 00:42:57,800 BOSS USED TO TELL ME WHEN I 1076 00:42:57,800 --> 00:42:59,600 WORKED FOR THE HOUSE. WHICH WAS 1077 00:42:59,600 --> 00:43:02,120 HE WANTED ME TO THINK OF MYSELF 1078 00:43:02,120 --> 00:43:04,400 AS A PUBLIC HEALTH SERVICE 1079 00:43:04,400 --> 00:43:05,840 EMPLOYEE WHO DIDN'T HAVE TO 1080 00:43:05,840 --> 00:43:08,560 RESPOND TO THE OMB IN THE WHITE 1081 00:43:08,560 --> 00:43:11,080 HOUSE. SO I WAS SUPPOSED TO 1082 00:43:11,080 --> 00:43:12,360 CONVEY TO HIM AND THE CONGRESS 1083 00:43:12,360 --> 00:43:13,960 -- AND WE TRIED TO MAKE THE 1084 00:43:13,960 --> 00:43:17,320 CONGRESS FOLLOW THAT, WHAT WAS 1085 00:43:17,320 --> 00:43:20,280 YOU NOW REFER TO AS PROFESSIONAL 1086 00:43:20,280 --> 00:43:22,280 JUDGMENT OF THE PUBLIC HEALTH 1087 00:43:22,280 --> 00:43:25,440 FIGURE, AND NOT TRY TO SUBS 1088 00:43:25,440 --> 00:43:27,040 INSTITUTE AND MICROMANAGE FROM 1089 00:43:27,040 --> 00:43:29,200 THE CONGRESSIONAL LEVEL WHAT WAS 1090 00:43:29,200 --> 00:43:32,720 THE NEXT BEST THING TO DO. BY 1091 00:43:32,720 --> 00:43:35,560 ACTING AS IF I WERE A PHS 1092 00:43:35,560 --> 00:43:37,760 EMPLOYEE, I GOT SOME PEOPLE GOT 1093 00:43:37,760 --> 00:43:38,640 SOME CONFIDENCE THAT THE 1094 00:43:38,640 --> 00:43:41,400 CONGRESS WAS LISTENING TO THEM. 1095 00:43:41,400 --> 00:43:43,560 SO THOSE PLAIN BROWN ENVELOPES 1096 00:43:43,560 --> 00:43:45,520 CONTINUE TO COME. I WOULD SAY 1097 00:43:45,520 --> 00:43:46,720 THE CONGRESS SHOULD LEARN TO 1098 00:43:46,720 --> 00:43:49,880 LISTEN TO EXPERTS AND NOT TRY TO 1099 00:43:49,880 --> 00:43:59,440 FREELANCE ON THEIR OWN. YOU ARE 1100 00:43:59,440 --> 00:44:01,600 MUTED. 1101 00:44:01,600 --> 00:44:03,120 >>I'M SORRY, I WAS SAYING 1102 00:44:03,120 --> 00:44:05,040 THANKS FOR SHARING AND I 1103 00:44:05,040 --> 00:44:06,480 APPRECIATE YOU RESPONDING TO A 1104 00:44:06,480 --> 00:44:07,640 QUESTION THAT WAS SLIGHTLY 1105 00:44:07,640 --> 00:44:11,440 OUTSIDE OF THE SCOPE OF YOUR 1106 00:44:11,440 --> 00:44:13,320 PRESENTATION. I WANT TO GO BACK 1107 00:44:13,320 --> 00:44:16,080 NOW AND ACKNOWLEDGE THE HANDS 1108 00:44:16,080 --> 00:44:17,080 FROM MY COLLEAGUES. DR. 1109 00:44:17,080 --> 00:44:19,360 AKINTOBI. 1110 00:44:19,360 --> 00:44:20,880 >>THANK YOU VERY MUCH, DR. 1111 00:44:20,880 --> 00:44:26,120 TOLBERT. I WANTED TO FIRST THANK 1112 00:44:26,120 --> 00:44:27,960 DR. WESTMORELAND FOR HIS 1113 00:44:27,960 --> 00:44:29,440 INSIGHTS AND JUST THE IMPORTANCE 1114 00:44:29,440 --> 00:44:32,360 OF US REMEMBERING THE HISTORY 1115 00:44:32,360 --> 00:44:34,840 AND THE POLITICS RELATED TO HOW 1116 00:44:34,840 --> 00:44:36,960 WE GOT HERE, I THINK IT IS 1117 00:44:36,960 --> 00:44:38,240 IMPORTANT FOR US AS WE THINK 1118 00:44:38,240 --> 00:44:40,480 ABOUT THE FUTURE, THE OARAC AND 1119 00:44:40,480 --> 00:44:43,040 IMPORTANT WORK WE ARE DOING IN 1120 00:44:43,040 --> 00:44:44,960 HIV RESOURCES. SO THANK YOU SO 1121 00:44:44,960 --> 00:44:48,880 MUCH FOR THAT. DR. GOODENOW, 1122 00:44:48,880 --> 00:44:50,920 MIGHT YOU SHARE AN EXAMPLE OF 1123 00:44:50,920 --> 00:44:54,600 TWO TO REMIND US OR ORIENT A FEW 1124 00:44:54,600 --> 00:44:57,720 OF OUR MEMBERS HOW THE COMMITTEE 1125 00:44:57,720 --> 00:44:59,360 LISTENING SESSIONS HAVE 1126 00:44:59,360 --> 00:45:02,360 TRANSLATED INTO ANY TYPE OF 1127 00:45:02,360 --> 00:45:04,160 ACTION. I THINK THAT IS 1128 00:45:04,160 --> 00:45:06,520 IMPORTANT. THE LISTENING IS 1129 00:45:06,520 --> 00:45:08,000 CRITICAL TO UNDERSTANDING 1130 00:45:08,000 --> 00:45:09,200 EXAMPLES OF HOW THEY MADE THEIR 1131 00:45:09,200 --> 00:45:11,920 WAY INTO DECISIONS RELATED TO 1132 00:45:11,920 --> 00:45:14,800 THE DIVISION OF OARAC I THINK IS 1133 00:45:14,800 --> 00:45:16,120 EVEN MORE IMPORTANT. IF YOU 1134 00:45:16,120 --> 00:45:17,880 COULD SHARE AN EXAMPLE OR TWO, 1135 00:45:17,880 --> 00:45:21,160 PLEASE. 1136 00:45:21,160 --> 00:45:22,880 >>THANKS FOR THAT QUESTION. 1137 00:45:22,880 --> 00:45:26,040 REALLY, I THINK THE BEST EXAMPLE 1138 00:45:26,040 --> 00:45:29,120 TRANSLATING WHAT WE HEARD INTO 1139 00:45:29,120 --> 00:45:32,320 ACTION IS DEVELOPMENT OF FOUR 1140 00:45:32,320 --> 00:45:36,200 SIGNATURE PROGRAMS. IN 1141 00:45:36,200 --> 00:45:38,040 PARTICULAR HIV AND AGING OR HIV 1142 00:45:38,040 --> 00:45:39,680 ACROSS THE LIFE SPAN AND FOR THE 1143 00:45:39,680 --> 00:45:42,680 EARLY CAREER INVESTIGATORS, 1144 00:45:42,680 --> 00:45:46,880 THOSE THEMES WERE -- HAVE BEEN 1145 00:45:46,880 --> 00:45:50,560 HEARD FROM EVERY PLACE WE HAVE 1146 00:45:50,560 --> 00:45:52,320 BEEN IN DIFFERENT WAYS BUT THOSE 1147 00:45:52,320 --> 00:45:55,120 ARE ABSOLUTELY THE MOST I WOULD 1148 00:45:55,120 --> 00:45:58,320 SAY RECURRING THEMES. EVEN 1149 00:45:58,320 --> 00:46:01,760 THOUGH WE HEAR SIMILAR PIECES OF 1150 00:46:01,760 --> 00:46:03,120 INFORMATION AND GET DIFFERENT -- 1151 00:46:03,120 --> 00:46:05,840 SIMILAR INSIGHTS FROM DIFFERENT 1152 00:46:05,840 --> 00:46:07,760 COMMUNITIES, I THINK THE REALLY 1153 00:46:07,760 --> 00:46:09,920 IMPORTANT ASPECT OF LISTENING 1154 00:46:09,920 --> 00:46:12,240 SESSIONS IS THAT IT ALSO GIVES 1155 00:46:12,240 --> 00:46:13,120 US SOME OF THE RARE COMMENTS 1156 00:46:13,120 --> 00:46:15,600 THAT WE DON'T ALWAYS HEAR. JUST 1157 00:46:15,600 --> 00:46:18,400 BECAUSE IT MIGHT BE ONE OR TWO 1158 00:46:18,400 --> 00:46:19,520 INDIVIDUALS MAKING THE COMMENT, 1159 00:46:19,520 --> 00:46:21,760 IT DOESN'T -- THIS IS NOT A 1160 00:46:21,760 --> 00:46:26,480 POPULARITY OR INFORMAL POLL TO 1161 00:46:26,480 --> 00:46:27,920 HOW MANY QUICK VOTES WE GET BUT 1162 00:46:27,920 --> 00:46:30,720 TO BE ABLE TO LISTEN AND TO HEAR 1163 00:46:30,720 --> 00:46:33,280 ALL THE VOICES THAT COME 1164 00:46:33,280 --> 00:46:34,760 TOGETHER IN DIFFERENT WAYS, THAT 1165 00:46:34,760 --> 00:46:36,760 HELP TO GUIDE THE PROGRAMS THAT 1166 00:46:36,760 --> 00:46:38,280 WE ARE SPONSORING WITH MORE 1167 00:46:38,280 --> 00:46:43,600 EMPHASIS. 1168 00:46:43,600 --> 00:46:45,520 >>THANKS FOR THE QUESTION, DR. 1169 00:46:45,520 --> 00:46:48,480 AKINTOBI AND MAUREEN, FOR THEIR 1170 00:46:48,480 --> 00:46:50,120 RESPONSES. GOOD TO KNOW THE FOUR 1171 00:46:50,120 --> 00:46:54,360 SIGNATURE PROGRAMS YOU DISCUSS 1172 00:46:54,360 --> 00:46:55,760 ARE A PRODUCT OF LISTENING 1173 00:46:55,760 --> 00:47:01,760 TOURS. SO I WANT TO MOVE ON NOW 1174 00:47:01,760 --> 00:47:05,200 TO DR. MONTANAIR. 1175 00:47:05,200 --> 00:47:07,280 >>THANK YOU, GOOD MORNING, 1176 00:47:07,280 --> 00:47:10,040 MAUREEN. REALLY INSPIRING 1177 00:47:10,040 --> 00:47:13,600 HISTORY LESSON, AMAZING HOW MUCH 1178 00:47:13,600 --> 00:47:15,120 WE ADDRESS THE SAME ISSUES AS 1179 00:47:15,120 --> 00:47:16,880 YOU NOTED IN A DIFFERENT SCALE. 1180 00:47:16,880 --> 00:47:19,160 I WANT TO SHARE WITH EVERYONE 1181 00:47:19,160 --> 00:47:20,640 THAT I HAVE THE PLEASURE TO JOIN 1182 00:47:20,640 --> 00:47:23,720 MAUREEN AT THE LISTENING SESSION 1183 00:47:23,720 --> 00:47:25,960 SAN JUAN PUERTO RICO, IT 1184 00:47:25,960 --> 00:47:27,680 PROVIDED A FIRSTHAND ACCOUNT AS 1185 00:47:27,680 --> 00:47:29,840 TO WHAT THE OUTCOME OF THESE 1186 00:47:29,840 --> 00:47:32,640 LISTENING SESSIONS ARE AT LEAST 1187 00:47:32,640 --> 00:47:34,640 FOR THIS PARTICULAR COMMUNITY. I 1188 00:47:34,640 --> 00:47:38,160 WANT TO STRESS IT WAS QUITE 1189 00:47:38,160 --> 00:47:40,320 IMPACTFUL EXERCISE, FIRST IT 1190 00:47:40,320 --> 00:47:41,920 BROUGHT TOGETHER ALL THE NIH 1191 00:47:41,920 --> 00:47:43,800 FUNDED INVESTIGATORS THAT HAVE 1192 00:47:43,800 --> 00:47:45,280 NOT OTHERWISE ACTUALLY COME 1193 00:47:45,280 --> 00:47:48,640 TOGETHER AS A GROUP. WITH 1194 00:47:48,640 --> 00:47:50,160 RESPECT TO COMMON PURPOSE OR 1195 00:47:50,160 --> 00:47:51,960 MISSION IN THE CONTEXT OF THE 1196 00:47:51,960 --> 00:47:55,840 AIDS AGENDA. IT ALSO PROVIDED A 1197 00:47:55,840 --> 00:48:00,360 LOT OF UNFILTERED COMMENTS FOR 1198 00:48:00,360 --> 00:48:03,440 MAUREEN AND HER STAFF. A LOT OF 1199 00:48:03,440 --> 00:48:04,240 SIGNATURE PROGRAMS THAT WERE 1200 00:48:04,240 --> 00:48:05,840 ALREADY HIGHLIGHTED AS AN 1201 00:48:05,840 --> 00:48:07,760 OUTCOME OF'S THESE LISTENING 1202 00:48:07,760 --> 00:48:10,440 SESSIONS. HE ALSO HAD THE 1203 00:48:10,440 --> 00:48:13,760 OUTCOME THAT IT ACTUALLY 1204 00:48:13,760 --> 00:48:16,360 IDENTIFIED COMMON THEMES WITHIN 1205 00:48:16,360 --> 00:48:17,920 THE GROUP THAT WERE 1206 00:48:17,920 --> 00:48:19,360 GEOGRAPHICALLY NOT IN THE SAME 1207 00:48:19,360 --> 00:48:21,280 LOCATION. WHICH THEN PROMPTED 1208 00:48:21,280 --> 00:48:22,840 DISCUSSIONS ABOUT COLLABORATION 1209 00:48:22,840 --> 00:48:25,320 AND INTEGRATION AND COALITION 1210 00:48:25,320 --> 00:48:27,080 BUILDING. SO I THINK THAT THE 1211 00:48:27,080 --> 00:48:28,400 LISTENING SESSION THAT I 1212 00:48:28,400 --> 00:48:30,520 ATTENDED WAS VERY IMPACTFUL, 1213 00:48:30,520 --> 00:48:32,360 VERY PRODUCTIVE AND HAD LONG 1214 00:48:32,360 --> 00:48:35,520 STANDING OUTCOMES. SO I WANT TO 1215 00:48:35,520 --> 00:48:37,760 COMMEND MAUREEN'S OFFICE FOR 1216 00:48:37,760 --> 00:48:41,280 SPONSORING THIS PROGRAM AND 1217 00:48:41,280 --> 00:48:41,920 ENCOURAGE THAT YOU WOULD 1218 00:48:41,920 --> 00:48:46,080 CONTINUE. THANK YOU. 1219 00:48:46,080 --> 00:48:49,520 >>THANKS FOR SHARING THAT, DR. 1220 00:48:49,520 --> 00:48:50,840 MONTANARA. THAT IS QUITE 1221 00:48:50,840 --> 00:48:54,000 POWERFUL TO HEAR. TO HEAR THE 1222 00:48:54,000 --> 00:48:57,640 OUTCOMES OF THAT. MOVING ON DR. 1223 00:48:57,640 --> 00:48:58,040 SLEASMAN. 1224 00:48:58,040 --> 00:49:01,160 >>I WANT TO FOLLOW ON WHAT LUIS 1225 00:49:01,160 --> 00:49:03,560 WAS TALKING ABOUT IN TERMS OF 1226 00:49:03,560 --> 00:49:05,400 LISTENING SESSION. ENGAGEMENT OF 1227 00:49:05,400 --> 00:49:06,760 STAKEHOLDERS IN RESEARCH AGENDA 1228 00:49:06,760 --> 00:49:10,280 IS ABSOLUTELY CRITICAL TO MOVING 1229 00:49:10,280 --> 00:49:13,720 FORWARD AND DEVELOPING HOW THE 1230 00:49:13,720 --> 00:49:16,120 NEXT PHASE OF THE OAR HIV 1231 00:49:16,120 --> 00:49:18,760 RESEARCH AGENDA. I AM INVOLVED 1232 00:49:18,760 --> 00:49:20,680 IN THREE DIFFERENT ADVOCACY 1233 00:49:20,680 --> 00:49:23,680 GROUPS OUTSIDE OF HIV, ONE IS 1234 00:49:23,680 --> 00:49:25,120 THE JEFFREY (INAUDIBLE) 1235 00:49:25,120 --> 00:49:27,320 FOUNDATION, THE OTHER PRIMARY 1236 00:49:27,320 --> 00:49:28,000 (INDISCERNIBLE) FOUNDATION, 1237 00:49:28,000 --> 00:49:29,560 NATIONAL KIDNEY FOUNDATION, ALL 1238 00:49:29,560 --> 00:49:31,480 ARE FOUNDATIONS THAT ARE HIGHLY 1239 00:49:31,480 --> 00:49:35,520 ENGAGED IN PATIENT ADVOCACY AND 1240 00:49:35,520 --> 00:49:39,120 A LOT OF DISCUSSIONS AROUND FOR 1241 00:49:39,120 --> 00:49:43,640 EXAMPLE COVID VACCINES AND COVID 1242 00:49:43,640 --> 00:49:45,920 IN PEOPLE WHO ARE HIGHLY 1243 00:49:45,920 --> 00:49:47,440 SUSCEPTIBLE. I HAVE TO THANK THE 1244 00:49:47,440 --> 00:49:51,160 CDC, THE CDC IS INVOLVED IN 1245 00:49:51,160 --> 00:49:52,200 THESE LISTENING SESSIONS THEY 1246 00:49:52,200 --> 00:49:53,080 COME TO EVERY SINGLE ONE OF 1247 00:49:53,080 --> 00:49:57,360 THEM. THE FRAMEWORK WE DEVELOPED 1248 00:49:57,360 --> 00:50:00,320 WAS AROUND OAR HAS DONE IN THE 1249 00:50:00,320 --> 00:50:02,480 HIV WORLD SO OAR IS LEADING THE 1250 00:50:02,480 --> 00:50:05,200 FIELD AND SADLY NOT SEEN HIV 1251 00:50:05,200 --> 00:50:06,640 REPRESENTATION IN THESE GROUPS 1252 00:50:06,640 --> 00:50:10,120 BUT I THINK THAT SOMETHING I 1253 00:50:10,120 --> 00:50:12,000 WOULD RECOMMEND IS ALL NIH NEEDS 1254 00:50:12,000 --> 00:50:14,440 TO BE MORE INVOLVED WITH THE 1255 00:50:14,440 --> 00:50:16,240 COMMUNITY BASED GROUPS GOING 1256 00:50:16,240 --> 00:50:19,240 FORE AND NOT HOLD BACK. 1257 00:50:19,240 --> 00:50:25,120 >>DR. SLEASMAN, DR. GANDHI. 1258 00:50:25,120 --> 00:50:27,680 >>THANK YOU SO MUCH. THAT WAS 1259 00:50:27,680 --> 00:50:31,080 EXTREMELY POWERFUL, DR. 1260 00:50:31,080 --> 00:50:32,400 WESTMORELAND, YOUR RECOUNTING 1261 00:50:32,400 --> 00:50:33,840 THE EARLY HISTORY OF WHAT 1262 00:50:33,840 --> 00:50:35,960 HAPPENED IN CONGRESS. THE REASON 1263 00:50:35,960 --> 00:50:37,560 THAT I THINK WE DO HAVE TO THINK 1264 00:50:37,560 --> 00:50:38,960 ABOUT THE CURRENT PANDEMIC, AN 1265 00:50:38,960 --> 00:50:41,600 WHAT HAPPENED IN CONGRESS, WITH 1266 00:50:41,600 --> 00:50:46,360 HIV IS MY UNDERSTANDING IS 1267 00:50:46,360 --> 00:50:48,160 DESPITE WHAT HAPPENED WITH THE 1268 00:50:48,160 --> 00:50:53,560 TERRIBLE STIGMATIZATION AND 1269 00:50:53,560 --> 00:50:55,880 TERRIBLE POLICIES BEGINNING OF 1270 00:50:55,880 --> 00:50:58,280 '80s TOWARDS HIV THE DENTS OF 1271 00:50:58,280 --> 00:51:00,400 CERTAIN PERSONALITIES DID LEAD 1272 00:51:00,400 --> 00:51:04,480 TO BIPARTISAN SUPPORT OF HIV AND 1273 00:51:04,480 --> 00:51:06,880 THAT WAS THROUGH FIRST CARE IN 1274 00:51:06,880 --> 00:51:11,120 1990 AND PIPFAR IN 2003. -- PEP 1275 00:51:11,120 --> 00:51:14,360 FAR IN 2003. NO WAY AROUND THE 1276 00:51:14,360 --> 00:51:16,120 BIPARTISAN, THERE NEEDS TO BE 1277 00:51:16,120 --> 00:51:16,960 BIPARTISAN SUPPORT BECAUSE THEY 1278 00:51:16,960 --> 00:51:19,080 ARE THE ONES, CONGRESS IS THE 1279 00:51:19,080 --> 00:51:20,800 ONE WHO WRITES CHECKS, THEY ARE 1280 00:51:20,800 --> 00:51:24,160 THE ONES WHO FUND OUR 1281 00:51:24,160 --> 00:51:29,520 ORGANIZATIONS. SO IT FEELS LIKE 1282 00:51:29,520 --> 00:51:30,560 I THINK WHAT I HAVE BEEN 1283 00:51:30,560 --> 00:51:32,080 WATCHING IN THE NEWS IS IT FEELS 1284 00:51:32,080 --> 00:51:33,800 LIKE THERE IS ONE SIDE IS RIGHT, 1285 00:51:33,800 --> 00:51:37,680 ONE SIDE IS WRONG ON COVID AS 1286 00:51:37,680 --> 00:51:39,520 OPPOSED TO COULD WE WORK WITH 1287 00:51:39,520 --> 00:51:42,600 MEMBERS OF CONGRESS THAT ARE ON 1288 00:51:42,600 --> 00:51:46,920 THE OTHER SIDE TO GET THIS 1289 00:51:46,920 --> 00:51:48,160 BIPARTISAN MOVEMENT BECAUSE IT 1290 00:51:48,160 --> 00:51:51,040 WORKED, I KNOW IT TOOK A LONG 1291 00:51:51,040 --> 00:51:53,800 TIME, NINE YEARS AT LEAST FROM 1292 00:51:53,800 --> 00:51:57,080 1981 TO RYAN WHITE CARE BUT IT 1293 00:51:57,080 --> 00:51:59,760 DID HAPPEN. I THINK IT WAS 1294 00:51:59,760 --> 00:52:02,280 REALLY STRONG PERSONALITIES THAT 1295 00:52:02,280 --> 00:52:06,840 ARGUED PASSIONATELY FOR THE 1296 00:52:06,840 --> 00:52:09,600 NEEDS FOR BIPARTISAN SUPPORT OF 1297 00:52:09,600 --> 00:52:11,320 HIV WHICH WAS NOT GOING AWAY, 1298 00:52:11,320 --> 00:52:11,920 NEITHER IS COVID. 1299 00:52:11,920 --> 00:52:15,760 >>YOU ARE COMPLETELY CORRECT. 1300 00:52:15,760 --> 00:52:17,880 ALL THESE THINGS HAD TO HAPPEN 1301 00:52:17,880 --> 00:52:22,320 ON A BIPARTISAN BASIS. AIDS 1302 00:52:22,320 --> 00:52:26,240 POLICY AND AIDS POLICY ACT NIH 1303 00:52:26,240 --> 00:52:27,960 REVITALIZATION ACT, RYAN WHITE 1304 00:52:27,960 --> 00:52:29,480 THOSE THINGS HAD SIGNIFICANT 1305 00:52:29,480 --> 00:52:31,600 REPUBLICAN LEADERSHIP. WHEN YOU 1306 00:52:31,600 --> 00:52:34,480 TALK ABOUT PEPFAR, IT WAS THE 1307 00:52:34,480 --> 00:52:38,120 REPUBLICAN LEADERSHIP THERE. I 1308 00:52:38,120 --> 00:52:43,880 WISH I COULD POINT YOU TOWARDS 1309 00:52:43,880 --> 00:52:46,000 SOME INSIPIENT BIPARTISAN SHIP 1310 00:52:46,000 --> 00:52:47,120 GOING ON IN THE CONGRESS RIGHT 1311 00:52:47,120 --> 00:52:51,840 NOW BUT AT THIS POINT I DON'T 1312 00:52:51,840 --> 00:52:52,960 THINK YOUR REVIEW OF THE NEWS IS 1313 00:52:52,960 --> 00:52:57,080 WRONG. I THINK THE SCORCHED 1314 00:52:57,080 --> 00:53:01,400 EARTH WEAN THE TWO PARTIES IS 1315 00:53:01,400 --> 00:53:07,760 HARD TO GET PAST. I WILL HAVE TO 1316 00:53:07,760 --> 00:53:09,200 -- WHEN I WORKED UP THERE, THERE 1317 00:53:09,200 --> 00:53:11,320 WERE MODERATE REPUBLICANS AND 1318 00:53:11,320 --> 00:53:15,560 MODERATE DEMOCRATS AND NOW THERE 1319 00:53:15,560 --> 00:53:17,520 ARE ONLY PEOPLE WHO THINK THEIR 1320 00:53:17,520 --> 00:53:20,920 PARTY IS THE ONLY ANSWER. SO I 1321 00:53:20,920 --> 00:53:24,000 DON'T KNOW. WE ARE ALL 1322 00:53:24,000 --> 00:53:25,240 STRUGGLING FIGURING HOW TO DO 1323 00:53:25,240 --> 00:53:26,480 THIS BUT I THINK YOU ARE RIGHT. 1324 00:53:26,480 --> 00:53:28,600 I THINK WE WON'T HAVE A 1325 00:53:28,600 --> 00:53:30,560 SIGNIFICANT BREAK THROUGH IN 1326 00:53:30,560 --> 00:53:31,760 LEGISLATION UNTIL WE DO GET IT. 1327 00:53:31,760 --> 00:53:37,960 >>YES. THANK YOU. 1328 00:53:37,960 --> 00:53:40,040 >>MR. WESTMORELAND, THANK YOU. 1329 00:53:40,040 --> 00:53:44,120 MOVING ON NOW TO DR. TURN BULL. 1330 00:53:44,120 --> 00:53:47,240 >>I WANT TO TAKE THE 1331 00:53:47,240 --> 00:53:48,440 OPPORTUNITY TO THANK YOU, DR. 1332 00:53:48,440 --> 00:53:49,640 WESTMORELAND FOR ALL THE WORK 1333 00:53:49,640 --> 00:53:51,160 THAT YOU HAVE DONE, PARTICULARLY 1334 00:53:51,160 --> 00:53:55,440 ON BEHALF OF THE OARAC. YOU HAD 1335 00:53:55,440 --> 00:53:56,520 YEARS AND YEARS OF SERVICE. 1336 00:53:56,520 --> 00:53:59,360 THANK YOU VERY MUCH. 1337 00:53:59,360 --> 00:54:00,360 >>MY PLEASURE. 1338 00:54:00,360 --> 00:54:04,120 >>DR. GOODENOW, I -- IN TERMS 1339 00:54:04,120 --> 00:54:06,400 OF THE SIGNATURE PROGRAMS, THE 1340 00:54:06,400 --> 00:54:07,720 SPECIFIC QUESTION AROUND THE 1341 00:54:07,720 --> 00:54:09,480 LISTENING SESSIONS, I WAS 1342 00:54:09,480 --> 00:54:10,760 WONDERING DURING THOSE LISTENING 1343 00:54:10,760 --> 00:54:14,440 SESSIONS THAT YOU HAVE HAD 1344 00:54:14,440 --> 00:54:19,080 WONDERING IF THE SUBJECT OR 1345 00:54:19,080 --> 00:54:20,440 CONVERSATIONS, HAD PARTICULARLY 1346 00:54:20,440 --> 00:54:22,320 AROUND INFANTS WHO WERE BORN 1347 00:54:22,320 --> 00:54:26,840 WITH HIV, WHO ARE NOW ADULTS 35 1348 00:54:26,840 --> 00:54:28,520 AND 40 AND WHETHER OR NOT THAT 1349 00:54:28,520 --> 00:54:33,440 CATEGORY WILL FALL INTO THE 1350 00:54:33,440 --> 00:54:34,160 SIGNATURE PROGRAM OF HIV AND 1351 00:54:34,160 --> 00:54:36,760 AIDS, PARTICULARLY SINCE THERE 1352 00:54:36,760 --> 00:54:39,000 WAS A CAVEAT TO THAT INITIATIVE 1353 00:54:39,000 --> 00:54:41,880 AND THAT SAYS OVER 50. IF THEY 1354 00:54:41,880 --> 00:54:46,760 ARE NOT THERE, WHERE WILL THEY 1355 00:54:46,760 --> 00:54:47,440 BE? 1356 00:54:47,440 --> 00:54:51,800 >>SO YES WE CERTAINLY HAVE 1357 00:54:51,800 --> 00:54:56,080 HEARD THAT GROUP REFERRED TO AND 1358 00:54:56,080 --> 00:54:59,120 THOSE PERINATALLY EXPOSED BUT 1359 00:54:59,120 --> 00:55:02,800 NOT INFECTED INDIVIDUALS AND 1360 00:55:02,800 --> 00:55:05,160 THOSE WHO WERE INFECTED 1361 00:55:05,160 --> 00:55:07,480 PERINATALLY. AS THEY AGE WITH 1362 00:55:07,480 --> 00:55:09,920 HIV. ONE OF THE GOOD PIECES OF 1363 00:55:09,920 --> 00:55:12,600 NEWS IS THAT BECAUSE OF 1364 00:55:12,600 --> 00:55:15,040 TREATMENT OF SOME OF THESE 1365 00:55:15,040 --> 00:55:17,160 BABIES WEREN'T ABLE TO GO ON TO 1366 00:55:17,160 --> 00:55:17,960 ANTI-RETROVIRALS VERY EARLY IN 1367 00:55:17,960 --> 00:55:20,080 THEIR LIVES AND SOME OF THEM ARE 1368 00:55:20,080 --> 00:55:23,160 NOW PARENTS OF THEIR OWN 1369 00:55:23,160 --> 00:55:24,280 FAMILIES AND THEIR CHILDREN ARE 1370 00:55:24,280 --> 00:55:28,920 NOT HIV INFECTED. BUT YES IN 1371 00:55:28,920 --> 00:55:30,720 TERMS OF THE AGING ISSUE, THE 1372 00:55:30,720 --> 00:55:33,080 AGING TOPIC, WE REALLY THINK 1373 00:55:33,080 --> 00:55:36,480 ABOUT HIV ACROSS THE LIFE SPAN. 1374 00:55:36,480 --> 00:55:39,160 THE AGE TIME OR LENGTH OF 1375 00:55:39,160 --> 00:55:41,520 INFECTION TIME IS NOT REALLY THE 1376 00:55:41,520 --> 00:55:44,680 CRITICAL FACTOR AND THEY ARE NOT 1377 00:55:44,680 --> 00:55:48,560 HARD DIVISIONS OF GROUPS INTO 1378 00:55:48,560 --> 00:55:50,280 DIFFERENT SUB GROUPS. . 1379 00:55:50,280 --> 00:55:54,360 I THINK THIS IS DEFINITELY A 1380 00:55:54,360 --> 00:55:55,960 MORE FLUID KIND OF COVERAGE IF 1381 00:55:55,960 --> 00:55:58,160 YOU WILL, ACROSS THE LIFE SPAN, 1382 00:55:58,160 --> 00:56:00,280 THERE'S DIFFERENT FEATURES OF 1383 00:56:00,280 --> 00:56:01,760 THE LIFE SPAN AND FOR DIFFERENT 1384 00:56:01,760 --> 00:56:02,880 PEOPLE CERTAINLY WOMEN HAVE 1385 00:56:02,880 --> 00:56:06,680 DIFFERENT ISSUES THAN MEN AGING 1386 00:56:06,680 --> 00:56:10,480 WITH HIV AND SO I THINK HAVING 1387 00:56:10,480 --> 00:56:13,160 SOME OF THESE PEOPLE AT THE 1388 00:56:13,160 --> 00:56:13,920 TABLE DURING SOME OF THE 1389 00:56:13,920 --> 00:56:15,800 LISTENING SESSIONS, I THINK THE 1390 00:56:15,800 --> 00:56:17,680 LISTENING SESSION WE WANT TO 1391 00:56:17,680 --> 00:56:20,200 THAT YOU HELPED SPONSOR IN NEW 1392 00:56:20,200 --> 00:56:22,040 YORK, BEFORE THE PANDEMIC, I 1393 00:56:22,040 --> 00:56:24,440 REMEMBER SPECIFICALLY THERE WERE 1394 00:56:24,440 --> 00:56:27,040 ONE OR TWO YOUNG PEOPLE THERE 1395 00:56:27,040 --> 00:56:29,000 WHO HAD BEEN PERINATALLY 1396 00:56:29,000 --> 00:56:30,280 INFECTED. IT WAS VERY, VERY 1397 00:56:30,280 --> 00:56:33,480 POWERFUL TO HAVE THEIR INPUT. 1398 00:56:33,480 --> 00:56:34,680 AND TO THE DISCUSSION WE HAVE 1399 00:56:34,680 --> 00:56:39,240 THERE. THANK YOU FOR THAT. 1400 00:56:39,240 --> 00:56:42,560 >>THANK YOU. 1401 00:56:42,560 --> 00:56:46,240 >>DR. MILLER. 1402 00:56:46,240 --> 00:56:51,400 >>THANKS. FIRST OF ALL I DID 1403 00:56:51,400 --> 00:56:53,720 WANT TO THANK DR. TIM 1404 00:56:53,720 --> 00:56:55,280 WESTMORELAND FOR YOUR WONDERFUL 1405 00:56:55,280 --> 00:56:56,680 PRESENTATION AND BRINGING US 1406 00:56:56,680 --> 00:56:59,520 REALLY ILLUSTRATING FOR US WHAT 1407 00:56:59,520 --> 00:57:02,720 CAN HAPPEN AS VERONICA SAID WHEN 1408 00:57:02,720 --> 00:57:04,840 THE RIGHT STRONG VOICES REALLY 1409 00:57:04,840 --> 00:57:08,560 CHIMED IN. IT REMINDS ME ALSO OF 1410 00:57:08,560 --> 00:57:11,720 THE LEADERSHIP OF 1411 00:57:11,720 --> 00:57:13,560 (INDISCERNIBLE) IN THOSE DAYS 1412 00:57:13,560 --> 00:57:15,160 AND YOU REMEMBER MAYBE REMEMBER 1413 00:57:15,160 --> 00:57:18,760 WE DO HAVE THE PUBLIC HEALTH 1414 00:57:18,760 --> 00:57:20,880 LEADERSHIP AWARD WHICH WE 1415 00:57:20,880 --> 00:57:24,600 AWARDED TO CONGRESSMAN WAXMAN. 1416 00:57:24,600 --> 00:57:26,400 IT WAS TONY FAUCI WHO PRESENTED 1417 00:57:26,400 --> 00:57:29,840 THAT AWARD TO HIM. VERY UNIQUE 1418 00:57:29,840 --> 00:57:31,600 EXAMPLE OF PUBLIC HEALTH 1419 00:57:31,600 --> 00:57:32,760 LEADERSHIP IN THOSE DAYS. THANK 1420 00:57:32,760 --> 00:57:36,280 YOU FOR ALL OF YOUR WORK. I 1421 00:57:36,280 --> 00:57:38,680 WANTED TO SIMPLY ECHO WHAT JOHN 1422 00:57:38,680 --> 00:57:41,720 SLEASMAN WAS SAYING BEFORE ABOUT 1423 00:57:41,720 --> 00:57:43,280 LISTENING TOURS AND THE MODEL 1424 00:57:43,280 --> 00:57:46,240 FOR THIS, THE PATIENT, NOT THE 1425 00:57:46,240 --> 00:57:48,440 PATIENT ONLY BUT ALSO THE 1426 00:57:48,440 --> 00:57:51,080 COMMUNITIES WHERE PATIENTS LIVE. 1427 00:57:51,080 --> 00:57:54,560 IMPORTANT TO HOW WE DEAL WITH A 1428 00:57:54,560 --> 00:57:56,280 DISEASE ACHRONIC DISEASE LIKE 1429 00:57:56,280 --> 00:57:59,520 HIV IS SO IMPORTANT AND HIV THAT 1430 00:57:59,520 --> 00:58:02,680 HAS BEEN IS GROUND BREAKING AND 1431 00:58:02,680 --> 00:58:06,600 HOW TO DO THAT. YOU MENTIONED 1432 00:58:06,600 --> 00:58:07,920 THERE SHOULD BE A BROADER NIH 1433 00:58:07,920 --> 00:58:09,320 APPROACH AND I WANTED TO ECHO 1434 00:58:09,320 --> 00:58:14,600 THAT. THANK YO THANK YOU. 1435 00:58:14,600 --> 00:58:17,880 >>THANK YOU, DR. MILLER. THESE 1436 00:58:17,880 --> 00:58:21,440 LISTENING TOURS ARE CERTAINLY 1437 00:58:21,440 --> 00:58:24,320 POPULAR AND LEADING THE WAY, 1438 00:58:24,320 --> 00:58:27,200 SOUNDS LIKE. MAUREEN, I HAVE A 1439 00:58:27,200 --> 00:58:27,960 COUPLE OF QUESTIONS MYSELF 1440 00:58:27,960 --> 00:58:30,520 RELATED TO THE LISTENING TOURS. 1441 00:58:30,520 --> 00:58:35,040 IN THE SECOND TIME I WANT TO 1442 00:58:35,040 --> 00:58:36,720 MAYBE ASK ONE, RELATED TO WHAT 1443 00:58:36,720 --> 00:58:38,120 YOU MIGHT HAVE BEEN HEARING FROM 1444 00:58:38,120 --> 00:58:40,560 THE EARLY CAREER INVESTIGATORS 1445 00:58:40,560 --> 00:58:44,240 AND MY QUESTION IS ABOUT THIS 1446 00:58:44,240 --> 00:58:46,320 CHALLENGE THAT WE HAVE NOW WITH 1447 00:58:46,320 --> 00:58:48,760 POST-DOCS WHO ARE DECIDING TO 1448 00:58:48,760 --> 00:58:53,040 LEAVE ACADEMIA AND TAKE 1449 00:58:53,040 --> 00:58:54,800 POSITIONS IN INDUSTRY. HAVE YOU 1450 00:58:54,800 --> 00:58:57,840 HEARD ANYTHING FROM THAT GROUP 1451 00:58:57,840 --> 00:59:01,120 ON YOUR LISTENING TOURS IN TERMS 1452 00:59:01,120 --> 00:59:02,680 OF WHY THEY MAYBE MAKING THIS 1453 00:59:02,680 --> 00:59:05,680 DECISION AND WHAT TYPE OF 1454 00:59:05,680 --> 00:59:07,720 INCENTIVES CAN KEEP THEM IN 1455 00:59:07,720 --> 00:59:14,760 ACADEMIC SCIENCE. CERTAINLY WHEN 1456 00:59:14,760 --> 00:59:17,240 WE HAVE THE LISTENING SESSIONS, 1457 00:59:17,240 --> 00:59:20,120 ONE APPROACH WE TAKE IS TO WORK 1458 00:59:20,120 --> 00:59:22,520 WITH SUBGROUPS OF PEOPLE, 1459 00:59:22,520 --> 00:59:23,800 MEETINGS WITH COMMUNITY PEOPLE 1460 00:59:23,800 --> 00:59:25,120 SEPARATE FROM THE ACADEMIC 1461 00:59:25,120 --> 00:59:26,240 COMMUNITY, FOR TWO REASONS. ONE 1462 00:59:26,240 --> 00:59:31,760 IS TO KEEP THE GROUP SMALL. AND 1463 00:59:31,760 --> 00:59:33,400 NOT HAVE HUGE ROOMS WHEN WE ARE 1464 00:59:33,400 --> 00:59:35,560 STILL MEETING IN PERSON BUT EVEN 1465 00:59:35,560 --> 00:59:38,440 LOTS AND LOTS OF PEOPLE ON THE 1466 00:59:38,440 --> 00:59:40,240 SCREEN BECAUSE IT REALLY DOES 1467 00:59:40,240 --> 00:59:42,680 HELP THE CONFERENCE THE GROUPS 1468 00:59:42,680 --> 00:59:45,840 HAVE 15, 20 PEOPLE IN THEM. SO 1469 00:59:45,840 --> 00:59:48,080 MORE GROUPS. THERE'S DIFFERENT 1470 00:59:48,080 --> 00:59:49,440 COMMENTARIES AND YOU HEAR THE 1471 00:59:49,440 --> 00:59:51,800 DIFFERENT NUANCES BETWEEN 1472 00:59:51,800 --> 00:59:53,360 DIFFERENT GROUPS OF INDIVIDUALS. 1473 00:59:53,360 --> 01:00:00,000 SO WITHIN THE ACADEMIC 1474 01:00:00,000 --> 01:00:01,000 CONVERSATIONS WE HAD, THE 1475 01:00:01,000 --> 01:00:02,240 POST-DOCS HAVE BEEN MENTIONED 1476 01:00:02,240 --> 01:00:03,280 AND SOMETIMES THERE ARE ACTUALLY 1477 01:00:03,280 --> 01:00:04,920 POST-DOCS THERE. I THINK THERE 1478 01:00:04,920 --> 01:00:09,160 ARE AMONG THEM MORE SHIER GROUP 1479 01:00:09,160 --> 01:00:11,640 TO SPEAK UP ESPECIALLY WHEN 1480 01:00:11,640 --> 01:00:13,000 THEIR FACULTY IS PRESENT AND 1481 01:00:13,000 --> 01:00:14,760 THAT'S SOME OF THE THINGS WE CAN 1482 01:00:14,760 --> 01:00:16,400 TIE IN TERMS OF TRYING TO BREAK 1483 01:00:16,400 --> 01:00:19,360 IT OUT MORE. WHAT WE HAVE BEEN 1484 01:00:19,360 --> 01:00:21,520 FOCUS CANNING ON HAS BEEN EARLY 1485 01:00:21,520 --> 01:00:23,920 CAREER INVESTIGATORS, PEOPLE WHO 1486 01:00:23,920 --> 01:00:25,240 ALREADY HAVE PASSED THROUGH 1487 01:00:25,240 --> 01:00:29,520 POST-DOCTORAL TRAINING AND ARE 1488 01:00:29,520 --> 01:00:31,520 STARTING AT FACULTY POSITIONS. 1489 01:00:31,520 --> 01:00:34,440 THE CHALLENGES THEY FACE IN 1490 01:00:34,440 --> 01:00:36,600 GETTING THEIR FIRST GRANTS AND 1491 01:00:36,600 --> 01:00:41,160 THE NUANCES OF REVIEWS AND 1492 01:00:41,160 --> 01:00:43,480 SCIENTIFIC MERIT COMMENTARIES 1493 01:00:43,480 --> 01:00:50,640 AND THINGS LIKE THAT. THE ISSUE 1494 01:00:50,640 --> 01:00:52,840 NOW WITH THE POST-DOCS THAT IS 1495 01:00:52,840 --> 01:00:54,080 ARISING IS REALLY IMPORTANT AND 1496 01:00:54,080 --> 01:00:55,960 I THINK IT WILL DEFINITELY BE 1497 01:00:55,960 --> 01:00:58,240 COMING UP MORE IN OUR LISTENING 1498 01:00:58,240 --> 01:00:59,640 SESSIONS. BECAUSE WE REALLY HAVE 1499 01:00:59,640 --> 01:01:03,160 TO LOOK AT THE WHOLE PIPELINE. 1500 01:01:03,160 --> 01:01:05,360 PEOPLE HAVE TALKED TO US ABOUT 1501 01:01:05,360 --> 01:01:06,720 FROM CLINICAL RESEARCH SIDE HOW 1502 01:01:06,720 --> 01:01:08,720 IMPORTANT THE K AWARDS ARE, 1503 01:01:08,720 --> 01:01:11,280 THERE IS ALSO A LOT OF 1504 01:01:11,280 --> 01:01:13,760 CHALLENGES WITH K AWARDS AND 1505 01:01:13,760 --> 01:01:15,480 REALLY ACHIEVING THE GOALS OF 1506 01:01:15,480 --> 01:01:19,600 SUPPORTING CAREER DEVELOPMENT 1507 01:01:19,600 --> 01:01:21,600 LUIS TALKED TO US AT ONE POINT 1508 01:01:21,600 --> 01:01:22,200 ABOUT SOME OF THE THINGS THEY 1509 01:01:22,200 --> 01:01:23,960 HAVE BEEN HEARING ABOUT K AWARDS 1510 01:01:23,960 --> 01:01:25,600 AND HOW THEY COULD POTENTIALLY 1511 01:01:25,600 --> 01:01:29,320 BE STRUCTURED DIFFERENTLY. THE 1512 01:01:29,320 --> 01:01:31,000 WHOLE DEVELOPMENTAL, THE WHOLE 1513 01:01:31,000 --> 01:01:34,800 PIPELINE OF DEVELOPING SCIENCE 1514 01:01:34,800 --> 01:01:35,920 AND SCIENTIFIC INVESTIGATORS 1515 01:01:35,920 --> 01:01:39,480 REALLY NEEDS TO BE LOOKED AT AS 1516 01:01:39,480 --> 01:01:44,040 TO WHERE CONSTRICTIONS AND WHAT 1517 01:01:44,040 --> 01:01:44,960 THE DIFFERENT SOLUTIONS ARE, 1518 01:01:44,960 --> 01:01:47,600 BECAUSE CLEARLY, WORKING IN 1519 01:01:47,600 --> 01:01:50,040 DIFFERENT SECTIONS OF THE 1520 01:01:50,040 --> 01:01:50,800 PIPELINE REQUIRE DIFFERENT TYPES 1521 01:01:50,800 --> 01:01:56,880 OF APPROACHES. I AGREE WITH YOU 1522 01:01:56,880 --> 01:01:59,080 AND WHAT IS HAPPENING FOR THE 1523 01:01:59,080 --> 01:02:00,600 FIELD BIOMEDICAL RESEARCH, IT IS 1524 01:02:00,600 --> 01:02:02,240 NOT SPECIFIC TO HIV BUT 1525 01:02:02,240 --> 01:02:04,800 CERTAINLY IMPACTING THE AGENTS 1526 01:02:04,800 --> 01:02:12,880 IN THE FIELD. THANK YOU FOR 1527 01:02:12,880 --> 01:02:15,880 COMMENTING ON THAT QUESTION. DR. 1528 01:02:15,880 --> 01:02:18,360 SLEASMAN, YOUR HAND IS UP, DO 1529 01:02:18,360 --> 01:02:18,920 YOU HAVE ANOTHER QUESTION? 1530 01:02:18,920 --> 01:02:22,840 >>I DON'T I THOUGHT I LOWERED 1531 01:02:22,840 --> 01:02:23,040 IT. 1532 01:02:23,040 --> 01:02:25,160 >>I WANT TO GET US BACK TO THE 1533 01:02:25,160 --> 01:02:26,880 AGENDA. DR. GOODENOW I BELIEVE I 1534 01:02:26,880 --> 01:02:30,640 HAND THIS BACK TO YOU TO 1535 01:02:30,640 --> 01:02:34,840 INTRODUCE OUR NEXT SPEAKER IN 1536 01:02:34,840 --> 01:02:35,520 THE SESSION. 1537 01:02:35,520 --> 01:02:39,520 >>YES. SO OUR NEXT PRESENTATION 1538 01:02:39,520 --> 01:02:41,240 IS FROM THE DIRECTOR OF THE 1539 01:02:41,240 --> 01:02:44,720 NATIONAL INSTITUTES ON AGING. 1540 01:02:44,720 --> 01:02:46,280 DR. RICHARD HODES. IS REALLY A 1541 01:02:46,280 --> 01:02:48,360 GREAT PLEASURE TO INTRODUCE HIM 1542 01:02:48,360 --> 01:02:51,400 TODAY. DR. HODES DIRECTS THE 1543 01:02:51,400 --> 01:02:53,000 NIA NATIONAL INSTITUTE ON AGING, 1544 01:02:53,000 --> 01:02:55,280 HE IS LEADING IMMUNOLOGIST WHO 1545 01:02:55,280 --> 01:02:58,360 IS NAMED NIA DIRECTOR IN 1993. 1546 01:02:58,360 --> 01:03:00,200 TO OVERSEE STUDIES OF THE 1547 01:03:00,200 --> 01:03:03,720 BIOLOGICAL CLINICAL BEHAVIORAL 1548 01:03:03,720 --> 01:03:06,200 AND SOCIAL ASPECTS OF AGING. 1549 01:03:06,200 --> 01:03:08,720 UNDER DR. HODES STEWARDSHIP THE 1550 01:03:08,720 --> 01:03:11,600 NIA BUDGET HAS GROWN TO NEARLY 1551 01:03:11,600 --> 01:03:13,280 1.6 BILLION REFLECTING INCREASE 1552 01:03:13,280 --> 01:03:14,600 PUBLIC INTEREST IN AGING AS 1553 01:03:14,600 --> 01:03:15,800 AMERICA AND THE WORLD GROWS 1554 01:03:15,800 --> 01:03:19,720 OLDER. DR. HODES DEVOTE HIS 1555 01:03:19,720 --> 01:03:21,160 TENURE TO DEVELOPMENT OF STRONG 1556 01:03:21,160 --> 01:03:24,440 DIVERSE AND BALANCED RESEARCH 1557 01:03:24,440 --> 01:03:26,040 PROGRAM FOCUS ON GENETICS AND 1558 01:03:26,040 --> 01:03:28,360 BIOLOGY OF AGING BASIC CLINICAL 1559 01:03:28,360 --> 01:03:29,960 STUDIES RELATED OR AIMED TO 1560 01:03:29,960 --> 01:03:33,120 REDUCE DISEASE AND DISABILITY 1561 01:03:33,120 --> 01:03:35,040 INCLUDING ALZHEIMER'S DISEASE 1562 01:03:35,040 --> 01:03:36,760 AND AGE RELATED COGNITIVE 1563 01:03:36,760 --> 01:03:38,840 CHANGE. THE INVESTIGATION OF THE 1564 01:03:38,840 --> 01:03:41,440 BEHAVIOR ON SOCIAL ASPECTS OF 1565 01:03:41,440 --> 01:03:43,200 AGING. ALSO THESE EFFORTS HAVE A 1566 01:03:43,200 --> 01:03:44,200 GOAL, IMPROVING THE HEALTH AND 1567 01:03:44,200 --> 01:03:46,280 QUALITY OF LIFE FOR OLDER PEOPLE 1568 01:03:46,280 --> 01:03:48,840 AND THEIR FAMILIES. THANK YOU, 1569 01:03:48,840 --> 01:03:51,720 RICHARD FOR BEING HERE AND TURN 1570 01:03:51,720 --> 01:03:53,640 THE FLOOR OVER TO YOU. 1571 01:03:53,640 --> 01:03:55,800 >>THANK YOU. IT IS A GREAT 1572 01:03:55,800 --> 01:03:58,280 PLEASURE TO BE HERE. I WANT TO 1573 01:03:58,280 --> 01:03:59,880 STRESS THE CLOSE RELATIONSHIP WE 1574 01:03:59,880 --> 01:04:04,040 HAVE HAD BETWEEN NIA AND YOUR 1575 01:04:04,040 --> 01:04:07,000 OFFICE. AND MORE BASICALLY, THE 1576 01:04:07,000 --> 01:04:09,880 RELEVANCE OF HIV TO AGING 1577 01:04:09,880 --> 01:04:12,960 RESEARCH. THE NEXT FEW SLIDES I 1578 01:04:12,960 --> 01:04:15,080 WILL TRY TO EMPHASIZE THAT, 1579 01:04:15,080 --> 01:04:17,080 AFTER MY PRESENTATION SOME OF MY 1580 01:04:17,080 --> 01:04:18,320 PROGRAM STAFF CLOSELY INVOLVED 1581 01:04:18,320 --> 01:04:20,840 WILL GET ON TO FURTHER 1582 01:04:20,840 --> 01:04:22,680 CONVERSATION. NIA MOSTLY 1583 01:04:22,680 --> 01:04:23,720 APOLOGIZE FOR THE FACT I CAN'T 1584 01:04:23,720 --> 01:04:27,040 BE WITH YOU AND ADVISORY COUNCIL 1585 01:04:27,040 --> 01:04:30,680 LONGER DO CONFLICTING COMMIT 1586 01:04:30,680 --> 01:04:31,920 COMMITMENTS. CAN WE GO TO THE 1587 01:04:31,920 --> 01:04:33,160 NEXT SLIDE PLEASE. 1588 01:04:33,160 --> 01:04:36,240 >>THIS IS A -- THE MISSION 1589 01:04:36,240 --> 01:04:38,720 STATEMENT THAT ACCOMPANY THE 1590 01:04:38,720 --> 01:04:41,480 ESTABLISHMENT OF NIA. I SHOW YOU 1591 01:04:41,480 --> 01:04:43,440 HERE BECAUSE IT DOES EXPRESS THE 1592 01:04:43,440 --> 01:04:44,320 BREADTH OF RESPONSIBILITIES FOR 1593 01:04:44,320 --> 01:04:45,840 THE AGING INSTITUTE. IN TERMS OF 1594 01:04:45,840 --> 01:04:47,320 SUPPORTING RESEARCH, I WILL COME 1595 01:04:47,320 --> 01:04:49,600 BACK TO THIS REPEATEDLY, THIS 1596 01:04:49,600 --> 01:04:51,160 RELATES TO RESEARCH MOST 1597 01:04:51,160 --> 01:04:53,440 BIOLOGIC MOLECULAR LEVELS, 1598 01:04:53,440 --> 01:04:55,120 THROUGH CLINICAL BEHAVIOR, 1599 01:04:55,120 --> 01:04:56,400 SOCIAL ECONOMIC RESEARCH. THAT 1600 01:04:56,400 --> 01:04:59,200 TOO REFLECTS THE BREADTH OF 1601 01:04:59,200 --> 01:05:02,200 OVERLAPPING INTEREST IN HIV AND 1602 01:05:02,200 --> 01:05:04,320 AGING. WE ALSO FOSTER CAREER 1603 01:05:04,320 --> 01:05:07,120 DEVELOPMENT AND TRAINING, 1604 01:05:07,120 --> 01:05:09,000 RESOURCES ROLE AND DISSEMINATE 1605 01:05:09,000 --> 01:05:13,080 INFORMATION TO THE PUBLIC. NEXT 1606 01:05:13,080 --> 01:05:15,640 SLIDE PLEASE. THE APPROPRIATION 1607 01:05:15,640 --> 01:05:17,520 HISTORY OF NIA IS REMARKABLE, 1608 01:05:17,520 --> 01:05:21,440 YOU SEE IN THE NEXT SLIDE THE 1609 01:05:21,440 --> 01:05:27,960 APPROPRIATION FOR 2023 NIH 1610 01:05:27,960 --> 01:05:29,600 OVERALL $47.7 BILLION, THE NIA 1611 01:05:29,600 --> 01:05:34,520 BUDGET FOR THIS CURRENT YEAR IS 1612 01:05:34,520 --> 01:05:37,160 4.4, $1 BILLION WITH GROWTH I 1613 01:05:37,160 --> 01:05:40,080 WILL SHOW YOU THAT MAKES NIA THE 1614 01:05:40,080 --> 01:05:42,440 THIRD LARGEST OF INSTITUTES 1615 01:05:42,440 --> 01:05:45,160 BEHIND NCI AND NIAID. THE 1616 01:05:45,160 --> 01:05:46,280 INCREASE THIS YEAR TARGETED 1617 01:05:46,280 --> 01:05:48,120 NUMBER OF AREAS BUT ONE OF THE 1618 01:05:48,120 --> 01:05:51,440 LARGEST OF THOSE IS AGAIN 1619 01:05:51,440 --> 01:05:57,120 INCREASE IN FUNDING ALLS MER'S 1620 01:05:57,120 --> 01:05:59,680 DISEASE AND DEMENTIA, ADRD $26 1621 01:05:59,680 --> 01:06:00,760 MILLION TO NIH OVERALL FOR THAT. 1622 01:06:00,760 --> 01:06:03,640 THE NEXT SLIDE PLEASE. THIS 1623 01:06:03,640 --> 01:06:05,720 SHOWS YOU THE PACE WHICH THE 1624 01:06:05,720 --> 01:06:07,720 BUDGET HAS INCREASED. SO AS 1625 01:06:07,720 --> 01:06:10,880 RECENTLY AS 2015, OVER A BILLION 1626 01:06:10,880 --> 01:06:15,840 DOLLARS TO WHERE WE ARE NOW AS 1627 01:06:15,840 --> 01:06:17,800 MENTIONED $4.4 BILLION, THIS HAS 1628 01:06:17,800 --> 01:06:19,880 BEEN A GROWTH INCLUDED A LARGE 1629 01:06:19,880 --> 01:06:21,080 COMPONENT SHOWN IN BLUE HERE, 1630 01:06:21,080 --> 01:06:24,360 THIS IS THE COMPONENT THAT IS 1631 01:06:24,360 --> 01:06:26,640 THE ACCRUED OR AGGRAVATED OF 1632 01:06:26,640 --> 01:06:28,360 TARGETED INCREASES WHICH 1633 01:06:28,360 --> 01:06:30,280 CONGRESS COMMITTED TO 1634 01:06:30,280 --> 01:06:32,520 ALZHEIMER'S RELATED DEMENTIA 1635 01:06:32,520 --> 01:06:34,080 RESEARCH, OVERALL BUDGET 1636 01:06:34,080 --> 01:06:36,040 INCREASE DRAMATICALLY, IN 1637 01:06:36,040 --> 01:06:38,520 PARTICULAR AD AND ADRD AND THIS 1638 01:06:38,520 --> 01:06:39,720 HAS IMPLICATIONS FOR RESEARCH 1639 01:06:39,720 --> 01:06:43,920 SUPPORT. NOW, I WANT TO 1640 01:06:43,920 --> 01:06:46,800 EMPHASIZE ONE ASPECT OF GROWTH 1641 01:06:46,800 --> 01:06:48,480 THAT HAS BEEN STRONG IN MIND 1642 01:06:48,480 --> 01:06:49,600 DURING OUR COMMITMENT IS TO MAKE 1643 01:06:49,600 --> 01:06:52,960 SURE THAT WE ARE RECRUITING 1644 01:06:52,960 --> 01:06:55,920 PEOPLE FROM DIVERSE BACKGROUNDS 1645 01:06:55,920 --> 01:06:58,000 Z ACROSS ALL DEMOGRAPHIC 1646 01:06:58,000 --> 01:06:59,600 DIMENSIONS BUT ALSO IN TERMS OF 1647 01:06:59,600 --> 01:07:02,040 SCIENTIFIC DISCIPLINES, TO MOST 1648 01:07:02,040 --> 01:07:03,640 APPROPRIATELY GROW PRODUCTIVELY 1649 01:07:03,640 --> 01:07:06,320 APPROACH TO AD AND ADRD, 1650 01:07:06,320 --> 01:07:07,800 IMPORTANT TO DRAW UPON TALENTS 1651 01:07:07,800 --> 01:07:10,920 OF PEOPLE WITH IN MANY AREAS. 1652 01:07:10,920 --> 01:07:12,200 ONE OF THE PROGRAMS, ONE 1653 01:07:12,200 --> 01:07:15,520 ILLUSTRATED HERE IS A SUPPLEMENT 1654 01:07:15,520 --> 01:07:17,320 PROGRAM IN WHICH WE NIA WILL 1655 01:07:17,320 --> 01:07:19,400 FUND ADMINISTRATIVE SUPPLEMENTS 1656 01:07:19,400 --> 01:07:22,480 TO GRANTS SUPPORTED BY ANY NIH 1657 01:07:22,480 --> 01:07:25,000 INSTITUTES, THOSE GRANTS MUST BE 1658 01:07:25,000 --> 01:07:28,400 NON-AD ADRD THEMSELVES. THOSE 1659 01:07:28,400 --> 01:07:30,840 FOR WHICH A CASE CAN BE MADE FOR 1660 01:07:30,840 --> 01:07:32,640 SUPPLEMENT TAKE ADVANTAGE OF 1661 01:07:32,640 --> 01:07:35,760 EXPERTISE AND CONTENT MATTER OF 1662 01:07:35,760 --> 01:07:37,200 THOSE GRANTS SUPPLEMENT IN A WAY 1663 01:07:37,200 --> 01:07:39,200 TO BECOME RELEVANT TO AD AND 1664 01:07:39,200 --> 01:07:42,400 ADRD. THE SHORT TERM GOAL IS 1665 01:07:42,400 --> 01:07:43,920 RESEARCH OF GREAT DIVERSITY, 1666 01:07:43,920 --> 01:07:45,320 RECRUITED TO THE FIELD AND 1667 01:07:45,320 --> 01:07:47,200 LONGER TERM AS BEGINNING TO SEE 1668 01:07:47,200 --> 01:07:48,640 NOW DEVELOPMENT OF MORE AND MORE 1669 01:07:48,640 --> 01:07:50,120 INVESTIGATORS BROUGHT INTO THE 1670 01:07:50,120 --> 01:07:52,080 FIELD FROM THAT STRATEGY. YOU 1671 01:07:52,080 --> 01:07:55,360 CAN SEE ESSENTIALLY ALL THE NIH 1672 01:07:55,360 --> 01:07:56,520 INSTITUTES HAVE BEEN PARENTS 1673 01:07:56,520 --> 01:07:57,880 PATING THE LAST YEAR OVER 200 1674 01:07:57,880 --> 01:08:00,280 SUPPLEMENTS AND $75 MILLION 1675 01:08:00,280 --> 01:08:03,880 INVESTED. THIS IS REFLECTED AS 1676 01:08:03,880 --> 01:08:05,440 WE TRACK IT IN THE FACT FROM 1677 01:08:05,440 --> 01:08:07,840 2015 THROUGH 2022, WHERE WE HAVE 1678 01:08:07,840 --> 01:08:10,440 THESE DATA AND THE DRAMATIC 1679 01:08:10,440 --> 01:08:12,920 INCREASE IN APPROPRIATIONS AND 1680 01:08:12,920 --> 01:08:14,880 BUDGET, OF THAT PERIOD ONE-THIRD 1681 01:08:14,880 --> 01:08:17,880 OF ALL OF OUR AWARDEES WERE 1682 01:08:17,880 --> 01:08:20,000 EITHER NEW OR EARLY STAGE 1683 01:08:20,000 --> 01:08:23,760 INVESTIGATORS AND THOSE 1684 01:08:23,760 --> 01:08:24,680 DEFINITIONS ARE PROBABLY WELL 1685 01:08:24,680 --> 01:08:26,480 KNOWN TO YOU, A FIFTH IN THE 1686 01:08:26,480 --> 01:08:27,880 CATEGORY WE NEWLY ESTABLISHED 1687 01:08:27,880 --> 01:08:29,680 AND DEFINED NEW TO THE FIELD. 1688 01:08:29,680 --> 01:08:30,840 THIS IS INVESTIGATORS NEVER 1689 01:08:30,840 --> 01:08:33,600 APPLY FOR ANY RESEARCH OF ANY 1690 01:08:33,600 --> 01:08:36,840 KIND RELATED TO AD ADRD AT ALL. 1691 01:08:36,840 --> 01:08:39,440 I THINK SERVES US WELL TO BRING 1692 01:08:39,440 --> 01:08:42,320 IN RESEARCHERS INCLUDING THOSE 1693 01:08:42,320 --> 01:08:43,840 STRONG IMPORTANT INTERFACE 1694 01:08:43,840 --> 01:08:49,040 BETWEEN HIV RESEARCH AND AGING. 1695 01:08:49,040 --> 01:08:54,520 NEXT SLIDE. SO AS HAS BEEN 1696 01:08:54,520 --> 01:08:56,880 CRITICAL IMPORTANT INTENSIFYING 1697 01:08:56,880 --> 01:08:58,960 THEME ACROSS NIH AND NATIONALLY, 1698 01:08:58,960 --> 01:09:01,160 HEALTH DISPARITIES FRAMEWORK IS 1699 01:09:01,160 --> 01:09:04,680 IMPORTANT TO NIA QUITE SOME 1700 01:09:04,680 --> 01:09:06,360 TIME. THIS IS A HEALTH 1701 01:09:06,360 --> 01:09:07,560 DISPARITIES RESEARCH FRAMEWORK. 1702 01:09:07,560 --> 01:09:10,120 I WILL POINT OUT PUBLISHED IN 1703 01:09:10,120 --> 01:09:12,520 2015. AND THE AUTHORS THIS CAME 1704 01:09:12,520 --> 01:09:15,960 FROM NIA BUT INCLUDED MARIE 1705 01:09:15,960 --> 01:09:19,080 BERNARD WHO LEADS NIA -- NIH 1706 01:09:19,080 --> 01:09:20,280 WIDE EFFORTS IN THIS DOMAIN WAS 1707 01:09:20,280 --> 01:09:25,640 THE DEPUTY DIRECTOR NIA FOR 13 1708 01:09:25,640 --> 01:09:27,520 YEARS, BUT TO MOVE TO TAKING 1709 01:09:27,520 --> 01:09:30,200 THIS AT THE NIH LEVEL, ANOTHER 1710 01:09:30,200 --> 01:09:35,800 CO-AUTHOR NOTED IS ELISEO PEREZ 1711 01:09:35,800 --> 01:09:38,120 STABLE. WENT ON TO BECOME 1712 01:09:38,120 --> 01:09:40,400 DIRECTOR OF NIMHD. A LONG 1713 01:09:40,400 --> 01:09:42,840 COMMITMENT AND EMPHASIZE IT 1714 01:09:42,840 --> 01:09:45,960 ISN'T JUST HEALTH DISPARITIES AT 1715 01:09:45,960 --> 01:09:48,760 SOCIETAL OR SOCIO CULTURAL LEVEL 1716 01:09:48,760 --> 01:09:49,840 BUT BEHAVIORAL RESEARCH AND 1717 01:09:49,840 --> 01:09:51,040 BIOLOGIC RESEARCH ACROSS THE 1718 01:09:51,040 --> 01:09:54,760 MATRIX TO ADDRESS AREAS RELEVANT 1719 01:09:54,760 --> 01:09:56,280 TO DIVERSITY DISPARITIES AND 1720 01:09:56,280 --> 01:09:57,920 EQUITY ACROSS THE FULL SPECTRUM 1721 01:09:57,920 --> 01:10:03,960 OF RESEARCH. SOME OF THE 1722 01:10:03,960 --> 01:10:05,000 PROGRAMS, THAT HAVE BEEN OVER 1723 01:10:05,000 --> 01:10:06,640 THE PAST YEARS A MEANS FOR 1724 01:10:06,640 --> 01:10:08,000 ACHIEVING THESE GOALS, A 1725 01:10:08,000 --> 01:10:09,440 NATIONAL STRATEGY FOR 1726 01:10:09,440 --> 01:10:13,160 RECRUITMENT AND PARTICIPATION OF 1727 01:10:13,160 --> 01:10:14,280 PARTICIPANTS IN ALZHEIMER'S AND 1728 01:10:14,280 --> 01:10:17,040 RELATED DEMENTIA RESEARCH HUGE 1729 01:10:17,040 --> 01:10:18,080 EFFORT THAT'S BEEN INSUFFICIENT 1730 01:10:18,080 --> 01:10:21,040 TO DATE. AND WHERE SUCCESS IS 1731 01:10:21,040 --> 01:10:23,080 ABSOLUTELY UNSATISFACTORY. SO WE 1732 01:10:23,080 --> 01:10:25,640 ARE LOOKING FOR MORE BETTER AND 1733 01:10:25,640 --> 01:10:27,760 MORE EFFECTIVE WAYS TO RECRUIT 1734 01:10:27,760 --> 01:10:29,480 DIVERSE POPULATIONS INTO 1735 01:10:29,480 --> 01:10:31,520 RESEARCH, REFLECT THE 1736 01:10:31,520 --> 01:10:32,480 POPULATIONS THAT OF COURSE ARE 1737 01:10:32,480 --> 01:10:34,560 RELEVANT FOR RESEARCH AND 1738 01:10:34,560 --> 01:10:35,640 LEARNING ABOUT RESEARCH AND 1739 01:10:35,640 --> 01:10:36,880 ULTIMATELY THOSE TARGETS OF WHAT 1740 01:10:36,880 --> 01:10:38,680 WE LEARNED IN TERMS OF IMPROVED 1741 01:10:38,680 --> 01:10:40,880 INTERVENTIONS. YOU CAN SEE SOME 1742 01:10:40,880 --> 01:10:41,920 OF THESE SPECIFIC AREAS HERE 1743 01:10:41,920 --> 01:10:44,320 TRYING TO PROVIDE RESOURCES TO 1744 01:10:44,320 --> 01:10:47,400 THE FIELD TO MAKE EASIER FOR 1745 01:10:47,400 --> 01:10:48,280 INVESTIGATORS TO TAILOR TARGETS 1746 01:10:48,280 --> 01:10:51,240 FOR RECRUITMENT AS THEY WORK AND 1747 01:10:51,240 --> 01:10:54,840 THE LAST BULLETED HERE CHROMES 1748 01:10:54,840 --> 01:10:57,080 CLINICAL RESEARCH SYSTEM, FIRST 1749 01:10:57,080 --> 01:10:58,520 TIME GIVING NEAR REAL TIME 1750 01:10:58,520 --> 01:11:01,640 ABILITY TO TRACK RECRUITMENT AND 1751 01:11:01,640 --> 01:11:03,080 DEMOGRAPHICS TO ALL OUR CLINICAL 1752 01:11:03,080 --> 01:11:04,280 TRIALS, WHICH IS GOING TO ALLOW 1753 01:11:04,280 --> 01:11:06,520 TO PROVIDE HELP AND ASSISTANCE 1754 01:11:06,520 --> 01:11:08,400 THOSE INVESTIGATORS NOT NEEDING 1755 01:11:08,400 --> 01:11:10,280 GOALS AN TARGETS NOT END OF YEAR 1756 01:11:10,280 --> 01:11:11,560 OR TWO OF PROGRESS REPORTS BUT 1757 01:11:11,560 --> 01:11:13,440 REAL TIME. SO TRY TO ENHANCE 1758 01:11:13,440 --> 01:11:14,560 EFFICIENCY OF RECRUITMENT 1759 01:11:14,560 --> 01:11:19,240 EFFORTS. TURN FIRST TO SOME 1760 01:11:19,240 --> 01:11:21,000 ASPECTS OF INTERSECTION OF HIV 1761 01:11:21,000 --> 01:11:23,880 AND AGING AND REPEAT FOLLOWING 1762 01:11:23,880 --> 01:11:26,840 MY PRESENTATION, YOU WILL BE 1763 01:11:26,840 --> 01:11:28,880 HEARING FROM SENIOR NIA STAFF 1764 01:11:28,880 --> 01:11:31,440 WHO HAVE BEEN MOST INVOLVED IN 1765 01:11:31,440 --> 01:11:33,120 THIS INTERACTION AND PROVIDING 1766 01:11:33,120 --> 01:11:37,240 MORE EXAMPLES OF CURRENT ONGOING 1767 01:11:37,240 --> 01:11:40,840 WORK TOGETHER. HERE VERY VIVIDLY 1768 01:11:40,840 --> 01:11:43,320 IS THE WELL KNOWN TO YOU, ALL OF 1769 01:11:43,320 --> 01:11:47,320 US, THE FACT THAT AGING IS 1770 01:11:47,320 --> 01:11:49,320 RELEVANT TO HIV AT THE LEVEL OF 1771 01:11:49,320 --> 01:11:51,080 THE EPIDEMIOLOGY AND 1772 01:11:51,080 --> 01:11:56,400 DEMOGRAPHICS OF INFECTION ITSELF 1773 01:11:56,400 --> 01:11:59,640 SO 50% OF PEOPLE WITH HIV IN THE 1774 01:11:59,640 --> 01:12:02,200 U.S. IS OVER 50 AND A LOT OF 1775 01:12:02,200 --> 01:12:04,880 THIS IS PEOPLE ACQUIRED HIV 1776 01:12:04,880 --> 01:12:06,400 INFECTION EARLY AGE TO SURVIVE 1777 01:12:06,400 --> 01:12:09,920 AGES OVER 50 BUT ALSO 17% OF NEW 1778 01:12:09,920 --> 01:12:11,320 INFECTIONS REMAIN THOSE IN 1779 01:12:11,320 --> 01:12:13,920 POPULATIONS OVER 50. SO OUR 1780 01:12:13,920 --> 01:12:16,160 DIVERSE EFFORTS WORKING WITH OAR 1781 01:12:16,160 --> 01:12:18,240 ARE TO PROMOTE HEALTHY AGING 1782 01:12:18,240 --> 01:12:20,560 AMONG OLDER ADULTS WITH HIV 1783 01:12:20,560 --> 01:12:22,720 ACROSS THE WHOLE BREADTH OF 1784 01:12:22,720 --> 01:12:25,400 BIOLOGIC THROUGH BEHAVIORAL 1785 01:12:25,400 --> 01:12:27,200 SOCIAL RESEARCH MENTIONED IN THE 1786 01:12:27,200 --> 01:12:37,360 PRIOR COMMENTS. GERO SCIENCE IS 1787 01:12:37,360 --> 01:12:39,000 RELEVENCE TO THIS. IT SPRINGS 1788 01:12:39,000 --> 01:12:41,080 THE REALIZATION AND AFFECT 1789 01:12:41,080 --> 01:12:42,080 HYPOTHESIS THAT MANY CHANGE 1790 01:12:42,080 --> 01:12:46,640 OCCUR WITH AGING OVER DOMAINS 1791 01:12:46,640 --> 01:12:50,040 THAT INCLUDE A VARIETY OF 1792 01:12:50,040 --> 01:12:54,640 MOLECULAR AND BIOLOGIC CHANGES 1793 01:12:54,640 --> 01:12:56,240 WHERE IN COMMON TO THE 1794 01:12:56,240 --> 01:12:58,600 ETIOLOGIES OF MULTIPLE DISEASE 1795 01:12:58,600 --> 01:13:00,800 AND CONDITIONS. MULTIPLE DISEASE 1796 01:13:00,800 --> 01:13:03,360 AND CONDITIONS HAVE AS A 1797 01:13:03,360 --> 01:13:04,640 COMMONALITY THE FACT AGING IS A 1798 01:13:04,640 --> 01:13:07,120 RISK FACTOR. FOR HIV, THIS 1799 01:13:07,120 --> 01:13:10,840 RELATES TO THE WAY WHICH HIV 1800 01:13:10,840 --> 01:13:12,040 INFECTION AND IMPORTANTLY NOT 1801 01:13:12,040 --> 01:13:15,600 JUST HIV INFECTION BUT TREATMENT 1802 01:13:15,600 --> 01:13:18,800 OF HIV INTERACTS WITH THE AGING 1803 01:13:18,800 --> 01:13:21,560 PROCESS, APPEARS SOME CASES TO 1804 01:13:21,560 --> 01:13:22,960 ACCELERATE CHANGES WHICH OCCUR 1805 01:13:22,960 --> 01:13:25,640 DURING AGING. SO THE COMPLEX 1806 01:13:25,640 --> 01:13:27,160 BIOLOGICAL REPACKS WITH AGING 1807 01:13:27,160 --> 01:13:29,000 AND AGE AND HIV INFECTION IS 1808 01:13:29,000 --> 01:13:30,520 EXCITED TO RESEARCH AND GERMANE 1809 01:13:30,520 --> 01:13:31,720 TO UNDERSTANDING THE PROCESSES 1810 01:13:31,720 --> 01:13:36,120 THAT WE CAN ADDRESS THEM IN REAL 1811 01:13:36,120 --> 01:13:38,040 WORLD PRACTICAL CLINICAL 1812 01:13:38,040 --> 01:13:41,240 OUTCOMES. NEXT PLEASE. SOME 1813 01:13:41,240 --> 01:13:43,200 EXAMPLES, OF HIV AGING RESEARCH, 1814 01:13:43,200 --> 01:13:45,680 I SHOW THIS AGAIN, THIS IS 1815 01:13:45,680 --> 01:13:48,960 ORGANIZATIONAL STRUCTURE TO 1816 01:13:48,960 --> 01:13:53,520 EMPHASIZE THAT THE RELATIONSHIP 1817 01:13:53,520 --> 01:13:55,200 SPANS ALL, DIVISION OF BIOLOGY, 1818 01:13:55,200 --> 01:13:57,840 CHANGES THAT OCCUR IN TERMS OF 1819 01:13:57,840 --> 01:13:59,400 ALTERED IMMUNE RESPONSE WITH 1820 01:13:59,400 --> 01:14:02,200 AGING, INFLAMMATORY RESPONSE. 1821 01:14:02,200 --> 01:14:04,120 ALTERATIONS IN PROTEIN FOLDING 1822 01:14:04,120 --> 01:14:06,800 AND SENESCENCE OF CELLS ARE 1823 01:14:06,800 --> 01:14:08,200 BASIC BIOLOGY OF AGING. DIVISION 1824 01:14:08,200 --> 01:14:10,320 OF NEUROSCIENCE, NOW LARGEST 1825 01:14:10,320 --> 01:14:12,320 AREA INCLUDES BUT NOT LIMITED TO 1826 01:14:12,320 --> 01:14:13,960 THE AD ALZHEIMER'S DEMENTIA THAT 1827 01:14:13,960 --> 01:14:20,480 I MENTIONED, HAS NOTED CRITICAL 1828 01:14:20,480 --> 01:14:22,040 INNEVER RELATIONSHIPS BETWEEN 1829 01:14:22,040 --> 01:14:23,720 HIV AND INFECTION AND PATHOLOGY 1830 01:14:23,720 --> 01:14:27,000 OF NEURODEGENERATION. DIVISION 1831 01:14:27,000 --> 01:14:29,440 OF GERIATRICS AND CLINICAL 1832 01:14:29,440 --> 01:14:30,840 GERONTOLOGY, THE FACT THAT 1833 01:14:30,840 --> 01:14:32,480 COMPLEXITY OF CLINICAL 1834 01:14:32,480 --> 01:14:35,240 CHALLENGES PEOPLE AS THEY AGE 1835 01:14:35,240 --> 01:14:36,440 INVOLVE CO-MORBIDITIES, IN 1836 01:14:36,440 --> 01:14:38,000 PARTICULAR FOR A DISCUSSION 1837 01:14:38,000 --> 01:14:40,600 TODAY HIV INFECTION INTERRELATES 1838 01:14:40,600 --> 01:14:42,240 WITH CO-MORBIDITIES OF AGING 1839 01:14:42,240 --> 01:14:43,040 CRITICALLY IMPORTANT PART TO 1840 01:14:43,040 --> 01:14:45,400 UNDERSTANDING HOW TO BEST MANAGE 1841 01:14:45,400 --> 01:14:49,920 AND SERVE OLDER ADULTS WITH HIV. 1842 01:14:49,920 --> 01:14:51,080 DIVISION OF BEHAVIORAL SOCIAL 1843 01:14:51,080 --> 01:14:53,080 RESEARCH AS WE LOOK NOT JUST AT 1844 01:14:53,080 --> 01:14:55,600 THE BEHAVIORAL ASPECT OF HIV 1845 01:14:55,600 --> 01:14:57,120 INFECTION OR RESPONSE TO 1846 01:14:57,120 --> 01:15:01,560 TREATMENT BUT ALSO WAY WE ASSESS 1847 01:15:01,560 --> 01:15:04,640 THE HEALTHCARE SYSTEMS AND 1848 01:15:04,640 --> 01:15:06,000 INFRASTRUCTURE, IMPORTANT TO 1849 01:15:06,000 --> 01:15:07,560 HOEING HOW TO BEST PROVIDE CARE 1850 01:15:07,560 --> 01:15:09,480 AND SERVICES FOR OLDER ADULTS 1851 01:15:09,480 --> 01:15:10,840 INCLUDING THOSE WITH 1852 01:15:10,840 --> 01:15:11,600 CO-MORBIDITIES AND MORE 1853 01:15:11,600 --> 01:15:12,960 SPECIFICALLY FOR TODAY INCLUDING 1854 01:15:12,960 --> 01:15:14,720 THOSE WITH HIV INFECTION. NEXT 1855 01:15:14,720 --> 01:15:18,440 PLEASE. SOME OF THE PRIORITY 1856 01:15:18,440 --> 01:15:22,320 AREAS HERE TO TOUCH ON THESE 1857 01:15:22,320 --> 01:15:25,960 BULLETS, UNDERSTANDING THE 1858 01:15:25,960 --> 01:15:27,520 INTERACTION BETWEEN GENETIC 1859 01:15:27,520 --> 01:15:29,120 CELLULAR CHANGES AND HIV 1860 01:15:29,120 --> 01:15:30,240 INFECTION UNDERSTANDING THOSE 1861 01:15:30,240 --> 01:15:31,960 MECHANISMS THAT ARE RELATED TO 1862 01:15:31,960 --> 01:15:33,400 THE CO-MORBIDITIES THAT OCCUR 1863 01:15:33,400 --> 01:15:36,200 WITH AGING, UNDERSTANDING THE 1864 01:15:36,200 --> 01:15:38,080 CONTRIBUTIONS OF INDIVIDUAL 1865 01:15:38,080 --> 01:15:38,760 DIFFERENCES AND STRUCTURAL 1866 01:15:38,760 --> 01:15:41,960 INSTITUTIONAL FACTORS, INCLUDING 1867 01:15:41,960 --> 01:15:45,080 IMPORTANT SOCIAL INEQUITIES AND 1868 01:15:45,080 --> 01:15:47,440 DISPARITIES WAY HIV MANIFESTS 1869 01:15:47,440 --> 01:15:48,880 ITSELF HOW WE EFFECT AND BEST 1870 01:15:48,880 --> 01:15:52,160 ADDRESS THE NEEDS OF PEOPLE WITH 1871 01:15:52,160 --> 01:15:54,240 HIV INFECTION. THE RELATION OF 1872 01:15:54,240 --> 01:15:56,320 HIV INFECTION AND COGNITIVE 1873 01:15:56,320 --> 01:15:58,360 DECLINE IS MORE ACUTE SPECIFIC 1874 01:15:58,360 --> 01:16:01,480 LATELY AND I KNOW IN PAST 1875 01:16:01,480 --> 01:16:02,640 CONVERSATION COVID INFECTION AS 1876 01:16:02,640 --> 01:16:03,520 ANOTHER VIRAL INFECTION AND 1877 01:16:03,520 --> 01:16:05,720 THERE TOO THE IMPACTS ON THE 1878 01:16:05,720 --> 01:16:09,200 NERVOUS SYSTEM, COGNITIVE 1879 01:16:09,200 --> 01:16:11,040 DECLINE BUT HIV LONG STANDING 1880 01:16:11,040 --> 01:16:12,520 FOCUS WHICH WE HAVE HAD 1881 01:16:12,520 --> 01:16:14,160 IMPORTANT COLLABORATIONS. 1882 01:16:14,160 --> 01:16:15,800 UNDERSTANDING THE ASSESSMENT OF 1883 01:16:15,800 --> 01:16:18,000 TREATMENT IN OLDER INDIVIDUALS 1884 01:16:18,000 --> 01:16:19,840 WITH HIV WHICH POLYPHARMACY 1885 01:16:19,840 --> 01:16:22,080 OTHER DRUGS IN RESPONSE TO HIV 1886 01:16:22,080 --> 01:16:23,480 TREATMENT ITSELF IS INFLUENCED 1887 01:16:23,480 --> 01:16:29,280 BY AGING PROCESS. NEXT PLEASE. 1888 01:16:29,280 --> 01:16:30,160 ANNOUNCEMENTS AND INITIATIVES 1889 01:16:30,160 --> 01:16:34,400 I'M REFERRING TO THE CENTRAL OF 1890 01:16:34,400 --> 01:16:37,040 HEALTH DISPARITIES DIVERSITY AND 1891 01:16:37,040 --> 01:16:39,560 APPROACHING STRUCTURAL RACISM. 1892 01:16:39,560 --> 01:16:42,320 HERE TOO WE HAVE HAD A LONG 1893 01:16:42,320 --> 01:16:43,840 STANDING AND VERY PERSONAL 1894 01:16:43,840 --> 01:16:46,160 INTEREST IN MANY ASPECTS HERE. I 1895 01:16:46,160 --> 01:16:48,040 GUESS FOR DISCUSSION TODAY 1896 01:16:48,040 --> 01:16:50,480 PERHAPS NEW RESEARCH, THE N IN 1897 01:16:50,480 --> 01:16:52,120 UNITE. THE NEW RESEARCH IN 1898 01:16:52,120 --> 01:16:53,560 HEALTH DISPARITIES MINORITY 1899 01:16:53,560 --> 01:16:55,720 HEALTH INEQUITIES AS THEY APPLY 1900 01:16:55,720 --> 01:16:58,240 TO HIV INFECTION IMPORTANT PART 1901 01:16:58,240 --> 01:17:00,160 OF OUR PARTNERSHIP BETWEEN NIA 1902 01:17:00,160 --> 01:17:06,240 AND OAR. AND THERE WAS TALK 1903 01:17:06,240 --> 01:17:08,880 EARLIER ABOUT THE STATE OF 1904 01:17:08,880 --> 01:17:10,800 TRAINEES, CAREER DEVELOPMENT 1905 01:17:10,800 --> 01:17:13,240 POST-DOCTORAL FELLOWS, AND 1906 01:17:13,240 --> 01:17:15,120 BALANCE BETWEEN THOSE GOING TO 1907 01:17:15,120 --> 01:17:17,160 ACADEMIC CAREERS AN THOSE 1908 01:17:17,160 --> 01:17:18,160 CHOOSING PRIVATE SECTOR INDUSTRY 1909 01:17:18,160 --> 01:17:20,680 AND OTHER AREAS. I WOULD COMMENT 1910 01:17:20,680 --> 01:17:23,400 HERE THAT AS WE KNOW IT IS ONLY 1911 01:17:23,400 --> 01:17:25,160 MINORITY FRACTION OF THOSE 1912 01:17:25,160 --> 01:17:26,480 PEOPLE WITH MANY BIOMEDICAL 1913 01:17:26,480 --> 01:17:28,200 Ph.D. DEGREES END UP IN 1914 01:17:28,200 --> 01:17:30,120 PROFESSIONAL ACADEMIC CAREERS. 1915 01:17:30,120 --> 01:17:33,640 AND WITH THIS IN MIND AS WELL AS 1916 01:17:33,640 --> 01:17:34,840 CHALLENGE OF DIVERSITY INCLUDING 1917 01:17:34,840 --> 01:17:36,600 THE DIVERSITY OF OUR WORK FORCE 1918 01:17:36,600 --> 01:17:40,880 WE INITIATED LAST YEAR, I THINK 1919 01:17:40,880 --> 01:17:41,520 NEW INNOVAR ITIVE PROGRAM WHICH 1920 01:17:41,520 --> 01:17:43,960 WAS A STARTUP CHALLENGE TO 1921 01:17:43,960 --> 01:17:47,120 FOSTER DIVERSITY AND INNOVATION 1922 01:17:47,120 --> 01:17:52,240 IN THE AREAS OF RESEARCH THAT 1923 01:17:52,240 --> 01:17:55,200 ARE ENTREPRENEURIAL. ON TOP OF 1924 01:17:55,200 --> 01:17:58,000 THE UNDERREPRESENTATION OF MANY 1925 01:17:58,000 --> 01:18:00,000 GROUPS IN THE BIOLOGIC WORK 1926 01:18:00,000 --> 01:18:02,080 FORCE ACADEMICALLY, IT IS MORE 1927 01:18:02,080 --> 01:18:04,040 PROFOUND IN IN SMALL BUSINESS 1928 01:18:04,040 --> 01:18:05,400 LARGE BUSINESS PHARMA AND 1929 01:18:05,400 --> 01:18:09,800 ENTREPRENEURIAL AREAS SO WHAT WE 1930 01:18:09,800 --> 01:18:11,240 DID IS ESTABLISH INITIATIVE 1931 01:18:11,240 --> 01:18:15,600 WHICH HAD 200 PEOPLE INITIALLY 1932 01:18:15,600 --> 01:18:17,320 RESPONDING. PROVIDED WITH 1933 01:18:17,320 --> 01:18:18,880 MENTORS, FOR THOSE WHO HAVE 1934 01:18:18,880 --> 01:18:20,200 EXPERTS IN THE FIELD OF 1935 01:18:20,200 --> 01:18:22,680 ENTREPRENEURIAL RESEARCH IN 1936 01:18:22,680 --> 01:18:23,960 BUSINESS, THEY WENT THROUGH A 1937 01:18:23,960 --> 01:18:25,200 CHALLENGE THAT INVOLVED THEIR 1938 01:18:25,200 --> 01:18:26,560 PROPOSING THEIR OWN RESEARCH 1939 01:18:26,560 --> 01:18:29,040 AREAS. HAVING EXPERT ASSISTANCE 1940 01:18:29,040 --> 01:18:32,600 IN GUIDANCE FOR WHAT IT MEANS TO 1941 01:18:32,600 --> 01:18:34,720 BE ENTREPRENEURIAL TO PROVIDE TO 1942 01:18:34,720 --> 01:18:37,040 POTENTIAL FUNDERS TO UNDERSTAND 1943 01:18:37,040 --> 01:18:39,240 WHAT IT MEANT -- MEANS TO HAVE 1944 01:18:39,240 --> 01:18:40,440 RESEARCH THAT DOES HAVE 1945 01:18:40,440 --> 01:18:43,480 TRANSLATIONAL PERSPECTIVE. THOSE 1946 01:18:43,480 --> 01:18:46,240 WE CAME DOWN TO 20 FINALISTS, 1947 01:18:46,240 --> 01:18:48,120 SELECTED FOR A BOOT CAMP WHICH 1948 01:18:48,120 --> 01:18:49,920 WAS QUITE INTENSIVE OVER WEEKS 1949 01:18:49,920 --> 01:18:50,840 IN WHICH THEY WORKED WITH 1950 01:18:50,840 --> 01:18:52,280 MENTORS TO COME UP WITH 1951 01:18:52,280 --> 01:18:55,560 PROPOSALS. AND THEN FROM THOSE 1952 01:18:55,560 --> 01:18:58,240 THE TOP FIVE RECEIVED A $60,000 1953 01:18:58,240 --> 01:19:00,880 AWARD TO ALLOW THEM TO FURTHER 1954 01:19:00,880 --> 01:19:03,440 BEGIN DEVELOPMENT OF A SMALL 1955 01:19:03,440 --> 01:19:04,800 BUSINESS APPLICATION WHICH THEN 1956 01:19:04,800 --> 01:19:07,280 WOULD COME TO NEA OR OTHER 1957 01:19:07,280 --> 01:19:07,960 RESEARCH INSTITUTES WITH 1958 01:19:07,960 --> 01:19:10,920 CONTINUED MENTORING. LONG TERM. 1959 01:19:10,920 --> 01:19:14,040 IT IS ENORMOUSLY SUCCESSFUL, THE 1960 01:19:14,040 --> 01:19:15,760 PICTURES OF 2022 CHALLENGE 1961 01:19:15,760 --> 01:19:17,800 WINNERS AND REPEAT THE PROGRAM 1962 01:19:17,800 --> 01:19:19,320 IN 2023. SO AS WE SHARE 1963 01:19:19,320 --> 01:19:22,480 COMMITMENT TO TRY TO MAKE THE 1964 01:19:22,480 --> 01:19:26,720 PATHWAY FOR ACADEMIC RESEARCH TO 1965 01:19:26,720 --> 01:19:28,760 BE AS RECEPTIVE AS IT CAN, WE 1966 01:19:28,760 --> 01:19:32,720 ARE EQUALLY COMMITTED TO 1967 01:19:32,720 --> 01:19:33,920 SUPPLYING THE NEEDS OF PRIVATE 1968 01:19:33,920 --> 01:19:36,320 SECTOR DOING THAT IN AREA WHERE 1969 01:19:36,320 --> 01:19:38,680 INCREASED DIVERSITY INCLUSION IS 1970 01:19:38,680 --> 01:19:42,360 VERY MUCH NEEDED. NEXT SLIDE. 1971 01:19:42,360 --> 01:19:43,800 SOME OTHER PROGRAMS MANY OF YOU 1972 01:19:43,800 --> 01:19:48,320 MAY BE AWARE OF BUTLER WILLIAM 1973 01:19:48,320 --> 01:19:50,800 PROGRAM, THE WEEK LONG IMMERSION 1974 01:19:50,800 --> 01:19:52,480 PROGRAM NIA RESPONDER SOD FOR 1975 01:19:52,480 --> 01:19:55,280 YEARS, NEW TO THE FIELD PEOPLE, 1976 01:19:55,280 --> 01:19:57,600 JUNIOR FACULTY DOCTORAL DEGREE, 1977 01:19:57,600 --> 01:20:00,440 A VERY STRONG EMPHASIS ON 1978 01:20:00,440 --> 01:20:03,160 DIVERSITY AND DISPARITIES 1979 01:20:03,160 --> 01:20:05,840 RESEARCH. THE MEETINGS HAD BEEN 1980 01:20:05,840 --> 01:20:07,840 IN PERSON I WILL COVID BUT LAST 1981 01:20:07,840 --> 01:20:09,160 TWO YEARS HAVING VIRTUAL TURNED 1982 01:20:09,160 --> 01:20:10,960 OUT EXTREMELY PRODUCTIVE WITH 1983 01:20:10,960 --> 01:20:14,480 FEEDBACK REVIEWS. SO IN 2023 1984 01:20:14,480 --> 01:20:15,760 PUBLIC HEALTH VIRTUALLY AS WELL 1985 01:20:15,760 --> 01:20:17,280 AND ENCOURAGE THOSE OF YOU TO 1986 01:20:17,280 --> 01:20:19,760 THINK ABOUT WAYS WHICH YOU YOUR 1987 01:20:19,760 --> 01:20:20,560 STUDENTS AND SCHOLARS MIGHT BE 1988 01:20:20,560 --> 01:20:22,040 INTERESTED IN PROFIT FROM THE 1989 01:20:22,040 --> 01:20:23,720 PROGRAM, THE LINK IS SHOWN HERE 1990 01:20:23,720 --> 01:20:25,880 AND OPEN FOR APPLICATIONS 1991 01:20:25,880 --> 01:20:30,160 THROUGH NEXT MONTH. NEXT PLEASE 1992 01:20:30,160 --> 01:20:31,920 AROUND ALZHEIMER'S RESEARCH WE 1993 01:20:31,920 --> 01:20:36,000 HAD ANNUAL SUMMITS THAT ARE IN 1994 01:20:36,000 --> 01:20:39,320 SERIES OF TWO THREE YEAR FOR 1995 01:20:39,320 --> 01:20:42,160 EACH KINDS OF SUMMITS. ONE IS 1996 01:20:42,160 --> 01:20:44,480 ALZHEIMER'S RESEARCH SUMMIT AND 1997 01:20:44,480 --> 01:20:46,520 OTHER IS ALZHEIMER'S RELATED 1998 01:20:46,520 --> 01:20:48,080 DEMENTIA SUMMIT AND THIRD WHAT 1999 01:20:48,080 --> 01:20:49,800 IS HAPPENING THIS YEAR, A SUMMIT 2000 01:20:49,800 --> 01:20:51,400 FOCUSED ON CARE SERVICES SUPPORT 2001 01:20:51,400 --> 01:20:53,440 PEOPLE LIVING WITH DEMENTIA AND 2002 01:20:53,440 --> 01:20:55,440 CARE PARTNERS AND CAREGIVERS. 2003 01:20:55,440 --> 01:20:59,480 THIS IS MARCH 20, 22ND, VIRTUAL, 2004 01:20:59,480 --> 01:21:00,960 STILL POSSIBLE TO SIGN UP AND I 2005 01:21:00,960 --> 01:21:02,440 STRESS HERE, SOME OF THE 2006 01:21:02,440 --> 01:21:05,720 CHALLENGES WE SEE WITH 2007 01:21:05,720 --> 01:21:08,320 INDIVIDUALS WITH HIV AIDS 2008 01:21:08,320 --> 01:21:09,880 CO-MORBIDITIES, A REAL 2009 01:21:09,880 --> 01:21:14,000 INTERSECTION I THINK OF SOCIAL 2010 01:21:14,000 --> 01:21:14,800 INFRASTRUCTURAL NEEDS. SO 2011 01:21:14,800 --> 01:21:17,560 EMPHASIZE PEOPLE HAVING IN MIND 2012 01:21:17,560 --> 01:21:18,640 THAT CONNECTION AND CONSIDERING 2013 01:21:18,640 --> 01:21:20,360 WHETHER THEY WANT TO SPEND TIME 2014 01:21:20,360 --> 01:21:22,360 AT THIS SUMMIT AND LEARNING THE 2015 01:21:22,360 --> 01:21:24,920 WAY IT INTERSECTS WITH SOME OF 2016 01:21:24,920 --> 01:21:26,360 THE OTHER BROADER CATEGORIES OF 2017 01:21:26,360 --> 01:21:27,840 CARE SERVICES FOR OLDER ADULTS 2018 01:21:27,840 --> 01:21:29,800 VERY MUCH INCLUDING THOSE WITH 2019 01:21:29,800 --> 01:21:33,600 HIV. NEXT PLEASE. TALK ABOUT 2020 01:21:33,600 --> 01:21:35,400 GERO SCIENCE A BIT, I WON'T GO 2021 01:21:35,400 --> 01:21:37,280 INTO IT AGAIN BUT TO SAY THE 2022 01:21:37,280 --> 01:21:39,520 FOURTH GERO SCIENCE SUMMIT 2023 01:21:39,520 --> 01:21:41,360 OCCURS THIS ONE HYBRID HOPEFULLY 2024 01:21:41,360 --> 01:21:43,360 BY APRIL WILL BE ALL RIGHT ON 2025 01:21:43,360 --> 01:21:44,880 CAMPUS. OPEN FOR REGISTRATION 2026 01:21:44,880 --> 01:21:46,520 NOW. THIS WILL DEAL WITH THE 2027 01:21:46,520 --> 01:21:51,640 MANY ASPECTS OF BASIC BIOLOGY OF 2028 01:21:51,640 --> 01:21:53,000 AND SOCIAL DETERMINANTS OF AGING 2029 01:21:53,000 --> 01:21:54,320 HOW THEY INTERSECT WITH 2030 01:21:54,320 --> 01:21:55,800 CONDITIONS OF THE DISEASE 2031 01:21:55,800 --> 01:22:01,520 RELEVANT TO HIV AMONG OTHERS. 2032 01:22:01,520 --> 01:22:02,640 FINALLY FROM MY PRESENTATION 2033 01:22:02,640 --> 01:22:05,240 TODAY A SERIES OF WAYS WHICH WE 2034 01:22:05,240 --> 01:22:06,840 HOPE WE CAN KEEP IN TOUCH WITH 2035 01:22:06,840 --> 01:22:09,520 YOU AND WHAT WE ARE DOING BEING 2036 01:22:09,520 --> 01:22:11,520 PROACTIVE SUBSCRIBING TO OUR 2037 01:22:11,520 --> 01:22:13,960 BLOG OR SUBSCRIBING TO ANY 2038 01:22:13,960 --> 01:22:17,760 ONLINE SERVICES. WE TREASURE THE 2039 01:22:17,760 --> 01:22:20,000 INPUT FROM ALL OF YOU IN YOUR 2040 01:22:20,000 --> 01:22:21,880 COMMUNITY AND HOPE THIS WILL 2041 01:22:21,880 --> 01:22:24,560 CONTINUE. LET ME STOP THERE AND 2042 01:22:24,560 --> 01:22:28,400 SEE WHAT WORKS ON YOUR AGENDA 2043 01:22:28,400 --> 01:22:30,080 AND MORE TALK ABOUT MAKING CLEAR 2044 01:22:30,080 --> 01:22:31,240 OTHER FOLKS AT NIA WILL BE 2045 01:22:31,240 --> 01:22:34,240 TALKING WITH YOU IN THE TIME TO 2046 01:22:34,240 --> 01:22:38,560 COME DURING THIS MEETING. 2047 01:22:38,560 --> 01:22:40,040 MARINE, WHERE ARE WE? WHAT CAN I 2048 01:22:40,040 --> 01:22:40,680 DO FOR YOU? 2049 01:22:40,680 --> 01:22:42,920 >>I WANT TO THANK YOU FOR A 2050 01:22:42,920 --> 01:22:44,360 GREAT PRESENTATION. IF YOU HAVE 2051 01:22:44,360 --> 01:22:46,720 A MINUTE OR TWO FOR COUPLE OF 2052 01:22:46,720 --> 01:22:48,920 QUESTIONS OR -- I KNOW YOU DO 2053 01:22:48,920 --> 01:22:52,720 HAVE TO LEAVE. I SEE THAT 2054 01:22:52,720 --> 01:22:56,000 (INAUDIBLE) FROM CDC HAS A 2055 01:22:56,000 --> 01:22:57,280 QUESTION. IS THAT OKAY? 2056 01:22:57,280 --> 01:22:58,040 >>ABSOLUTELY. 2057 01:22:58,040 --> 01:23:01,160 >>GREAT. 2058 01:23:01,160 --> 01:23:02,440 >>THANK YOU VERY MUCH FOR A 2059 01:23:02,440 --> 01:23:05,280 TOUR DE FORCE, INCREDIBLE WORK. 2060 01:23:05,280 --> 01:23:06,800 YOU HIGHLIGHTED NUMBER OF AREAS 2061 01:23:06,800 --> 01:23:09,360 FOR RESEARCH FROM LIKE DISEASES 2062 01:23:09,360 --> 01:23:11,080 THAT PREDOMINANTLY OCCUR IN 2063 01:23:11,080 --> 01:23:12,880 OLDER AGE AND THEN SOME OF THE 2064 01:23:12,880 --> 01:23:14,320 ASPECTS OF AGING AMONG PEOPLE 2065 01:23:14,320 --> 01:23:15,920 WITH HIV. I HAD A QUESTION FOR 2066 01:23:15,920 --> 01:23:20,120 YOU PERSONALLY. WHICH IS FROM 2067 01:23:20,120 --> 01:23:22,920 THE FUNDAMENTAL CELLULAR ASPECTS 2068 01:23:22,920 --> 01:23:27,640 OF AGING WHETHER GLYCOSYLATIONS 2069 01:23:27,640 --> 01:23:30,120 TO FORMIZATION, TELOME LINK, -- 2070 01:23:30,120 --> 01:23:31,000 PHOSPHORYLATION, WHATEVER, 2071 01:23:31,000 --> 01:23:33,280 THERE'S A MOVEMENT OF SCIENCE 2072 01:23:33,280 --> 01:23:36,360 INTO CLINICAL TRIALS. I WAS JUST 2073 01:23:36,360 --> 01:23:37,280 WONDERING, DO YOU HAVE ANY SENSE 2074 01:23:37,280 --> 01:23:38,560 OF WHAT YOU THINK WOULD BE THE 2075 01:23:38,560 --> 01:23:43,600 MOST PROMISING INTERVENTIONAL 2076 01:23:43,600 --> 01:23:44,280 CLINICAL TRIALS THAT COULD 2077 01:23:44,280 --> 01:23:46,600 BENEFIT PEOPLE WITH HIV AT THIS 2078 01:23:46,600 --> 01:23:48,600 TIME? ARE THERE ANY THAT ARE 2079 01:23:48,600 --> 01:23:51,720 INCLUDING PEOPLE WITH HIV? 2080 01:23:51,720 --> 01:23:53,120 >>GREAT QUESTION. STARTING WITH 2081 01:23:53,120 --> 01:23:54,920 THE BASIC, IT IS THE QUESTION 2082 01:23:54,920 --> 01:23:56,040 WHETHER THERE WERE TREATMENTS 2083 01:23:56,040 --> 01:23:59,240 FOR INTERVENTION NOT FOR A 2084 01:23:59,240 --> 01:24:00,080 SPECIFIC DISEASE OR CONDITION 2085 01:24:00,080 --> 01:24:02,000 RELATED TO AGING BUT COULD 2086 01:24:02,000 --> 01:24:03,600 INTERVENE SOMEHOW IN AGING 2087 01:24:03,600 --> 01:24:06,000 PROCESSES THAT ARE RELEVANT TO 2088 01:24:06,000 --> 01:24:07,160 MULTIPLE CONDITIONS DISEASES 2089 01:24:07,160 --> 01:24:08,520 MAKE A DIFFERENCE, THERE'S BEEN 2090 01:24:08,520 --> 01:24:10,200 A LONG STANDING ONE. THE 2091 01:24:10,200 --> 01:24:11,280 INTERVENTION AROUND THE LONGEST 2092 01:24:11,280 --> 01:24:13,320 SURE YOU ARE AWARE, IS CALORIC 2093 01:24:13,320 --> 01:24:15,440 RESTRICTION. AND WHAT ITS 2094 01:24:15,440 --> 01:24:17,120 PRACTICALITIES WERE BUT MORE 2095 01:24:17,120 --> 01:24:18,840 RECENTLY THERE'S SOME -- THIS IS 2096 01:24:18,840 --> 01:24:20,360 SOME VERY IMPRESSIVE PROGRESS, 2097 01:24:20,360 --> 01:24:25,000 IN AREAS AROUND THE PILLARS 2098 01:24:25,000 --> 01:24:26,880 MECHANISMS OF AGING ONE WHICH I 2099 01:24:26,880 --> 01:24:28,040 COULD FOCUS ON MAYBE TO YOUR 2100 01:24:28,040 --> 01:24:29,560 QUESTION, SPECIFICALLY IS THAT 2101 01:24:29,560 --> 01:24:32,240 OF SENESCENCE. CELLULAR 2102 01:24:32,240 --> 01:24:36,040 SENESCENCE. JUST TO BRING PEOPLE 2103 01:24:36,040 --> 01:24:38,040 UP TO COMMON BASES FOR THIS, 2104 01:24:38,040 --> 01:24:39,360 THIS IS DESCRIBED AS A 2105 01:24:39,360 --> 01:24:41,120 PHENOMENON WHICH SAYS IF YOU 2106 01:24:41,120 --> 01:24:43,360 CULTURE CELLS IN VITRO, IN 2107 01:24:43,360 --> 01:24:45,920 TISSUE CULTURE THEY SINs AND 2108 01:24:45,920 --> 01:24:47,920 STOP DIVIDING. THAT WAS BIG NEWS 2109 01:24:47,920 --> 01:24:50,440 IN 19 # 0s BECAUSE UNTIL THEN 2110 01:24:50,440 --> 01:24:51,480 THE LANGUAGE WAS INDIVIDUAL 2111 01:24:51,480 --> 01:24:53,840 CELLS WERE IMMORTAL. NOW AS A 2112 01:24:53,840 --> 01:24:55,120 RESULT OF CELLULAR SENESCENCE 2113 01:24:55,120 --> 01:24:56,280 AND CHARACTERIZING WHAT IT MEANS 2114 01:24:56,280 --> 01:25:00,680 FOR THEM TO SINESCE IN THE PAST 2115 01:25:00,680 --> 01:25:02,320 DECADE QUITE EXTRAORDINARY 2116 01:25:02,320 --> 01:25:03,680 PROGRESS IDENTIFYING NORMAL 2117 01:25:03,680 --> 01:25:06,040 ANIMALS AN INDIVIDUALS AS THEY 2118 01:25:06,040 --> 01:25:07,880 AGE, SENESCENCE CELLS APPEAR, 2119 01:25:07,880 --> 01:25:09,160 CAN BE IDENTIFIED BY GENE 2120 01:25:09,160 --> 01:25:11,600 EXPRESSION PATTERNS WHAT THEY 2121 01:25:11,600 --> 01:25:12,840 SECRETE, THEY INCREASE NUMBERS 2122 01:25:12,840 --> 01:25:15,400 WITH AGING, THEY ARE IN ALL 2123 01:25:15,400 --> 01:25:18,040 TISSUES. AND THEY DON'T JUST SIT 2124 01:25:18,040 --> 01:25:19,200 THERE CELLS THAT CAN'T DIVIDE 2125 01:25:19,200 --> 01:25:21,040 ANY MORE, BECAUSE OF THE 2126 01:25:21,040 --> 01:25:22,160 SECRETORY PHENOTYPES HAVE 2127 01:25:22,160 --> 01:25:23,920 ADVERSE EFFECTS IN MANY DOMAINS 2128 01:25:23,920 --> 01:25:25,680 ANDY MENTIONS. IN ANIMAL STUDIES 2129 01:25:25,680 --> 01:25:28,280 OVER THE PAST FEW YEARS DRAMATIC 2130 01:25:28,280 --> 01:25:32,680 FINDINGS WENT THROUGH CLEVER 2131 01:25:32,680 --> 01:25:36,080 GENETIC MANIPULATIONS, 2132 01:25:36,080 --> 01:25:37,120 SENESCENCE CELLS WERE 2133 01:25:37,120 --> 01:25:38,760 SELECTIVELY ELIMINATED. 2134 01:25:38,760 --> 01:25:40,560 FUNCTION, MOTOR FUNCTION, 2135 01:25:40,560 --> 01:25:41,480 COGNITIVE FUNCTION LIFE SPAN ALL 2136 01:25:41,480 --> 01:25:45,120 INCREASE. TO YOUR POINT ABOUT 2137 01:25:45,120 --> 01:25:47,000 CLINICAL TRANSLATION AFTER THIS 2138 01:25:47,000 --> 01:25:48,200 -- APOLOGIZE FOR THE LONG BUILD 2139 01:25:48,200 --> 01:25:52,240 UP TO IT. NOW QUITE REMARKABLY 2140 01:25:52,240 --> 01:25:53,640 THIS IS INTO CLINICAL TRIALS 2141 01:25:53,640 --> 01:25:55,840 PRIVATE SECTOR IS TAKEN UP 2142 01:25:55,840 --> 01:25:57,720 LOOKING AT DRUGS THAT HAVE 2143 01:25:57,720 --> 01:26:00,880 RELATIVELY SELECTIVE IMPACTS ON 2144 01:26:00,880 --> 01:26:02,160 SENESCENCE CELLS. IN THE 2145 01:26:02,160 --> 01:26:03,800 BEGINNING AS MAKES NO SENSE 2146 01:26:03,800 --> 01:26:06,920 TRANSLATION NOT TRYING TO IF YOU 2147 01:26:06,920 --> 01:26:08,720 WILL CURE AGE OR EXTEND LIFE 2148 01:26:08,720 --> 01:26:10,280 SPAN BUT FIRST LOOKING AT 2149 01:26:10,280 --> 01:26:12,560 SPECIFIC CONDITIONS, AND THEY 2150 01:26:12,560 --> 01:26:14,200 INVOLVE SKIN CONDITIONS, 2151 01:26:14,200 --> 01:26:15,520 MUSCULOSKELETAL CONDITIONS, 2152 01:26:15,520 --> 01:26:17,600 WHERE SENESCENCE CELLS 2153 01:26:17,600 --> 01:26:19,760 ACCUMULATIONS HAPPEN, EASY TO 2154 01:26:19,760 --> 01:26:21,760 MONITOR WHEN SENESCENCE CELLS 2155 01:26:21,760 --> 01:26:23,760 ARE AFFECTED BY TREATMENT. A 2156 01:26:23,760 --> 01:26:24,640 QUITE EXTRAORDINARY PACE, THIS 2157 01:26:24,640 --> 01:26:26,440 IS MOVING INTO CLINICAL AREAS. 2158 01:26:26,440 --> 01:26:27,840 I THINK WE ARE NOT QUITE THERE 2159 01:26:27,840 --> 01:26:31,080 YET. TO MY KNOWLEDGE AT LEAST 2160 01:26:31,080 --> 01:26:33,400 FOR HIV INFECTION. BUT EXTENT WE 2161 01:26:33,400 --> 01:26:35,920 ARE LOOKING AT IMPACTS ON THE 2162 01:26:35,920 --> 01:26:39,720 IMMUNE SYSTEM AND ELIMINATING 2163 01:26:39,720 --> 01:26:41,200 SENESCENCE CELLS BY 2164 01:26:41,200 --> 01:26:42,640 TRANSCRIPTIONAL FACTOR 2165 01:26:42,640 --> 01:26:43,880 MANIPULATIONS, YOU MENTION 2166 01:26:43,880 --> 01:26:44,720 SPECIFIC LIP REVERSING CHANGES 2167 01:26:44,720 --> 01:26:47,720 OF AGING AND ENHANCING 2168 01:26:47,720 --> 01:26:49,600 RESPONSIVENESS OF THE SYSTEM, 2169 01:26:49,600 --> 01:26:52,440 ONE CAN IMAGINE HERE IMPACT ON 2170 01:26:52,440 --> 01:26:54,080 ERADICATING INFECTION INCLUDING 2171 01:26:54,080 --> 01:26:56,520 CHRONIC INFECTION. THAT IS 2172 01:26:56,520 --> 01:26:58,040 PROBABLY TRAJECTORY THAT MAKES 2173 01:26:58,040 --> 01:27:01,400 MOST SENSE TO ME AS ONE RELEVANT 2174 01:27:01,400 --> 01:27:04,360 TO HIV AT PRESENT. SO THE PACE 2175 01:27:04,360 --> 01:27:07,480 EARLY STAGES BUT QUITE 2176 01:27:07,480 --> 01:27:09,720 EXTRAORDINARY AS A RATE OF 2177 01:27:09,720 --> 01:27:11,120 DEVELOPMENT I WOULD THINK. 2178 01:27:11,120 --> 01:27:14,880 >>GREAT. ARE THERE ANY -- I 2179 01:27:14,880 --> 01:27:16,720 DON'T SEE ANY OTHER HANDS BUT IF 2180 01:27:16,720 --> 01:27:18,120 YOU HAVE TIME FOR ONE MORE 2181 01:27:18,120 --> 01:27:19,960 QUESTION IF THERE IS ONE. 2182 01:27:19,960 --> 01:27:22,920 >>HAPPY TO. 2183 01:27:22,920 --> 01:27:24,520 >>BLANTON, CAN YOU SEE ANYTHING 2184 01:27:24,520 --> 01:27:25,760 THAT I'M MISSING? 2185 01:27:25,760 --> 01:27:30,040 >>I DON'T SEE HANDS. ACTUALLY 2186 01:27:30,040 --> 01:27:32,040 DR. BRANDEAU. 2187 01:27:32,040 --> 01:27:34,120 >>THANK YOU FOR THE GREAT 2188 01:27:34,120 --> 01:27:34,840 PRESENTATIONS, SUPER 2189 01:27:34,840 --> 01:27:39,000 INTERESTING. MY QUESTION, I 2190 01:27:39,000 --> 01:27:41,040 THOUGHT YOUR WHAT YOU TALKED 2191 01:27:41,040 --> 01:27:43,120 ABOUT WITH THE SESSIONS FOR 2192 01:27:43,120 --> 01:27:45,320 INVESTIGATORS NEW TO THE FIELD 2193 01:27:45,320 --> 01:27:48,600 REALLY EXCITING. AND YOUR 2194 01:27:48,600 --> 01:27:50,280 BUSINESS DEVELOPMENT STARTUP 2195 01:27:50,280 --> 01:27:51,600 IDEAS OR WHATEVER YOU WANT TO 2196 01:27:51,600 --> 01:27:55,120 CALL THAT.MENT I WONDER IF OTHER 2197 01:27:55,120 --> 01:27:57,600 PARTS OF NIH ARE DOING SUCH 2198 01:27:57,600 --> 01:27:59,200 THINGS? THEY SEEM LIKE REALLY 2199 01:27:59,200 --> 01:28:01,800 WONDERFUL WAYS OF WE HAVE TALKED 2200 01:28:01,800 --> 01:28:04,920 ABOUT A LOT OF SCHOLARS, DON'T 2201 01:28:04,920 --> 01:28:06,840 STAY IN ACADEMIA FOR BETTER OR 2202 01:28:06,840 --> 01:28:09,680 WORSE. OR DON'T DO BAYING IS 2203 01:28:09,680 --> 01:28:10,000 RESEARCH. . 2204 01:28:10,000 --> 01:28:10,720 THEY JUST SEEM LIKE WONDERFUL 2205 01:28:10,720 --> 01:28:13,040 WAYS TO ENGAGE PEOPLE, WONDER IF 2206 01:28:13,040 --> 01:28:14,200 OTHER PARTS OF NIH ARE DOING 2207 01:28:14,200 --> 01:28:15,280 SIMILAR THINGS. 2208 01:28:15,280 --> 01:28:17,320 >>I DO THINK IT IS RELATIVELY 2209 01:28:17,320 --> 01:28:18,720 NOW, SO WE FIRST INSTITUTED THE 2210 01:28:18,720 --> 01:28:22,720 PROGRAM, PRESENTED IT AT ONE OF 2211 01:28:22,720 --> 01:28:25,040 OUR THURSDAY MORNING MEETINGS 2212 01:28:25,040 --> 01:28:26,480 INSTITUTE DIRECTORS, WELL 2213 01:28:26,480 --> 01:28:27,640 RECEIVED WITH INTEREST SO WE 2214 01:28:27,640 --> 01:28:29,280 TALKED TO OTHER INSTITUTES BUT 2215 01:28:29,280 --> 01:28:30,560 SO NEW THERE'S NOT TIME FOR IT 2216 01:28:30,560 --> 01:28:33,480 TO BE PICKED UP AS YET. THAT 2217 01:28:33,480 --> 01:28:36,240 SPECIFIC PROGRAMMING. 2218 01:28:36,240 --> 01:28:38,440 >>THANK YOU SO MUCH AGAIN 2219 01:28:38,440 --> 01:28:39,880 RICHARD, GOOD TO SEE YOU, GOOD 2220 01:28:39,880 --> 01:28:41,320 LUCK WITH YOUR NEXT MEETING. 2221 01:28:41,320 --> 01:28:42,560 >>MY PLEASURE. 2222 01:28:42,560 --> 01:28:47,680 >>TAKE IT. BYE-BYE. BLANTON, 2223 01:28:47,680 --> 01:28:49,080 BACK TO YOU. 2224 01:28:49,080 --> 01:28:52,920 >>THANK YOU, MAUREEN. SO WE 2225 01:28:52,920 --> 01:28:56,400 HAVE TWO ADDITIONAL SPEAKERS IN 2226 01:28:56,400 --> 01:28:57,400 THIS SESSION AND CERTAINLY GOING 2227 01:28:57,400 --> 01:28:58,960 TO HAVE A RICH DISCUSSION 2228 01:28:58,960 --> 01:29:02,400 AFTERWARDS. SO I WANT TO NOW 2229 01:29:02,400 --> 01:29:05,080 INTRODUCE DR. STACY LAWRENCE, 2230 01:29:05,080 --> 01:29:08,880 THE NIA DIVISION OF AGING AND 2231 01:29:08,880 --> 01:29:13,880 BIOLOGY AND DR. BASAL ELDAHDAH 2232 01:29:13,880 --> 01:29:15,400 DIVISION OF GERIATRIC AND 2233 01:29:15,400 --> 01:29:16,760 CLINICAL GERONTOLOGY. WELCOME, 2234 01:29:16,760 --> 01:29:22,840 COLLEAGUES. 2235 01:29:22,840 --> 01:29:28,240 >>THANK YOU. I WANT TO THANK 2236 01:29:28,240 --> 01:29:30,560 DR. HODES FOR COMPREHENSIVE 2237 01:29:30,560 --> 01:29:32,120 OVERVIEW OF NIA AND INTRODUCING 2238 01:29:32,120 --> 01:29:32,960 OUR HIV RESEARCH THAT WE 2239 01:29:32,960 --> 01:29:39,200 SUPPORT. BAS AL WILL AND I WILL 2240 01:29:39,200 --> 01:29:43,720 PROVIDE ADDITIONAL FOCUS ON THE 2241 01:29:43,720 --> 01:29:44,600 CIVIC DIVISIONS DR. HODES 2242 01:29:44,600 --> 01:29:45,720 MENTIONED. ALSO RECENT 2243 01:29:45,720 --> 01:29:48,080 HIGHLIGHTS FROM HIV STUDIES 2244 01:29:48,080 --> 01:29:53,720 SUPPORTED BY NIA. TO INTRODUCE 2245 01:29:53,720 --> 01:29:54,560 THE NIH AVE TEAM. IN I A 2246 01:29:54,560 --> 01:29:57,640 DIVISION TO MYSELF AND BASIL, 2247 01:29:57,640 --> 01:30:01,160 THE TEAM ALSO INCLUDES DR.S 2248 01:30:01,160 --> 01:30:05,520 MELISSA GERALD, MACKOITH 2249 01:30:05,520 --> 01:30:07,920 (PHONETIC) AND MIA MACK, AND 2250 01:30:07,920 --> 01:30:09,920 THEY SHOULD BE AVAILABLE AT THE 2251 01:30:09,920 --> 01:30:10,800 CONCLUSION OF THE PRESENTATION 2252 01:30:10,800 --> 01:30:16,160 TO ANSWER QUESTIONS. AS DR. 2253 01:30:16,160 --> 01:30:18,440 HODES MENTIONED THERE ARE FOUR 2254 01:30:18,440 --> 01:30:19,080 SCIENTIFIC DIVISIONS AND I WILL 2255 01:30:19,080 --> 01:30:21,160 START WITH THE DIVISION OF AGING 2256 01:30:21,160 --> 01:30:24,760 BIOLOGY. WHICH IS DIVISION I 2257 01:30:24,760 --> 01:30:26,360 REPRESENT IN THE WORK GROUP AT 2258 01:30:26,360 --> 01:30:28,520 NIA. THIS DIVISION HAS A FOCUS 2259 01:30:28,520 --> 01:30:30,680 ON UNDERSTANDING THE IMPACT OF 2260 01:30:30,680 --> 01:30:32,960 HIV INFECTION AND PATHOGENESIS, 2261 01:30:32,960 --> 01:30:34,320 IN THE CONTEXT OF AGING RELATED 2262 01:30:34,320 --> 01:30:36,320 GENETIC MOLECULAR AND CELLULAR 2263 01:30:36,320 --> 01:30:38,560 CHANGES. AS WELL AS 2264 01:30:38,560 --> 01:30:39,680 PHYSIOLOGICAL OUTCOMES. WE 2265 01:30:39,680 --> 01:30:40,560 SUPPORT RESEARCH TO UNDERSTAND 2266 01:30:40,560 --> 01:30:42,680 THE MOLECULAR MECHANISMS THAT 2267 01:30:42,680 --> 01:30:44,880 MAY BE COMMON TO MULTIPLE 2268 01:30:44,880 --> 01:30:46,400 CO-MORBID STATES IN AGING. 2269 01:30:46,400 --> 01:30:48,760 INCLUDING AGING WITH HIV. AND WE 2270 01:30:48,760 --> 01:30:50,520 ALSO PROVIDE RESEARCH RESOURCES 2271 01:30:50,520 --> 01:30:53,360 TO ADVANCE THESE AND OTHER AGING 2272 01:30:53,360 --> 01:30:58,640 STUDIES. NEXT SLIDE. MANY OF 2273 01:30:58,640 --> 01:31:00,080 THE STUDIES SUPPORT AIMING TO 2274 01:31:00,080 --> 01:31:00,680 UNDERSTAND THE INTERACTIONS 2275 01:31:00,680 --> 01:31:02,720 AMONG THE HALLMARKS OF AGING, AS 2276 01:31:02,720 --> 01:31:05,520 WELL AS MECHANISMS INVOLVED IN 2277 01:31:05,520 --> 01:31:07,280 IMPORTANT CROSS TALK. DR. HODES 2278 01:31:07,280 --> 01:31:09,120 MENTIONED A LITTLE BIT ABOUT THE 2279 01:31:09,120 --> 01:31:12,720 HALLMARKS OF AGING, WHICH ARE 2280 01:31:12,720 --> 01:31:13,840 BIOCHEMICAL CHANGES THAT OCCUR 2281 01:31:13,840 --> 01:31:16,960 IN ALL ORGANISMS THAT EXPERIENCE 2282 01:31:16,960 --> 01:31:19,920 BIOLOGICAL AGING AND LEAD TO 2283 01:31:19,920 --> 01:31:21,880 PROGRESSIVE LOSS OF OR I GUESS 2284 01:31:21,880 --> 01:31:23,200 DEFICITS LEAD TO PROGRESSIVE 2285 01:31:23,200 --> 01:31:26,200 LOSS OF PHYSIOLOGICAL INTEGRITY 2286 01:31:26,200 --> 01:31:27,080 IMPAIRED FUNCTION LEADING TO 2287 01:31:27,080 --> 01:31:28,840 FRAILTY AN CO-MORBIDITIES 2288 01:31:28,840 --> 01:31:31,680 ASSOCIATED WITH AGING. THESE 2289 01:31:31,680 --> 01:31:34,080 CHANGES INCLUDE DYSFUNCTION, 2290 01:31:34,080 --> 01:31:35,480 CELLULAR SENESCENCE WE HAD A 2291 01:31:35,480 --> 01:31:37,120 CONVERSATION ABOUT. 2292 01:31:37,120 --> 01:31:39,320 MITOCHONDRIAL DYSFUNCTION, 2293 01:31:39,320 --> 01:31:41,040 MICROBIOME DYSBIOSIS, LOSS OF 2294 01:31:41,040 --> 01:31:43,200 PROTEIN INTEGRITY, EPIGENETIC 2295 01:31:43,200 --> 01:31:46,000 CHANGES AMONG MANY OTHERS. THE 2296 01:31:46,000 --> 01:31:48,360 DIVISION ALSO SUPPORTS RESEARCH 2297 01:31:48,360 --> 01:31:49,960 EXAMINATIONS SIGNALING PATHWAYS 2298 01:31:49,960 --> 01:31:51,680 AND MECHANISMS INVOLVED IN 2299 01:31:51,680 --> 01:31:54,080 INTERORGAN COMMUNICATION, WHICH 2300 01:31:54,080 --> 01:31:56,080 AS SOME OF YOU MAY KNOW IS THE 2301 01:31:56,080 --> 01:31:58,600 GATEKEEPER FOR METABOLIC HEALTH 2302 01:31:58,600 --> 01:32:00,800 THESE MULTI-DIRECTIONAL 2303 01:32:00,800 --> 01:32:03,720 INTERACTIONS BETWEEN THE VARIOUS 2304 01:32:03,720 --> 01:32:05,640 ORGANS ALONG WITH THE CENTRAL 2305 01:32:05,640 --> 01:32:07,880 NERVOUS SYSTEM HELPED MAINTAIN 2306 01:32:07,880 --> 01:32:10,800 WHOLE BODY HOMEOSTASIS AND 2307 01:32:10,800 --> 01:32:12,200 ENSURES SORT OF OUR ABILITY TO 2308 01:32:12,200 --> 01:32:16,000 ADAPT TO OUR ENVIRONMENT. HIV 2309 01:32:16,000 --> 01:32:17,360 INFECTION HAS BEEN SHOWN TO 2310 01:32:17,360 --> 01:32:19,520 IMPACT SEVERAL OF THESE 2311 01:32:19,520 --> 01:32:21,360 PROCESSES AND MANY HIV STUDIES 2312 01:32:21,360 --> 01:32:23,800 WITHIN OUR DIVISION PORTFOLIO 2313 01:32:23,800 --> 01:32:29,920 ARE FOCUSED ON THESE AREAS. AS 2314 01:32:29,920 --> 01:32:31,800 DR. HODES MENTIONED OUR DIVISION 2315 01:32:31,800 --> 01:32:33,920 IS ALSO LEADING EFFORTS ON GERO 2316 01:32:33,920 --> 01:32:35,560 SCIENCE WHICH IS FOCUSED ON 2317 01:32:35,560 --> 01:32:38,800 DISCOVERY AN TRANSLATION OF 2318 01:32:38,800 --> 01:32:40,280 BIOLOGICAL TARGETS TO 2319 01:32:40,280 --> 01:32:41,160 INTERVENTIONS THAT PREVENT 2320 01:32:41,160 --> 01:32:42,480 MINIMIZE OR REVERSE AGING 2321 01:32:42,480 --> 01:32:46,320 RELATED DEFICITS. THESE 2322 01:32:46,320 --> 01:32:47,720 DEFICITS ARE WHAT DIMINISHED 2323 01:32:47,720 --> 01:32:49,640 QUALITY OF LIFE FOR OLDER 2324 01:32:49,640 --> 01:32:52,120 INDIVIDUALS. OUR DIVISION 2325 01:32:52,120 --> 01:32:53,760 SUPPORTS TWO SPECIFIC PROGRAMS 2326 01:32:53,760 --> 01:32:55,400 THAT LOOK AT PRE-CLINICAL 2327 01:32:55,400 --> 01:32:56,960 RESEARCH TO IDENTIFY 2328 01:32:56,960 --> 01:32:59,720 INTERVENTIONS THAT IMPACT NOT 2329 01:32:59,720 --> 01:33:05,200 JUST LONGEVITY BUT HEALTH SPAN. 2330 01:33:05,200 --> 01:33:07,840 AND AGAIN WE WILL BE HOLDING THE 2331 01:33:07,840 --> 01:33:11,400 FOURTH GERO SCIENCE SUMMIT, WILL 2332 01:33:11,400 --> 01:33:13,480 TAKE PLACE NEXT MONTH, INCLUDES 2333 01:33:13,480 --> 01:33:14,400 PRESENTATIONS OF RELEVANCE TO 2334 01:33:14,400 --> 01:33:15,720 THE HIV COMMUNITY. AND IF YOU 2335 01:33:15,720 --> 01:33:18,520 WOULD LIKE ADDITIONAL 2336 01:33:18,520 --> 01:33:22,840 INFORMATION ABOUT GERO SCIENCE 2337 01:33:22,840 --> 01:33:24,760 MORE BROADLY OR SUMMIT FIND ON 2338 01:33:24,760 --> 01:33:28,640 OUR DIVISION OF AGING WEBSITE. 2339 01:33:28,640 --> 01:33:29,640 LASTLY, FOR THE DIVISION OF 2340 01:33:29,640 --> 01:33:30,880 AGING BIOLOGY, I WANT TO 2341 01:33:30,880 --> 01:33:33,520 HIGHLIGHT A COUPLE OF RECENT 2342 01:33:33,520 --> 01:33:37,760 STUDIES THAT PROVIDE COMPELLING 2343 01:33:37,760 --> 01:33:39,440 EVIDENCE HIV INFECTION CAUSES 2344 01:33:39,440 --> 01:33:42,520 ACCELERATED AGING. TWO GROUPS 2345 01:33:42,520 --> 01:33:45,040 THAT HAVE SHOWN USING VARIOUS 2346 01:33:45,040 --> 01:33:47,080 EPIGENETIC PLAQUES WHICH MEASURE 2347 01:33:47,080 --> 01:33:48,680 GENERAL IF I CAN MODIFICATIONS 2348 01:33:48,680 --> 01:33:51,040 OR METHYLATION CHANGES TO THE 2349 01:33:51,040 --> 01:33:52,200 GENOME, THAT HAVE BEEN 2350 01:33:52,200 --> 01:33:54,920 ASSOCIATED WITH CELLULAR AGING, 2351 01:33:54,920 --> 01:33:57,560 OCCUR FROM THE VERY BEGINNING OF 2352 01:33:57,560 --> 01:34:01,360 HIV INFECTION AS A STRESSOR AND 2353 01:34:01,360 --> 01:34:03,560 SHOWS ABOUT A TWO TO FIVE YEAR 2354 01:34:03,560 --> 01:34:06,400 ACCELERATION IN BIOLOGICAL AGE. 2355 01:34:06,400 --> 01:34:07,880 THESE STUDIES WERE PERFORMED AT 2356 01:34:07,880 --> 01:34:11,920 A SMALL NUMBER OF PARTICIPANTS 2357 01:34:11,920 --> 01:34:13,160 SO MORE WORK NEEDS TO BE DONE IN 2358 01:34:13,160 --> 01:34:15,920 THIS AREA TO UNDERSTAND DURATION 2359 01:34:15,920 --> 01:34:18,520 OF THIS ACCELERATION WHETHER 2360 01:34:18,520 --> 01:34:19,720 ACCELERATION AGING FLUCTUATES 2361 01:34:19,720 --> 01:34:24,600 OVER TIME. AND WITH EFFECTIVE 2362 01:34:24,600 --> 01:34:25,920 INTERVERTEBRAL TREATMENT. MORE 2363 01:34:25,920 --> 01:34:27,920 RESEARCH NEEDS TO BE DONE TO 2364 01:34:27,920 --> 01:34:31,120 LINK STUDIES TO MORBIDITY AND 2365 01:34:31,120 --> 01:34:36,000 MORTALITY IN PEOPLE WITH HIV. SO 2366 01:34:36,000 --> 01:34:38,400 THE DIVISION OF NEUROSCIENCE IS 2367 01:34:38,400 --> 01:34:43,760 REPRESENTED BY DR.S MACKOWITSTS 2368 01:34:43,760 --> 01:34:45,920 WITH OUR TEAM AT NIAND THAT 2369 01:34:45,920 --> 01:34:47,280 FOCUSES ON FURTHERING ARE THE 2370 01:34:47,280 --> 01:34:50,000 UNDERSTANDING OF NOT ONLY 2371 01:34:50,000 --> 01:34:51,360 DEMENTIA AND AGE AND THE 2372 01:34:51,360 --> 01:34:52,800 NEUROLOGICAL PROCESSES 2373 01:34:52,800 --> 01:34:55,160 ASSOCIATED WITH A NORMALLY AGING 2374 01:34:55,160 --> 01:34:56,680 BRAIN. THIS DIVISION SUPPORTS 2375 01:34:56,680 --> 01:34:58,520 BASIC CLINICAL EPIDEMIOLOGICAL 2376 01:34:58,520 --> 01:35:02,000 STUDIES OF ALZHEIMER'S DISEASE 2377 01:35:02,000 --> 01:35:04,000 ON RELATED DEMENTIA AGING AS 2378 01:35:04,000 --> 01:35:05,360 WELL AS RELATIONSHIPS BETWEEN 2379 01:35:05,360 --> 01:35:06,640 HIV INFECTION AND COGNITIVE 2380 01:35:06,640 --> 01:35:09,440 DECLINE ESPECIALLY IN 2381 01:35:09,440 --> 01:35:10,880 ALZHEIMER'S DISEASE AND OTHER 2382 01:35:10,880 --> 01:35:11,960 NEUROLOGICAL IMPAIRMENTS IN 2383 01:35:11,960 --> 01:35:13,680 PEOPLE WITH HIV AND ADVANCING 2384 01:35:13,680 --> 01:35:19,520 AGE. SO THE DIVISION OF 2385 01:35:19,520 --> 01:35:21,320 NEUROSCIENCE PORTFOLIO INCLUDE 2386 01:35:21,320 --> 01:35:22,840 SEVERAL STUDIES, INCLUDING THESE 2387 01:35:22,840 --> 01:35:25,480 THAT ARE LISTED HERE FROM 2388 01:35:25,480 --> 01:35:28,080 COLLABORATION BETWEEN THE NIA 2389 01:35:28,080 --> 01:35:32,000 AND OAR THAT WAS INITIATED IN I 2390 01:35:32,000 --> 01:35:34,880 THINK 2018, 2019, TO ASSESS 2391 01:35:34,880 --> 01:35:36,880 SIMILARITIES AND DIFFERENCES IN 2392 01:35:36,880 --> 01:35:39,320 HIV ASSOCIATED NEUROLOGICAL 2393 01:35:39,320 --> 01:35:41,160 COMPLICATIONS IN ALZHEIMER'S 2394 01:35:41,160 --> 01:35:42,520 DISEASE. SIX STUDIES SUPPORTED 2395 01:35:42,520 --> 01:35:45,640 THROUGH THIS PARTNERSHIP, WITH 2396 01:35:45,640 --> 01:35:48,400 YEARLY PROGRESS UPDATES, AS WELL 2397 01:35:48,400 --> 01:35:49,760 AS OPPORTUNITIES AMONG THE 2398 01:35:49,760 --> 01:35:52,320 AWARDED RESEARCHERS OR 2399 01:35:52,320 --> 01:35:54,640 COLLABORATION AND NETWORKING. 2400 01:35:54,640 --> 01:35:55,440 THERE HAVE BEEN SEVERAL 2401 01:35:55,440 --> 01:35:59,320 IMPORTANT DISCOVERIES MADE 2402 01:35:59,320 --> 01:35:59,760 ALREADY FROM THESE 2403 01:35:59,760 --> 01:36:02,480 INVESTIGATORS. AND I WILL JUST 2404 01:36:02,480 --> 01:36:05,040 HIGHLIGHT ONE OF THE STUDIES LED 2405 01:36:05,040 --> 01:36:09,920 BY DR.S SUSAN AND JOHN QUERY 2406 01:36:09,920 --> 01:36:11,520 FROM THE SCHOOL OF MEDICINE 2407 01:36:11,520 --> 01:36:15,760 MOUNT SINAI. NEXT SLIDE PLEASE. 2408 01:36:15,760 --> 01:36:19,440 SO ON THIS STUDY DR.S MORBELA 2409 01:36:19,440 --> 01:36:21,000 FOUND HIV DURATION BUT NOT 2410 01:36:21,000 --> 01:36:23,800 ACTIVE BRAIN INFECTION PREDICTS 2411 01:36:23,800 --> 01:36:26,560 CRITICAL CORTICAL DATA 2412 01:36:26,560 --> 01:36:29,440 DEPOSITION. ABNORMAL DEPOSITION 2413 01:36:29,440 --> 01:36:31,880 OF THE ANTIMICROBIAL PEPTIDE 2414 01:36:31,880 --> 01:36:34,800 AMYLOID BETA, IS CHARACTERISTIC 2415 01:36:34,800 --> 01:36:36,560 OF ALZHEIMER'S DISEASE. SO THE 2416 01:36:36,560 --> 01:36:38,760 OBJECTIVE OF THIS STUDY WAS TO 2417 01:36:38,760 --> 01:36:41,120 ELUCIDATE RISK FACTORS FOR BRAIN 2418 01:36:41,120 --> 01:36:42,760 AMYLOID BETA IN A COHORT THAT 2419 01:36:42,760 --> 01:36:44,960 WAS ENRICHED FOR HIV AND OTHER 2420 01:36:44,960 --> 01:36:48,560 NEUROTROPIC AGENTS. IN THE 2421 01:36:48,560 --> 01:36:50,040 FIGURE YOU CAN SEE PATTERNS OF 2422 01:36:50,040 --> 01:36:51,720 AMYLOID BETA DEPOSITION IN THE 2423 01:36:51,720 --> 01:36:55,320 BRAIN OF HIV HIV PATIENTS AND TS 2424 01:36:55,320 --> 01:36:59,760 STUDY SHOWED HIV STATUS IS 2425 01:36:59,760 --> 01:37:05,080 PROTECTIVE FOR AMYLOID, IN SHORT 2426 01:37:05,080 --> 01:37:07,000 NO INCREASED EVIDENCE OF AMYLOID 2427 01:37:07,000 --> 01:37:09,760 BETA IN HIV, OR GREATER HIV 2428 01:37:09,760 --> 01:37:11,320 DISEASE DURATION AS RISK FOR 2429 01:37:11,320 --> 01:37:15,240 AMYLOID DEPOSITION. THIS 2430 01:37:15,240 --> 01:37:17,080 REPLACES CHRONOLOGICAL AGE AS A 2431 01:37:17,080 --> 01:37:21,400 RISK FACTOR. FINALLY, PTAU IN 2432 01:37:21,400 --> 01:37:23,040 NEURONS, NOT CORTICAL AMYLOID 2433 01:37:23,040 --> 01:37:24,840 BETA DEPOSITION, IS ASSOCIATED 2434 01:37:24,840 --> 01:37:26,680 WITH DECREASED GLOBAL COGNITIVE 2435 01:37:26,680 --> 01:37:32,200 SCORE. MORE INFORMATION CAN BE 2436 01:37:32,200 --> 01:37:34,960 FOUND ON THE DIVISION OF 2437 01:37:34,960 --> 01:37:36,240 NEUROSCIENCES WEBSITE. I THINK 2438 01:37:36,240 --> 01:37:40,880 WITH THAT I WILL TURN IT OVER TO 2439 01:37:40,880 --> 01:37:41,080 BASIL. 2440 01:37:41,080 --> 01:37:44,760 >>THANK YOU, STACY. IF WE COULD 2441 01:37:44,760 --> 01:37:46,400 HAVE THE NEXT SLIDE PLEASE.LY 2442 01:37:46,400 --> 01:37:48,200 TALK ABOUT OTHER TWO DIVISIONS, 2443 01:37:48,200 --> 01:37:50,520 DIVISION OF GERIATRICS AND 2444 01:37:50,520 --> 01:37:52,360 CLINICAL GERONTOLOGY, SUPPORTS 2445 01:37:52,360 --> 01:37:54,160 CLINICAL TRANSLATIONAL RESEARCH 2446 01:37:54,160 --> 01:37:56,760 ON HEALTH AND DISEASE AND THE 2447 01:37:56,760 --> 01:37:58,800 AGENT AS WELL AS RESEARCH IN 2448 01:37:58,800 --> 01:38:01,240 AGING OVER THE HUMAN LIFE SPAN 2449 01:38:01,240 --> 01:38:02,440 INCLUDING RELATIONSHIPS TO 2450 01:38:02,440 --> 01:38:04,840 HEALTH OUTCOMES. AS DR. HODES 2451 01:38:04,840 --> 01:38:07,040 PRESENTED HIS TALK, THE BULLET 2452 01:38:07,040 --> 01:38:10,400 THAT MAPS TO OUR DIVISIONS 2453 01:38:10,400 --> 01:38:12,320 INTEREST RELATE TO HIV IS THIS 2454 01:38:12,320 --> 01:38:13,960 ONE, ENHANCING ASSESSMENT AND 2455 01:38:13,960 --> 01:38:15,040 TREATMENT OF OLDER INDIVIDUALS 2456 01:38:15,040 --> 01:38:17,600 WITH HIV AND CO-MORBIDITIES 2457 01:38:17,600 --> 01:38:18,960 POLYPHARMACY, DISABILITY OR 2458 01:38:18,960 --> 01:38:19,800 DISPARITIES IN HEALTH OUT. 2459 01:38:19,800 --> 01:38:26,960 COOUTCOMES.SO THERE ARE TWO FRAS 2460 01:38:26,960 --> 01:38:28,640 THAT DESCRIBE AN INDIVIDUAL WITH 2461 01:38:28,640 --> 01:38:31,040 MULTIPLE CHRONIC CONDITIONS, THE 2462 01:38:31,040 --> 01:38:33,320 CO-MORBIDITY MODEL, FOCUSES ON 2463 01:38:33,320 --> 01:38:35,160 INDEX CONDITION, AT THE CENTER 2464 01:38:35,160 --> 01:38:39,200 OF AN INDIVIDUAL'S EXPERIENCE, 2465 01:38:39,200 --> 01:38:40,640 CO-OCCURRING WITH SEVERAL OTHER 2466 01:38:40,640 --> 01:38:41,440 CO-MORBIDITIES BUT IN CLINICAL 2467 01:38:41,440 --> 01:38:43,080 AGING RESEARCH, THERE'S A 2468 01:38:43,080 --> 01:38:46,560 FRAMEWORK BASED ON THE IDEA OF 2469 01:38:46,560 --> 01:38:47,680 MULTI-MORBIDITY. AND THIS 2470 01:38:47,680 --> 01:38:49,440 DISTINCTION IS IMPORTANT FOR A 2471 01:38:49,440 --> 01:38:51,240 FEW DIFFERENT REASONS. ONE IS 2472 01:38:51,240 --> 01:38:53,320 THAT IT RECOGNIZES THAT PEOPLE 2473 01:38:53,320 --> 01:38:55,240 MAY HAVE MORE THAN JUST 2474 01:38:55,240 --> 01:38:56,960 DIAGNOSED CO-OCCURRING DISEASES, 2475 01:38:56,960 --> 01:38:58,760 THEY MAY ALSO HAVE CONDITIONS 2476 01:38:58,760 --> 01:39:01,200 AND SYNDROMES LIKE DISABILITY OF 2477 01:39:01,200 --> 01:39:03,360 RECURRENT FALLS, HEARING OR 2478 01:39:03,360 --> 01:39:05,840 VISUAL IMPAIRMENT, SARCOPENIA, 2479 01:39:05,840 --> 01:39:09,120 MANY OTHERS. ALSO TO EFFECTIVELY 2480 01:39:09,120 --> 01:39:10,240 MANAGE MULTIPLE CONCURRENT 2481 01:39:10,240 --> 01:39:12,240 DISEASES AND CONDITIONS, THERE 2482 01:39:12,240 --> 01:39:14,040 NEEDS TO BE A SHIFT FROM 2483 01:39:14,040 --> 01:39:15,560 TREATING EACH ONE INDIVIDUALLY 2484 01:39:15,560 --> 01:39:17,200 TO UNDERSTANDING HOW ALL THE 2485 01:39:17,200 --> 01:39:18,400 CONDITIONS INTERACT WITH EACH 2486 01:39:18,400 --> 01:39:19,720 OTHER, THE TRADE-OFFS THAT NEED 2487 01:39:19,720 --> 01:39:22,680 TO BE CONSIDERED IN DOING SO, 2488 01:39:22,680 --> 01:39:23,840 AND HOW INDIVIDUALS INTERACT 2489 01:39:23,840 --> 01:39:24,960 WITH THE HEALTHCARE SYSTEM AS A 2490 01:39:24,960 --> 01:39:29,720 RESULT. THEN THIRDLY, 2491 01:39:29,720 --> 01:39:30,880 MULTI-MORBIDITY MODEL PLACES THE 2492 01:39:30,880 --> 01:39:33,280 FOCUS BACK ON THE PATIENT, THE 2493 01:39:33,280 --> 01:39:34,840 INDIVIDUAL WHO IS AT THE CENTER 2494 01:39:34,840 --> 01:39:36,960 OF THIS. AND WHO IS MORE THAN 2495 01:39:36,960 --> 01:39:38,680 JUST THE SUM OF THEIR DISEASES 2496 01:39:38,680 --> 01:39:40,440 AND THEIR CONDITIONS, BUT 2497 01:39:40,440 --> 01:39:42,720 SOMEONE WHO EXISTS IN A SOCIAL 2498 01:39:42,720 --> 01:39:44,200 CULTURAL AND ENVIRONMENTAL 2499 01:39:44,200 --> 01:39:49,000 MILIEU. NEXT SLIDE PLEASE. SO 2500 01:39:49,000 --> 01:39:50,680 THIS IS AN EXAMPLE OF ONE OF THE 2501 01:39:50,680 --> 01:39:52,520 MANY STUDIES THAT WE ARE 2502 01:39:52,520 --> 01:39:54,480 CURRENTLY SUPPORTING, THIS IS 2503 01:39:54,480 --> 01:39:57,600 FROM DR. EMILY HYLE INFECTIOUS 2504 01:39:57,600 --> 01:40:00,320 DISEASE SPECIALIST AT MASS 2505 01:40:00,320 --> 01:40:01,880 GENERAL HOSPITAL AND HARVARD 2506 01:40:01,880 --> 01:40:04,160 MEDICAL SCHOOL. HER AND HER TIME 2507 01:40:04,160 --> 01:40:06,160 DEVELOPED A MICROSIMULATION 2508 01:40:06,160 --> 01:40:07,280 MODEL OF MULTI-MORBIDITY FOR 2509 01:40:07,280 --> 01:40:11,080 PEOPLE AGING WITH HIV. BY 2510 01:40:11,080 --> 01:40:13,160 POPULATING THIS MODEL WITH 2511 01:40:13,160 --> 01:40:16,040 PUBLISHED DATA FROM COHORT AND 2512 01:40:16,040 --> 01:40:17,480 FROM CLINICAL TRIALS, THEY CAN 2513 01:40:17,480 --> 01:40:19,080 PROJECT LONG TERM CLINICAL 2514 01:40:19,080 --> 01:40:21,280 OUTCOMES AND COSTS FOR PEOPLE 2515 01:40:21,280 --> 01:40:23,240 AGING WITH HIV IN THE US. 2516 01:40:23,240 --> 01:40:27,160 HEADACHE ALSO COMPARE CROSS 2517 01:40:27,160 --> 01:40:29,280 EFFECTIVENESS FOR DIFFERENT 2518 01:40:29,280 --> 01:40:30,240 STRATEGIES FOR INTERVENTION 2519 01:40:30,240 --> 01:40:31,400 DIAGNOSESSIS AN TREATMENT OF 2520 01:40:31,400 --> 01:40:32,200 SEVERAL CURRENT CONDITIONS 2521 01:40:32,200 --> 01:40:33,840 INCLUDING ONES NOTED HERE, 2522 01:40:33,840 --> 01:40:35,200 DEPRESSION, DEMENTIA, CARDS OWE 2523 01:40:35,200 --> 01:40:38,080 VASCULAR DISEASE AND HIV. -- 2524 01:40:38,080 --> 01:40:39,120 CARDIOVASCULAR DISEASE AN HIV. 2525 01:40:39,120 --> 01:40:40,200 ON THE RIGHT HAND SIDE YOU CAN 2526 01:40:40,200 --> 01:40:42,040 SEE SAMPLE MODEL OUTCOMES FOR 2527 01:40:42,040 --> 01:40:43,840 CUMULATIVE INCIDENCE OF 2528 01:40:43,840 --> 01:40:46,000 DEMENTIA, OVER THE NEXT 35 YEARS 2529 01:40:46,000 --> 01:40:49,840 AMONG PEOPLE IDENTIFIED AS 2530 01:40:49,840 --> 01:40:51,880 ANNOUNCED AT BIRTH. FIGURE ALSO 2531 01:40:51,880 --> 01:40:53,440 INCLUDES SENSITIVITY ANALYSES 2532 01:40:53,440 --> 01:40:55,320 BASED ON MODEL TWOFOLD, INCREASE 2533 01:40:55,320 --> 01:40:57,160 IN DEMENTIA INCIDENCE AMONG 2534 01:40:57,160 --> 01:41:00,160 PEOPLE WITH HIV WHICH IS THE 2535 01:41:00,160 --> 01:41:01,680 ORANGE LINE. OR AMONG PEOPLE 2536 01:41:01,680 --> 01:41:03,720 WITH HIV FULLY ENGAGED IN HIV 2537 01:41:03,720 --> 01:41:05,920 CARE WHICH IS THE BLUE LINE. SO 2538 01:41:05,920 --> 01:41:07,920 THE IDEA BEHIND THE STUDY TO 2539 01:41:07,920 --> 01:41:09,800 UNDERSTAND HOW MULTIPLE CHRONIC 2540 01:41:09,800 --> 01:41:11,440 CONDITIONS CONVERGE IN 2541 01:41:11,440 --> 01:41:13,400 INDIVIDUALS, HOW THEY LEAD TO 2542 01:41:13,400 --> 01:41:15,360 ADDITIVE EFFECTS HOW THERE MAYBE 2543 01:41:15,360 --> 01:41:17,160 COMPETING RISKS FOR VARIOUS 2544 01:41:17,160 --> 01:41:19,360 OUTCOMES AND HOW THEY INFECT -- 2545 01:41:19,360 --> 01:41:23,040 HAVE AN EFFECT ON CARE AND COST. 2546 01:41:23,040 --> 01:41:28,880 I WANT TO HIGHLIGHT ONE NI ASHES 2547 01:41:28,880 --> 01:41:31,080 PROGRAM THE GEM STAR PROGRAM, A 2548 01:41:31,080 --> 01:41:33,160 PRE-K PROGRAM FOR EARLY CAREER 2549 01:41:33,160 --> 01:41:35,200 PHYSICIANS OR DENTISTS 2550 01:41:35,200 --> 01:41:36,960 INTERESTED IN RESEARCH CAREER 2551 01:41:36,960 --> 01:41:39,120 THAT BRIDGES THEIR CLINICAL 2552 01:41:39,120 --> 01:41:40,720 SPECIALTY WITH AGING RESEARCH. 2553 01:41:40,720 --> 01:41:44,160 IT PROVIDES TWO YEARS OF 2554 01:41:44,160 --> 01:41:46,080 RESEARCH SUPPORT AND AWARDEES 2555 01:41:46,080 --> 01:41:48,520 ARE ALSO EXPECTED TO SECURE SOME 2556 01:41:48,520 --> 01:41:50,440 INDEPENDENTLY SUPPORTED 2557 01:41:50,440 --> 01:41:52,200 PROFESSIONAL DEVELOPMENT. WILL 2558 01:41:52,200 --> 01:41:53,680 IS ALSO A YEARLY INVESTIGATORS 2559 01:41:53,680 --> 01:41:55,040 MEETING FOR NETWORKING AND 2560 01:41:55,040 --> 01:41:58,480 ADDITIONAL MENTORING. IT IS VERY 2561 01:41:58,480 --> 01:42:00,800 WELL SUBSCRIBED PROGRAM, VERY 2562 01:42:00,800 --> 01:42:01,720 COMPETITIVE, SINCE WE STARTED 2563 01:42:01,720 --> 01:42:04,240 THE PROGRAM IN 2011, THERE'S 2564 01:42:04,240 --> 01:42:08,600 BEEN EIGHT GEMSSTAR AWARDEES 2565 01:42:08,600 --> 01:42:10,680 FOCUSING ON HIV AND AGING 2566 01:42:10,680 --> 01:42:13,640 RESEARCH PROJECTS AND YOU MAY 2567 01:42:13,640 --> 01:42:15,240 RECOGNIZE MANY NAMES HERE, 2568 01:42:15,240 --> 01:42:16,400 MOSTLY THEY ARE INDIVIDUAL WHOSE 2569 01:42:16,400 --> 01:42:18,080 HAVE INFECTIOUS DISEASE 2570 01:42:18,080 --> 01:42:19,960 SPECIALTY TRAINING, AND WE ARE 2571 01:42:19,960 --> 01:42:21,960 NOW SEEING THAT THE EARLIER 2572 01:42:21,960 --> 01:42:23,360 AWARDEES OF THIS PROGRAM ARE 2573 01:42:23,360 --> 01:42:25,400 GOING ON TO COMPETE SUCCESSFULLY 2574 01:42:25,400 --> 01:42:28,040 FOR RO1s AND K AWARDS, AND 2575 01:42:28,040 --> 01:42:30,160 TAKING LEADERSHIP POSITIONS IN 2576 01:42:30,160 --> 01:42:32,160 THEIR INSTITUTIONS AS WELL AS IN 2577 01:42:32,160 --> 01:42:34,040 OTHER PROFESSIONAL SOCIETIES. 2578 01:42:34,040 --> 01:42:40,840 VERY SUCCESSFUL PROGRAM. SO I 2579 01:42:40,840 --> 01:42:42,120 WILL PRESENT THE NEXT FEW SLIDES 2580 01:42:42,120 --> 01:42:44,240 ON BEHALF OF MY COLLEAGUE, DR. 2581 01:42:44,240 --> 01:42:45,840 MELISSA GERALD IN OUR DIVISION 2582 01:42:45,840 --> 01:42:48,080 OF BEHAVIORAL SOCIAL RESEARCH, 2583 01:42:48,080 --> 01:42:50,520 THIS DIVISION SUPPORTS SOCIAL 2584 01:42:50,520 --> 01:42:51,920 BEHAVIORAL PSYCHOLOGICAL AND 2585 01:42:51,920 --> 01:42:53,480 ECONOMIC RESEARCH AND RESEARCH 2586 01:42:53,480 --> 01:42:56,320 TRAINING ON THE PROCESSES OF 2587 01:42:56,320 --> 01:42:57,800 AGING OF BOTH THE INDIVIDUAL AND 2588 01:42:57,800 --> 01:43:00,400 SOCIETAL LEVELS. THE TUITION 2589 01:43:00,400 --> 01:43:02,000 SUPPORTS BASIC RESEARCH, THAT 2590 01:43:02,000 --> 01:43:03,240 DOWN THE ROAD CAN HAVE 2591 01:43:03,240 --> 01:43:04,520 IMPLICATIONS FOR HEALTH AND 2592 01:43:04,520 --> 01:43:06,640 INTERVENTION RESEARCH AIMED AT 2593 01:43:06,640 --> 01:43:07,880 IMPROVING PHYSICAL HEALTH OR 2594 01:43:07,880 --> 01:43:09,640 PSYCHOLOGICAL HEALTH AND WELL 2595 01:43:09,640 --> 01:43:12,320 BEING OR BOTH. NEXT SLIDE 2596 01:43:12,320 --> 01:43:17,840 PLEASE. AS THE WORD CLOUD SHOWS 2597 01:43:17,840 --> 01:43:20,080 HERE NIA IS FUNDING HIV AIDS 2598 01:43:20,080 --> 01:43:21,840 RESEARCH FOCUS ON BROAD RANGE OF 2599 01:43:21,840 --> 01:43:29,000 TOPIC AREAS. NEXT SLIDE. AND AS 2600 01:43:29,000 --> 01:43:30,720 EXAMPLE OF SPECIFIC RESEARCH 2601 01:43:30,720 --> 01:43:33,320 SUPPORTED BY THIS DIVISION, THIS 2602 01:43:33,320 --> 01:43:37,960 IS ONE, NEWLY FUNDED RO1 FROM 2603 01:43:37,960 --> 01:43:43,680 DR. J,SUS, CHIEF OF DIVISION OF 2604 01:43:43,680 --> 01:43:44,680 PREVENGES SCIENCE AND HIV AIDS 2605 01:43:44,680 --> 01:43:45,600 SCIENCE OF THE AIDS RESEARCH 2606 01:43:45,600 --> 01:43:49,640 INSTITUTE AT UCSF. SO THE 2607 01:43:49,640 --> 01:43:52,320 PREMISE FOR THE STUDY IS WHILE 2608 01:43:52,320 --> 01:43:54,840 THERE IS SOME EVIDENCE 2609 01:43:54,840 --> 01:43:55,840 SUGGESTING SEXUAL HEALTH IN GAY 2610 01:43:55,840 --> 01:43:57,640 MEN IS NEGATIVELY AFFECTED BY 2611 01:43:57,640 --> 01:43:59,760 STIGMA BASED ON HOMOSEXUALITY, 2612 01:43:59,760 --> 01:44:06,560 RACE AGE AN HIV STATUS, DR HIS 2613 01:44:06,560 --> 01:44:08,200 PROJECT WHETHER WHEN THESE 2614 01:44:08,200 --> 01:44:09,640 FACTORS COMBINED AFFECTED HEALTH 2615 01:44:09,640 --> 01:44:14,280 IN OLDER GAY MEN SO RACIAL 2616 01:44:14,280 --> 01:44:15,920 HOMOSEXUAL AND HIV STATUS, 2617 01:44:15,920 --> 01:44:20,280 STRUCTURAL RACISM AND 2618 01:44:20,280 --> 01:44:21,680 DISCRIMINATION RESOURCES AN 2619 01:44:21,680 --> 01:44:23,160 BIOMARKERS OF HEALTH AGING IN 2620 01:44:23,160 --> 01:44:25,040 GAY MEN, IN FOUR RACIAL ETHNIC 2621 01:44:25,040 --> 01:44:26,880 GROUPS. AFRICAN AMERICAN, 2622 01:44:26,880 --> 01:44:27,920 LATINX, ASIAN AMERICAN AND 2623 01:44:27,920 --> 01:44:32,280 WHITE. AN ACROSS HIV STATUS. 2624 01:44:32,280 --> 01:44:33,840 THE TEAM IS GUIDED BY SEVERAL 2625 01:44:33,840 --> 01:44:37,000 THEORIES STRESSED ACROSS THAT 2626 01:44:37,000 --> 01:44:37,760 SOCIAL INTEGRATION STIGMA AND 2627 01:44:37,760 --> 01:44:40,200 THEY HYPOTHESIZE THAT SEXUAL AND 2628 01:44:40,200 --> 01:44:42,040 ETHNIC RACIAL MINORITIES ARE 2629 01:44:42,040 --> 01:44:43,480 EXPOSED TO STRESSORS IN THE FORM 2630 01:44:43,480 --> 01:44:45,320 OF STRUCTURAL RACISM, 2631 01:44:45,320 --> 01:44:46,960 DISCRIMINATION AND STIGMA. AND 2632 01:44:46,960 --> 01:44:48,280 THAT EXPERIENCING STIGMA THROUGH 2633 01:44:48,280 --> 01:44:51,640 THE ACTIONS OF OVERS CAN LEAD TO 2634 01:44:51,640 --> 01:44:52,960 INCORPORATION OF SOCIETAL AND 2635 01:44:52,960 --> 01:44:54,920 WHAT IS CONCEPT OF SELF ALSO 2636 01:44:54,920 --> 01:44:56,640 CALLED INTERNALIZED STIGMA WHICH 2637 01:44:56,640 --> 01:44:59,240 MAY LEAD TO SIGNIFICANT HEALTH 2638 01:44:59,240 --> 01:45:01,120 INEQUITIES THROUGH PHYSIOLOGICAL 2639 01:45:01,120 --> 01:45:04,640 EFFECTS AND INTERNALIZATION. SO 2640 01:45:04,640 --> 01:45:08,320 NEXT SLIDE PLEASE. SO THANKS 2641 01:45:08,320 --> 01:45:09,560 FOR YOUR ATTENTION. THAT IS JUST 2642 01:45:09,560 --> 01:45:11,800 A SNAP SHOT OF WHAT WE DO AT 2643 01:45:11,800 --> 01:45:13,360 NIA. THERE IS PLENTY MORE TO 2644 01:45:13,360 --> 01:45:14,760 TALK ABOUT BUT GIVEN THE TIME I 2645 01:45:14,760 --> 01:45:19,760 WILL HAND IT OVER TO DR. BANSAL 2646 01:45:19,760 --> 01:45:20,920 NOW. 2647 01:45:20,920 --> 01:45:24,440 >>ALL RIGHT. THANK YOU, DR. 2648 01:45:24,440 --> 01:45:26,880 LAWRENCE AND ELDAHDAH FOR THE 2649 01:45:26,880 --> 01:45:30,480 TWO PRESENTATIONS. IF YOU COULD 2650 01:45:30,480 --> 01:45:31,640 PLEASE MAYBE STOP SHARING YOUR 2651 01:45:31,640 --> 01:45:32,880 SLIDES FOR THE MOMENT. I WOULD 2652 01:45:32,880 --> 01:45:35,920 LIKE TO ENTER DEUCE OUR NEXT 2653 01:45:35,920 --> 01:45:38,920 PRESENTER. SO NEXT ON THE AGENDA 2654 01:45:38,920 --> 01:45:41,960 IS DR. GEETANJALI BANSAL. SO DR. 2655 01:45:41,960 --> 01:45:43,800 BANSAL IS A SENIOR SCIENCE 2656 01:45:43,800 --> 01:45:46,520 OFFICER AT THE OAR. SHE LEADS 2657 01:45:46,520 --> 01:45:50,560 THE OAR HIV AND AGING SIGNATURE 2658 01:45:50,560 --> 01:45:52,720 PROGRAM AND PARTICIPATE IN THE 2659 01:45:52,720 --> 01:45:56,040 OAR EARLY CAREER INVESTIGATORS 2660 01:45:56,040 --> 01:45:57,640 HIV PROGRAM WITH SHARED 2661 01:45:57,640 --> 01:45:58,480 RESPONSIBILITY FOR CROSS CUTTING 2662 01:45:58,480 --> 01:46:01,120 AREAS OF RESEARCH INCLUDING HIV 2663 01:46:01,120 --> 01:46:02,880 ASSOCIATED CO-MORBIDITIES, 2664 01:46:02,880 --> 01:46:04,920 CO-INFECTIONS AND COMPLICATIONS. 2665 01:46:04,920 --> 01:46:07,720 SO IN THE SECOND TIME I WANT TO 2666 01:46:07,720 --> 01:46:09,320 HAND THIS OVER -- IN THE SAKE OF 2667 01:46:09,320 --> 01:46:10,240 TIME I WILL HAND IT TO DR. 2668 01:46:10,240 --> 01:46:11,240 BANSAL TO WRAP UP THE 2669 01:46:11,240 --> 01:46:13,440 PRESENTATIONS IN THIS SESSION. 2670 01:46:13,440 --> 01:46:16,720 >>THANK YOU, DR. TOLBERT. THANK 2671 01:46:16,720 --> 01:46:21,680 YOU, DR. ELDAHDAH AND DR. 2672 01:46:21,680 --> 01:46:23,160 CARRINGTON-LAWRENCE. I'M GOING 2673 01:46:23,160 --> 01:46:26,920 TO PROVIDE AN OVERVIEW OF THE 2674 01:46:26,920 --> 01:46:30,640 NIH OAR HIV AND AGING PORTFOLIO 2675 01:46:30,640 --> 01:46:34,280 AND THE BRIEFLY THE SIGNATURE -- 2676 01:46:34,280 --> 01:46:35,520 AGING SIGNATURE PROGRAM. NEXT 2677 01:46:35,520 --> 01:46:38,920 SLIDE PLEASE. WITH THE SUCCESS 2678 01:46:38,920 --> 01:46:40,440 OF ANTI-RETROVIRAL THERAPIES 2679 01:46:40,440 --> 01:46:42,680 PEOPLE WITH HIV ARE LIVING 2680 01:46:42,680 --> 01:46:44,520 LONGER AND NOW CAN HAVE NEARLY 2681 01:46:44,520 --> 01:46:46,080 NORMAL LIFE SPAN WITH 2682 01:46:46,080 --> 01:46:46,920 APPROPRIATE TREATMENT. MORE THAN 2683 01:46:46,920 --> 01:46:49,360 HALF OF THE PEOPLE WITH HIV IN 2684 01:46:49,360 --> 01:46:50,400 THE UNITED STATES ARE 50 YEARS 2685 01:46:50,400 --> 01:46:54,400 OR OLDER. THIS AGE GROUP IS 2686 01:46:54,400 --> 01:46:56,080 STEADILY INCREASING, VERSUS THE 2687 01:46:56,080 --> 01:46:57,360 STABLE NUMBERS IN THE YOUNGER 2688 01:46:57,360 --> 01:47:03,640 AGE GROUPS. NEXT SLIDE PLEASE. 2689 01:47:03,640 --> 01:47:06,160 IN 2020, 17% OF DIAGNOSIS OF HIV 2690 01:47:06,160 --> 01:47:09,280 INFECTION IN THE U.S. WERE AMONG 2691 01:47:09,280 --> 01:47:15,560 PEOPLE AGE 50 OR OLDER. 43% IN 2692 01:47:15,560 --> 01:47:18,680 30 TO 49 YEARS AGE GROUP AND 40% 2693 01:47:18,680 --> 01:47:21,480 IN THE YOUNGER POPULATION. THE 2694 01:47:21,480 --> 01:47:23,400 PROCESS OF AGING IS ACROSS THE 2695 01:47:23,400 --> 01:47:25,920 LIFE SPAN. IN FACT EPIGENETIC 2696 01:47:25,920 --> 01:47:27,200 CHANGES HAVE BEEN SEEN IN THE 2697 01:47:27,200 --> 01:47:29,400 YOUNG PEOPLE THAT ARE NEARLY 2698 01:47:29,400 --> 01:47:32,600 INFECT WITH HIV AND ON 2699 01:47:32,600 --> 01:47:33,440 ANTI-RETROVIRALS. WE HAVE HEARD 2700 01:47:33,440 --> 01:47:35,080 FROM THE OLDER COMMUNITY REP 2701 01:47:35,080 --> 01:47:37,040 RECENTLY ABOUT THEIR NEEDS AN 2702 01:47:37,040 --> 01:47:38,800 CHALLENGES THEY ARE FACING AND 2703 01:47:38,800 --> 01:47:40,080 BEING RESPONSIVE TO THAT, THE 2704 01:47:40,080 --> 01:47:41,280 FOCUS OF THIS PRESENTATION IS ON 2705 01:47:41,280 --> 01:47:42,720 THE OLDER AND OF THE AGING 2706 01:47:42,720 --> 01:47:48,320 SPECTRUM. NEXT SLIDE PLEASE. 2707 01:47:48,320 --> 01:47:50,080 OLDER ADULTS WITH HIV FACE THE 2708 01:47:50,080 --> 01:47:52,800 SAME ISSUES AS THEIR PEERS 2709 01:47:52,800 --> 01:47:53,960 WITHOUT HIV AS WELL AS SOME 2710 01:47:53,960 --> 01:47:56,120 UNIQUE CHALLENGES. THEY ARE MORE 2711 01:47:56,120 --> 01:47:57,760 LIKELY THAN THE PEERS WITHOUT 2712 01:47:57,760 --> 01:47:59,880 HIV TO EXPERIENCE CERTAIN AGE 2713 01:47:59,880 --> 01:48:02,200 RELATED COMPLICATIONS, MOST 2714 01:48:02,200 --> 01:48:05,320 COMMON CO-MORBIDITIES BEING 2715 01:48:05,320 --> 01:48:07,080 NEUROCOGNITIVE IMPAIRMENT, 2716 01:48:07,080 --> 01:48:10,400 MUSCLE DISORDERS, FRAILTY, 2717 01:48:10,400 --> 01:48:12,480 CARDIOVASCULAR DISEASE, MAKING 2718 01:48:12,480 --> 01:48:13,400 POLYPHARMACY AND DRUG DRUG 2719 01:48:13,400 --> 01:48:15,680 INTERACTIONS MAJOR ISSUES. ON 2720 01:48:15,680 --> 01:48:17,440 SOCIAL BEHAVIORAL SIDE PEOPLE 2721 01:48:17,440 --> 01:48:19,400 AGING WITH HIV FACE MULTIPLE 2722 01:48:19,400 --> 01:48:22,520 INTERSECTIONAL STIGMAS, FOR 2723 01:48:22,520 --> 01:48:25,040 EXAMPLE, HIV AND AGEISM, SOCIAL 2724 01:48:25,040 --> 01:48:26,280 ISOLATION, INCREASE CAREGIVER 2725 01:48:26,280 --> 01:48:27,760 BURDEN AND OTHER MENTAL 2726 01:48:27,760 --> 01:48:28,680 CO-MORBIDITIES FOUND IN THE 2727 01:48:28,680 --> 01:48:31,400 INTERSECTION OF AGING AND HIV. 2728 01:48:31,400 --> 01:48:33,040 THIS AGE GROUP HAS MORE COMPLEX 2729 01:48:33,040 --> 01:48:35,480 CARE AND SUPPORT SERVICE NEEDS 2730 01:48:35,480 --> 01:48:36,840 DUE TO THESE DISTINCTIVE 2731 01:48:36,840 --> 01:48:43,360 CHALLENGES. NEXT SLIDE PLEASE. 2732 01:48:43,360 --> 01:48:45,280 AGING WITH HIV HAS MULTIPLE 2733 01:48:45,280 --> 01:48:47,280 FACETS. AND REQUIRES A 2734 01:48:47,280 --> 01:48:48,120 MULTI-DIMENSIONAL RESPONSE. THIS 2735 01:48:48,120 --> 01:48:50,360 IS REFLECTED BY THE CURRENT HIV 2736 01:48:50,360 --> 01:48:52,240 AND AGING PORTFOLIO THAT IS 2737 01:48:52,240 --> 01:48:55,320 SUPPORTED BY 17 OF THE 27 NIH 2738 01:48:55,320 --> 01:48:57,920 INSTITUTES CENTERS AND OFFICES. 2739 01:48:57,920 --> 01:48:59,680 THE TOTAL NIH INVESTMENT IN HIV 2740 01:48:59,680 --> 01:49:04,280 AND AGING RESEARCH FOR FY 22 IS 2741 01:49:04,280 --> 01:49:05,880 $119 MILLION, ABOUT 5% OF THE 2742 01:49:05,880 --> 01:49:08,520 TOTAL HIV FUNDS. OVERALL, 2743 01:49:08,520 --> 01:49:11,760 RESEARCH ON HIV AND AGING WOULD 2744 01:49:11,760 --> 01:49:13,680 BENEFIT FROM GROWTH. WHAT I AM 2745 01:49:13,680 --> 01:49:16,440 SHOWING HERE THE PAST FIVE 2746 01:49:16,440 --> 01:49:18,480 YEARS, HAVE INCREASED FUNDING 2747 01:49:18,480 --> 01:49:20,280 FOR HIV AND AGING RESEARCH BY 2748 01:49:20,280 --> 01:49:26,520 50% OR MORE. NEXT SLIDE PLEASE. 2749 01:49:26,520 --> 01:49:29,280 THE PORTFOLIO INCLUDES RESEARCH 2750 01:49:29,280 --> 01:49:30,600 FUNDED THROUGH A VARIETY OF 2751 01:49:30,600 --> 01:49:31,720 FUNDING MECHANISMS THE LARGEST 2752 01:49:31,720 --> 01:49:34,840 IS THE RO1, MAJORITY OF THESE 2753 01:49:34,840 --> 01:49:37,760 GRANTS ARE UNSOLICITED. THE 2754 01:49:37,760 --> 01:49:39,480 RO1s ARE FOLLOWED CLOSELY BY 2755 01:49:39,480 --> 01:49:41,760 COOPERATIVE AGREEMENTS, MAJORITY 2756 01:49:41,760 --> 01:49:45,840 OF WHICH ARE COMPOSED OF HIV 2757 01:49:45,840 --> 01:49:49,440 COHORTS SUCH AS MAX WISE. THE 2758 01:49:49,440 --> 01:49:52,880 REST INCLUDE CFARS, THE TISSUE 2759 01:49:52,880 --> 01:49:57,600 CONSORTIUM OR REPOSITORIES AND 2760 01:49:57,600 --> 01:49:58,920 OTHER TYPES OF GENETIC 2761 01:49:58,920 --> 01:50:02,920 APPLICATIONS. NEXT SLIDE PLEASE 2762 01:50:02,920 --> 01:50:04,360 RESEARCH IN HIV AND AGING 2763 01:50:04,360 --> 01:50:08,720 PORTFOLIO FALLS UNDER ALL THE 2764 01:50:08,720 --> 01:50:10,960 HIV RESEARCH PRIORITIES MAJORITY 2765 01:50:10,960 --> 01:50:12,960 BEING IN CROSS CUTTING RESEARCH 2766 01:50:12,960 --> 01:50:14,520 AND ADDRESS THERAPIES FOR HIV 2767 01:50:14,520 --> 01:50:15,800 ASSOCIATED CO-MORBIDITIES AND 2768 01:50:15,800 --> 01:50:18,440 CO-INFECTIONS. CROSS CUTTING 2769 01:50:18,440 --> 01:50:20,000 RESECTION INCLUDES BASIC AS WELL 2770 01:50:20,000 --> 01:50:21,480 AS BEHAVIORAL AND SOCIAL 2771 01:50:21,480 --> 01:50:23,840 SCIENCES RESEARCH, TRAINING 2772 01:50:23,840 --> 01:50:26,240 AMONG OTHERS. THE NIH HIV 2773 01:50:26,240 --> 01:50:27,680 PROGRAM ALSO SUPPORTS RESEARCH 2774 01:50:27,680 --> 01:50:29,040 ON THE DEVELOPMENT OF EVIDENCE 2775 01:50:29,040 --> 01:50:31,120 BASED STRATEGIES AND EVALUATING 2776 01:50:31,120 --> 01:50:32,720 STRATEGIES FOR RISK MANAGEMENT 2777 01:50:32,720 --> 01:50:34,640 OF CO-MORBIDITIES AND EVALUATING 2778 01:50:34,640 --> 01:50:37,840 AND REFINING INTEGRATED CARE 2779 01:50:37,840 --> 01:50:38,760 PREVENTIONS INTERVENTIONS FOR 2780 01:50:38,760 --> 01:50:40,440 PEOPLE WITH HIV. SEVERAL 2781 01:50:40,440 --> 01:50:41,200 EXAMPLES ARE SHOWN BY THE 2782 01:50:41,200 --> 01:50:43,480 COLLEAGUES EARLIER TOO. THESE 2783 01:50:43,480 --> 01:50:45,880 GENERALLY COME UNDER NEXT 2784 01:50:45,880 --> 01:50:47,040 GENERATION THERAPIES. SOME OF 2785 01:50:47,040 --> 01:50:51,320 THESE PROGRAMS ALSO HELP EXPAND 2786 01:50:51,320 --> 01:50:52,320 CLINICIANS CROSS TRAINED IN HIV 2787 01:50:52,320 --> 01:50:57,560 AND OTHER RELEVANT DISCIPLINES. 2788 01:50:57,560 --> 01:50:59,080 THIS SLIDE SHOWS THE MAJOR TOPIC 2789 01:50:59,080 --> 01:51:01,080 AREAS COVERED BY THE PROJECTS IN 2790 01:51:01,080 --> 01:51:05,240 THE HIV AND AGING RESEARCH 2791 01:51:05,240 --> 01:51:06,080 PORTFOLIO. VIEW PORTFOLIO 2792 01:51:06,080 --> 01:51:07,200 ANALYSIS PLATFORM THAT USES TEXT 2793 01:51:07,200 --> 01:51:10,320 MINING FOR ANALYSIS AND RATES 2794 01:51:10,320 --> 01:51:12,080 ACROSS PROJECTS OF SIMILAR 2795 01:51:12,080 --> 01:51:13,640 TOPICS. THE LISTED TOPICS ARE 2796 01:51:13,640 --> 01:51:15,760 MAJOR TEAMS ON AREAS WE SAW 2797 01:51:15,760 --> 01:51:17,120 RATHER THAN COMPREHENSIVE 2798 01:51:17,120 --> 01:51:19,480 LISTING OF ALL THE TOPICS IN THE 2799 01:51:19,480 --> 01:51:21,240 PEAK. SO THIS SLIDE HIGHLIGHTS 2800 01:51:21,240 --> 01:51:23,160 THE BREATH AND DEPTH OF THE HIV 2801 01:51:23,160 --> 01:51:25,240 AND AGING RESEARCH PORTFOLIO 2802 01:51:25,240 --> 01:51:27,320 THAT ENCOMPASSES CO-MORBIDITIES 2803 01:51:27,320 --> 01:51:29,080 AND COMPLICATIONS PREVENTION, 2804 01:51:29,080 --> 01:51:30,800 TREATMENT, CARE SERVICES, AS 2805 01:51:30,800 --> 01:51:33,000 WELL AS THE NEXT GENERATION OF 2806 01:51:33,000 --> 01:51:35,800 HIV RESEARCH CENTERS. NEXT 2807 01:51:35,800 --> 01:51:40,160 SLIDE PLEASE. CURRENTLY THERE 2808 01:51:40,160 --> 01:51:42,160 ARE TWO ACTIVE FOAs TO US 2809 01:51:42,160 --> 01:51:44,320 CANNED ON HIV AND AGING, THESE 2810 01:51:44,320 --> 01:51:46,520 ARE LONG STANDING FUNDING 2811 01:51:46,520 --> 01:51:49,160 OPPORTUNITIES WITH -- SINCE 2812 01:51:49,160 --> 01:51:50,800 2012, CURRENTLY 7 ICs ARE 2813 01:51:50,800 --> 01:51:54,000 PARTICIPATING IN IT. AND 2814 01:51:54,000 --> 01:51:55,000 THERE'S CERTAINLY IS ROOM FOR 2815 01:51:55,000 --> 01:52:01,720 MORE. NEXT SLIDE PLEASE. SO 2816 01:52:01,720 --> 01:52:04,160 THIS IS DR. GOODENOW ALREADY 2817 01:52:04,160 --> 01:52:05,720 COVERED THIS SO BRIEFLY BASED ON 2818 01:52:05,720 --> 01:52:07,400 THE PORTFOLIO ANALYSIS AND INPUT 2819 01:52:07,400 --> 01:52:09,520 FROM VARIOUS PERSPECTIVES AND 2820 01:52:09,520 --> 01:52:12,720 COMMUNITY VOICES, NIH OAR 2821 01:52:12,720 --> 01:52:13,760 INSTITUTED SIGNATURE PROGRAM ON 2822 01:52:13,760 --> 01:52:17,080 HIV AND AGING. AND AIMS TO 2823 01:52:17,080 --> 01:52:19,560 CATALYZE COLLABORATIONS TO 2824 01:52:19,560 --> 01:52:21,200 ADDRESS RESEARCH AT INTERSECTION 2825 01:52:21,200 --> 01:52:23,200 OF HIV AND AGING. NEXT SLIDE 2826 01:52:23,200 --> 01:52:27,760 PLEASE. TO FURTHER GOALS OF 2827 01:52:27,760 --> 01:52:29,440 CATALYZING THIS RESEARCH AND 2828 01:52:29,440 --> 01:52:30,600 EXPANDING THE POOL OF HIV AND 2829 01:52:30,600 --> 01:52:34,920 AGING RESEARCHERS, OAR PARTNERED 2830 01:52:34,920 --> 01:52:37,000 WITH NIA AND TO FUND SUPPLEMENTS 2831 01:52:37,000 --> 01:52:38,040 AND WE DID THAT IN THE LAST 2832 01:52:38,040 --> 01:52:42,680 FISCAL YEAR. WE HAD A ROBUST 2833 01:52:42,680 --> 01:52:44,880 RESPONSE INCLUDING 17 AWARDS 2834 01:52:44,880 --> 01:52:46,920 INCLUDING NON-HIV AND HIV PARENT 2835 01:52:46,920 --> 01:52:49,520 GRANTS PROPOSING IMPORTANT HIV 2836 01:52:49,520 --> 01:52:51,560 AGING RESEARCH AND A FEW 2837 01:52:51,560 --> 01:52:54,240 SUPPORTING ESR RESEARCH. WE ARE 2838 01:52:54,240 --> 01:52:55,400 NOW IN DISCUSSION WITH MULTIPLE 2839 01:52:55,400 --> 01:52:58,480 OTHER ICs FOR ANOTHER SUCH 2840 01:52:58,480 --> 01:52:59,080 OPPORTUNITY FOR ONE YEAR 2841 01:52:59,080 --> 01:53:01,280 SUPPLEMENTS. IN I A DIVISION 2842 01:53:01,280 --> 01:53:04,840 NIH OAR AND NIA FORM A THINK 2843 01:53:04,840 --> 01:53:06,200 TANK SINCE LAST SEPTEMBER, WE 2844 01:53:06,200 --> 01:53:07,760 HAD SOME EXCELLENT DISCUSSIONS 2845 01:53:07,760 --> 01:53:10,920 AND WOULD LIKE TO THANK OUR NIA 2846 01:53:10,920 --> 01:53:12,560 COLLEAGUES PARTICULARLY BASIL, 2847 01:53:12,560 --> 01:53:14,680 STACY AND MELISSA. WE ARE 2848 01:53:14,680 --> 01:53:16,280 DISCUSSING COMMUNITY NEEDS 2849 01:53:16,280 --> 01:53:17,280 RESEARCH QUESTIONS THAT WILL BE 2850 01:53:17,280 --> 01:53:18,680 IMPORTANT FOR HIV AND AGING 2851 01:53:18,680 --> 01:53:21,080 RESEARCH AND STRATEGIES TO 2852 01:53:21,080 --> 01:53:22,720 FACILITATE INTERDISCIPLINARY 2853 01:53:22,720 --> 01:53:23,880 RESEARCH AND ACCELERATE 2854 01:53:23,880 --> 01:53:24,960 IMPLEMENTATION OF RESEARCH 2855 01:53:24,960 --> 01:53:30,360 RESULTS. NEXT SLIDE. BASED ON 2856 01:53:30,360 --> 01:53:32,480 THINK TANK'S RECOMMENDATIONS, 2857 01:53:32,480 --> 01:53:34,480 NIH OAR LAUNCHED A MULTI-IC HIV 2858 01:53:34,480 --> 01:53:37,280 AND AGING WORKING GROUP, CO-LED 2859 01:53:37,280 --> 01:53:43,000 BY NIH OAR AND NIA. TO FOCUS ON 2860 01:53:43,000 --> 01:53:45,600 THERE ARE CURRENTLY TEN MEMBERS 2861 01:53:45,600 --> 01:53:47,440 ICs REPRESENTING THE HIV AND 2862 01:53:47,440 --> 01:53:49,400 AGING PORTFOLIO. THE WORK GROUP 2863 01:53:49,400 --> 01:53:51,480 AND DIVERSE TOO LINK NIH 2864 01:53:51,480 --> 01:53:53,400 COMMUNITY, THAT IS PEOPLE WITH 2865 01:53:53,400 --> 01:53:55,720 NIH AND RESEARCHERS, AND 2866 01:53:55,720 --> 01:53:57,840 RELEVANT US GOVERNMENT PARTNERS 2867 01:53:57,840 --> 01:54:01,320 IN DISCUSSIONS TO FOST DEPOSIT 2868 01:54:01,320 --> 01:54:02,880 COLLABORATIONS -- FOSTER 2869 01:54:02,880 --> 01:54:04,560 COLLABORATIONS TO RESEARCH GAPS 2870 01:54:04,560 --> 01:54:06,120 AND FACILITATE INTERDISCIPLINARY 2871 01:54:06,120 --> 01:54:07,160 RESEARCH AND TRAINING IN HIV AND 2872 01:54:07,160 --> 01:54:09,440 AGING SPACE. THE WORK GROUP IS 2873 01:54:09,440 --> 01:54:14,640 ALSO DISCUSSING DIVERSE TO HOLD 2874 01:54:14,640 --> 01:54:16,240 WORKSHOP THIS FALL. SO I WILL 2875 01:54:16,240 --> 01:54:20,080 STOP HERE. 2876 01:54:20,080 --> 01:54:22,320 >>GREAT, THANK YOU DR. BANSAL. 2877 01:54:22,320 --> 01:54:27,640 SO THIS IS -- HAS BEEN A VERY 2878 01:54:27,640 --> 01:54:31,800 INCIINSIGHTFUL RICH PART OF THE 2879 01:54:31,800 --> 01:54:32,960 AGENDA. WE HAVE TIME FOR 2880 01:54:32,960 --> 01:54:36,120 COMMENTS AND FEEDBACK FROM THE 2881 01:54:36,120 --> 01:54:38,800 OARAC. HAVE HANDS GOING UP. SO 2882 01:54:38,800 --> 01:54:43,520 WE WILL START WITH DR. SLEASMAN 2883 01:54:43,520 --> 01:54:48,120 >>MY QUESTION IS MOSTLY FOR 2884 01:54:48,120 --> 01:54:49,840 BASIL. BUT LEAVE IT UP TO 2885 01:54:49,840 --> 01:54:51,920 ANYBODY TO ANSWER. REALLY HAS TO 2886 01:54:51,920 --> 01:54:58,640 DO WITH THE ROLE OF OAR IN 2887 01:54:58,640 --> 01:55:02,160 TRANS-INSTITUTE RESEARCH. SO 2888 01:55:02,160 --> 01:55:05,400 ADULT CLINICAL TRIALS WITH THE 2889 01:55:05,400 --> 01:55:07,680 ACTG, THEIR AVERAGE IN AGO OF 2890 01:55:07,680 --> 01:55:08,960 THEIR ENROLLEES IN CLINICAL 2891 01:55:08,960 --> 01:55:12,360 TRIALS THAT WERE 50, AND IT IS 2892 01:55:12,360 --> 01:55:14,480 AN EXCELLENT OPPORTUNITY, TO BE 2893 01:55:14,480 --> 01:55:19,560 EFFECTIVE AGING AND HIV INFECTED 2894 01:55:19,560 --> 01:55:23,480 INDIVIDUALS. I WONDERED HOW 2895 01:55:23,480 --> 01:55:25,120 MUCH TRANS-COOPERATION IS THERE 2896 01:55:25,120 --> 01:55:31,040 BETWEEN AGING AND THE ACTG AND 2897 01:55:31,040 --> 01:55:31,960 OTHER CLINICAL TRIAL NETWORKS 2898 01:55:31,960 --> 01:55:34,520 THAT ARE INVOLVED? AND WHETHER 2899 01:55:34,520 --> 01:55:37,480 OR NOT OAR CAN MAKE ANY 2900 01:55:37,480 --> 01:55:39,040 RECOMMENDATIONS TO HELP 2901 01:55:39,040 --> 01:55:42,600 FACILITATE THIS THROUGH TARGETED 2902 01:55:42,600 --> 01:55:46,080 FUNDING OR CROSS-INSTITUTE 2903 01:55:46,080 --> 01:55:49,800 WORKING GROUP. 2904 01:55:49,800 --> 01:55:52,680 >>SO I WILL START, SURE MY 2905 01:55:52,680 --> 01:55:53,600 COLLEAGUES WILL PROBABLY CHIME 2906 01:55:53,600 --> 01:55:55,840 IN AS WELL. WE HAVE BEEN HAVING 2907 01:55:55,840 --> 01:55:57,840 ONGOING CONVERSATIONS WITH THE 2908 01:55:57,840 --> 01:56:01,080 ACTG LEADERSHIP, FOR A FEW YEARS 2909 01:56:01,080 --> 01:56:03,600 NOW. AND ABSOLUTELY I THINK THAT 2910 01:56:03,600 --> 01:56:09,200 THAT IS A VERY UNIQUE RESOURCE 2911 01:56:09,200 --> 01:56:10,200 TO EXPLORE QUESTIONS OF AGING 2912 01:56:10,200 --> 01:56:12,520 RESEARCH AND HIV. SO THOSE 2913 01:56:12,520 --> 01:56:14,040 CONVERSATIONS ARE ONGOING, THERE 2914 01:56:14,040 --> 01:56:16,160 ARE PROJECTS THAT WE HAVE OUR 2915 01:56:16,160 --> 01:56:18,720 EYE ON. AND NOT SURE I CAN SAY 2916 01:56:18,720 --> 01:56:21,840 MORE ABOUT THAT JUST YET. BUT IT 2917 01:56:21,840 --> 01:56:23,960 IS CERTAINLY SOMETHING ON OUR 2918 01:56:23,960 --> 01:56:24,400 RADAR. 2919 01:56:24,400 --> 01:56:27,640 >>ARE YOU GUYS PROVIDING A 2920 01:56:27,640 --> 01:56:28,840 DIRECTIVE YOU ARE THE AGING 2921 01:56:28,840 --> 01:56:30,040 EXPERTS ARE YOU PROVIDING A 2922 01:56:30,040 --> 01:56:31,760 DIRECT CONSULTATION WITH THE 2923 01:56:31,760 --> 01:56:34,160 ACTG? 2924 01:56:34,160 --> 01:56:35,920 >>SO WE HAVE BEEN CONVERSING 2925 01:56:35,920 --> 01:56:38,440 WITH THEIR LEADERSHIP ABOUT 2926 01:56:38,440 --> 01:56:40,360 AGING QUESTIONS, AND OUR PLAN IS 2927 01:56:40,360 --> 01:56:41,480 TO DO MORE OF THAT. 2928 01:56:41,480 --> 01:56:45,480 >>GREAT. THANK YOU. 2929 01:56:45,480 --> 01:56:47,280 >>DR. MONTANER. 2930 01:56:47,280 --> 01:56:49,360 >>YES, THANK YOU. IT IS JUST A 2931 01:56:49,360 --> 01:56:50,800 COUPLE OF OBSERVATIONS AND 2932 01:56:50,800 --> 01:56:53,880 SUGGESTIONS. THAT I WAS REALLY 2933 01:56:53,880 --> 01:56:55,720 IMPRESSED BY THE PROGRAM THAT 2934 01:56:55,720 --> 01:56:57,360 WAS PRESENTED ON THE SUPPLEMENTS 2935 01:56:57,360 --> 01:57:01,800 RELATIVE TO EXISTING RESEARCH 2936 01:57:01,800 --> 01:57:03,720 GEARED TOWARDS AGING AND 2937 01:57:03,720 --> 01:57:06,920 ALZHEIMER'S AND I WANTED TO 2938 01:57:06,920 --> 01:57:08,360 PERHAPS ENCOURAGE DIALOGUE WITH 2939 01:57:08,360 --> 01:57:10,840 THE RCA MY PROGRAM, MINORITY 2940 01:57:10,840 --> 01:57:12,920 INSTITUTION PROGRAM FOR THE 2941 01:57:12,920 --> 01:57:15,200 CENTERS BECAUSE YOU KNOW, I 2942 01:57:15,200 --> 01:57:17,240 REVIEW A LOT OF PILOTS AT LEAST 2943 01:57:17,240 --> 01:57:18,520 TWO OR THREE AND THEY HAVE A LOT 2944 01:57:18,520 --> 01:57:21,600 OF INITIATIVES THAT WOULD FOSTER 2945 01:57:21,600 --> 01:57:24,360 BOTH DIVERSITY AND DIRECTED 2946 01:57:24,360 --> 01:57:25,800 RESEARCH TOWARDS NIA OBJECTIVES 2947 01:57:25,800 --> 01:57:27,720 AT THE SAME TIME. SO I WOULD 2948 01:57:27,720 --> 01:57:30,200 ENCOURAGE SOME DIALOGUE BETWEEN 2949 01:57:30,200 --> 01:57:32,040 THESE PROGRAMS TO TRY TO 2950 01:57:32,040 --> 01:57:33,280 SYNERGIZE EXISTING EFFORTS THAT 2951 01:57:33,280 --> 01:57:35,280 ALREADY HAVE IDENTIFIED 2952 01:57:35,280 --> 01:57:38,800 DEVELOPMENT OF DIVERSE WORK 2953 01:57:38,800 --> 01:57:41,840 FORCE FROM -- AND N,A OBJECTIVES 2954 01:57:41,840 --> 01:57:44,160 ON RESEARCH BECAUSE IT SEEMED TO 2955 01:57:44,160 --> 01:57:45,800 BE SOME SILOED ISSUES HERE AN 2956 01:57:45,800 --> 01:57:46,840 EVERYONE IS TRYING TO DO THE 2957 01:57:46,840 --> 01:57:48,880 SAME THING BUT IF THERE COULD BE 2958 01:57:48,880 --> 01:57:49,920 MORE COALITION THAT WOULD BE 2959 01:57:49,920 --> 01:57:52,200 EXCELLENT. THE SECOND POINT IS 2960 01:57:52,200 --> 01:57:55,080 FOLLOWING JOHN'S COMMENT OF 2961 01:57:55,080 --> 01:57:57,760 TRANS-RESEARCH BECAUSE I SEE NIA 2962 01:57:57,760 --> 01:57:59,400 IS NOT ONE OF THE FUNDERS OF 2963 01:57:59,400 --> 01:58:01,360 MARKING ANY COLLABORATORY ON -- 2964 01:58:01,360 --> 01:58:02,640 BUT WE AS A WHOLE GROUP, THIS IS 2965 01:58:02,640 --> 01:58:06,520 A GROUP OF TEN INITIATIVES, THAT 2966 01:58:06,520 --> 01:58:09,840 PRIMARILY BY THE NIAID AND WITH 2967 01:58:09,840 --> 01:58:11,840 MULTIPLE PARTNERS. AND THE FIELD 2968 01:58:11,840 --> 01:58:13,360 IS MOVING MORE TOWARDS TRYING TO 2969 01:58:13,360 --> 01:58:17,080 GET A GREATER UNDERSTANDING OF 2970 01:58:17,080 --> 01:58:20,960 LONG TERM ART. 20 YEARS MORE ART 2971 01:58:20,960 --> 01:58:24,120 ON THE BURDEN OF EPIGENETICS AND 2972 01:58:24,120 --> 01:58:25,840 AGING STARTS TO COME INTO FOCUS 2973 01:58:25,840 --> 01:58:28,960 AS AN AREA AND AGAIN, A 2974 01:58:28,960 --> 01:58:32,240 SUPPLEMENTING INITIATIVE THAT IS 2975 01:58:32,240 --> 01:58:35,280 TIED TO THE COLLABORATORY COULD 2976 01:58:35,280 --> 01:58:38,400 SPIN OFF RO1s THAT WOULD GO 2977 01:58:38,400 --> 01:58:40,040 INTO THE EXISTING PROGRAM 2978 01:58:40,040 --> 01:58:41,040 ANNOUNCEMENTS SO THAT IS 2979 01:58:41,040 --> 01:58:43,160 SOMETHING ELSE THAT I WOULD 2980 01:58:43,160 --> 01:58:44,040 ENCOURAGE YOU TO AT LEAST 2981 01:58:44,040 --> 01:58:50,240 CONSIDER. 2982 01:58:50,240 --> 01:58:54,920 >>I AGREE WITH YOU ON BOTH. 2983 01:58:54,920 --> 01:58:58,000 >>DO WE HAVE ANY OTHER 2984 01:58:58,000 --> 01:59:00,560 COMMENTS? DR. GANDHI? 2985 01:59:00,560 --> 01:59:03,880 >>YES, WE -- THESE WERE GREAT 2986 01:59:03,880 --> 01:59:09,360 PRESENTATIONS, WE HAVE A 2987 01:59:09,360 --> 01:59:10,840 GEMSSTAR AT UCSF THROUGH THE 2988 01:59:10,840 --> 01:59:12,720 GOLDEN COME PASS PROGRAM, WHICH 2989 01:59:12,720 --> 01:59:15,040 IS A COMPREHENSIVE CARE PROGRAM 2990 01:59:15,040 --> 01:59:16,640 FOR PEOPLE WHO ARE OLDER LIVING 2991 01:59:16,640 --> 01:59:19,920 WITH HIV. THE QUESTION I HAVE IS 2992 01:59:19,920 --> 01:59:23,480 THAT THERE'S BASIC SCIENCE ON 2993 01:59:23,480 --> 01:59:25,040 AGING, BASIC SCIENCE ON CHRONIC 2994 01:59:25,040 --> 01:59:27,240 INFLAMMATION AND THERE IS 2995 01:59:27,240 --> 01:59:28,520 INCREASINGLY IMPLEMENTATION 2996 01:59:28,520 --> 01:59:31,920 SCIENCE. AND TRYING TO WORK ON 2997 01:59:31,920 --> 01:59:33,920 PROGRAMS THAT BEYOND THE 2998 01:59:33,920 --> 01:59:36,240 PATHOPHYSIOLOGY DIRECTLY WORK ON 2999 01:59:36,240 --> 01:59:38,240 LINKING PEOPLE TO CARE, THIS IS 3000 01:59:38,240 --> 01:59:40,160 WHAT OUR PROGRAM DOES, PROVIDING 3001 01:59:40,160 --> 01:59:41,160 CARDIOLOGY CARE EARLIER FOR 3002 01:59:41,160 --> 01:59:43,440 THOSE WHO ARE OLDER, PROVIDING 3003 01:59:43,440 --> 01:59:46,560 -- WE PROVIDE MEMORY CARE, BRAIN 3004 01:59:46,560 --> 01:59:49,640 HEALTH CLASSES, WE PROVIDE 3005 01:59:49,640 --> 01:59:51,680 DEXs EARLIER. IT IS A VERY 3006 01:59:51,680 --> 01:59:54,000 CLINICAL PROGRAM, THE GOLDEN 3007 01:59:54,000 --> 01:59:58,640 COMPASS PROGRAM. WONDERING ABOUT 3008 01:59:58,640 --> 02:00:00,440 THE INTEREST FROM OFFICE OF AIDS 3009 02:00:00,440 --> 02:00:03,720 RESEARCH TO PUSH FOR MORE 3010 02:00:03,720 --> 02:00:04,960 GEMSSTAR OR IMPLEMENTATION 3011 02:00:04,960 --> 02:00:06,600 SCIENCE STUDIES ON AGING. 3012 02:00:06,600 --> 02:00:08,160 BEYOND THE PATHOPHYSIOLOGY, IF 3013 02:00:08,160 --> 02:00:10,960 YOU DON'T ACCELERATE CARE, MORE 3014 02:00:10,960 --> 02:00:13,960 QUICKLY FOR PEOPLE WHO ARE 3015 02:00:13,960 --> 02:00:14,800 YOUNGER WITH HIV BECAUSE THEY 3016 02:00:14,800 --> 02:00:18,080 ARE AGING INTERNALLY AT EARLIER 3017 02:00:18,080 --> 02:00:20,040 RATES, IT IS REALLY ABOUT 3018 02:00:20,040 --> 02:00:21,160 CLINICAL CARE PROGRAMS I THINK. 3019 02:00:21,160 --> 02:00:22,680 AND EVALUATING CLINICAL CARE 3020 02:00:22,680 --> 02:00:30,480 PROGRAMS. 3021 02:00:30,480 --> 02:00:36,320 >>IF I MAY YOU MADE A VERY NICE 3022 02:00:36,320 --> 02:00:38,680 POINT, DR. GANDHI. ONE OF THE 3023 02:00:38,680 --> 02:00:39,800 GOALS AND ONE OF THE THINGS WE 3024 02:00:39,800 --> 02:00:44,360 HAVE DISCUSSED WITH NEA AND OUR 3025 02:00:44,360 --> 02:00:46,320 THINK TANK AN DISCUSSING WITH 3026 02:00:46,320 --> 02:00:48,000 NIH WORKING GROUP IS HOW TO 3027 02:00:48,000 --> 02:00:49,200 FACILITATE FOSTERING 3028 02:00:49,200 --> 02:00:51,280 IMPLEMENTATION OF RESEARCH AS A 3029 02:00:51,280 --> 02:00:52,280 RESULT SO EVIDENCE BASED 3030 02:00:52,280 --> 02:00:54,920 INTERVENTIONS AND STRATEGIES ARE 3031 02:00:54,920 --> 02:00:56,160 DEVELOPED WITH NIH FUNDED 3032 02:00:56,160 --> 02:00:58,640 RESEARCH BUT HOW CAN THEY 3033 02:00:58,640 --> 02:01:01,360 ACTUALLY REACH CLINIC FASTER. SO 3034 02:01:01,360 --> 02:01:03,200 ONE OF THE GOALS OF THE WORKING 3035 02:01:03,200 --> 02:01:04,800 GROUP, AND THAT IS WHAT OUR 3036 02:01:04,800 --> 02:01:06,520 ENDEAVOR IS TO LINK RELEVANT 3037 02:01:06,520 --> 02:01:08,720 PARTNERS TOGETHER, WITH -- AND 3038 02:01:08,720 --> 02:01:11,360 HAVE DISCUSSIONS THAT WOULD BE 3039 02:01:11,360 --> 02:01:14,280 INFORMED AND INVOLVED WITH THE 3040 02:01:14,280 --> 02:01:15,640 COMMUNITY SO THAT WE CAN ADDRESS 3041 02:01:15,640 --> 02:01:22,240 ALL THOSE NEEDS. 3042 02:01:22,240 --> 02:01:26,440 >>THANK YOU. 3043 02:01:26,440 --> 02:01:31,840 >>DR. -- THIS WILL BE THE LAST 3044 02:01:31,840 --> 02:01:33,080 QUESTION WE WILL TAKE THE 3045 02:01:33,080 --> 02:01:37,200 SESSION. 3046 02:01:37,200 --> 02:01:37,720 >>THANK YOU ALL THIS IS A 3047 02:01:37,720 --> 02:01:39,320 REALLY FANTASTIC INITIATIVE. 3048 02:01:39,320 --> 02:01:39,920 JUST WANTED TO POINT OUT FROM 3049 02:01:39,920 --> 02:01:42,440 THE BASIC SCIENCE SIDE, FROM 3050 02:01:42,440 --> 02:01:49,160 HIV RESEARCH, THERE'S MANY 3051 02:01:49,160 --> 02:01:50,960 CLEAR MOLECULAR LINKS WITH THE 3052 02:01:50,960 --> 02:01:51,560 AGING PATHWAYS THAT HAVE BEEN 3053 02:01:51,560 --> 02:01:52,800 DISCOVERED IN THE PAST BY US 3054 02:01:52,800 --> 02:01:59,960 AND OTHERS. YOU KNOW, HIV 3055 02:01:59,960 --> 02:02:00,520 PROTEINS DIRECTLY INTERFERE 3056 02:02:00,520 --> 02:02:01,160 WITH AGING RELATED PROTEINS 3057 02:02:01,160 --> 02:02:04,240 LIKE -- IT IS REALLY SOMETHING 3058 02:02:04,240 --> 02:02:05,600 THAT HAS BEEN INCREDIBLY 3059 02:02:05,600 --> 02:02:09,880 INTRIGUING FROM THE BEGINNING. 3060 02:02:09,880 --> 02:02:10,440 AND I THINK ESPECIALLY ALSO 3061 02:02:10,440 --> 02:02:11,280 BASIC SCIENCE RESEARCH PROGRAMS 3062 02:02:11,280 --> 02:02:18,960 EXPLORING THIS BETTER AND 3063 02:02:18,960 --> 02:02:19,560 GETTING A BETTER MOLECULAR 3064 02:02:19,560 --> 02:02:24,000 INSIGHT HERE ARE NEEDED TO 3065 02:02:24,000 --> 02:02:24,560 FULLY ELUCIDATE THIS VERY 3066 02:02:24,560 --> 02:02:26,440 INTRIGUING INTERACTIONS THAT 3067 02:02:26,440 --> 02:02:27,000 MIGHT HAVE STRONG CLINICAL 3068 02:02:27,000 --> 02:02:35,400 IMPLICATIONS. 3069 02:02:35,400 --> 02:02:36,680 >>I SEE A FEW NODS THERE AN 3070 02:02:36,680 --> 02:02:44,760 AGREEMENT DR. OTT. I APPRECIATE 3071 02:02:44,760 --> 02:02:45,320 THAT COMMENT AND WE HAVE TO 3072 02:02:45,320 --> 02:02:46,840 MOVE INTO THE BREAK. YOU HAVE 3073 02:02:46,840 --> 02:02:47,480 ABOUT 13 MINUTES TO STRETCH AND 3074 02:02:47,480 --> 02:02:50,120 WALK AROUND HIS NECK A BITE TO 3075 02:02:50,120 --> 02:02:55,000 EAT AND WILL START PROMPTLY AT 1:15 3076 02:02:55,000 --> 02:02:55,560 WELCOME BACK FROM THE SHORT 3077 02:02:55,560 --> 02:02:57,600 BREAK. WE WANT TO CONTINUE WITH 3078 02:02:57,600 --> 02:03:01,120 THE AGENDA HERE. AND IF YOU 3079 02:03:01,120 --> 02:03:01,760 LOOK IN YOUR BRIEFING BOOK, YOU 3080 02:03:01,760 --> 02:03:02,840 WILL SEE THAT WE HAVE THRE 3081 02:03:02,840 --> 02:03:07,600 TALKS IN THE NEXT PART OF THE 3082 02:03:07,600 --> 02:03:15,280 AGENDA, AND WE'LL FOLLOW THOSE 3083 02:03:15,280 --> 02:03:18,320 WITH A SHORT DISCUSSION SESSION 3084 02:03:18,320 --> 02:03:18,960 SO LET ME GO AHEAD AND INTO THE 3085 02:03:18,960 --> 02:03:19,480 FIRST TWO SPEAKERS IN THE 3086 02:03:19,480 --> 02:03:21,840 SESSION THOSE WOULD BE DOCTORS 3087 02:03:21,840 --> 02:03:28,720 JUDY LEVISON AND DR. THEODORE 3088 02:03:28,720 --> 02:03:32,200 RUEL. DR. LEVISON IS PROFESSOR 3089 02:03:32,200 --> 02:03:32,840 OF OBSTETRICS & GYNECOLOGY AND 3090 02:03:32,840 --> 02:03:33,240 FAMILY AND 3091 02:03:33,240 --> 02:03:33,760 COMMUNITY MEDICINE, BAYLOR 3092 02:03:33,760 --> 02:03:34,320 COLLEGE OF MEDICINE, 3093 02:03:34,320 --> 02:03:34,920 MEMBER, TREATMENT OF HIV DURING 3094 02:03:34,920 --> 02:03:35,480 PREGNANCY AND PREVENTION OF 3095 02:03:35,480 --> 02:03:45,880 PERINATAL TRANSMISSION 3096 02:03:49,840 --> 02:03:50,400 PROVIDES CONSULTATION FOR THE 3097 02:03:50,400 --> 02:03:51,160 NATIONAL PERINATAL HOTLINE. AND 3098 02:03:51,160 --> 02:03:56,440 WORK IN THE AREA OF HIV HAD LED 3099 02:03:56,440 --> 02:03:57,000 HER TO CONSULT ON PROJECTS 3100 02:03:57,000 --> 02:03:57,600 WORLDWIDE IN HER WORK IS THE 3101 02:03:57,600 --> 02:04:00,960 FIRST IN THE UNITED STATES TO 3102 02:04:00,960 --> 02:04:01,600 DEVELOP A CURRICULUM FOR GROUP 3103 02:04:01,600 --> 02:04:02,200 PRENATAL CARE FOR WOMEN LIVING 3104 02:04:02,200 --> 02:04:05,040 WITH HIV, AND TO FOLLOW THE 3105 02:04:05,040 --> 02:04:08,320 OUTCOMES OF THAT PROGRAM. DR. 3106 02:04:08,320 --> 02:04:09,480 RUEL IS PROFESSOR OF 3107 02:04:09,480 --> 02:04:10,120 PEDIATRICS, CHIEF, DIVISION OF 3108 02:04:10,120 --> 02:04:10,880 PEDIATRIC INFECTIOUS DISEASES 3109 02:04:10,880 --> 02:04:11,440 AND GLOBAL HEALTH, DIRECTOR, 3110 02:04:11,440 --> 02:04:12,040 PEDIATRIC INFECTIOUS DISEASES 3111 02:04:12,040 --> 02:04:12,480 FELLOWSHIP, 3112 02:04:12,480 --> 02:04:13,040 UNIVERSITY OF CALIFORNIA, SAN 3113 02:04:13,040 --> 02:04:13,680 FRANCISCO BENIOFF CHILDREN’S 3114 02:04:13,680 --> 02:04:14,080 HOSPITAL, 3115 02:04:14,080 --> 02:04:14,600 CO-CHAIR, PANEL ON ART AND 3116 02:04:14,600 --> 02:04:15,240 MEDICAL MANAGEMENT OF CHILDREN 3117 02:04:15,240 --> 02:04:25,520 LIVING WITH HIV 3118 02:04:27,480 --> 02:04:27,960 THE RESEARCH FOCUSES ON 3119 02:04:27,960 --> 02:04:28,560 OPTIMIZATION AND OUTCOMES FOR 3120 02:04:28,560 --> 02:04:31,000 CHILDREN LIVING WITH HIV 3121 02:04:31,000 --> 02:04:34,640 INFECTION AND DR. RUEL SERVES 3122 02:04:34,640 --> 02:04:43,280 AS COCHAIR PEDIATRIC RETROVIRAL 3123 02:04:43,280 --> 02:04:43,840 PANEL TO PUBLISH CHILDREN'S 3124 02:04:43,840 --> 02:04:44,480 GUIDELINES FOR CHILDREN IN THE 3125 02:04:44,480 --> 02:04:45,160 UNITED STATES AND IS VICE CHAIR 3126 02:04:45,160 --> 02:04:45,600 OF THE WORLD HEALTH 3127 02:04:45,600 --> 02:04:49,520 ORGANIZATION SO DR. LEVISON I 3128 02:04:49,520 --> 02:04:50,360 WILL PASS IT OVER TO YOU NOW. 3129 02:04:50,360 --> 02:04:54,440 >>DR. LEVISON: THANK YOU SO 3130 02:04:54,440 --> 02:04:54,920 MUCH FOR GIVING US THE 3131 02:04:54,920 --> 02:04:55,520 OPPORTUNITY TO TELL YOU ABOUT 3132 02:04:55,520 --> 02:04:57,000 CHANGES IN THE NEW 3133 02:04:57,000 --> 02:04:57,560 RECOMMENDATIONS FOR INFANT 3134 02:04:57,560 --> 02:04:59,960 FEEDING AND PREVENTION OF 3135 02:04:59,960 --> 02:05:01,680 PEDIATRIC HIV INFECTION IN THE 3136 02:05:01,680 --> 02:05:06,160 US, WHAT THEY ARE AND WHY NOW. 3137 02:05:06,160 --> 02:05:12,680 I HAVE NO DISCLOSURES. 3138 02:05:12,680 --> 02:05:13,240 HOPE BY THE END YOU WILL BE 3139 02:05:13,240 --> 02:05:13,840 ABLE TO DESCRIBE SOME OF THE 3140 02:05:13,840 --> 02:05:19,560 CHANGES IN THE PERINATAL HIV 3141 02:05:19,560 --> 02:05:20,200 GUIDELINES RELEASED ON JANUARY 3142 02:05:20,200 --> 02:05:29,120 31 OF THIS YEAR WHICH DISPLAYS 3143 02:05:29,120 --> 02:05:29,720 THE SCIENCE AND THE SOCIAL 3144 02:05:29,720 --> 02:05:31,240 CONTRACT THAT SUPPORTED THOSE 3145 02:05:31,240 --> 02:05:34,800 CHANGES. 3146 02:05:34,800 --> 02:05:35,400 FIRST OF ALL WHAT HAS BEEN THE 3147 02:05:35,400 --> 02:05:36,600 FEEDING GUIDELINES FOR PEOPLE 3148 02:05:36,600 --> 02:05:46,920 LIVING WITH HIV? 3149 02:05:49,840 --> 02:05:50,360 HTLV-III/LAV-INFECTED WOMEN 3150 02:05:50,360 --> 02:05:50,880 SHOULD BE ADVISED AGAINST 3151 02:05:50,880 --> 02:05:52,040 PROCEEDING TO AVOID POSTNATAL 3152 02:05:52,040 --> 02:05:57,200 TRANSMISSION TO A CHILD WHO MAY 3153 02:05:57,200 --> 02:05:57,840 NOT GET INFECTED IN 2015 WAS A 3154 02:05:57,840 --> 02:05:59,040 BIG STEP FORWARD IN THE 3155 02:05:59,040 --> 02:06:00,320 PERINATAL GUIDELINES AND ONE 3156 02:06:00,320 --> 02:06:03,120 SENTENCE WAS ADDED. 3157 02:06:03,120 --> 02:06:03,760 IN DISCUSSING THE AVOIDANCE OF 3158 02:06:03,760 --> 02:06:04,560 BREAST-FEEDING IS A STRONG 3159 02:06:04,560 --> 02:06:09,680 STANDARD RECOMMENDATION FOR 3160 02:06:09,680 --> 02:06:11,080 HIV-INFECTED WOMEN IN THE 3161 02:06:11,080 --> 02:06:14,200 UNITED STATES. THE PANEL NOTES 3162 02:06:14,200 --> 02:06:14,800 THAT WOMEN MAY FACE SOCIAL, 3163 02:06:14,800 --> 02:06:15,280 FAMILIAL, AND PERSONAL 3164 02:06:15,280 --> 02:06:20,640 PRESSURES TO BREAST-FEED 3165 02:06:20,640 --> 02:06:21,240 DESPITE THIS RECOMMENDATION 3166 02:06:21,240 --> 02:06:21,800 THAT IS IMPORTANT TO BEGIN 3167 02:06:21,800 --> 02:06:22,440 ADDRESSING POSSIBLE BARRIERS TO 3168 02:06:22,440 --> 02:06:23,000 FORMULA FEEDING DURING THE 3169 02:06:23,000 --> 02:06:23,520 ANTENATAL PERIOD. 3170 02:06:23,520 --> 02:06:25,200 NEXT SLIDE. 3171 02:06:25,200 --> 02:06:33,320 2018 WAS A LITTLE DIFFERENT. 3172 02:06:33,320 --> 02:06:36,360 AT AN ENTIRE NEW SECTION WAS 3173 02:06:36,360 --> 02:06:38,360 ADDED TO THE GUIDELINES. SOME 3174 02:06:38,360 --> 02:06:38,960 OF THE LANGUAGE WERE STILL 3175 02:06:38,960 --> 02:06:40,960 PRETTY NEGATIVE AND THE SECTION 3176 02:06:40,960 --> 02:06:43,600 OPEN WITH THE FOLLOWING: 3177 02:06:43,600 --> 02:06:44,040 BREAST-FEEDING IS NOT 3178 02:06:44,040 --> 02:06:45,600 RECOMMENDED FOR WOMEN LIVING 3179 02:06:45,600 --> 02:06:49,000 WITH HIV IN THE UNITED STATES 3180 02:06:49,000 --> 02:06:51,840 AND WOMEN WHO HAVE QUESTIONS 3181 02:06:51,840 --> 02:06:52,400 ABOUT BREAST-FEEDING OR WHO 3182 02:06:52,400 --> 02:06:53,000 DESIRE TO BREAST-FEED SHOULD 3183 02:06:53,000 --> 02:06:55,240 RECEIVE PATIENT CENTERED, 3184 02:06:55,240 --> 02:06:55,840 EVIDENCE BASED COUNSELING ON 3185 02:06:55,840 --> 02:06:57,200 INFANT FEEDING OPTIONS. 3186 02:06:57,200 --> 02:07:04,240 WIN-WIN MEN WITH HIV CHOOSE TO 3187 02:07:04,240 --> 02:07:04,840 BREAST-FEED DESPITE INTENSIVE 3188 02:07:04,840 --> 02:07:05,480 COUNSELORS SHOULD BE COUNSELED 3189 02:07:05,480 --> 02:07:06,120 TO USE HARM REDUCTION MEASURES 3190 02:07:06,120 --> 02:07:07,760 TO MINIMIZE THE RISK OF HIV 3191 02:07:07,760 --> 02:07:13,480 TRANSMISSION. 3192 02:07:13,480 --> 02:07:14,000 YOU CAN SEE HIGHLIGHTED IN 3193 02:07:14,000 --> 02:07:14,600 YELLOW THAT IS OUR SIGNAL AND 3194 02:07:14,600 --> 02:07:15,240 THE GUIDELINES PANEL THAT THESE 3195 02:07:15,240 --> 02:07:16,800 THINGS ARE NEW. 3196 02:07:16,800 --> 02:07:17,400 AND FOR THOSE OF YOU WHO HAVE 3197 02:07:17,400 --> 02:07:18,640 SEEN THE GUIDELINES, YOU WILL 3198 02:07:18,640 --> 02:07:20,800 RECOGNIZE THIS FORMAT. NEXT 3199 02:07:20,800 --> 02:07:24,320 SLIDE PLEASE. 3200 02:07:24,320 --> 02:07:28,160 THE MAJOR CHANGES THE 3201 02:07:28,160 --> 02:07:28,640 FOLLOWING. THE PRIMARY 3202 02:07:28,640 --> 02:07:29,200 RECOMMENDATION IS NOT TO 3203 02:07:29,200 --> 02:07:34,640 SUPPORT PARENTAL CHOICE THROUGH 3204 02:07:34,640 --> 02:07:35,280 SHARED DECISION-MAKING AND NOT 3205 02:07:35,280 --> 02:07:35,880 A SPECIFIC INTERFEEDING MODE. 3206 02:07:35,880 --> 02:07:39,840 NEXT SLIDE. 3207 02:07:39,840 --> 02:07:40,440 THIS IS SOME OF THE THINGS WE 3208 02:07:40,440 --> 02:07:41,920 TOOK INTO CONSIDERATION IN WAYS 3209 02:07:41,920 --> 02:07:44,560 THAT DON'T THINK WE HAD BEFORE. 3210 02:07:44,560 --> 02:07:45,160 FIRST THE HEALTH BENEFITS FROM 3211 02:07:45,160 --> 02:07:47,240 BREAST-FEEDING. 3212 02:07:47,240 --> 02:07:50,560 FOR THE INFANT WE KNOW THAT 3213 02:07:50,560 --> 02:07:51,040 THERE IS A LOWER RISK OF 3214 02:07:51,040 --> 02:07:52,680 INFANTS DEVELOPING ASTHMA, 3215 02:07:52,680 --> 02:08:00,240 OBESITY, TYPE I DIABETES, 3216 02:08:00,240 --> 02:08:00,840 RESPIRATORY DISEASE, OTITIS 3217 02:08:00,840 --> 02:08:09,480 MEDIUS -- AND FOR THE 3218 02:08:09,480 --> 02:08:10,040 PROCEEDING PARENT ARE ALSO 3219 02:08:10,040 --> 02:08:10,640 ADVANTAGES DECREASED RISK OF 3220 02:08:10,640 --> 02:08:15,720 HYPERTENSION, AND REDUCING RISK 3221 02:08:15,720 --> 02:08:16,320 OF BREAST AND OVARIAN CANCERS. 3222 02:08:16,320 --> 02:08:16,840 BLACK WOMEN ARE 3223 02:08:16,840 --> 02:08:21,760 DISPROPORTIONATELY AFFECTED BY 3224 02:08:21,760 --> 02:08:22,280 HIV AND PEOPLE OF COLOR 3225 02:08:22,280 --> 02:08:22,920 EXPERIENCE A GREATER BURDEN OF 3226 02:08:22,920 --> 02:08:23,560 MANY HEALTH CONDITIONS THAT MAY 3227 02:08:23,560 --> 02:08:26,000 BE ALLEVIATED BY BREAST-FEEDING. 3228 02:08:26,000 --> 02:08:26,520 CULTURAL CONSIDERATIONS: 3229 02:08:26,520 --> 02:08:29,800 ENVIRONMENTAL SOCIAL AND 3230 02:08:29,800 --> 02:08:30,400 FAMILIAL PRESSURE TO CONSIDER 3231 02:08:30,400 --> 02:08:30,960 BREAST-FEEDING AND THE FEAR 3232 02:08:30,960 --> 02:08:31,560 THAT NOT BREAST-FEEDING WOULD 3233 02:08:31,560 --> 02:08:33,480 LEAD TO DISCLOSURE OF THEIR HIV 3234 02:08:33,480 --> 02:08:39,080 STATUS. NEXT SLIDE. 3235 02:08:39,080 --> 02:08:43,800 SO, WHAT IS THE RISK OF HIV 3236 02:08:43,800 --> 02:08:51,800 VIA BREASTFEEDING? 3237 02:08:51,800 --> 02:08:52,280 WITHOUT MATERNAL INFANT 3238 02:08:52,280 --> 02:08:56,880 PROPHYLAXIS THE RISK IS ABOUT 3239 02:08:56,880 --> 02:08:57,920 15-20% OVER TWO YEARS IN 3240 02:08:57,920 --> 02:08:58,560 ACHIEVING AND MAINTAINING VIRAL 3241 02:08:58,560 --> 02:09:06,080 SUPPRESSION DURING ART AND 3242 02:09:06,080 --> 02:09:06,560 POSTPARTUM DECREASES 3243 02:09:06,560 --> 02:09:07,640 TRANSMISSION RISK LESS THAN 1% 3244 02:09:07,640 --> 02:09:10,360 BUT NOT ZERO. 3245 02:09:10,360 --> 02:09:12,680 NEXT SLIDE. 3246 02:09:12,680 --> 02:09:13,240 AND I THINK YOU'RE GOING TO 3247 02:09:13,240 --> 02:09:14,120 TAKE IT FROM HERE. 3248 02:09:14,120 --> 02:09:17,960 >>DR. RUEL: THANKS JUDY SO WE 3249 02:09:17,960 --> 02:09:18,560 ARE NOT GOING TO TURN TO LOOK 3250 02:09:18,560 --> 02:09:24,160 AT SOME OF THE CONTENT AND HOW 3251 02:09:24,160 --> 02:09:24,760 THERE ARE KEY PARTS FOR PEOPLE 3252 02:09:24,760 --> 02:09:25,360 RECOGNIZING THERE IS MUCH THAT 3253 02:09:25,360 --> 02:09:25,880 WE WON'T BE ABLE 3254 02:09:25,880 --> 02:09:30,040 TO HIGHLIGHT TODAY. 3255 02:09:30,040 --> 02:09:31,000 TO START WITH THE OVERVIEW, 3256 02:09:31,000 --> 02:09:36,800 AND COUNSELING AND MANAGEMENT, 3257 02:09:36,800 --> 02:09:37,400 FOR PEOPLE WITH HIV WHO ARE 3258 02:09:37,400 --> 02:09:38,440 NOT ON TREATMENT AND DO NOT 3259 02:09:38,440 --> 02:09:40,280 HAVE SUPPRESSED VIRAL LOAD AT 3260 02:09:40,280 --> 02:09:40,760 THE TIME OF DELIVERY 3261 02:09:40,760 --> 02:09:41,400 RECOMMENDATIONS REMAIN THE SAME 3262 02:09:41,400 --> 02:09:42,960 WHICH IS REPLACING FEEDING 3263 02:09:42,960 --> 02:09:47,160 FORMULA OR BANK 3264 02:09:47,160 --> 02:09:47,720 PASTEURIZED DONOR HUMAN MILK 3265 02:09:47,720 --> 02:09:48,280 IS RECOMMENDED TO LIMIT THE 3266 02:09:48,280 --> 02:09:53,200 RISK OF HIV TRANSMISSION. 3267 02:09:53,200 --> 02:09:53,760 AND OF COURSE NEW CONTENT IS 3268 02:09:53,760 --> 02:09:54,320 FOR INDIVIDUALS WITH HIV ON 3269 02:09:54,320 --> 02:09:55,000 TREATMENT WILL HAVE A 3270 02:09:55,000 --> 02:09:56,200 CONSISTENTLY SUPPRESSED 3271 02:09:56,200 --> 02:09:57,080 VIRAL LOAD DURING PREGNANCY 3272 02:09:57,080 --> 02:09:58,680 WHICH INCLUDES AT A MINIMUM 3273 02:09:58,680 --> 02:09:59,240 THROUGH THE THIRD TRIMESTER 3274 02:09:59,240 --> 02:10:02,160 AND AT THE TIME OF DELIVERY. 3275 02:10:02,160 --> 02:10:02,720 THE IDEA IS THAT THEY SHOULD 3276 02:10:02,720 --> 02:10:03,200 BE COUNSELED OPENLY ON 3277 02:10:03,200 --> 02:10:12,320 DIFFERENT OPTIONS, FROM FORMULA 3278 02:10:12,320 --> 02:10:12,920 FEEDING BANKED DONOR MILK, OR 3279 02:10:12,920 --> 02:10:19,680 BREAST-FEEDING. 3280 02:10:19,680 --> 02:10:20,280 INFANT FEEDING OPTIONS THAT 3281 02:10:20,280 --> 02:10:20,720 ELIMINATE THE RISK OF 3282 02:10:20,720 --> 02:10:21,320 TRANSMISSION OUR FORMULA AND 3283 02:10:21,320 --> 02:10:21,960 THAT MILK AND RECOGNIZING THAT 3284 02:10:21,960 --> 02:10:25,240 FULLY SUPPRESSIVE ART 3285 02:10:25,240 --> 02:10:25,680 DURING PREGNANCY AND 3286 02:10:25,680 --> 02:10:26,200 BREAST-FEEDING DECREASES 3287 02:10:26,200 --> 02:10:26,800 PRESSING TRANSMISSION TO LESS 3288 02:10:26,800 --> 02:10:27,680 THAN 1%, BUT WE CANNOT SAY ZERO 3289 02:10:27,680 --> 02:10:37,960 YET. NEXT SLIDE. 3290 02:10:38,200 --> 02:10:38,800 THE HIGHLIGHTS ALSO HIGHLIGHT 3291 02:10:38,800 --> 02:10:41,200 WHAT TO DO IF THERE IS CONCERN 3292 02:10:41,200 --> 02:10:46,440 ABOUT -- BREAST-FEEDING SHOULD 3293 02:10:46,440 --> 02:10:50,560 BE STOPPED. REPLACING WITH 3294 02:10:50,560 --> 02:10:54,200 FEEDING FORMULA. BUT THE VIRAL 3295 02:10:54,200 --> 02:10:58,640 LOAD IS DETECTABLE THERE IS 3296 02:10:58,640 --> 02:10:59,280 REALLY A SHIFT IN THE GUIDANCE 3297 02:10:59,280 --> 02:11:00,920 BACK TO THE MORE DIRECTIVE IDEA 3298 02:11:00,920 --> 02:11:03,640 OF CESSATION OF BREAST-FEEDING, 3299 02:11:03,640 --> 02:11:07,000 AND INITIATION OF A GREATER 3300 02:11:07,000 --> 02:11:07,600 DEGREE OF PROPHYLAXIS FOR THE 3301 02:11:07,600 --> 02:11:08,480 INFANT IN THAT CONTEXT. NEXT 3302 02:11:08,480 --> 02:11:14,080 SLIDE. 3303 02:11:14,080 --> 02:11:14,680 SO ONE OF THE MORE CHALLENGING 3304 02:11:14,680 --> 02:11:15,280 PARTS OF THE GUIDANCE WAS TO 3305 02:11:15,280 --> 02:11:17,040 GET CONSENSUS ON WHAT TO DO 3306 02:11:17,040 --> 02:11:18,440 WITH PROPHYLAXIS FOR INFANTS 3307 02:11:18,440 --> 02:11:20,800 WHO ARE BREAST-FEEDING IN THIS 3308 02:11:20,800 --> 02:11:21,280 CONTEXT. THERE WAS REAL 3309 02:11:21,280 --> 02:11:23,600 DIVERSITY ACROSS THE PANEL. 3310 02:11:23,600 --> 02:11:26,480 MOST PANEL MEMBERS AGREED THAT 3311 02:11:26,480 --> 02:11:31,440 TWO WEEKS OF ZDV AS YOU WOULD 3312 02:11:31,440 --> 02:11:32,080 WITH HIGHER OR LOWER RISK WOULD 3313 02:11:32,080 --> 02:11:32,800 BE SUFFICIENT BUT SOME FELT 3314 02:11:32,800 --> 02:11:40,360 THAT FULL ACCESS OR LONGER, 4-6 3315 02:11:40,360 --> 02:11:40,960 WEEKS WHICH WAS UNTIL A FEW 3316 02:11:40,960 --> 02:11:41,520 YEARS AGO WAS OUR STANDARD 3317 02:11:41,520 --> 02:11:43,720 WOULD BE PREFERRED. IN SOME 3318 02:11:43,720 --> 02:11:49,000 RECOMMENDED SIX WEEKS WITH 3319 02:11:49,000 --> 02:11:49,560 NEVIRAPINE AND SOME OTHERS 3320 02:11:49,560 --> 02:11:50,080 OPTED FOR CONTINUATION OF 3321 02:11:50,080 --> 02:11:56,160 PROPHYLAXIS SUCH AS NEVIRAPINE 3322 02:11:56,160 --> 02:11:56,600 FOR THE DURATION OF 3323 02:11:56,600 --> 02:11:57,160 BREAST-FEEDING AND THE LAST 3324 02:11:57,160 --> 02:11:59,280 SLIDE HIGHLIGHTS ONE OF THE BIG 3325 02:11:59,280 --> 02:12:04,000 CHALLENGES WITH THIS VERSION. 3326 02:12:04,000 --> 02:12:04,520 YOU KNOW RECOMMENDING AND 3327 02:12:04,520 --> 02:12:05,120 SUPPORTING BREAST-FEEDING NOW 3328 02:12:05,120 --> 02:12:06,720 MEANT WE HAD TO DEVELOP A LOT 3329 02:12:06,720 --> 02:12:07,320 OF NEW CONTENT AROUND WHAT TO 3330 02:12:07,320 --> 02:12:11,480 DO. 3331 02:12:11,480 --> 02:12:15,360 FOR INSTANCE WHEN SOMETHING 3332 02:12:15,360 --> 02:12:19,040 LIKE MASTITIS HAPPENS. 3333 02:12:19,040 --> 02:12:19,600 THERE'S A LOT OF NEW CONTENT 3334 02:12:19,600 --> 02:12:23,320 THERE BUT A LOT OF IT IS MADE 3335 02:12:23,320 --> 02:12:23,800 UP TO ADDRESS THE NEW 3336 02:12:23,800 --> 02:12:26,440 CHALLENGES WE HAVE NOW. AND WE 3337 02:12:26,440 --> 02:12:26,800 REALLY 3338 02:12:26,800 --> 02:12:27,360 REALIZE THAT THERE ARE A LOT 3339 02:12:27,360 --> 02:12:28,000 OF GAPS THE PROCESS THAT LIMIT 3340 02:12:28,000 --> 02:12:35,600 WHAT WE CAN SAY, 3341 02:12:35,600 --> 02:12:36,080 IN THE STRENGTH OF THE 3342 02:12:36,080 --> 02:12:36,680 RECOMMENDATIONS. TO DATE NEW 3343 02:12:36,680 --> 02:12:37,240 STUDIES HAVE SYSTEMATICALLY 3344 02:12:37,240 --> 02:12:37,720 EVALUATE THE RISK OF 3345 02:12:37,720 --> 02:12:38,160 TRANSMISSION THROUGH 3346 02:12:38,160 --> 02:12:38,800 BREAST-FEEDING IN THIS CONTEXT 3347 02:12:38,800 --> 02:12:39,440 OF AFFECTED MATERNAL TREATMENT 3348 02:12:39,440 --> 02:12:43,080 THAT WE HAVE AND WE KNOW DATA 3349 02:12:43,080 --> 02:12:43,720 THAT EXIST IN THE FREQUENCY OF 3350 02:12:43,720 --> 02:12:44,280 VIRAL LOAD TESTING FOR THE 3351 02:12:44,280 --> 02:12:46,560 INFANTS AND MOTHERS. 3352 02:12:46,560 --> 02:12:47,160 A LOT OF THIS IS PUT OUT THERE 3353 02:12:47,160 --> 02:12:56,000 AS OUR BEST ESTIMATES 3354 02:12:56,000 --> 02:12:56,600 ON THE CATEGORY OF MORE EXPERT 3355 02:12:56,600 --> 02:12:57,200 GUIDANCE AND UNFORTUNATELY NOT 3356 02:12:57,200 --> 02:12:57,840 DRIVEN BY AS MUCH DATA BY WE 3357 02:12:57,840 --> 02:12:59,040 WOULD LIKE. 3358 02:12:59,040 --> 02:12:59,640 WANTED TO HIGHLIGHT THE LAST 3359 02:12:59,640 --> 02:13:05,400 PART OF THE CONTENT. ENGAGING 3360 02:13:05,400 --> 02:13:06,000 CHILD PROTECTIVE SERVICES OR 3361 02:13:06,000 --> 02:13:06,560 SIMILAR AGENCIES IS NOT AN 3362 02:13:06,560 --> 02:13:07,200 APPROPRIATE RESPONSE TO INFANT 3363 02:13:07,200 --> 02:13:07,840 FEEDING CHOICE OF AN INDIVIDUAL 3364 02:13:07,840 --> 02:13:09,680 WITH HIV. 3365 02:13:09,680 --> 02:13:11,200 IN THIS REALLY POINT TO A REAL 3366 02:13:11,200 --> 02:13:11,760 PROBLEMATIC HISTORY IN THE 3367 02:13:11,760 --> 02:13:18,960 RELATIONSHIP BETWEEN PROVIDERS, 3368 02:13:18,960 --> 02:13:22,560 PARENTS AND THEIR INFANTS 3369 02:13:22,560 --> 02:13:25,600 3370 02:13:25,600 --> 02:13:28,880 3371 02:13:28,880 --> 02:13:29,480 HISTORICALLY THAT HAS LED TO A 3372 02:13:29,480 --> 02:13:30,000 LOT OF HARM AND TRAUMA IN 3373 02:13:30,000 --> 02:13:30,560 PARENTING AND THE FAMILY 3374 02:13:30,560 --> 02:13:31,160 STRUCTURE AND THIS IS REALLY 3375 02:13:31,160 --> 02:13:31,720 IMPORTANT TO MEMBERS OF THE 3376 02:13:31,720 --> 02:13:32,280 COMMUNITY AND PROVIDERS TO 3377 02:13:32,280 --> 02:13:32,840 INCLUDE SPECIFICALLY AS THE 3378 02:13:32,840 --> 02:13:33,480 GUIDELINES SHOW HIGHLIGHTED IN 3379 02:13:33,480 --> 02:13:34,200 THE MAIN BOX. NEXT SLIDE. 3380 02:13:34,200 --> 02:13:37,040 SO, TO HIGHLIGHT A FEW NEW 3381 02:13:37,040 --> 02:13:37,680 THINGS ABOUT THE PROCESS THIS 3382 02:13:37,680 --> 02:13:41,040 YEAR. 3383 02:13:41,040 --> 02:13:41,600 AS YOU MENTIONED, THERE WAS 3384 02:13:41,600 --> 02:13:43,480 EARLY IMPORTANT 3385 02:13:43,480 --> 02:13:45,320 3386 02:13:45,320 --> 02:13:51,160 , INPUT FROM THE COMMUNITY 3387 02:13:51,160 --> 02:13:51,680 THAT LED TO THIS CHANGE. 3388 02:13:51,680 --> 02:13:52,240 MEMBERS OF THE WELL PROJECT 3389 02:13:52,240 --> 02:13:52,800 INTERNATIONAL COMMUNITY OF 3390 02:13:52,800 --> 02:13:53,440 WOMEN LIVING WITH HIV IN NORTH 3391 02:13:53,440 --> 02:14:03,960 AMERICAN OTHERS, INDIVIDUALS 3392 02:14:04,600 --> 02:14:05,160 AND FAMILIES AND PEOPLE IN THE 3393 02:14:05,160 --> 02:14:05,800 PANEL HAVE WORKED WITH; ANOTHER 3394 02:14:05,800 --> 02:14:12,680 KEY CONTRIBUTOR WERE LACTATION 3395 02:14:12,680 --> 02:14:13,280 SPECIALISTS FROM THE CDC THAT 3396 02:14:13,280 --> 02:14:13,880 GUIDANCE TO HELP US. THERE WAS 3397 02:14:13,880 --> 02:14:14,480 A NEW LEVEL OF COLLABORATION 3398 02:14:14,480 --> 02:14:25,040 BETWEEN PERINATAL AND PEDIATRIC 3399 02:14:37,360 --> 02:14:37,920 PANELS. WE WORK TOGETHER IN THE 3400 02:14:37,920 --> 02:14:38,480 PAST BUT THIS WAS MUCH MORE 3401 02:14:38,480 --> 02:14:39,120 INTERACTIVE WITH CO-EDITING OF 3402 02:14:39,120 --> 02:14:39,640 THE KEY PORTIONS OF THE 3403 02:14:39,640 --> 02:14:40,240 GUIDELINES. THIS IS SOMETHING 3404 02:14:40,240 --> 02:14:40,840 WE ANTICIPATE WILL BE A LASTING 3405 02:14:40,840 --> 02:14:41,440 THERE IS LESS OF A RISK OF 3406 02:14:41,440 --> 02:14:41,960 PARALLELING AND SLIGHTLY 3407 02:14:41,960 --> 02:14:42,560 NUANCED OUT THERE. NEXT SLIDE. 3408 02:14:42,560 --> 02:14:43,120 SO WE WANTED TO FINISH BY 3409 02:14:43,120 --> 02:14:45,400 POINTING OUT 3410 02:14:45,400 --> 02:14:45,880 THAT THIS CHANGE IN THE 3411 02:14:45,880 --> 02:14:46,480 GOVERNANCE COME TO THE RIGHT 3412 02:14:46,480 --> 02:14:48,600 TIME WHAT WE SEE HERE ARE 3413 02:14:48,600 --> 02:14:49,240 CALLED TO THE NATIONAL CLINICAL 3414 02:14:49,240 --> 02:14:50,640 CONSULTATION CENTER FOR BOTH 3415 02:14:50,640 --> 02:14:55,960 JUDY AND I WORK. AS MANY OF YOU 3416 02:14:55,960 --> 02:14:56,600 KNOW WE SUPPORTED THE ENDEAVOR 3417 02:14:56,600 --> 02:14:57,120 REFERRED TO A LOT IN THE 3418 02:14:57,120 --> 02:14:57,760 GALLONS WERE WE TO QUESTIONS 3419 02:14:57,760 --> 02:15:04,600 ABOUT THE GUIDELINES. 3420 02:15:04,600 --> 02:15:05,200 AND YOU CAN SEE THE HEIGHT OF 3421 02:15:05,200 --> 02:15:05,760 THE BARS IS THE PORTION OF 3422 02:15:05,760 --> 02:15:06,240 CALLS TO THE PERINATAL 3423 02:15:06,240 --> 02:15:11,200 GUIDELINES, IN WHICH BREAST OR 3424 02:15:11,200 --> 02:15:11,840 CHEST BEATING WERE DISCUSSED 3425 02:15:11,840 --> 02:15:12,440 STARTING IN 2014 AT SOMETHING 3426 02:15:12,440 --> 02:15:17,600 LIKE 4% OF CALLS UP THE LAST 3427 02:15:17,600 --> 02:15:18,080 YEAR OVER 1/4 OF CALLS 3428 02:15:18,080 --> 02:15:18,560 CONCERNED INTEREST IN 3429 02:15:18,560 --> 02:15:22,080 BREAST/CHEST FEEDING, 3430 02:15:22,080 --> 02:15:22,600 IMPORTANT TIME TO PROVIDE 3431 02:15:22,600 --> 02:15:23,080 GUIDANCE TO THIS RISING 3432 02:15:23,080 --> 02:15:23,640 INTEREST IN PROVIDERS AND 3433 02:15:23,640 --> 02:15:24,040 FAMILIES. 3434 02:15:24,040 --> 02:15:26,160 NEXT SLIDE. 3435 02:15:26,160 --> 02:15:31,360 AND TO FURTHER SUPPORT THAT, 3436 02:15:31,360 --> 02:15:31,960 THIS IS A STUDY THAT WAS DONE 3437 02:15:31,960 --> 02:15:37,240 BY SOME RESIDENTS AT UCSF THAT 3438 02:15:37,240 --> 02:15:37,880 REACHED OUT TO US TO HELP WITH 3439 02:15:37,880 --> 02:15:38,520 THIS PROJECT AS WELL. THIS WAS 3440 02:15:38,520 --> 02:15:40,920 A SERVICE PROVIDERS ACROSS THE 3441 02:15:40,920 --> 02:15:43,160 US, 3442 02:15:43,160 --> 02:15:45,440 3443 02:15:45,440 --> 02:15:45,880 AND IT FOUND REALLY 3444 02:15:45,880 --> 02:15:46,520 HIGHLIGHTED THE DISCOMFORT THAT 3445 02:15:46,520 --> 02:15:47,120 WAS FELT BY PROVIDERS AT THIS 3446 02:15:47,120 --> 02:15:47,680 TIME. THIS WAS BASICALLY TO 3447 02:15:47,680 --> 02:15:51,720 2021 INTO 2022. 42% HAD CARED 3448 02:15:51,720 --> 02:15:52,320 FOR PEOPLE WITH THIS INTEREST 3449 02:15:52,320 --> 02:15:52,760 BUT ONLY 10% HAD AN 3450 02:15:52,760 --> 02:15:54,680 INSTITUTIONAL 3451 02:15:54,680 --> 02:15:57,760 3452 02:15:57,760 --> 02:15:58,320 PROTOCOL AND REALLY ALL OF 3453 02:15:58,320 --> 02:15:58,920 THEM EXPRESSED DISCOMFORT WITH 3454 02:15:58,920 --> 02:15:59,560 NOT HAVING GUIDANCE. TRYING TO 3455 02:15:59,560 --> 02:16:00,960 NAVIGATE 3456 02:16:00,960 --> 02:16:05,040 3457 02:16:05,040 --> 02:16:08,520 3458 02:16:08,520 --> 02:16:09,080 THE PERSONAL SENSE OF ETHICS 3459 02:16:09,080 --> 02:16:09,560 TO DISAGREEMENTS ACROSS 3460 02:16:09,560 --> 02:16:10,200 PROVIDERS, TRYING TO ALIGN WITH 3461 02:16:10,200 --> 02:16:10,800 HOSPITAL POLICIES AND NOT GET 3462 02:16:10,800 --> 02:16:11,440 IN TROUBLE, A LOT OF FEAR AND A 3463 02:16:11,440 --> 02:16:12,040 LOT OF DISCOMFORT AS THEY TRY 3464 02:16:12,040 --> 02:16:20,560 TO BALANCE DESIRES TO ADDRESS 3465 02:16:20,560 --> 02:16:21,080 PERSON'S CHOICE BUT ISSUES 3466 02:16:21,080 --> 02:16:21,720 WITH PATERNALISM AND THE FORMAL 3467 02:16:21,720 --> 02:16:22,360 STRUCTURE OF THE GUIDELINES OUT 3468 02:16:22,360 --> 02:16:23,000 THERE, SO COMING OUT AT A GREAT 3469 02:16:23,000 --> 02:16:23,320 TIME. 3470 02:16:23,320 --> 02:16:27,680 >>DR. LEVISON: SO IN ADDITION 3471 02:16:27,680 --> 02:16:28,200 PATIENTS IN THE US HAVE 3472 02:16:28,200 --> 02:16:28,720 STRUGGLED TO NAVIGATE THE 3473 02:16:28,720 --> 02:16:29,320 INFANT FEEDING OPTIONS IN THE 3474 02:16:29,320 --> 02:16:34,960 ABSENCE OF MORE GUIDANCE. THERE 3475 02:16:34,960 --> 02:16:35,560 HAVE BEEN SOME WOMEN WHO HAVE 3476 02:16:35,560 --> 02:16:36,120 GONE FROM DOCTOR TO DOCTOR 3477 02:16:36,120 --> 02:16:36,720 UNTIL THEY FOUND SOMEONE WHO 3478 02:16:36,720 --> 02:16:37,360 WOULD SUPPORT WHAT THEY WANTED 3479 02:16:37,360 --> 02:16:38,560 TO DO. 3480 02:16:38,560 --> 02:16:39,120 AND IT HAS LED TO A LOT OF 3481 02:16:39,120 --> 02:16:44,800 MISTRUST. 3482 02:16:44,800 --> 02:16:45,360 AS ONE PERSON SAID THE FIRST 3483 02:16:45,360 --> 02:16:45,880 THING YOU HAVE TO DO AS A 3484 02:16:45,880 --> 02:16:46,520 HEALTHCARE PROVIDER IS RESTORE 3485 02:16:46,520 --> 02:16:48,240 TRUST. 3486 02:16:48,240 --> 02:16:48,680 I NEED A HEALTHCARE 3487 02:16:48,680 --> 02:16:49,200 PROFESSIONAL AND NOT AN 3488 02:16:49,200 --> 02:16:54,200 INVESTIGATIVE. AND THEN CC 3489 02:16:54,200 --> 02:16:59,720 KOVIN (PHONETIC) WHO HAS BEEN A 3490 02:16:59,720 --> 02:17:00,360 REALLY ARTICULATE SPOKESPERSON 3491 02:17:00,360 --> 02:17:01,000 FOR THE COMMUNITY SAID THAT IT 3492 02:17:01,000 --> 02:17:01,600 IS VERY IMPORTANT THAT WE ARE 3493 02:17:01,600 --> 02:17:03,120 GIVEN A CHOICE, NOT GIVEN A 3494 02:17:03,120 --> 02:17:03,680 CHOICE LIKE I JUST NEED TO 3495 02:17:03,680 --> 02:17:12,200 SUPPORT WHAT MY DECISION IS. 3496 02:17:12,200 --> 02:17:12,800 IT IS NOT MY PROVIDER'S PLACE 3497 02:17:12,800 --> 02:17:13,400 TO TELL ME WHAT TO DO WITH MY 3498 02:17:13,400 --> 02:17:14,000 LEFT AND MY BABIES I NEED YOU 3499 02:17:14,000 --> 02:17:14,560 TO LEAVE THE SPACE OPEN FOR 3500 02:17:14,560 --> 02:17:17,520 DISCUSSION AND CHOICE. 3501 02:17:17,520 --> 02:17:18,040 AND THE RESOURCES THAT WE 3502 02:17:18,040 --> 02:17:18,680 ADVISE EVERYBODY IN EVERY TALK 3503 02:17:18,680 --> 02:17:29,200 TO CONSIDER ARE THE HIV-INFO 3504 02:17:32,040 --> 02:17:32,560 @NIH.GOV GUIDELINES WHERE YOU 3505 02:17:32,560 --> 02:17:33,080 HAVE THE PEDIATRIC AND 3506 02:17:33,080 --> 02:17:33,680 PERINATAL GUIDELINES AND THE 3507 02:17:33,680 --> 02:17:34,200 NATIONAL 3508 02:17:34,200 --> 02:17:34,720 WILL INITIAL CONSULTATION 3509 02:17:34,720 --> 02:17:35,360 CENTER AND AT THE PEOPLE AT THE 3510 02:17:35,360 --> 02:17:36,000 BEGINNING OF EVERY TALK IF YOU 3511 02:17:36,000 --> 02:17:36,680 DO NOT REMEMBER 3512 02:17:36,680 --> 02:17:37,280 ANYTHING ABOUT WHAT I SAID PUT 3513 02:17:37,280 --> 02:17:37,920 THIS NUMBER AND PUT IT IN YOUR 3514 02:17:37,920 --> 02:17:47,680 PHONE. NEXT SLIDE. 3515 02:17:47,680 --> 02:17:48,160 WE HAVE SOME REALLY DEEP 3516 02:17:48,160 --> 02:17:48,680 ACKNOWLEDGMENTS TO OUR 3517 02:17:48,680 --> 02:17:49,280 PATIENTS, THE PERINATAL PANEL 3518 02:17:49,280 --> 02:17:49,920 AND A PEDIATRIC PEBBLE IN THE 3519 02:17:49,920 --> 02:17:51,840 CDC. 3520 02:17:51,840 --> 02:17:53,760 THE OFFICE OF AIDS RESEARCH 3521 02:17:53,760 --> 02:17:54,360 ADVISORY COUNCIL AND THE WELL 3522 02:17:54,360 --> 02:17:54,960 PROJECT SPECIFIC INDIVIDUALS 3523 02:17:54,960 --> 02:17:55,520 WITHOUT WHOM THIS WOULD NOT 3524 02:17:55,520 --> 02:18:02,760 HAVE HAPPENED. DEB STORM, 3525 02:18:02,760 --> 02:18:03,360 WHO MANY OF YOU KNOW HAVE LED 3526 02:18:03,360 --> 02:18:04,000 THE PANEL THROUGH MANY EDITS TO 3527 02:18:04,000 --> 02:18:04,600 REACH CONSENSUS AND I BET WE 3528 02:18:04,600 --> 02:18:05,160 HAVE A RECORD FOR HOW MANY 3529 02:18:05,160 --> 02:18:05,800 EDITS, HOW MANY VERSES WE WENT 3530 02:18:05,800 --> 02:18:09,480 THROUGH AND ATHENA KOURTIS OUR 3531 02:18:09,480 --> 02:18:19,600 VOICES CDC AND LEALAH POLLOCK 3532 02:18:19,600 --> 02:18:20,240 CO-AUTHOR ON THE BULK OF INFANT 3533 02:18:20,240 --> 02:18:21,360 FEEDING GUIDELINES AND ELAINE 3534 02:18:21,360 --> 02:18:23,320 ABRAMS. WITH THANK YOU. 3535 02:18:23,320 --> 02:18:26,080 >>CHAIR TOLBERT: THANK YOU 3536 02:18:26,080 --> 02:18:30,840 DRS. LEVINSON AND RUEL FOR THE 3537 02:18:30,840 --> 02:18:31,440 PRESENTATION WE WILL MOVE ON 3538 02:18:31,440 --> 02:18:36,520 COLLEAGUES WITH OUR VERY OWN 3539 02:18:36,520 --> 02:18:38,400 ORAC MEMBER DR. MILLER AND, 3540 02:18:38,400 --> 02:18:39,040 EXECUTIVE DIRECTOR FOR FORUM OF 3541 02:18:39,040 --> 02:18:39,680 COLLABORATIVE RESEARCH, 3542 02:18:39,680 --> 02:18:42,960 UNIVERSITY OF CALIFORNIA, 3543 02:18:42,960 --> 02:18:46,000 BERKELEY. 3544 02:18:46,000 --> 02:18:46,520 SHE DEVELOPED AND TAUGHT A 3545 02:18:46,520 --> 02:18:47,120 COURSE BASED ON CASE STUDIES 3546 02:18:47,120 --> 02:18:51,960 FROM THE FORUMS, RICH HISTORY 3547 02:18:51,960 --> 02:18:52,600 OF FACILITATING BOTH AT THE FDA 3548 02:18:52,600 --> 02:18:58,960 AND DRUG DEVELOPMENT. 3549 02:18:58,960 --> 02:18:59,440 SHE MENTORS INTERNS AND 3550 02:18:59,440 --> 02:19:00,000 FELLOWS PURSUING REGULATORY 3551 02:19:00,000 --> 02:19:00,560 BIOTECH AND TRANSLATIONAL 3552 02:19:00,560 --> 02:19:07,280 MEDICINE CAREERS. DR. MILLER 3553 02:19:07,280 --> 02:19:08,280 3554 02:19:08,280 --> 02:19:08,840 SERVES ON NUMEROUS INDUSTRY 3555 02:19:08,840 --> 02:19:09,480 AND GOVERNMENT ADVISORY BOARDS 3556 02:19:09,480 --> 02:19:10,080 AND HAS PUBLISHED EXTENSIVELY 3557 02:19:10,080 --> 02:19:10,640 ON REVELATORY STRATEGIES 3558 02:19:10,640 --> 02:19:14,920 RELATED TO HIV AND HCV. I WILL 3559 02:19:14,920 --> 02:19:15,680 HAND IT OVER TO A COLLEAGUE DR. 3560 02:19:15,680 --> 02:19:16,240 MILLER. 3561 02:19:16,240 --> 02:19:19,640 >>DR. MILLER: THANK YOU SO 3562 02:19:19,640 --> 02:19:20,480 MUCH FOR THAT VERY KIND 3563 02:19:20,480 --> 02:19:24,520 INTRODUCTION. 3564 02:19:24,520 --> 02:19:25,160 AND IT IS MY PLEASURE-- IT IS 3565 02:19:25,160 --> 02:19:31,400 ACTUALLY MY HONOR-- TO BE ABLE 3566 02:19:31,400 --> 02:19:32,000 TO GIVE SOME FEEDBACK ON ONE OF 3567 02:19:32,000 --> 02:19:33,520 OUR RECENT WORKSHOPS. DO I MOVE 3568 02:19:33,520 --> 02:19:35,600 THE SLIDE FORWARD? 3569 02:19:35,600 --> 02:19:36,360 >>I WILL ADVANCE THEM FOR YOU. 3570 02:19:36,360 --> 02:19:44,440 >>DR. MILLER: GREAT PLEASE. 3571 02:19:44,440 --> 02:19:45,080 FIRST OF ALL I WANTED TO GIVE A 3572 02:19:45,080 --> 02:19:49,120 HUGE APPLAUSE AND THANK YOU TO 3573 02:19:49,120 --> 02:19:49,720 ALL OF OUR WORKSHOP PLANNING 3574 02:19:49,720 --> 02:19:54,080 GROUP MEMBERS. 3575 02:19:54,080 --> 02:19:54,960 I WANT TO POINT OUT THAT IT 3576 02:19:54,960 --> 02:19:55,960 WAS MONICA GANDY WHO IS ALSO ON 3577 02:19:55,960 --> 02:20:06,520 THE CALL TODAY, AND TIM WOOKEN 3578 02:20:06,800 --> 02:20:07,240 (PHONETIC) FROM CORNELL 3579 02:20:07,240 --> 02:20:07,880 UNIVERSITY WHO APPROACHES WITH 3580 02:20:07,880 --> 02:20:09,560 SOME CHALLENGES THEY WERE 3581 02:20:09,560 --> 02:20:18,960 SEEING WITH RESPECT TO THE 3582 02:20:18,960 --> 02:20:22,000 ACTG PROGRAM AND CLINICAL 3583 02:20:22,000 --> 02:20:22,520 TRIALS, USING NON-ACTING 3584 02:20:22,520 --> 02:20:23,160 RETROVIRAL. WHEN WE AGREED THAT 3585 02:20:23,160 --> 02:20:27,600 THE FORUM , ON THIS OR AT LEAST 3586 02:20:27,600 --> 02:20:30,960 THE FIRST ONE ALSO POSSIBLY A 3587 02:20:30,960 --> 02:20:32,560 SERIES OF WORKSHOPS, WE SAID 3588 02:20:32,560 --> 02:20:33,080 OKAY BUT LET'S TAKE THIS 3589 02:20:33,080 --> 02:20:36,040 OUTSIDE THE BROADER-- INTO A 3590 02:20:36,040 --> 02:20:36,640 BROADER CONTEXT SO IT IS NOT 3591 02:20:36,640 --> 02:20:42,440 JUST AN ACTG-FOCUSED ISSUE BUT 3592 02:20:42,440 --> 02:20:47,320 REALLY KIND OF TAKING A BROADER 3593 02:20:47,320 --> 02:20:47,920 VIEW OF WHO ARE THE PATIENTS 3594 02:20:47,920 --> 02:20:49,600 THAT MOST NEED LONG-ACTING 3595 02:20:49,600 --> 02:20:50,160 TREATMENT AND WHAT ARE THE 3596 02:20:50,160 --> 02:20:53,040 ISSUES AND HOW CAN WE AS A 3597 02:20:53,040 --> 02:20:53,600 BROADER HIV COMMUNITY START 3598 02:20:53,600 --> 02:20:58,360 DEALING WITH THIS? 3599 02:20:58,360 --> 02:20:58,960 ALSO THANK YOU FOR MENTIONING 3600 02:20:58,960 --> 02:21:01,200 OUR INTERNS IN YOUR 3601 02:21:01,200 --> 02:21:09,560 INTRODUCTION. NAYRI ALAJALI, 3602 02:21:09,560 --> 02:21:10,200 HER NAME STARTS WITH A AND THAT 3603 02:21:10,200 --> 02:21:20,720 IS WHY SHE IS AT THE TOP BUT 3604 02:21:21,360 --> 02:21:21,880 YOU SHOULD ALSO BE AT THE TOP 3605 02:21:21,880 --> 02:21:22,440 BECAUSE SHE DID ALL OF THE 3606 02:21:22,440 --> 02:21:23,040 HEAVY LIFTING FOR ORGANIZING 3607 02:21:23,040 --> 02:21:23,840 THIS REPORT AND USING AN 3608 02:21:23,840 --> 02:21:24,440 ADAPTIVE WILL REPORT SHE IS 3609 02:21:24,440 --> 02:21:26,680 WORKING ON FOCUSING 3610 02:21:26,680 --> 02:21:29,200 SPECIFICALLY ON REIMBURSEMENT 3611 02:21:29,200 --> 02:21:31,880 HOME ISSUES THAT SHE WILL BE 3612 02:21:31,880 --> 02:21:32,480 PRESENTING FOR HER GRADUATION 3613 02:21:32,480 --> 02:21:36,960 FROM THE MPH PROGRAM. 3614 02:21:36,960 --> 02:21:39,560 AND SO AS YOU CAN SEE, THIS IS 3615 02:21:39,560 --> 02:21:49,000 THE BROAD STAKEHOLDER GROUP 3616 02:21:49,000 --> 02:21:49,600 THAT THE FORUM WORKS WITH AND 3617 02:21:49,600 --> 02:21:50,040 WE HAVE INDUSTRY AND 3618 02:21:50,040 --> 02:21:52,360 GOVERNMENTAL AGENCIES, AND 3619 02:21:52,360 --> 02:21:53,720 ACADEMIC RESEARCHERS ALL COMING 3620 02:21:53,720 --> 02:21:54,320 TOGETHER TO TRY AND DEAL WITH 3621 02:21:54,320 --> 02:21:58,920 THE ISSUES. NEXT SLIDE. 3622 02:21:58,920 --> 02:21:59,480 SO THE OVERALL WORKSHOP GOAL 3623 02:21:59,480 --> 02:22:07,120 THEN WAS TO IMPROVE ACCESS TO 3624 02:22:07,120 --> 02:22:13,040 LONG-ACTING ANTIRETROVIRAL 3625 02:22:13,040 --> 02:22:13,600 THERAPY BUT PEOPLE WHO MOST 3626 02:22:13,600 --> 02:22:14,200 NEED THESE THERAPIES AND THIS 3627 02:22:14,200 --> 02:22:14,840 IS A VERY HIGH-LEVEL GOAL THAT 3628 02:22:14,840 --> 02:22:16,760 WE HAVE TRIED TO ADDRESS. WHEN 3629 02:22:16,760 --> 02:22:17,360 WE TALK ABOUT PEOPLE WHO MOST 3630 02:22:17,360 --> 02:22:24,920 NEED THESE THERAPIES, THERE'S 3631 02:22:24,920 --> 02:22:25,440 SO MANY DIFFERENT WAYS TO 3632 02:22:25,440 --> 02:22:27,640 DESCRIBE THEM. BUT I THINK 3633 02:22:27,640 --> 02:22:28,200 PEOPLE THAT HAVE CHALLENGES 3634 02:22:28,200 --> 02:22:29,080 WITH ADHERING TO A DAILY ORAL 3635 02:22:29,080 --> 02:22:33,680 REGIMEN, FOR MANY DIFFERENT 3636 02:22:33,680 --> 02:22:34,280 REASONS, BUT ALSO PEOPLE WHO 3637 02:22:34,280 --> 02:22:34,760 HAVE BEEN HISTORICALLY 3638 02:22:34,760 --> 02:22:35,360 UNDERREPRESENTED IN CLINICAL 3639 02:22:35,360 --> 02:22:38,080 RESEARCH. 3640 02:22:38,080 --> 02:22:38,640 I WANT TO POINT OUT HERE THE 3641 02:22:38,640 --> 02:22:39,240 VERY BEGINNING THAT WHEN WE 3642 02:22:39,240 --> 02:22:44,800 TALK ABOUT ACCESS, WE DON'T 3643 02:22:44,800 --> 02:22:49,160 JUST MEAN THAT THEY CAN JUST GO 3644 02:22:49,160 --> 02:22:52,640 AND GET THE DRUGS. 3645 02:22:52,640 --> 02:22:53,240 WE WANT RECOGNITIONS FOR SAFE 3646 02:22:53,240 --> 02:22:53,840 AND EFFECTIVE USE AND WE WANT 3647 02:22:53,840 --> 02:22:55,720 THESE THERAPIES TO BE AVAILABLE 3648 02:22:55,720 --> 02:22:59,280 AND ALSO ADMINISTERED, SO WHEN 3649 02:22:59,280 --> 02:22:59,760 WE ARE TALKING ABOUT 3650 02:22:59,760 --> 02:23:04,480 LONG-ACTING INJECTABLES, IT IS 3651 02:23:04,480 --> 02:23:05,080 A DIFFERENT MATTER THAN JUST 3652 02:23:05,080 --> 02:23:05,640 GOING TO THE PHARMACY AND 3653 02:23:05,640 --> 02:23:12,400 GIVING THEM YOUR PRESCRIPTION. 3654 02:23:12,400 --> 02:23:12,880 THEY ALSO NEED TO BE 3655 02:23:12,880 --> 02:23:13,440 REIMBURSABLE ACCESS REALLY 3656 02:23:13,440 --> 02:23:17,280 ENTAILS QUITE A FEW DIFFERENT, 3657 02:23:17,280 --> 02:23:17,880 SOMETIMES KIND OF STICKY KIND 3658 02:23:17,880 --> 02:23:18,480 OF POLICY ISSUES THAT WE NEED 3659 02:23:18,480 --> 02:23:28,960 TO GET THROUGH. NEXT SLIDE. 3660 02:23:29,760 --> 02:23:30,240 SO AS WE WORKED WITH OUR 3661 02:23:30,240 --> 02:23:30,840 PLANNING GROUP, WE STARTED TO 3662 02:23:30,840 --> 02:23:31,440 THINK ABOUT WHAT ARE SOME OF 3663 02:23:31,440 --> 02:23:35,240 THE CONSIDERATIONS THAT WE NEED 3664 02:23:35,240 --> 02:23:35,880 TO INCLUDE AS WE THINK OF THIS 3665 02:23:35,880 --> 02:23:38,600 TOPIC? ONE OF THE FIRST ONE IS 3666 02:23:38,600 --> 02:23:39,240 THAT YOU KNOW WE REALLY NEED TO 3667 02:23:39,240 --> 02:23:39,840 ACCEPT AND RECOGNIZE THE FACT 3668 02:23:39,840 --> 02:23:42,480 THAT 3669 02:23:42,480 --> 02:23:45,160 3670 02:23:45,160 --> 02:23:45,760 IT IS IMPORTANT FOR PEOPLE WHO 3671 02:23:45,760 --> 02:23:46,400 WILL STAND TO BENEFIT FROM NEW 3672 02:23:46,400 --> 02:23:47,280 THERAPEUTIC INTERVENTIONS TO 3673 02:23:47,280 --> 02:23:47,840 ACTUALLY BE INVOLVED 3674 02:23:47,840 --> 02:23:52,000 IN THE CLINICAL RESEARCH 3675 02:23:52,000 --> 02:23:52,560 THAT ASSESSES THE SAFETY AND 3676 02:23:52,560 --> 02:23:54,760 EFFICACY OF THESE 3677 02:23:54,760 --> 02:23:55,280 INTERVENTIONS. THIS IS SO 3678 02:23:55,280 --> 02:23:55,840 IMPORTANT AND WE COULD DO A 3679 02:23:55,840 --> 02:24:00,200 WHOLE DAY WORKSHOP 3680 02:24:00,200 --> 02:24:00,720 JUST ON THE BENEFITS OF 3681 02:24:00,720 --> 02:24:01,240 PARTICIPATING IN CLINICAL 3682 02:24:01,240 --> 02:24:05,040 RESEARCH. AND THESE BENEFITS 3683 02:24:05,040 --> 02:24:05,520 ARE EVIDENT BOTH AT THE 3684 02:24:05,520 --> 02:24:06,040 INDIVIDUAL AND COMMUNITY 3685 02:24:06,040 --> 02:24:10,800 LEVELS. 3686 02:24:10,800 --> 02:24:17,520 SO IT IS REALLY IMPORTANT TO 3687 02:24:17,520 --> 02:24:18,000 NOT TO CONTINUE HAVE 3688 02:24:18,000 --> 02:24:18,600 HISTORICALLY UNDERREPRESENTED 3689 02:24:18,600 --> 02:24:19,160 POPULATIONS IN THE CLINICAL 3690 02:24:19,160 --> 02:24:19,800 RESEARCH PARADIGM AND THIS GOES 3691 02:24:19,800 --> 02:24:20,400 FOR ALL DISEASES. THIS IS NOT 3692 02:24:20,400 --> 02:24:24,320 UNIQUE TO HIV. 3693 02:24:24,320 --> 02:24:28,600 ANOTHER BIG CONSIDERATION IS 3694 02:24:28,600 --> 02:24:29,200 THAT MANY PEOPLE ARE EXCLUDED 3695 02:24:29,200 --> 02:24:32,200 IN EARLY-- ESPECIALLY 3696 02:24:32,200 --> 02:24:32,800 PREAPPROVAL-- CLINICAL RESEARCH 3697 02:24:32,800 --> 02:24:35,760 AND OFTEN THIS IS FOR SAFETY 3698 02:24:35,760 --> 02:24:36,400 REASONS. AND THAT IS SOMETHING 3699 02:24:36,400 --> 02:24:39,720 WE NEED TO WORK WITH. 3700 02:24:39,720 --> 02:24:40,240 AND I PUT HERE A SPECIAL 3701 02:24:40,240 --> 02:24:44,080 POPULATIONS IN QUOTATION MARKS. 3702 02:24:44,080 --> 02:24:44,680 IN THIS CASE WE ARE TALKING 3703 02:24:44,680 --> 02:24:45,280 FOR EXAMPLE PEOPLE WHO INJECT 3704 02:24:45,280 --> 02:24:46,680 DRUGS, HAVE MENTAL HEALTH 3705 02:24:46,680 --> 02:24:50,920 ISSUES AND/OR OTHER 3706 02:24:50,920 --> 02:24:51,560 COMORBIDITIES BUT ALSO PATIENTS 3707 02:24:51,560 --> 02:24:54,680 IN RURAL SETTINGS WHO ARE FAR 3708 02:24:54,680 --> 02:24:55,320 AWAY FROM TRADITIONAL CLINICAL 3709 02:24:55,320 --> 02:24:57,800 TRIAL CENTERS. AND AND THEY MAY 3710 02:24:57,800 --> 02:25:00,120 HAVE DIFFERENT ISSUES 3711 02:25:00,120 --> 02:25:00,720 THAT THEY ARE DEALING WITH IN 3712 02:25:00,720 --> 02:25:01,320 THEIR DAILY LIVES FROM PEOPLE 3713 02:25:01,320 --> 02:25:04,760 LIVING IN URBAN CENTERS. 3714 02:25:04,760 --> 02:25:08,840 BUT IT IS-- THERE ARE REASONS 3715 02:25:08,840 --> 02:25:09,480 WHY WE NEED TO BE VERY CAREFUL 3716 02:25:09,480 --> 02:25:13,280 ABOUT THE SAFETY EARLY ON. 3717 02:25:13,280 --> 02:25:15,560 BUT WE NEED TO RECOGNIZE THAT. 3718 02:25:15,560 --> 02:25:19,040 AND PLAN FOR INCLUSION IN 3719 02:25:19,040 --> 02:25:22,200 CLINICAL TRIALS 3720 02:25:22,200 --> 02:25:22,840 AS SOON IT IS LEGITIMATE TO DO 3721 02:25:22,840 --> 02:25:25,400 SO. 3722 02:25:25,400 --> 02:25:28,360 AND WE REALLY LACK-- AS A 3723 02:25:28,360 --> 02:25:29,920 RESULT OF THIS 3724 02:25:29,920 --> 02:25:30,960 HAVING NOT INCLUDED MANY OF 3725 02:25:30,960 --> 02:25:35,240 THESE PATIENTS-- WE LACK 3726 02:25:35,240 --> 02:25:35,800 INFORMATION AT THE TIME OF 3727 02:25:35,800 --> 02:25:37,480 APPROVAL ON HOW THESE DRUGS 3728 02:25:37,480 --> 02:25:39,800 COULD SAFELY BE USED, AND THEIR 3729 02:25:39,800 --> 02:25:43,960 EFFECTIVENESS IN WHAT I CALL 3730 02:25:43,960 --> 02:25:44,600 "REAL-WORLD PATIENTS." PATIENTS 3731 02:25:44,600 --> 02:25:48,120 THAT DEAL WITH ALL OF THE REAL 3732 02:25:48,120 --> 02:25:48,880 ISSUES OF MENTAL HEALTH, 3733 02:25:48,880 --> 02:25:49,720 ADDICTION, UNSTABLE HOUSING, 3734 02:25:49,720 --> 02:25:51,960 ETC., ETC. NEXT SLIDE. 3735 02:25:51,960 --> 02:25:54,880 OH, IN THE SOUL ABOUT THE 3736 02:25:54,880 --> 02:26:04,200 BENEFIT IN RISK. IT WILL BE 3737 02:26:04,200 --> 02:26:04,720 DIFFERENT IN DIFFERENT 3738 02:26:04,720 --> 02:26:05,360 POPULATIONS SO WHAT BENEFIT WE 3739 02:26:05,360 --> 02:26:05,920 EXPECT AND WHAT RISK WE ARE 3740 02:26:05,920 --> 02:26:07,120 WILLING TO LIVE WITH WHEN WE 3741 02:26:07,120 --> 02:26:08,160 TALK ABOUT PEOPLE WITH UNIQUE 3742 02:26:08,160 --> 02:26:12,160 NEEDS WHO ARE REALLY 3743 02:26:12,160 --> 02:26:13,240 EXPERIENCING AN UNMET MEDICAL 3744 02:26:13,240 --> 02:26:18,000 NEED. AND THE DIFFERENT RISKS 3745 02:26:18,000 --> 02:26:21,000 WE MAY TALK ABOUT, MAY BE 3746 02:26:21,000 --> 02:26:21,560 VIEWED DIFFERENTLY IN THESE 3747 02:26:21,560 --> 02:26:24,200 PREPARATIONS OF THE OTHER 3748 02:26:24,200 --> 02:26:24,840 CONSIDERATIONS WE INCLUDED ARE 3749 02:26:24,840 --> 02:26:31,960 IN THE NEXT SLIDE. 3750 02:26:31,960 --> 02:26:32,560 AT THE MOMENT WE ONLY HAVE ONE 3751 02:26:32,560 --> 02:26:33,160 REGIMENT THAT IS LONG-ACTING 3752 02:26:33,160 --> 02:26:33,680 INJECTABLE APPROVE FOR 3753 02:26:33,680 --> 02:26:43,840 TREATMENT AND I AM USING 3754 02:26:43,840 --> 02:26:50,760 CABENUVA HERE IS A SHORT FORM, 3755 02:26:50,760 --> 02:27:01,240 AND SOME OF THE ISSUES ARE 3756 02:27:02,280 --> 02:27:07,720 VIROLOGICALLY SUPPRESSED, NO 3757 02:27:07,720 --> 02:27:08,320 PREVIOUS TREATMENT FAILURES AND 3758 02:27:08,320 --> 02:27:08,960 RELEVANT RESISTANT MUTATIONS TO 3759 02:27:08,960 --> 02:27:12,960 A VERY SPECIFIC INDICATION. 3760 02:27:12,960 --> 02:27:13,520 IN THE FUTURE THAT MIGHT NOT 3761 02:27:13,520 --> 02:27:14,120 BE THE CASE ESPECIALLY WE ALL 3762 02:27:14,120 --> 02:27:14,760 DECIDE WE ARE GOING TO LEARN AS 3763 02:27:14,760 --> 02:27:15,360 MUCH AS WE CAN FROM THIS FIRST 3764 02:27:15,360 --> 02:27:19,760 ITERATION OF LONG-ACTING ART, 3765 02:27:19,760 --> 02:27:21,720 AND APPLY THOSE LESSONS TO 3766 02:27:21,720 --> 02:27:23,520 ADDITIONAL REGIMENTS AS WE CAN 3767 02:27:23,520 --> 02:27:24,440 FORWARD. AND POSSIBLY FOR 3768 02:27:24,440 --> 02:27:30,840 FUTURE LA ART WE CAN THINK 3769 02:27:30,840 --> 02:27:31,480 ABOUT HOW WE CAN PLAN AHEAD FOR 3770 02:27:31,480 --> 02:27:33,080 SEAMLESS TRANSITION TO DIVERSE 3771 02:27:33,080 --> 02:27:33,720 POPULATIONS BEFORE THE TIME OF 3772 02:27:33,720 --> 02:27:37,680 APPROVAL. 3773 02:27:37,680 --> 02:27:38,280 SO LET'S LEARN AS MUCH AS WE 3774 02:27:38,280 --> 02:27:42,760 CAN FROM THIS FIRST THERAPY. 3775 02:27:42,760 --> 02:27:43,320 BUT THEN ALSO THINK TOWARDS 3776 02:27:43,320 --> 02:27:43,920 THE FUTURE AND SEE HOW THAT 3777 02:27:43,920 --> 02:27:47,520 MIGHT BE DIFFERENT. 3778 02:27:47,520 --> 02:27:48,080 BUT BECAUSE THIS IS THE ONLY 3779 02:27:48,080 --> 02:27:48,720 ONE THAT IS APPROVED, A LOT OF 3780 02:27:48,720 --> 02:27:51,120 THE DISCUSSION FOCUSED ON THE 3781 02:27:51,120 --> 02:27:52,200 SPECIFIC DRUG LABEL AND ISSUES 3782 02:27:52,200 --> 02:27:52,800 RELATED TO THIS PARTICULAR 3783 02:27:52,800 --> 02:27:53,480 THERAPY. 3784 02:27:53,480 --> 02:27:56,840 NEXT SLIDE. 3785 02:27:56,840 --> 02:28:04,360 SO THE OBJECTIVE THEN OF THE 3786 02:28:04,360 --> 02:28:04,960 WORKSHOP WAS TO IDENTIFY AND 3787 02:28:04,960 --> 02:28:14,280 DISCUSS CHALLENGES AND THE 3788 02:28:14,280 --> 02:28:14,880 EXECUTION OF CLINICAL TRIALS 3789 02:28:14,880 --> 02:28:15,440 AND ASSESSING THERAPIES FOR 3790 02:28:15,440 --> 02:28:16,040 POPULATIONS MOST AT NEED FOR 3791 02:28:16,040 --> 02:28:16,560 SUCH SERVICE AND TO FIND 3792 02:28:16,560 --> 02:28:17,160 RECOMMENDER SOLUTIONS TO SOME 3793 02:28:17,160 --> 02:28:22,480 OF THESE CHALLENGES. NEXT SLIDE. 3794 02:28:22,480 --> 02:28:27,400 WE TALKED ABOUT ABOUT WHAT CAN 3795 02:28:27,400 --> 02:28:28,000 WE LEARN FROM OTHER FIELDS SUCH 3796 02:28:28,000 --> 02:28:30,960 AS PSYCHIATRY AND WE SPENT A 3797 02:28:30,960 --> 02:28:33,360 LOT OF TIME ON THE PATIENT 3798 02:28:33,360 --> 02:28:33,960 PERSPECTIVE ON THE IMPACT OF 3799 02:28:33,960 --> 02:28:34,560 LONG-ACTING THERAPIES IN THE 3800 02:28:34,560 --> 02:28:37,840 ROLE OF CLINICAL TRIAL 3801 02:28:37,840 --> 02:28:38,320 NETWORKS. AND EVIDENCE 3802 02:28:38,320 --> 02:28:42,280 GENERATION FOR THE SAFETY AND 3803 02:28:42,280 --> 02:28:42,800 EFFICACY AND ADHERENCE TO 3804 02:28:42,800 --> 02:28:43,400 CHALLENGE POPULATION BOTH IN 3805 02:28:43,400 --> 02:28:44,000 PREAPPROVAL AND POST 3806 02:28:44,000 --> 02:28:44,600 PREAPPROVAL CLINICAL RESEARCH 3807 02:28:44,600 --> 02:28:47,560 PHASE AND THE ROLES, THE 3808 02:28:47,560 --> 02:28:48,120 DIFFERENT ROLES THAT THE 3809 02:28:48,120 --> 02:28:51,960 REGULATORY PROCESS WHICH 3810 02:28:51,960 --> 02:28:52,560 RESULTS IN A DRUG LABEL OR THE 3811 02:28:52,560 --> 02:28:55,080 INDICATION FOR USE, IN CLINICAL 3812 02:28:55,080 --> 02:28:55,680 PRACTICE WHICH IS REALLY THE 3813 02:28:55,680 --> 02:28:58,480 TREATMENT GUIDELINES. 3814 02:28:58,480 --> 02:28:59,080 AND FACILITATING AND ENSURING 3815 02:28:59,080 --> 02:29:04,080 ACCESS, I PUT HERE THE WEB LINK 3816 02:29:04,080 --> 02:29:04,680 TO ALL OF THIS INFORMATION IN 3817 02:29:04,680 --> 02:29:05,640 TERMS OF AGENDA AND PRESENTATION 3818 02:29:05,640 --> 02:29:08,240 ON OUR WEBSITE. NEXT SLIDE. 3819 02:29:08,240 --> 02:29:11,840 SO, HERE ARE JUST SOME 3820 02:29:11,840 --> 02:29:21,120 HIGH-LEVEL FINDINGS. THERE WAS 3821 02:29:21,120 --> 02:29:21,720 SUCH A RICH DISCUSSION BUT I 3822 02:29:21,720 --> 02:29:22,360 WANTED TO HIGHLIGHT SOME OF THE 3823 02:29:22,360 --> 02:29:24,920 KEY FINDINGS. GREG -- GAVE AN 3824 02:29:24,920 --> 02:29:29,680 AMAZING CONVERSATION THAT AT 3825 02:29:29,680 --> 02:29:30,960 HCV PEOPLE WERE VERY SUCCESSFUL 3826 02:29:30,960 --> 02:29:34,160 IN INCLUDING ACTIVELY INJECTING 3827 02:29:34,160 --> 02:29:34,840 DRUG USERS IN PREAPPROVAL 3828 02:29:34,840 --> 02:29:40,080 TRIALS. AND THE DATA EMANATING 3829 02:29:40,080 --> 02:29:40,560 FROM THIS WAS REALLY 3830 02:29:40,560 --> 02:29:41,040 INFORMATIVE BUT ALSO 3831 02:29:41,040 --> 02:29:42,320 INSTRUMENTAL 3832 02:29:42,320 --> 02:29:45,440 FOR ACCESS TO THE TREATMENT. 3833 02:29:45,440 --> 02:29:46,000 SO THE LESSON HERE IS THAT WE 3834 02:29:46,000 --> 02:29:48,920 CAN BE SUCCESSFUL 3835 02:29:48,920 --> 02:29:49,440 WORKING WITH PEOPLE WHO 3836 02:29:49,440 --> 02:29:49,960 ACTIVELY INJECT DRUGS IN 3837 02:29:49,960 --> 02:29:50,800 CLINICAL TRIAL SETTINGS, 3838 02:29:50,800 --> 02:29:51,480 INCLUDING PRE-MARKETING 3839 02:29:51,480 --> 02:29:55,000 APPROVAL. AND THE MESSAGE THAT 3840 02:29:55,000 --> 02:29:59,800 WAS PUT OUT WAS BE BRAVE. DON'T 3841 02:29:59,800 --> 02:30:00,360 ASSUME YOU CAN'T DO THESE 3842 02:30:00,360 --> 02:30:04,440 TRIALS. BE BRAVE BUT PLAN 3843 02:30:04,440 --> 02:30:07,480 CAREFULLY AND PLAN INCLUSIVELY. 3844 02:30:07,480 --> 02:30:08,080 WE THEN HAD ANOTHER VERY NICE 3845 02:30:08,080 --> 02:30:12,400 PRESENTATION BY JONATHAN WU 3846 02:30:12,400 --> 02:30:12,920 (PHONETIC) WHO IS DOING A 3847 02:30:12,920 --> 02:30:13,520 PSYCHIATRY FELLOWSHIP AT THE 3848 02:30:13,520 --> 02:30:14,120 GEORGE WASHINGTON UNIVERSITY, 3849 02:30:14,120 --> 02:30:20,440 AND INCIDENTALLY I CAN'T HELP 3850 02:30:20,440 --> 02:30:21,000 BUT MENTION WAS ONE OF OUR 3851 02:30:21,000 --> 02:30:22,600 EARLY MPH INTERNS FROM UC 3852 02:30:22,600 --> 02:30:29,000 BERKELEY BACK IN 2014. 3853 02:30:29,000 --> 02:30:29,520 HE TALKED ABOUT WHAT THE 3854 02:30:29,520 --> 02:30:30,120 PSYCHIATRY FIELD DOES IN TERMS 3855 02:30:30,120 --> 02:30:32,280 OF IMPLEMENTATION 3856 02:30:32,280 --> 02:30:32,880 WITHIN COMMUNITIES WHERE THEY 3857 02:30:32,880 --> 02:30:34,920 GO INTO THE COMMUNITIES 3858 02:30:34,920 --> 02:30:39,360 AND TO THE INJECTIONS. 3859 02:30:39,360 --> 02:30:39,960 AND FIND THE PATIENTS AND KEEP 3860 02:30:39,960 --> 02:30:40,480 THEM ON TREATMENT AND HOW 3861 02:30:40,480 --> 02:30:44,000 COST-EFFECTIVE THIS IS BEEN, 3862 02:30:44,000 --> 02:30:49,640 ESPECIALLY WHEN IT COMES TO 3863 02:30:49,640 --> 02:30:50,080 REDUCING THE NEED FOR 3864 02:30:50,080 --> 02:30:50,680 HOSPITALIZATION IN THE LESSON 3865 02:30:50,680 --> 02:30:51,280 HERE IS THAT THE COST BENEFIT 3866 02:30:51,280 --> 02:30:51,840 GETS BETTER AND BETTER OVER 3867 02:30:51,840 --> 02:30:52,760 TIME. 3868 02:30:52,760 --> 02:30:53,360 THE INITIAL INVESTMENT IN ALL 3869 02:30:53,360 --> 02:30:56,080 OF THIS REALLY PAYS OFF. 3870 02:30:56,080 --> 02:30:56,600 AND THE MESSAGE TO US IS, 3871 02:30:56,600 --> 02:30:57,120 LET'S CONSIDER COMMUNITY 3872 02:30:57,120 --> 02:30:58,480 OUTREACH 3873 02:30:58,480 --> 02:31:03,040 IMPLEMENTATION MODEL TO -- -- 3874 02:31:03,040 --> 02:31:03,560 BECAUSE THERE IS SUCH AN 3875 02:31:03,560 --> 02:31:06,040 OVERLAP BETWEEN PEOPLE WITH HIV 3876 02:31:06,040 --> 02:31:07,280 AND PEOPLE WITH PSYCHOSIS. NEXT 3877 02:31:07,280 --> 02:31:10,880 SLIDE. 3878 02:31:10,880 --> 02:31:12,880 ANOTHER SET OF FINDINGS WAS 3879 02:31:12,880 --> 02:31:16,360 THE PATIENT PERSPECTIVE. 3880 02:31:16,360 --> 02:31:16,800 THEY DESCRIBED THESE 3881 02:31:16,800 --> 02:31:27,240 LONG-ACTING THERAPIES AS 3882 02:31:28,040 --> 02:31:28,600 (INDISCERNIBLE) -- THIS IS FROM 3883 02:31:28,600 --> 02:31:29,200 A DIFFERENT VERSION AND AGAIN 3884 02:31:29,200 --> 02:31:29,680 WE SHOULD NOT GROUP ALL 3885 02:31:29,680 --> 02:31:30,320 PATIENTS INTO ONE GROUP. THERE 3886 02:31:30,320 --> 02:31:30,880 ARE MANY REASONS WHY PEOPLE 3887 02:31:30,880 --> 02:31:37,320 PREFER LONG-ACTING, IS DIVERSE 3888 02:31:37,320 --> 02:31:37,920 AND DIFFERENT AS PATIENTS OR 3889 02:31:37,920 --> 02:31:38,560 ANY OTHER MESSAGE THAT IS CLEAR 3890 02:31:38,560 --> 02:31:39,160 COME TO IS THAT INVESTIGATORS 3891 02:31:39,160 --> 02:31:40,560 NEED TO RESPECT 3892 02:31:40,560 --> 02:31:41,040 THE COMMUNITIES THEY ARE 3893 02:31:41,040 --> 02:31:42,280 SERVING AND I WILL ECHO WHAT -- 3894 02:31:42,280 --> 02:31:50,000 THERE'S A TYPO-- REAL OR 3895 02:31:50,000 --> 02:31:50,600 PERCEIVED THREATS AND WE NEED 3896 02:31:50,600 --> 02:31:57,880 TO UNDERSTAND THEM IN WHICH 3897 02:31:57,880 --> 02:31:58,480 THESE POPULATIONS OPERATE AND 3898 02:31:58,480 --> 02:31:59,120 PATIENTS NEED TO BE RECOGNIZED 3899 02:31:59,120 --> 02:32:05,800 IN RESEARCH AND POLICY 3900 02:32:05,800 --> 02:32:06,520 DISCUSSIONS. WE HEARD YOU HAVE 3901 02:32:06,520 --> 02:32:12,360 TO SEE US I AM. WE HAVE TO 3902 02:32:12,360 --> 02:32:12,960 RECOGNIZE THEM IN THE FULL 3903 02:32:12,960 --> 02:32:13,560 DIVERSITY NOT JUST ASSUME THEY 3904 02:32:13,560 --> 02:32:15,200 ARE ALL ONE CATEGORY OF PEOPLE. 3905 02:32:15,200 --> 02:32:17,840 AND THE MESSAGE HERE IS THAT 3906 02:32:17,840 --> 02:32:20,720 LONG-ACTING ART SHOULD BE 3907 02:32:20,720 --> 02:32:21,320 AVAILABLE TO ALL AND AGAIN WE 3908 02:32:21,320 --> 02:32:23,040 NEED TO SUBSTANTIATE THAT WITH 3909 02:32:23,040 --> 02:32:26,520 THE APPROPRIATE EVIDENCE. NEXT 3910 02:32:26,520 --> 02:32:31,280 SLIDE. 3911 02:32:31,280 --> 02:32:31,840 WE TALKED ABOUT RESEARCH 3912 02:32:31,840 --> 02:32:32,480 OPPORTUNITIES IN RURAL AMERICA 3913 02:32:32,480 --> 02:32:33,520 AND AS I MENTIONED, IT WAS 3914 02:32:33,520 --> 02:32:34,480 MONICA AND KIM THEY CAME TO US 3915 02:32:34,480 --> 02:32:45,040 ON BEHALF OF THE ACTG, CLINICAL 3916 02:32:45,320 --> 02:32:45,880 TRIALS NETWORK AND WANT TO TAKE 3917 02:32:45,880 --> 02:32:46,520 THE TIME TO CONGRATULATE MONICA 3918 02:32:46,520 --> 02:32:52,720 ON THE WARD 86 PILOT PROGRAM 3919 02:32:52,720 --> 02:32:55,840 AND TAKE THE TIME TO ALSO 3920 02:32:55,840 --> 02:33:00,800 REALLY APPRECIATE THE PRESS 3921 02:33:00,800 --> 02:33:01,440 RELEASE THAT CAME OUT AFTER HER 3922 02:33:01,440 --> 02:33:06,960 PRESENTATION ON THIS PROGRAM 3923 02:33:06,960 --> 02:33:09,240 WITH MANY DIFFERENT 3924 02:33:09,240 --> 02:33:09,880 INSTITUTIONS, AND DIVISIONS OF 3925 02:33:09,880 --> 02:33:11,080 THE NIH PARTICIPATING IN 3926 02:33:11,080 --> 02:33:12,640 COMMENTARY THERE. 3927 02:33:12,640 --> 02:33:14,520 IT WAS A WONDERFUL PRESS 3928 02:33:14,520 --> 02:33:15,080 RELEASE. 3929 02:33:15,080 --> 02:33:15,680 BUT WHAT WE HAVE IN THESE RULE 3930 02:33:15,680 --> 02:33:19,160 SETTINGS AND SALLY HOTTERS 3931 02:33:19,160 --> 02:33:19,760 (PHONETIC) REMARK SPECIFICALLY 3932 02:33:19,760 --> 02:33:24,760 ABOUT WEST VIRGINIA, HOTSPOTS 3933 02:33:24,760 --> 02:33:25,400 FOR HIV INCIDENCE BUT REALLY 3934 02:33:25,400 --> 02:33:32,200 SUCH A PAUCITY OF CLINICAL 3935 02:33:32,200 --> 02:33:32,840 TRIALS AND USING THE NIH FUNDED 3936 02:33:32,840 --> 02:33:33,440 -- THIS IS AN OPPORTUNITY I 3937 02:33:33,440 --> 02:33:34,040 THINK FOR ALL OF US TO THINK 3938 02:33:34,040 --> 02:33:34,600 ACROSS THE NIH AND WHAT IS 3939 02:33:34,600 --> 02:33:42,960 BEING FUNDED-- IS THE IDEA 3940 02:33:42,960 --> 02:33:44,360 STATES AND PUERTO RICO PROGRAM, 3941 02:33:44,360 --> 02:33:44,920 AN OPPORTUNITY FOR RESEARCH 3942 02:33:44,920 --> 02:33:45,560 WERE RESEARCH CAPACITIES BEING 3943 02:33:45,560 --> 02:33:46,440 BUILT OUT AND THEY HAD A GREAT 3944 02:33:46,440 --> 02:33:51,320 CONTRIBUTIONS TO THE COVID 3945 02:33:51,320 --> 02:33:51,880 RESEARCH AND TREATMENT AND 3946 02:33:51,880 --> 02:33:54,000 DIAGNOSIS AND VACCINES. 3947 02:33:54,000 --> 02:33:57,960 AND SO THE LESSON HERE FOR US 3948 02:33:57,960 --> 02:33:58,560 IS, RURAL OR NONTRADITIONAL 3949 02:33:58,560 --> 02:34:04,720 RESEARCH SUBJECTS HAVE 3950 02:34:04,720 --> 02:34:05,200 CAPACITY, PATIENTS AND 3951 02:34:05,200 --> 02:34:05,840 RESOURCES AND WE SHOULD NOT BE 3952 02:34:05,840 --> 02:34:06,440 AFRAID TO CONSIDER SOME OF 3953 02:34:06,440 --> 02:34:07,040 THESE ASIDES ARE BOTH PUBLIC 3954 02:34:07,040 --> 02:34:07,560 AND PRIVATELY FUNDED HIV 3955 02:34:07,560 --> 02:34:10,640 RESEARCH. NEXT SLIDE. 3956 02:34:10,640 --> 02:34:14,520 AND THEN, KIND OF GETTING INTO 3957 02:34:14,520 --> 02:34:25,000 THE REGULATORY ISSUES HERE, 3958 02:34:28,920 --> 02:34:29,440 BEFORE APPROVAL WE ALL ACCEPT 3959 02:34:29,440 --> 02:34:30,080 THE CLINICAL RESEARCH OBJECTIVE 3960 02:34:30,080 --> 02:34:30,720 IS TO GET THE DRUGS APPROVED AS 3961 02:34:30,720 --> 02:34:31,280 EFFICIENTLY AS POSSIBLE TO 3962 02:34:31,280 --> 02:34:31,800 ENSURE ACCESS TO THE NEW 3963 02:34:31,800 --> 02:34:33,800 THERAPY IS POSSIBLE. AND 3964 02:34:33,800 --> 02:34:34,400 WITHOUT FDA APPROVAL THE DRUG 3965 02:34:34,400 --> 02:34:35,000 IS NOT REALLY ACCESSIBLE TO 3966 02:34:35,000 --> 02:34:38,640 ANYONE. SO WE NEED THAT. 3967 02:34:38,640 --> 02:34:39,160 BUT THE DIRECT LABEL, THE 3968 02:34:39,160 --> 02:34:43,720 INDICATION FOR USE, WILL BE 3969 02:34:43,720 --> 02:34:44,360 BASED ON THE DATA SUBMITTED BY 3970 02:34:44,360 --> 02:34:45,960 THE SPONSOR TO THE AGENCY. AND 3971 02:34:45,960 --> 02:34:53,000 IF YOU WANT TO CHANGE THIS 3972 02:34:53,000 --> 02:34:53,520 INDICATION, THAT WOULD 3973 02:34:53,520 --> 02:34:55,720 GENERALLY REQUIRE RANDOMIZED 3974 02:34:55,720 --> 02:34:56,320 TRIALS, IN THE DATA SUBMITTED 3975 02:34:56,320 --> 02:34:56,920 BY THE SPONSOR TO THE FDA AND I 3976 02:34:56,920 --> 02:35:07,400 WANT TO POINT OUT THAT FOR 3977 02:35:13,520 --> 02:35:14,080 CABENUVA WE HAD A VERY SPECIFIC 3978 02:35:14,080 --> 02:35:14,640 INDICATION REGARDING THE -- 3979 02:35:14,640 --> 02:35:15,200 SUPPRESSION SO IT BECOMES 3980 02:35:15,200 --> 02:35:15,800 BOUNCER WORKING ON THE CENTER 3981 02:35:15,800 --> 02:35:16,440 TRIAL SIZE, AND GETTING THE 3982 02:35:16,440 --> 02:35:17,040 DRUG APPROVAL AS EFFICIENTLY AS 3983 02:35:17,040 --> 02:35:17,640 POSSIBLE BUT NOT FORGETTING 3984 02:35:17,640 --> 02:35:24,920 WHAT I CALL THE "ADHERENCE 3985 02:35:24,920 --> 02:35:25,560 CHALLENGE" PATIENT EARLY IN THE 3986 02:35:25,560 --> 02:35:26,200 PROCESS AND REALLY PLANNING ON 3987 02:35:26,200 --> 02:35:26,840 HOW WE ARE GOING TO MEET THEIR 3988 02:35:26,840 --> 02:35:27,920 NEEDS. 3989 02:35:27,920 --> 02:35:28,520 AND THERE ARE MANY OPTIONS FOR 3990 02:35:28,520 --> 02:35:33,480 LATE STAGE OR SOME OPTIONS FOR 3991 02:35:33,480 --> 02:35:36,680 LATE STAGE OR PREAPPROVAL TRIAL 3992 02:35:36,680 --> 02:35:37,280 DESIGN, SUCH AS IMMEDIATE VS. 3993 02:35:37,280 --> 02:35:37,920 DELAYED START. AND WHEN WE GO 3994 02:35:37,920 --> 02:35:43,840 TO THE NEXT SLIDE, WE CAN TALK 3995 02:35:43,840 --> 02:35:44,480 ABOUT OTHER SOURCES OF EVIDENCE 3996 02:35:44,480 --> 02:35:48,720 FOR EFFICACY AS WELL. 3997 02:35:48,720 --> 02:35:49,280 AND I'M NOT GOING TO GO INTO 3998 02:35:49,280 --> 02:35:49,880 ALL OF THESE IN GREAT DETAIL. 3999 02:35:49,880 --> 02:35:52,160 BUT WE HAD 4000 02:35:52,160 --> 02:35:52,720 VERY RICH DISCUSSIONS ON HOW 4001 02:35:52,720 --> 02:35:54,080 TO DO STUDIES 4002 02:35:54,080 --> 02:35:55,840 4003 02:35:55,840 --> 02:35:56,520 IN COMMUNITIES OUTSIDE OF THE 4004 02:35:56,520 --> 02:36:01,200 MAIN CENTERS, EITHER DURING THE 4005 02:36:01,200 --> 02:36:02,520 PREAPPROVAL PROCESS OR 4006 02:36:02,520 --> 02:36:02,920 ESPECIALLY 4007 02:36:02,920 --> 02:36:04,200 PLANNING FOR THIS AROUND 4008 02:36:04,200 --> 02:36:06,160 THE TIME OF APPROVAL 4009 02:36:06,160 --> 02:36:09,760 AND GOING FORWARD. 4010 02:36:09,760 --> 02:36:11,040 AND ONE THING THAT REALLY CAME 4011 02:36:11,040 --> 02:36:15,600 OUT TOO, IS THAT WE KNOW THE 4012 02:36:15,600 --> 02:36:16,120 DRUGS WERE. WE KNOW THE 4013 02:36:16,120 --> 02:36:22,240 EFFICACY. WE DEMONSTRATED THAT. 4014 02:36:22,240 --> 02:36:22,800 BUT BUT WE REALLY WANTED IN 4015 02:36:22,800 --> 02:36:23,400 SOME OF THESE PREPARATIONS IS 4016 02:36:23,400 --> 02:36:23,960 TO LAY TO REST ANY CONCERNS 4017 02:36:23,960 --> 02:36:24,840 ABOUT 4018 02:36:24,840 --> 02:36:29,720 SPECIFIC SAFETY ISSUES. 4019 02:36:29,720 --> 02:36:31,160 AND SO WE CAN ALSO THINK ABOUT 4020 02:36:31,160 --> 02:36:33,760 DOING SAFETY MONITORING, 4021 02:36:33,760 --> 02:36:34,360 SINGLEARM STUDIES FOR EXAMPLE 4022 02:36:34,360 --> 02:36:36,720 THE FOCUS JUST ON THE SAFETY IN 4023 02:36:36,720 --> 02:36:37,320 TERMS OF DRUG INTERACTIONS 4024 02:36:37,320 --> 02:36:42,400 DURING PREGNANCY, COMORBIDITIES 4025 02:36:42,400 --> 02:36:43,040 AND ISSUES LIKE DRUG RESISTANCE 4026 02:36:43,040 --> 02:36:51,400 THAT MAY ARISE. NEXT SLIDE. 4027 02:36:51,400 --> 02:36:51,880 AND THEN ANOTHER SET OF 4028 02:36:51,880 --> 02:36:56,160 FINDINGS WAS THAT WE DO HAVE 4029 02:36:56,160 --> 02:36:56,800 APPROVAL OPPORTUNITIES ONCE THE 4030 02:36:56,800 --> 02:36:59,600 DRUGS APPROVED THERE IS A 4031 02:36:59,600 --> 02:37:03,080 COLLABORATIVE 4032 02:37:03,080 --> 02:37:03,560 NETWORK AND THERE ARE 4033 02:37:03,560 --> 02:37:04,160 INVESTIGATOR INITIATED STUDY 4034 02:37:04,160 --> 02:37:04,800 FOR WE CAN THINK ABOUT THIS IS 4035 02:37:04,800 --> 02:37:05,560 WHERE SOME OF THE RULES SETTINGS 4036 02:37:05,560 --> 02:37:11,320 REALLY COULD PLAY A BIG ROLE. 4037 02:37:11,320 --> 02:37:13,160 DOING AND EFFICACY STUDY THAT 4038 02:37:13,160 --> 02:37:13,520 RULES 4039 02:37:13,520 --> 02:37:14,160 AND CONDITIONS STUDIES WE HAVE 4040 02:37:14,160 --> 02:37:18,000 EFFICACY AND EFFECTIVENESS TOO 4041 02:37:18,000 --> 02:37:18,640 AT THE SAME TIME AND WE CAN USE 4042 02:37:18,640 --> 02:37:21,000 HUB AND SPOKE MODELS. 4043 02:37:21,000 --> 02:37:22,080 AND ONE AREA THAT HAS BEEN 4044 02:37:22,080 --> 02:37:26,240 UNEXPLORED THUS FAR IN HIV IS 4045 02:37:26,240 --> 02:37:26,840 THE USE OF REAL-WORLD DATA AND 4046 02:37:26,840 --> 02:37:30,920 HOW WE BRING THAT 4047 02:37:30,920 --> 02:37:31,520 AS REAL-WORLD EVIDENCE OF THE 4048 02:37:31,520 --> 02:37:40,360 FORTH. NEXT SLIDE. 4049 02:37:40,360 --> 02:37:40,920 SO IN CONCLUSION WITH ALL OF 4050 02:37:40,920 --> 02:37:42,920 THESE, THE CHANGING OF THE DRUG 4051 02:37:42,920 --> 02:37:43,480 LABEL OR INDICATION NOT THE 4052 02:37:43,480 --> 02:37:48,160 ONLY PATH TO INCREASE SUCCESS. 4053 02:37:48,160 --> 02:37:48,600 THE ROLE OF TREATMENT 4054 02:37:48,600 --> 02:37:50,560 GUIDELINES IS VERY SIGNIFICANT 4055 02:37:50,560 --> 02:37:51,200 IN FACILITATING REIMBURSEMENT 4056 02:37:51,200 --> 02:37:57,920 AND -- WILL BE TALKING ABOUT 4057 02:37:57,920 --> 02:37:58,520 THE HIV GUIDELINES PANEL THAT 4058 02:37:58,520 --> 02:38:00,400 IS SUPPORTED BY NIH, AND HAS 4059 02:38:00,400 --> 02:38:01,440 PLAYED SUCH AN AMAZING ROLE IN 4060 02:38:01,440 --> 02:38:04,440 OUR HIV HISTORY IN THIS 4061 02:38:04,440 --> 02:38:09,920 COUNTRY. 4062 02:38:09,920 --> 02:38:10,520 AND THAT THE GUIDELINE PANELS 4063 02:38:10,520 --> 02:38:11,040 LOOK AT THE TOTALITY OF 4064 02:38:11,040 --> 02:38:13,360 EVIDENCE FROM DIFFERENT 4065 02:38:13,360 --> 02:38:17,120 SOURCES. WHEREAS THE FDA-- THE 4066 02:38:17,120 --> 02:38:17,720 LABEL-- IS REALLY JUST THE DATA 4067 02:38:17,720 --> 02:38:18,360 THAT IS PRESENTED TO THE FDA BY 4068 02:38:18,360 --> 02:38:21,720 THE SPONSOR FOR THE INITIAL 4069 02:38:21,720 --> 02:38:26,680 APPROVAL. NEXT SLIDE. 4070 02:38:26,680 --> 02:38:27,240 SOME KEY TAKE-HOME POINT IS 4071 02:38:27,240 --> 02:38:29,040 THAT IT IS POSSIBLE TO ENGAGE 4072 02:38:29,040 --> 02:38:31,960 HARD-TO-REACH INDIVIDUALS IN 4073 02:38:31,960 --> 02:38:34,280 ART WITH HIGH LEVELS OF 4074 02:38:34,280 --> 02:38:40,080 SUCCESS. WE HAVE THEACTG 5359, 4075 02:38:40,080 --> 02:38:40,800 THE PILOT STUDY LED BY MONICA 4076 02:38:40,800 --> 02:38:46,040 GANDY ON WARD 86. AND AGAIN 4077 02:38:46,040 --> 02:38:46,680 CONGRATULATIONS MONICA FOR ALL 4078 02:38:46,680 --> 02:38:50,320 YOUR WORK IN THIS AREA. 4079 02:38:50,320 --> 02:38:53,840 WE ARE CONCERNED ABOUT SAFETY, 4080 02:38:53,840 --> 02:39:00,160 IN TERMS OF POPULATIONS. FOR 4081 02:39:00,160 --> 02:39:02,840 EXAMPLE THE POSSIBILITY OF 4082 02:39:02,840 --> 02:39:03,480 DRUG RESISTANCE BUT AT THE SAME 4083 02:39:03,480 --> 02:39:04,120 TIME WE NEED TO THINK ABOUT THE 4084 02:39:04,120 --> 02:39:06,800 UNMET MEDICAL NEED OF PEOPLE 4085 02:39:06,800 --> 02:39:07,320 WHO ARE AT THE END OF ORAL 4086 02:39:07,320 --> 02:39:10,200 TREATMENT OPTIONS. IN THAT 4087 02:39:10,200 --> 02:39:15,480 SITUATION, LONG-ACTING ART 4088 02:39:15,480 --> 02:39:17,040 COULD BE LIFE SAVING FOR THEM 4089 02:39:17,040 --> 02:39:18,480 AND ALSO CABENUVA IS THE FIRST 4090 02:39:18,480 --> 02:39:27,160 ITERATION OF LA ART, AND 4091 02:39:27,160 --> 02:39:27,720 SUBSEQUENT THERAPIES WILL 4092 02:39:27,720 --> 02:39:28,320 BECOME EASIER ESPECIALLY THEY 4093 02:39:28,320 --> 02:39:31,920 HAVE LONGER PERIODS OF 4094 02:39:31,920 --> 02:39:32,480 ACTIVITY, SO THAT MAYBE THE 4095 02:39:32,480 --> 02:39:33,120 INJECTION WILL ONLY HAVE TO BE 4096 02:39:33,120 --> 02:39:33,800 DONE EVERY FOUR MONTHS OR EVERY 4097 02:39:33,800 --> 02:39:38,120 SIX MONTHS. OR THE IMPLANT OR 4098 02:39:38,120 --> 02:39:39,360 THE PATCH OR WHATEVER THE 4099 02:39:39,360 --> 02:39:40,600 ADMINISTRATION METHOD IS. NEXT 4100 02:39:40,600 --> 02:39:43,720 SLIDE. 4101 02:39:43,720 --> 02:39:50,320 SOME GENERAL ACCOMMODATIONS. 4102 02:39:50,320 --> 02:39:54,920 WE AS A COMMUNITY WORK 4103 02:39:54,920 --> 02:39:55,520 COLLABORATIVELY TO GENERATE 4104 02:39:55,520 --> 02:39:56,120 USEFUL DATA FOR BOTH TREATMENT 4105 02:39:56,120 --> 02:39:56,720 GUIDELINE PANELS AND FOR THE 4106 02:39:56,720 --> 02:39:59,400 REGULATORY AUTHORITIES. 4107 02:39:59,400 --> 02:39:59,960 WE SHOULD FOCUS ON EFFICACY 4108 02:39:59,960 --> 02:40:02,760 AND SAFETY. 4109 02:40:02,760 --> 02:40:03,360 AND REALLY TO PUT ALL OPTIONS 4110 02:40:03,360 --> 02:40:11,000 ON THE TABLE. LET'S WORK 4111 02:40:11,000 --> 02:40:11,560 MULTIPLE AVENUES FOR DATA 4112 02:40:11,560 --> 02:40:12,120 LET'S FIND THE BEST USE FOR 4113 02:40:12,120 --> 02:40:13,880 INDUSTRY SPONSORED TRIALS, AND 4114 02:40:13,880 --> 02:40:17,280 ACADEMIC LED CLINICAL RESEARCH. 4115 02:40:17,280 --> 02:40:17,840 LET'S ALSO THINK ABOUT WHAT 4116 02:40:17,840 --> 02:40:20,560 ARE THE UNIQUE CONTRIBUTIONS 4117 02:40:20,560 --> 02:40:21,120 THAT OTHER COMMUNITIES COULD 4118 02:40:21,120 --> 02:40:22,160 BRING? 4119 02:40:22,160 --> 02:40:29,520 AND MARINE, ONE OF YOUR 4120 02:40:29,520 --> 02:40:30,120 COMMENTS AT THE MEETING AND 4121 02:40:30,120 --> 02:40:30,680 THANK YOU SO MUCH AGAIN FOR 4122 02:40:30,680 --> 02:40:34,680 ATTENDING A WORKSHOP, 4123 02:40:34,680 --> 02:40:35,280 WAS THAT WE NEED TO ALSO THINK 4124 02:40:35,280 --> 02:40:36,760 ABOUT BRINGING TO RESEARCH 4125 02:40:36,760 --> 02:40:37,360 OTHER ECONOMIC CENTERS INTO 4126 02:40:37,360 --> 02:40:37,960 THE COMMUNITIES AND THAT THIS 4127 02:40:37,960 --> 02:40:41,240 REFLECTED 4128 02:40:41,240 --> 02:40:41,840 WHAT YOU KEEP HEARING ON YOUR 4129 02:40:41,840 --> 02:40:46,760 LISTENING TOURS. 4130 02:40:46,760 --> 02:40:47,360 AND I THINK IT WILL BRING DATA 4131 02:40:47,360 --> 02:40:49,000 FROM DIFFERENT SOURCES TO 4132 02:40:49,000 --> 02:40:52,480 CONSISTENCY 4133 02:40:52,480 --> 02:40:53,040 IN THE DATA OUTCOMES WILL 4134 02:40:53,040 --> 02:40:53,680 REALLY INCREASE THE CONFIDENCE 4135 02:40:53,680 --> 02:40:57,800 IN FINDINGS IS REMOVED FROM 4136 02:40:57,800 --> 02:40:58,280 THESE HIGHLY CONTROLLED 4137 02:40:58,280 --> 02:40:58,920 RANDOMIZED CLINICAL TRIALS AT 4138 02:40:58,920 --> 02:40:59,440 THE BEGINNING OF THE DRUG 4139 02:40:59,440 --> 02:41:00,840 DEVELOPMENT PATHWAY, TO THE 4140 02:41:00,840 --> 02:41:04,080 IMPLEMENTATION PROGRAMS, AND 4141 02:41:04,080 --> 02:41:04,640 THE USE OF THESE DRUGS IN 4142 02:41:04,640 --> 02:41:06,960 REAL-WORLD SETTINGS. NEXT SLIDE. 4143 02:41:06,960 --> 02:41:12,120 LET'S REMEMBER THAT WE NEED TO 4144 02:41:12,120 --> 02:41:17,440 APPLY THE COMBINATION APPROACH 4145 02:41:17,440 --> 02:41:18,040 NOT JUST THE DIRECT REGIMENT 4146 02:41:18,040 --> 02:41:22,840 BUT ALSO A DRUG MEASUREMENT 4147 02:41:22,840 --> 02:41:23,440 PLUS A BEHAVIORAL SUPPORT. AND 4148 02:41:23,440 --> 02:41:24,080 WE NEED TO BRING OLD PLAYERS TO 4149 02:41:24,080 --> 02:41:29,240 THE TABLE. 4150 02:41:29,240 --> 02:41:29,800 WE HAD A VERY GOOD GROUP AND 4151 02:41:29,800 --> 02:41:30,360 WE NOTICE THAT OKAY WE WERE 4152 02:41:30,360 --> 02:41:32,560 MISSING A COUPLE OF 4153 02:41:32,560 --> 02:41:33,160 ORGANIZATIONS AND STAKEHOLDER 4154 02:41:33,160 --> 02:41:39,760 GROUPS FOR CONTINUING 4155 02:41:39,760 --> 02:41:40,360 DISCUSSIONS; WE WOULD LIKE TO 4156 02:41:40,360 --> 02:41:40,840 BRING IN THE VETERANS 4157 02:41:40,840 --> 02:41:43,120 ADMINISTRATION AND INDIAN 4158 02:41:43,120 --> 02:41:44,600 HEALTH SERVICE, AND THINK ABOUT 4159 02:41:44,600 --> 02:41:46,520 REPRESENTATIONS FROM 4160 02:41:46,520 --> 02:41:47,160 ADOLESCENTS AND THEIR SPECIFIC 4161 02:41:47,160 --> 02:41:51,080 NEEDS AND FOR MORE EFFICIENT 4162 02:41:51,080 --> 02:41:53,920 RECRUITMENT INTO THESE TRIALS. 4163 02:41:53,920 --> 02:41:54,560 WE SHOULD DEFINITELY CONSIDER 4164 02:41:54,560 --> 02:41:56,520 EUROPEAN COLLABORATORS. NEXT 4165 02:41:56,520 --> 02:41:59,440 SLIDE. 4166 02:41:59,440 --> 02:42:05,480 LET'S LEARN FROM THE PROOF OF 4167 02:42:05,480 --> 02:42:06,960 CONCEPT THAT WE DO HAVE DEFINED 4168 02:42:06,960 --> 02:42:08,240 IMPLEMENTABLE OPTIONS. FOR 4169 02:42:08,240 --> 02:42:08,760 EXAMPLE MONEY BECAUSE YOU 4170 02:42:08,760 --> 02:42:19,160 REALLY OUTLINE THIS. 4171 02:42:23,400 --> 02:42:23,960 THE AMOUNT OF INVESTMENT YOU 4172 02:42:23,960 --> 02:42:24,600 HAVE MADE INTO THIS PROGRAM AND 4173 02:42:24,600 --> 02:42:25,160 SUPPORT IS AVAILABLE TO THE 4174 02:42:25,160 --> 02:42:25,800 PATIENTS AND THE CLINIC STAFF. 4175 02:42:25,800 --> 02:42:26,560 HOW WILL WE IMPLEMENT THIS ON A 4176 02:42:26,560 --> 02:42:29,200 LARGE SCALE? HIS HOME TESTING 4177 02:42:29,200 --> 02:42:31,480 SUFFICIENT FOR THIS PURPOSE? IS 4178 02:42:31,480 --> 02:42:38,320 QUALITATIVE TEST EFFICIENT? CAN 4179 02:42:38,320 --> 02:42:38,960 WE USE RETAIL PHARMACIES AND WE 4180 02:42:38,960 --> 02:42:39,560 SHOULD CONSIDER LOWER INCOME 4181 02:42:39,560 --> 02:42:44,400 COUNTRIES. 4182 02:42:44,400 --> 02:42:45,000 AND THAT IS IT SO I WANTED TO 4183 02:42:45,000 --> 02:42:45,640 HIGHLIGHT OUR WORKSHOP GOALS TO 4184 02:42:45,640 --> 02:42:46,160 BRING IT BACK UP TO THE 4185 02:42:46,160 --> 02:42:46,760 TOTALITY OF WHAT WE ARE TALKING 4186 02:42:46,760 --> 02:42:50,600 ABOUT. I WANT TO THANK THE HIV 4187 02:42:50,600 --> 02:42:51,200 FORUM SPONSORS AND THANK YOU 4188 02:42:51,200 --> 02:42:52,560 FOR YOUR ATTENTION. 4189 02:42:52,560 --> 02:42:58,240 >>CHAIR TOLBERT: THANK YOU DR. 4190 02:42:58,240 --> 02:43:02,560 MILLER FOR THE PRESENTATION. 4191 02:43:02,560 --> 02:43:03,080 WE ARE TIGHT ON TIME AND I 4192 02:43:03,080 --> 02:43:04,320 WANT TO ACKNOWLEDGE OUR NEXT 4193 02:43:04,320 --> 02:43:09,480 SPEAKER, WHO IS A DIRECTOR OF 4194 02:43:09,480 --> 02:43:14,280 ARPAH. 4195 02:43:14,280 --> 02:43:14,880 WANT TO USE MY CHAIR DISCRETION 4196 02:43:14,880 --> 02:43:15,520 HERE TO TRY TO GET TO A COUPLE 4197 02:43:15,520 --> 02:43:17,560 OF COMMENTS BEFORE WE MOVE ON 4198 02:43:17,560 --> 02:43:23,800 TO THE NEXT PART OF THE AGENDA. 4199 02:43:23,800 --> 02:43:30,960 >>I WANT TO MAKE A QUICK 4200 02:43:30,960 --> 02:43:34,720 COMMENT MINDFUL OF TIME. I WANT 4201 02:43:34,720 --> 02:43:38,880 TO THANK THE SPEAKERS FOR AN 4202 02:43:38,880 --> 02:43:39,520 OUTSTANDING PRESENTATION AND I 4203 02:43:39,520 --> 02:43:40,120 THINK THE MAIN ISSUE HERE AS 4204 02:43:40,120 --> 02:43:41,680 YOU POINTED OUT IN YOUR SLIDE 4205 02:43:41,680 --> 02:43:44,680 PARTICULARLY SLIDE 18, IS THE 4206 02:43:44,680 --> 02:43:49,640 MESSAGING. 4207 02:43:49,640 --> 02:43:50,240 AND THE FACT THAT WE ARE GOING 4208 02:43:50,240 --> 02:43:50,760 TO GET A LOT OF CONFUSION 4209 02:43:50,760 --> 02:43:52,040 PUSHBACK MOSTLY BY PROVIDERS 4210 02:43:52,040 --> 02:43:52,640 BUT TO A LESSER EXTENT BY THE 4211 02:43:52,640 --> 02:44:01,480 COMMUNITY. 4212 02:44:01,480 --> 02:44:02,000 AND I THINK WHAT WOULD BE 4213 02:44:02,000 --> 02:44:02,640 REALLY WISE FOR US IS TO THINK 4214 02:44:02,640 --> 02:44:13,160 OFF LINE WITH ROHAN'S INPUT, 4215 02:44:15,520 --> 02:44:16,080 PROVIDE INFORMATION OUTSIDE OF 4216 02:44:16,080 --> 02:44:17,280 THE GUIDELINES AND WEBSITES, 4217 02:44:17,280 --> 02:44:26,160 AND A TOUR OF FORCE AND ENGAGE 4218 02:44:26,160 --> 02:44:26,720 PAF, ENDORSES CHANGE AND 4219 02:44:26,720 --> 02:44:27,280 PROVIDE SOME GRANULARITY ON 4220 02:44:27,280 --> 02:44:28,480 PROTOCOLS FOR 4221 02:44:28,480 --> 02:44:33,240 MONITORING VIRAL LOAD, AND 4222 02:44:33,240 --> 02:44:33,760 WHAT TO DO THE CASE OF 4223 02:44:33,760 --> 02:44:41,480 MASTITIS, AND HOW DO WE WEAN. 4224 02:44:41,480 --> 02:44:42,040 THE KINDS OF QUESTION THAT 4225 02:44:42,040 --> 02:44:42,640 FAMILIES WITH HIV AND PROVIDERS 4226 02:44:42,640 --> 02:44:47,440 ARE GOING TO HAVE. THIS IS THE 4227 02:44:47,440 --> 02:44:48,040 START OF THE KICKOFF AND THEN 4228 02:44:48,040 --> 02:44:48,640 WE CAN REALLY GET THIS ON THE 4229 02:44:48,640 --> 02:44:51,280 ROAD AND PROVIDE SUPPORT ACROSS 4230 02:44:51,280 --> 02:44:53,760 COUNTRY FOR THIS. 4231 02:44:53,760 --> 02:44:55,320 >>CHAIR TOLBERT; 4232 02:44:55,320 --> 02:44:59,680 ALL RIGHT THANK YOU DR. 4233 02:44:59,680 --> 02:45:10,160 SLEASMAN. WE WILL GO TO DR. 4234 02:45:13,800 --> 02:45:16,720 TURNBUL NEXT. 4235 02:45:16,720 --> 02:45:20,280 >>I AGREE HUNDRED PERCENT WITH 4236 02:45:20,280 --> 02:45:24,680 DR. SLEASMAN AND HIS ASSESSMENT 4237 02:45:24,680 --> 02:45:25,160 PARTICULARLY AROUND THE 4238 02:45:25,160 --> 02:45:25,760 GARLANDS AND THERE HAS BEEN A 4239 02:45:25,760 --> 02:45:26,320 LOT OF CHATTER AROUND THIS 4240 02:45:26,320 --> 02:45:31,360 CALLOUS PARTICULARLY IN THE 4241 02:45:31,360 --> 02:45:31,920 COMMUNITIES, BUT NOBODY IS 4242 02:45:31,920 --> 02:45:36,800 REALLY QUITE SURE WHAT IS, AND 4243 02:45:36,800 --> 02:45:37,440 REALLY MAKING INFORMED CONSENT 4244 02:45:37,440 --> 02:45:41,360 AND I WHOLEHEARTEDLY AGREE, HOW 4245 02:45:41,360 --> 02:45:41,920 WE GET THIS INFORMATION OUT 4246 02:45:41,920 --> 02:45:43,800 THERE NOT ONLY TO THE PROVIDERS 4247 02:45:43,800 --> 02:45:44,400 BUT TO THE WOMEN AS WELL AND 4248 02:45:44,400 --> 02:45:48,240 THAT IS THE FIRST THING. 4249 02:45:48,240 --> 02:45:48,840 THE SECOND THING IS I WANT TO 4250 02:45:48,840 --> 02:45:50,840 SAY THANK YOU TO DR. MILLER FOR 4251 02:45:50,840 --> 02:45:54,000 YOUR PRESENTATION. 4252 02:45:54,000 --> 02:45:58,720 MY QUESTION TO YOU WOULD BE, 4253 02:45:58,720 --> 02:45:59,240 HAVE YOU LOOKED AT, OR 4254 02:45:59,240 --> 02:46:08,720 DISCUSSED, OR EVEN THOUGHT 4255 02:46:08,720 --> 02:46:12,560 ABOUT -- LIKE THE SUCCESS OR 4256 02:46:12,560 --> 02:46:13,120 NON-SUCCESS OF ESTABLISHING 4257 02:46:13,120 --> 02:46:13,760 CLINICAL TRIAL PRACTICES WITHIN 4258 02:46:13,760 --> 02:46:15,800 THE COMMUNITIES. NUMBER ONE. 4259 02:46:15,800 --> 02:46:20,560 AND IN TERMS OF ENGAGING 4260 02:46:20,560 --> 02:46:24,280 PERSONS WITH LIVED EXPERIENCE, 4261 02:46:24,280 --> 02:46:24,880 IN THE ACTUAL DEVELOPMENT AND 4262 02:46:24,880 --> 02:46:29,440 CREATION OF THE RESEARCH 4263 02:46:29,440 --> 02:46:30,000 STUDIES, WHEN WE TALK ABOUT 4264 02:46:30,000 --> 02:46:30,640 INCLUSION THAT IS WHAT I THINK 4265 02:46:30,640 --> 02:46:32,680 ABOUT. 4266 02:46:32,680 --> 02:46:33,240 IF YOU COULD RESPOND TO THAT 4267 02:46:33,240 --> 02:46:33,720 DR. MILLER THAT WILL BE 4268 02:46:33,720 --> 02:46:36,280 HELPFUL. 4269 02:46:36,280 --> 02:46:38,440 >>DR. MILLER: THANK YOU SO 4270 02:46:38,440 --> 02:46:45,680 MUCH DR. TURNBULL. GOOD TO SEE 4271 02:46:45,680 --> 02:46:46,240 YOU GET AN ABSOLUTELY I AM 4272 02:46:46,240 --> 02:46:46,840 SORRY IT DID NOT COME THROUGH 4273 02:46:46,840 --> 02:46:48,200 MORE CLEARLY. ABSOLUTELY THE 4274 02:46:48,200 --> 02:46:48,800 LIVED EXPERIENCE NEEDS TO BE A 4275 02:46:48,800 --> 02:46:56,560 ON THE TABLE, AT THE TABLE AS 4276 02:46:56,560 --> 02:46:59,480 WE RECOGNIZE AND WORK WHEN WE 4277 02:46:59,480 --> 02:47:00,080 SEE THE PEOPLE THAT WE ARE 4278 02:47:00,080 --> 02:47:00,640 TRYING TO SERVE AND THAT IS 4279 02:47:00,640 --> 02:47:01,640 ABSOLUTELY THE CASE. 4280 02:47:01,640 --> 02:47:02,240 WE HAD SOME REPRESENTATION AT 4281 02:47:02,240 --> 02:47:08,280 THE MEETING BUT OBVIOUSLY, 4282 02:47:08,280 --> 02:47:11,040 AGAIN, IT IS SUCH A DIVERSITY 4283 02:47:11,040 --> 02:47:11,640 AND FULL JOY THAT WE NEED TO 4284 02:47:11,640 --> 02:47:14,960 RECOGNIZE 4285 02:47:14,960 --> 02:47:15,560 AND NOT JUST KIND OF FOCUS ON 4286 02:47:15,560 --> 02:47:16,120 ONE OR TWO CATEGORIES OF 4287 02:47:16,120 --> 02:47:17,280 PATIENTS. 4288 02:47:17,280 --> 02:47:18,000 >>THANK YOU. 4289 02:47:18,000 --> 02:47:19,880 >>CHAIR TOLBERT: 4290 02:47:19,880 --> 02:47:26,120 THANK YOU DR. MILLER. DR. MHETA 4291 02:47:26,120 --> 02:47:30,440 AND GANDI I WILL CIRCLE BACK TO 4292 02:47:30,440 --> 02:47:30,880 YOU AFTER THE GUARD 4293 02:47:30,880 --> 02:47:31,480 REPRESENTATIONS AND I WANT TO 4294 02:47:31,480 --> 02:47:32,120 KEEP US ON SCHEDULE BECAUSE WE 4295 02:47:32,120 --> 02:47:33,280 DO HAVE ADDITIONAL GUESTS. 4296 02:47:33,280 --> 02:47:35,080 SO I'M GOING TO GO AHEAD AND 4297 02:47:35,080 --> 02:47:45,600 PROCEED AND INTRODUCE OUR NEXT 4298 02:47:50,800 --> 02:47:56,000 PRESENTERRENEE WEGRZYN, PHD, 4299 02:47:56,000 --> 02:47:56,600 DIRECTOR, ADVANCED RESEARCH 4300 02:47:56,600 --> 02:47:57,160 PROJECTS AGENCY FOR HEALTH 4301 02:47:57,160 --> 02:47:57,400 (ARPA-H) 4302 02:47:57,400 --> 02:48:00,080 . 4303 02:48:00,080 --> 02:48:00,600 PREVIOUSLY SERVED AS VICE 4304 02:48:00,600 --> 02:48:01,240 PRESIDENT OF GINKGO BY WORKING 4305 02:48:01,240 --> 02:48:07,240 HEALTH INNOVATION AT CONCENTRIC 4306 02:48:07,240 --> 02:48:07,880 -- WHICH HE FOCUS AND APPLY THE 4307 02:48:07,880 --> 02:48:08,480 TOOLS OF SYNTHETIC BIOLOGY TO 4308 02:48:08,480 --> 02:48:09,080 OUTPACE INFECTIOUS DISEASES. 4309 02:48:09,080 --> 02:48:13,400 SHE COMES TO ARPAH WITH 4310 02:48:13,400 --> 02:48:14,040 EXPERIENCED WORKING FOR OVER A 4311 02:48:14,040 --> 02:48:14,680 DECADE OF THE DEFENSE ADVANCED 4312 02:48:14,680 --> 02:48:25,200 RESEARCH PROJECTS, DARPA. FIVE 4313 02:48:25,560 --> 02:48:26,040 OF THOSE YEARS AS A PROGRAM 4314 02:48:26,040 --> 02:48:26,600 MANAGER WITH A $250 MILLION 4315 02:48:26,600 --> 02:48:27,160 FOLIO, AND IS A TECHNICAL 4316 02:48:27,160 --> 02:48:27,720 ADVISOR TO THE INTELLIGENCE 4317 02:48:27,720 --> 02:48:34,280 ADVANCED RESEARCH PROJECT 4318 02:48:34,280 --> 02:48:41,560 ACTIVITY DR. WEGRZYN LEVERAGE 4319 02:48:41,560 --> 02:48:43,000 THE TOOLS OF-- TO SUPPORT THE 4320 02:48:43,000 --> 02:48:43,560 DOMESTIC OF BIO ECONOMY AND 4321 02:48:43,560 --> 02:48:44,160 STORED BY THREATS WE ARE VERY 4322 02:48:44,160 --> 02:48:46,640 PLEASED TO HAVE DR. WEGRZYN 4323 02:48:46,640 --> 02:48:47,240 WITH US TODAY AND I WILL HAND 4324 02:48:47,240 --> 02:48:48,560 IT OVER TO YOU. 4325 02:48:48,560 --> 02:48:56,560 >>DR. WERGZYN: 4326 02:48:56,560 --> 02:49:03,600 THANK YOU APPRECIATE THE 4327 02:49:03,600 --> 02:49:04,200 INVITATION TO PARTICIPATE AND I 4328 02:49:04,200 --> 02:49:04,800 AM EXCITED TO SHARE WITH YOU 4329 02:49:04,800 --> 02:49:09,000 LITTLE ABOUT 4330 02:49:09,000 --> 02:49:09,560 ARPAH THE NEW FEDERAL AGENCY 4331 02:49:09,560 --> 02:49:10,200 THAT STARTED AT LAB THE END OF 4332 02:49:10,200 --> 02:49:10,840 LAST YEAR AND I WANT YOU TO THE 4333 02:49:10,840 --> 02:49:11,440 MISSION OF PROGRESS WAS MADE 4334 02:49:11,440 --> 02:49:11,960 BUT MORE IMPORTANTLY OUR 4335 02:49:11,960 --> 02:49:12,560 BUSINESS MODEL. 4336 02:49:12,560 --> 02:49:13,160 AS WE GROW YOU CAN UNDERSTAND 4337 02:49:13,160 --> 02:49:17,720 WHAT ARE THE BEST WAYS TO WORK 4338 02:49:17,720 --> 02:49:18,280 WITH ARPAH SINCE THIS IS 4339 02:49:18,280 --> 02:49:18,800 BRAND-NEW TO THE HEALTH 4340 02:49:18,800 --> 02:49:21,840 ECOSYSTEM. NEXT SLIDE. 4341 02:49:21,840 --> 02:49:25,440 SO VERY IMPORTANTLY, OUR 4342 02:49:25,440 --> 02:49:25,960 MISSION IS SIMPLY PUT TO 4343 02:49:25,960 --> 02:49:26,520 ACCELERATE BETTER HEALTH 4344 02:49:26,520 --> 02:49:30,040 OUTCOMES FOR EVERYONE. WE 4345 02:49:30,040 --> 02:49:30,680 MEASURE OUR SUCCESS IN TERMS OF 4346 02:49:30,680 --> 02:49:33,880 HEALTH OUTCOMES SO WE LOVE THE 4347 02:49:33,880 --> 02:49:34,480 ACADEMIC RESEARCH BUT WE ARE 4348 02:49:34,480 --> 02:49:41,440 NOT INTERESTED IN A LOT OF 4349 02:49:41,440 --> 02:49:42,040 PUBLICATIONS FOR SCIENCE WE 4350 02:49:42,040 --> 02:49:42,640 WANT TO PUT TOOLS IN THE HANDS 4351 02:49:42,640 --> 02:49:49,400 OF AMERICANS THAT ARE GOING TO 4352 02:49:49,400 --> 02:49:49,960 IMPROVE THEIR HEALTH MOVING 4353 02:49:49,960 --> 02:49:50,600 FORWARD AND IMPROVE THE HEALTH 4354 02:49:50,600 --> 02:49:51,240 OF EVERYONE AND YOU WILL SEE AS 4355 02:49:51,240 --> 02:49:57,520 WE TALK ABOUT OUR ORGANIZATION 4356 02:49:57,520 --> 02:49:58,120 HOW WE ARE TRYING TO INCLUDE 4357 02:49:58,120 --> 02:49:58,600 EQUITY AND DIVERSITY IN 4358 02:49:58,600 --> 02:49:59,240 EVERYTHING WE DO IN THE DESIGN 4359 02:49:59,240 --> 02:50:01,360 OF OUR PROGRAMS. NEXT SLIDE. 4360 02:50:01,360 --> 02:50:01,960 SO AS IT WAS MENTIONED IN THE 4361 02:50:01,960 --> 02:50:12,520 INTRODUCTION THIS IS PRESIDENT 4362 02:50:13,960 --> 02:50:21,480 BIDEN'S VISION, TO BE IN AN 4363 02:50:21,480 --> 02:50:22,120 ORGANIZATION SO AUDACIOUS THAT 4364 02:50:22,120 --> 02:50:27,080 WE CAN TRY IDEAS THAT BREAK THE 4365 02:50:27,080 --> 02:50:30,240 MOLD AND GET ALL OF THE THINGS 4366 02:50:30,240 --> 02:50:30,840 IN A GOVERNMENT AGENCY IN ONE 4367 02:50:30,840 --> 02:50:33,520 PLACE OF THE CONTRACT AND SHOP, 4368 02:50:33,520 --> 02:50:34,120 OUR LEGAL TEAM AND ARE A TEAM 4369 02:50:34,120 --> 02:50:40,120 AND THE BUDGETING SO WE CAN 4370 02:50:40,120 --> 02:50:40,720 START TO BRING THE TECHNICAL 4371 02:50:40,720 --> 02:50:41,320 LEADERS TO LAUNCH PROGRAMS TO 4372 02:50:41,320 --> 02:50:41,880 DO JUST WHAT THE PRESIDENT 4373 02:50:41,880 --> 02:50:47,800 CALLED US ON TO DO. 4374 02:50:47,800 --> 02:50:48,360 I WILL SPEND A LITTLE BIT OF 4375 02:50:48,360 --> 02:50:49,000 TIME ON THE SLIDE BECAUSE IT IS 4376 02:50:49,000 --> 02:50:49,640 IMPORTANT TO UNDERSTAND HOW WE 4377 02:50:49,640 --> 02:50:50,240 ARE DIFFERENT THAN THE REST OF 4378 02:50:50,240 --> 02:50:53,120 THE HEALTHCARE ECOSYSTEM. WE 4379 02:50:53,120 --> 02:50:53,760 ARE HERE TO CATALYZE THE ENTIRE 4380 02:50:53,760 --> 02:50:54,320 ECOSYSTEM AND WE HAVE A FEW 4381 02:50:54,320 --> 02:50:59,720 SPECIAL AUTHORITIES THAT 4382 02:50:59,720 --> 02:51:00,320 CONGRESS HAS GIVEN US AND THE 4383 02:51:00,320 --> 02:51:00,920 PRESIDENT HAS SIGNED INTO LAW 4384 02:51:00,920 --> 02:51:01,560 THAT MAKES THIS POSSIBLE. HERE 4385 02:51:01,560 --> 02:51:03,520 I AM THE ARPAH DIRECTOR AND I 4386 02:51:03,520 --> 02:51:05,520 REPORT DIRECTLY TO SEC. 4387 02:51:05,520 --> 02:51:09,160 BECERRA. A LOT OF THE 4388 02:51:09,160 --> 02:51:09,800 DECISION-MAKING THAT I'M GOING 4389 02:51:09,800 --> 02:51:10,960 TO DO IS DONE IN THE CAPACITY 4390 02:51:10,960 --> 02:51:14,840 OF HHS INDEPENDENT OF NIH WE 4391 02:51:14,840 --> 02:51:19,840 ARE NOT AN INCIDENT WITHIN NIH. 4392 02:51:19,840 --> 02:51:20,440 WE ARE AN INDEPENDENT AGENCY 4393 02:51:20,440 --> 02:51:21,520 BUT BEING BUILT INSIDE OF NIH 4394 02:51:21,520 --> 02:51:22,120 WHAT THAT HELPS US DO IS FROM 4395 02:51:22,120 --> 02:51:22,760 THE ONE WE WERE ABLE TO HIT THE 4396 02:51:22,760 --> 02:51:27,040 GROUND RUNNING. HAVE PAYROLL 4397 02:51:27,040 --> 02:51:27,600 AND WE DID NOT NEED TO HAVE 4398 02:51:27,600 --> 02:51:30,520 STAFF TO DO THAT, GETTING ALL 4399 02:51:30,520 --> 02:51:31,160 OF OUR IT EQUIPMENT AND ALL OF 4400 02:51:31,160 --> 02:51:31,800 THE THINGS THAT YOU NEED TO BE 4401 02:51:31,800 --> 02:51:32,560 A GOVERNMENT EMPLOYEE, 4402 02:51:32,560 --> 02:51:40,040 INCLUDING HEALTHCARE BENEFITS 4403 02:51:40,040 --> 02:51:40,680 ETC. THEY WERE ABLE TO HELP US 4404 02:51:40,680 --> 02:51:41,280 WITH AND NOW AS WE TRANSITION 4405 02:51:41,280 --> 02:51:41,880 INTO THE MORE TECHNICAL WORK 4406 02:51:41,880 --> 02:51:45,520 THAT I WILL TALK A LITTLE BIT 4407 02:51:45,520 --> 02:51:46,160 ABOUT, WE ARE RIGHT ADJACENT TO 4408 02:51:46,160 --> 02:51:47,800 SUBJECT MATTER EXPERTS CAN HELP 4409 02:51:47,800 --> 02:51:50,560 US DESIGN OUR PROGRAMS EVEN IF 4410 02:51:50,560 --> 02:51:51,200 THE PROGRAM MANAGER IS THE SOLE 4411 02:51:51,200 --> 02:51:51,760 DECISION-MAKER. THERE IS AN 4412 02:51:51,760 --> 02:51:57,960 IMPORTANT DIFFERENTIATOR. AT 4413 02:51:57,960 --> 02:51:58,600 ARPAH WE DID NOT DESIGN ON THE 4414 02:51:58,600 --> 02:52:01,600 PROGRAM TO WORK ON THROUGH THE 4415 02:52:01,600 --> 02:52:05,200 PROJECT SESSION BUT WE WOULD 4416 02:52:05,200 --> 02:52:05,840 DECIDE TO FUND THE PROPOSAL AND 4417 02:52:05,840 --> 02:52:07,000 HELP SHAPE WHAT THE PROPOSAL 4418 02:52:07,000 --> 02:52:07,920 AND THE WORK LOOKS LIKE. WE 4419 02:52:07,920 --> 02:52:12,240 WON'T BE ISSUING ANY GRANTS. 4420 02:52:12,240 --> 02:52:12,760 THIS WILL BE COOPERATIVE 4421 02:52:12,760 --> 02:52:13,400 AGREEMENTS, CONTRACTS AND OTHER 4422 02:52:13,400 --> 02:52:23,920 TRANSACTIONAL AUTHORITIES FOR 4423 02:52:24,760 --> 02:52:25,200 THOSE AFICIONADOS IN THE 4424 02:52:25,200 --> 02:52:25,800 ACQUISITION AND THE FEDERAL 4425 02:52:25,800 --> 02:52:26,440 GOVERNMENT. CONGRESS INITIALLY 4426 02:52:26,440 --> 02:52:27,440 GIVES $1 BILLION TO START. WITH 4427 02:52:27,440 --> 02:52:31,080 RECENT APPROPRIATIONS WE HAVE 4428 02:52:31,080 --> 02:52:33,280 1.5 BILLION NOT LINKED TO ANY 4429 02:52:33,280 --> 02:52:33,880 SINGLE DISEASE THESE ARE OPEN 4430 02:52:33,880 --> 02:52:34,680 DOLLARS MEANT TO BE A PLACE FOR 4431 02:52:34,680 --> 02:52:35,280 PROGRAM MANAGERS TO COME IN 4432 02:52:35,280 --> 02:52:37,080 WITH THE BIG IDEA THAT THEY 4433 02:52:37,080 --> 02:52:40,200 WANT TO SOLVE IN ANY CAPACITY. 4434 02:52:40,200 --> 02:52:40,800 MAYBE IT IS A CANCER MOONSHOT 4435 02:52:40,800 --> 02:52:43,280 SPECIFIC PROGRAM. IT COULD BE 4436 02:52:43,280 --> 02:52:44,560 SOMETHING COMPLETELY DIFFERENT, 4437 02:52:44,560 --> 02:52:48,160 NEUROSCIENCE FOCUSED, 4438 02:52:48,160 --> 02:52:48,840 HIV-FOCUSED OR DEVELOPING NEW 4439 02:52:48,840 --> 02:52:52,560 DEVICE. ALL OF THOSE ARE 4440 02:52:52,560 --> 02:52:53,160 WITHIN THE SCOPE AND WE HAVE 4441 02:52:53,160 --> 02:53:03,640 THAT FREEDOM TO TRANSACT, BY 4442 02:53:08,720 --> 02:53:09,280 RISK AND SHOW THAT SOMETHING IS 4443 02:53:09,280 --> 02:53:09,880 POSSIBLE WE ARE A PLACE, THAT 4444 02:53:09,880 --> 02:53:10,520 NO HIGHER RISK TYPE OF PROJECT 4445 02:53:10,520 --> 02:53:11,160 WILL BE ABLE TO BE PURSUED THAT 4446 02:53:11,160 --> 02:53:11,680 IS A ROLE HERE. 4447 02:53:11,680 --> 02:53:12,160 WE DO NOT HAVE INTERNAL 4448 02:53:12,160 --> 02:53:14,320 RESEARCH LABS, THIS IS STRICTLY 4449 02:53:14,320 --> 02:53:15,880 A FUNDING AGENCY, EXTRAMURAL 4450 02:53:15,880 --> 02:53:22,360 RESEARCH. ON OTHER INTERESTING 4451 02:53:22,360 --> 02:53:22,960 PART OF HOW WE ARE BUILT IS THE 4452 02:53:22,960 --> 02:53:33,640 CONGRESS HAS CAPPED US AT 210 4453 02:53:33,640 --> 02:53:34,120 EMPLOYEES WE HAVE A VERY 4454 02:53:34,120 --> 02:53:38,880 FLEXIBLE AND ADAPTABLE 4455 02:53:38,880 --> 02:53:39,440 WORKFORCE AND IS A PROJECT 4456 02:53:39,440 --> 02:53:40,080 MANAGER LAUNCHES THE PROGRAM ON 4457 02:53:40,080 --> 02:53:43,480 GENE EDITING THAT CAN AUGMENT A 4458 02:53:43,480 --> 02:53:44,120 TEAM OF CONTRACTORS TO SUPPORT 4459 02:53:44,120 --> 02:53:49,840 THE WORK IN THE TEAM MAY LEAVE 4460 02:53:49,840 --> 02:53:50,440 THE ORGANIZATION WHEN ANOTHER 4461 02:53:50,440 --> 02:53:51,040 PROGRAM MANAGER COMES IN WHO 4462 02:53:51,040 --> 02:53:51,640 HAS A NEUROSURGERY PROGRAM TO 4463 02:53:51,640 --> 02:53:52,280 BE A COMPLETELY DIFFERENT SKILL 4464 02:53:52,280 --> 02:53:54,600 SET. AND IN THIS WAY WE ARE 4465 02:53:54,600 --> 02:53:55,120 REALLY BEING ABLE TO BE 4466 02:53:55,120 --> 02:53:56,520 FLEXIBLE AND RELEVANT AND 4467 02:53:56,520 --> 02:53:57,120 ADAPTABLE WITH OUR WORKFORCE 4468 02:53:57,120 --> 02:53:57,720 AND WITH THAT WE WOULD NOT BE 4469 02:53:57,720 --> 02:53:58,280 ABLE TO DO IN A STRUCTURE. 4470 02:53:58,280 --> 02:54:05,560 GOING TO THE NEXT SLIDE. 4471 02:54:05,560 --> 02:54:06,120 THIS IS OUR ECOSYSTEM SO YOU 4472 02:54:06,120 --> 02:54:06,720 ARE ALL PART OF OUR ECOSYSTEM 4473 02:54:06,720 --> 02:54:17,200 ARE STAKEHOLDERS AT NIH, TO 4474 02:54:18,840 --> 02:54:19,400 MAKE SURE THAT OUR TRANSITIONAL 4475 02:54:19,400 --> 02:54:19,920 PARTNERS AND THE PRIVATE 4476 02:54:19,920 --> 02:54:21,800 INVESTORS ARE AWARE OF US AND 4477 02:54:21,800 --> 02:54:22,320 HELP INFORM THE PROGRAM 4478 02:54:22,320 --> 02:54:27,960 DESIGNED TO ENSURE THE 4479 02:54:27,960 --> 02:54:28,560 TRANSITION. WE DO NOT WANT TO 4480 02:54:28,560 --> 02:54:29,200 CREATE A CLIFF AT THE BACK END, 4481 02:54:29,200 --> 02:54:29,800 WE WANT ALL THESE INNOVATIONS 4482 02:54:29,800 --> 02:54:30,440 TO EXIST IN THE REAL WORLD AND 4483 02:54:30,440 --> 02:54:31,040 TO SERVE OUR CUSTOMERS IN ALL 4484 02:54:31,040 --> 02:54:36,000 OF THE ARPAS, WE HAVE THE 4485 02:54:36,000 --> 02:54:36,600 LARGEST CUSTOMER BASE IN THE 4486 02:54:36,600 --> 02:54:39,960 MOST DIVERSE CUSTOMER BASE, THE 4487 02:54:39,960 --> 02:54:40,600 AMERICAN PEOPLE AND THE PUBLIC 4488 02:54:40,600 --> 02:54:43,040 AND PATIENT GROUPS AND OUR 4489 02:54:43,040 --> 02:54:43,640 PERFORMERS, THESE ARE THE FOLKS 4490 02:54:43,640 --> 02:54:45,920 WE FOUND A PREDOMINANTLY FROM 4491 02:54:45,920 --> 02:54:46,560 ACADEMIA AND FROM INDUSTRY AND 4492 02:54:46,560 --> 02:54:51,600 BUSINESS OR TEAMS THAT ARE 4493 02:54:51,600 --> 02:54:52,240 BUILT OR ARE A BLEND OF THE TWO 4494 02:54:52,240 --> 02:54:52,840 SOMETHING THAT WE ANTICIPATE 4495 02:54:52,840 --> 02:54:54,960 WILL HAPPEN VERY COMMONLY. NEXT 4496 02:54:54,960 --> 02:54:59,960 SLIDE. 4497 02:54:59,960 --> 02:55:00,520 WHAT THIS ALL CREATE IS WHAT 4498 02:55:00,520 --> 02:55:05,960 WE LIKE TO THINK ABOUT AS A 4499 02:55:05,960 --> 02:55:06,480 FLYWHEEL OF PROGRAMS AND 4500 02:55:06,480 --> 02:55:07,080 PROGRAM MANAGERS AND PROGRAM 4501 02:55:07,080 --> 02:55:07,560 MANAGERS HAVE A TERM 4502 02:55:07,560 --> 02:55:08,160 APPOINTMENT THREE YEARS. THEY 4503 02:55:08,160 --> 02:55:08,760 CAN STAY UP TO AN ADDITIONAL 4504 02:55:08,760 --> 02:55:09,400 THREE YEARS FOR A TOTAL OF SIX 4505 02:55:09,400 --> 02:55:10,000 AND THEN THEY WILL LEAVE THE 4506 02:55:10,000 --> 02:55:12,200 ORGANIZATION. WE ASKED HIM TO 4507 02:55:12,200 --> 02:55:17,080 TAKE A RISK ON AS. WE GIVEN THE 4508 02:55:17,080 --> 02:55:19,080 OPPORTUNITY TO GET A BIG BACK 4509 02:55:19,080 --> 02:55:28,960 AND COUNT, TYPICALLY $50-$150 4510 02:55:28,960 --> 02:55:29,600 MILLION DOLLAR PROGRAMS AND WE 4511 02:55:29,600 --> 02:55:30,480 OFFER A COMPETITIVE SALARY, 4512 02:55:30,480 --> 02:55:40,320 OUTSIDE OF THE GS SCALE. WE ARE 4513 02:55:40,320 --> 02:55:40,920 NOT GOING TO REQUIRE ANYBODY 4514 02:55:40,920 --> 02:55:41,560 TO MOVE SO THAT IS ONE BENEFIT 4515 02:55:41,560 --> 02:55:46,000 OF A POST-COVID ENVIRONMENT AND 4516 02:55:46,000 --> 02:55:46,640 WE HAVE PROGRAM MANAGERS ALL 4517 02:55:46,640 --> 02:55:47,240 OVER THE COUNTRY AND IT WILL BE 4518 02:55:47,240 --> 02:55:49,000 BUSY TRAVELING. THEY ARE GOING 4519 02:55:49,000 --> 02:55:49,600 TO BE ENGAGING WITH PATIENTS 4520 02:55:49,600 --> 02:55:50,120 AND CUSTOMERS WITH LIVED 4521 02:55:50,120 --> 02:55:53,480 EXPERIENCES. THEY WILL BE 4522 02:55:53,480 --> 02:55:54,040 WORKING WITH THE BEST AND 4523 02:55:54,040 --> 02:55:54,680 BRIGHTEST THAT UNIVERSITIES AND 4524 02:55:54,680 --> 02:55:57,200 HOSPITALS ALL OVER THE COUNTRY. 4525 02:55:57,200 --> 02:55:58,440 AND SO ONE FINAL POINT IF YOU 4526 02:55:58,440 --> 02:56:06,040 LOOK AT ARPA-H I HOPE TO HIRE 4527 02:56:06,040 --> 02:56:06,640 20 PROGRAM MANAGERS THIS YEAR 4528 02:56:06,640 --> 02:56:07,280 AND IF YOU LOOK AT ADDITION YOU 4529 02:56:07,280 --> 02:56:08,840 WILL SEE 20 TOTAL PROJECT IN 4530 02:56:08,840 --> 02:56:09,440 TWO YEARS FROM NOW IT WILL BE 4531 02:56:09,440 --> 02:56:15,960 COMPLETELY DIFFERENT COLLECTION 4532 02:56:15,960 --> 02:56:16,480 OF PROGRAMS AND PROJECTS 4533 02:56:16,480 --> 02:56:17,080 BECAUSE WE ARE GOING TO HAVE 4534 02:56:17,080 --> 02:56:17,680 NEW PROGRAM MANAGERS, AND THE 4535 02:56:17,680 --> 02:56:18,200 OTHER PROGRAMS WILL BE 4536 02:56:18,200 --> 02:56:18,800 GRADUATING. IN THIS WAY WE ARE 4537 02:56:18,800 --> 02:56:19,360 ABLE TO SERVE THE ENTIRE 4538 02:56:19,360 --> 02:56:22,280 ECOSYSTEM. NEXT SLIDE. 4539 02:56:22,280 --> 02:56:27,800 I THINK IT IS HELPFUL, ONE OF 4540 02:56:27,800 --> 02:56:28,440 THE MOST IMPORTANT THINGS THAT 4541 02:56:28,440 --> 02:56:29,040 I CAN DO AND I THINK WHAT THE 4542 02:56:29,040 --> 02:56:29,680 PRESIDENT CALLED ON ME WAS TO 4543 02:56:29,680 --> 02:56:31,240 BRING THE ARPA ATTITUDE AND 4544 02:56:31,240 --> 02:56:35,160 CULTURE TO ARPA-H. AND THESE 4545 02:56:35,160 --> 02:56:35,800 ARE SOME OF THE ORGANIZATIONAL 4546 02:56:35,800 --> 02:56:36,360 ATTRIBUTES WE TREASURE AND 4547 02:56:36,360 --> 02:56:40,480 PROTECT. ONE IS THAT THE 4548 02:56:40,480 --> 02:56:41,000 PROGRAM MANAGERS ARE THE 4549 02:56:41,000 --> 02:56:45,360 NUCLEUS OF OUR ORGANIZATION. 4550 02:56:45,360 --> 02:56:45,960 SO WE REALLY HOLD SACRED THE 4551 02:56:45,960 --> 02:56:46,600 ABILITY TO MANAGE HIS PROGRAMS 4552 02:56:46,600 --> 02:56:47,160 INDEPENDENTLY SO WE CAN TAKE 4553 02:56:47,160 --> 02:56:54,800 THIS RISK. AND I CONSIDER 4554 02:56:54,800 --> 02:56:55,440 MYSELF A SOMEBODY WHO WORKS FOR 4555 02:56:55,440 --> 02:56:56,040 THIS PROGRAM MANAGERS AND GOES 4556 02:56:56,040 --> 02:56:56,640 TO THE HILL AND BLOCKS AND 4557 02:56:56,640 --> 02:56:57,240 TACKLES AND MAKE SURE WE HAVE 4558 02:56:57,240 --> 02:57:01,600 THOSE FREEDOMS BECAUSE WE WANT 4559 02:57:01,600 --> 02:57:02,240 TO CREATE THE INLET AND GPS THE 4560 02:57:02,240 --> 02:57:12,680 SAME WAY ARPA DID BUT FOR 4561 02:57:18,560 --> 02:57:19,080 HEALTH. WE SEE THE FUTURE OF 4562 02:57:19,080 --> 02:57:19,640 RADICAL CHANGE TO ITERATIVE 4563 02:57:19,640 --> 02:57:20,240 PROJECT, BRUTE FORCE PROJECT 4564 02:57:20,240 --> 02:57:26,680 NEED NOT APPLY. 4565 02:57:26,680 --> 02:57:30,000 AUTONOMY IS KEY AS WELL. YOU 4566 02:57:30,000 --> 02:57:30,640 ALREADY SEE THE STRUCTURES THAT 4567 02:57:30,640 --> 02:57:31,160 WE HAVE IN REPORTING UP A 4568 02:57:31,160 --> 02:57:37,720 DIFFERENT HIERARCHY CHAIN. 4569 02:57:37,720 --> 02:57:38,280 ARE PROGRAM MANAGERS ONCE 4570 02:57:38,280 --> 02:57:38,880 THEY GET THE BANK ACCOUNT IT 4571 02:57:38,880 --> 02:57:39,480 REALLY IS UP TO THEM TO PICK 4572 02:57:39,480 --> 02:57:40,040 THE TEAM OF PERFORMERS AND 4573 02:57:40,040 --> 02:57:40,680 SOLVERS THAT WILL WORK TO SOLVE 4574 02:57:40,680 --> 02:57:43,200 THE PROBLEM. 4575 02:57:43,200 --> 02:57:43,800 I WILL TALK A LITTLE BIT ABOUT 4576 02:57:43,800 --> 02:57:44,360 PROGRAM STRUCTURE IN JUST A 4577 02:57:44,360 --> 02:57:44,880 MOMENT. AND FINALLY, I 4578 02:57:44,880 --> 02:57:51,080 MENTIONED TERM LIMITS. I AM 4579 02:57:51,080 --> 02:57:51,640 TERM LIMITED AS THE PROGRAM 4580 02:57:51,640 --> 02:57:52,280 MANAGERS ARE SO WE HAVE A SENSE 4581 02:57:52,280 --> 02:57:55,440 OF URGENCY WHEN WE ARRIVE. 4582 02:57:55,440 --> 02:57:56,000 WE KNOW THIS IS AN INCREDIBLE 4583 02:57:56,000 --> 02:57:56,480 OPPORTUNITY TO MAKE A 4584 02:57:56,480 --> 02:57:57,120 DIFFERENCE AND WE ARE GOING TO 4585 02:57:57,120 --> 02:57:57,760 MAKE EVERY MINUTE COUNT. NEXT 4586 02:57:57,760 --> 02:58:07,880 SLIDE. 4587 02:58:08,960 --> 02:58:09,560 THE NEXT FEW SLIDES I'M GOING 4588 02:58:09,560 --> 02:58:10,160 TO WALK YOU THROUGH WHAT DOES 4589 02:58:10,160 --> 02:58:16,640 THIS MODEL LOOK LIKE? SO RIGHT 4590 02:58:16,640 --> 02:58:17,280 NOW, WITH THE PROGRAM MANAGERS 4591 02:58:17,280 --> 02:58:19,720 ARRIVE BEFORE SOMEBODY COMES ON 4592 02:58:19,720 --> 02:58:20,360 BOARD, WE LIKE TO SAY PROGRAM 4593 02:58:20,360 --> 02:58:22,000 MANAGERS THINK LIKE CEOS AND 4594 02:58:22,000 --> 02:58:23,720 THE COOS OF THE PROGRAM AND 4595 02:58:23,720 --> 02:58:30,720 BECOME TO ARPA-H WITH CLEARLY 4596 02:58:30,720 --> 02:58:31,360 ARTICULATE A PROBLEM IN HEALTHY 4597 02:58:31,360 --> 02:58:31,880 WANT TO SOLVE SO IT IS A 4598 02:58:31,880 --> 02:58:32,520 COMMISSION OF THE TWO THINGS WE 4599 02:58:32,520 --> 02:58:33,120 HIGHER ON. AND THEN BRING A 4600 02:58:33,120 --> 02:58:38,400 PROGRAM MANAGER IN. IT TAKES 4601 02:58:38,400 --> 02:58:39,000 ABOUT THREE OR FOUR MONTHS TO 4602 02:58:39,000 --> 02:58:39,640 WRAP UP A SOLICITATION, TALK TO 4603 02:58:39,640 --> 02:58:40,240 THE STAKEHOLDERS THAT WILL BE 4604 02:58:40,240 --> 02:58:44,800 KEY PLAYERS HERE, AND THEN 4605 02:58:44,800 --> 02:58:49,040 LAUNCH THOSE PROGRAMS, WANT TO 4606 02:58:49,040 --> 02:58:49,640 SOLICITATION HAS A PROPOSALS 4607 02:58:49,640 --> 02:58:50,280 THE PROGRAM MANAGER WILL SELECT 4608 02:58:50,280 --> 02:58:50,880 THE PERFORMERS OR TEAMS THAT 4609 02:58:50,880 --> 02:58:51,520 WILL BE THE SOLVERS TO ADDRESS 4610 02:58:51,520 --> 02:58:52,560 THAT CHALLENGE MOVING FORWARD. 4611 02:58:52,560 --> 02:58:59,200 NEXT SLIDE. 4612 02:58:59,200 --> 02:58:59,800 THIS IS REALLY A MODEL FOR THE 4613 02:58:59,800 --> 02:59:00,400 PROGRAM MANAGER IS A LOT OF 4614 02:59:00,400 --> 02:59:08,640 CONTACT WITH PERFORMERS. THIS 4615 02:59:08,640 --> 02:59:09,200 IS WHY WE DON'T USE A GRANT 4616 02:59:09,200 --> 02:59:09,800 SPACE, ACQUISITION SYSTEM WE 4617 02:59:09,800 --> 02:59:10,400 USE CONTRACTS AND COOPERATIVE 4618 02:59:10,400 --> 02:59:11,000 AGREEMENTS BECAUSE WE HAVE A 4619 02:59:11,000 --> 02:59:12,080 SEAT AT THE TABLE WE WANT ALL 4620 02:59:12,080 --> 02:59:12,680 OF OUR TEAM TO BE SUCCESSFUL 4621 02:59:12,680 --> 02:59:14,160 BUT WE KNOW THERE'S A RISKY 4622 02:59:14,160 --> 02:59:20,080 SOME OF THEM WILL NOT BE 4623 02:59:20,080 --> 02:59:20,720 SUCCESSFUL. BY BEING VERY CLOSE 4624 02:59:20,720 --> 02:59:23,120 TO THE WORK WE CAN IDENTIFY 4625 02:59:23,120 --> 02:59:23,640 THOSE THAT ARE NOT BEEN 4626 02:59:23,640 --> 02:59:24,240 SUCCESSFUL AND WE CAN DOUBLE 4627 02:59:24,240 --> 02:59:24,720 DOWN WE CAN HELP THEM 4628 02:59:24,720 --> 02:59:26,560 ACCELERATE AND GRADUATED FOR 4629 02:59:26,560 --> 02:59:27,160 THOSE EFFORTS THAT MAYBE ARE 4630 02:59:27,160 --> 02:59:34,440 NOT QUITE AS SUCCESSFUL IT IS 4631 02:59:34,440 --> 02:59:35,040 RESPONSIBILITY OF THE PROGRAM 4632 02:59:35,040 --> 02:59:35,600 MANAGER TO PIVOT AND DIVERT 4633 02:59:35,600 --> 02:59:39,000 RESOURCES TO OTHER SOURCES SO 4634 02:59:39,000 --> 02:59:39,520 WE WILL HAVE A VERY WELL 4635 02:59:39,520 --> 02:59:40,160 RESOURCED PROGRAMS BUT WE HAVE 4636 02:59:40,160 --> 02:59:44,920 A GOAL IN MIND. WE ARE GOING 4637 02:59:44,920 --> 02:59:45,440 TO BE REALLY FOCUSED ON 4638 02:59:45,440 --> 02:59:46,000 ACHIEVING THAT GOAL. THESE 4639 02:59:46,000 --> 02:59:46,640 PROGRAM MANAGERS HAVE A REALLY 4640 02:59:46,640 --> 02:59:57,040 IMPORTANT RESPONSIBILITY 4641 02:59:57,880 --> 02:59:58,320 AND BEING A STEWARD OF 4642 02:59:58,320 --> 03:00:06,680 TAXPAYER DOLLARS. 4643 03:00:06,680 --> 03:00:07,240 I WILL TELL YOU TO A LITTLE 4644 03:00:07,240 --> 03:00:07,800 BIT ABOUT THE NEW OFFICE IN 4645 03:00:07,800 --> 03:00:08,440 CAPABILITY THAT WE ARE SETTING 4646 03:00:08,440 --> 03:00:09,080 UP BECAUSE THIS IS SO CRITICAL 4647 03:00:09,080 --> 03:00:13,080 IN CONSCIENCE WITH DARPA, MANY 4648 03:00:13,080 --> 03:00:13,600 OTHER PROGRAMS LIKE THE 4649 03:00:13,600 --> 03:00:17,200 DEPARTMENT OF DEFENSE TO BE IN 4650 03:00:17,200 --> 03:00:17,840 ADVANCED DEVELOPER AND TAKE THE 4651 03:00:17,840 --> 03:00:18,400 CAPABILITIES ALL THE WAY TO 4652 03:00:18,400 --> 03:00:21,920 COMPLETE TECHNOLOGY READINESS. 4653 03:00:21,920 --> 03:00:22,480 THAT DOES NOT EXIST IN THE 4654 03:00:22,480 --> 03:00:23,120 HEALTH SECTOR SO WE REALLY RELY 4655 03:00:23,120 --> 03:00:24,520 SO MUCH ON THE PRIVATE SECTOR 4656 03:00:24,520 --> 03:00:25,040 TO BE ABLE TO HELP US 4657 03:00:25,040 --> 03:00:30,360 TRANSITION PROJECTS. 4658 03:00:30,360 --> 03:00:30,640 AND ON THE 4659 03:00:30,640 --> 03:00:31,200 I WILL WALK YOU THROUGH HOW 4660 03:00:31,200 --> 03:00:31,760 DOES THE PROGRAM MANAGER DO 4661 03:00:31,760 --> 03:00:32,120 THIS? 4662 03:00:32,120 --> 03:00:34,680 AND SO WE HAVE ADOPTED AT 4663 03:00:34,680 --> 03:00:45,160 ARPA-H WHAT ARE CALLED THE 4664 03:00:52,040 --> 03:00:52,640 HEIMEYER QUESTIONS (PHONETIC), 4665 03:00:52,640 --> 03:00:58,680 STARTED BY DIRECTOR HEILMEYER. 4666 03:00:58,680 --> 03:00:59,280 WHAT ARE YOU TRYING TO DO? WHAT 4667 03:00:59,280 --> 03:00:59,800 HEALTH PROBABLY TRYING TO 4668 03:00:59,800 --> 03:01:02,040 SOLVE? WHAT IS A NEW APPROACH? 4669 03:01:02,040 --> 03:01:02,600 WHAT IS THE COMPANY THAT YOU 4670 03:01:02,600 --> 03:01:03,200 KNOW ABOUT THAT YOU KNOW WILL 4671 03:01:03,200 --> 03:01:06,920 BE A GAME CHANGER 4672 03:01:06,920 --> 03:01:07,480 TO REALLY SOLVE THIS PROBLEM 4673 03:01:07,480 --> 03:01:08,040 AND WANT TO GIVE IT A SHOT? 4674 03:01:08,040 --> 03:01:13,480 WHAT ARE THE RISKS? 4675 03:01:13,480 --> 03:01:14,000 WHAT WILL PREVENT US FROM 4676 03:01:14,000 --> 03:01:14,600 REACHING OUR OBJECTIVE? HOW 4677 03:01:14,600 --> 03:01:15,160 LONG WILL IT TAKE? HOW MUCH 4678 03:01:15,160 --> 03:01:16,280 WILL IT COST? AND MOST OF THESE 4679 03:01:16,280 --> 03:01:16,840 PROJECTS THAT WE WILL PURSUE 4680 03:01:16,840 --> 03:01:17,520 PROBABLY WILL HAVE SOMETHING ON 4681 03:01:17,520 --> 03:01:28,000 THE LINE OF 5, 10, 15 YEARS 4682 03:01:28,280 --> 03:01:28,720 UNTIL WE KNOW IF IT IS 4683 03:01:28,720 --> 03:01:29,360 SUCCESSFUL OR NOT MAYBE THAT IS 4684 03:01:29,360 --> 03:01:30,000 HOW LONG IT TAKES TO GET TO THE 4685 03:01:30,000 --> 03:01:30,640 CLINIC AND THAT'S OKAY BECAUSE 4686 03:01:30,640 --> 03:01:31,240 WE NEED TO HAVE MEASURES FOR 4687 03:01:31,240 --> 03:01:31,800 INTERIM SUCCESS, SO WE KNOW 4688 03:01:31,800 --> 03:01:32,400 THAT WE ARE MOVING ALONG AND 4689 03:01:32,400 --> 03:01:35,200 HAVE GO, NO GO DECISIONS AND 4690 03:01:35,200 --> 03:01:36,680 DE-RISKING THIS FOR THE REST OF 4691 03:01:36,680 --> 03:01:38,720 OUR ECOSYSTEM TO TRANSITION TO. 4692 03:01:38,720 --> 03:01:39,280 WE'VE ADDED TWO ADDITIONAL 4693 03:01:39,280 --> 03:01:44,480 QUESTIONS AT ARPA-H. ONE IS TO 4694 03:01:44,480 --> 03:01:45,120 ENSURE EQUITABLE ACCESS FOR ALL 4695 03:01:45,120 --> 03:01:46,560 PEOPLE. 4696 03:01:46,560 --> 03:01:51,080 4697 03:01:51,080 --> 03:01:51,640 EVERY PROGRAM MANAGER BEFORE 4698 03:01:51,640 --> 03:01:52,240 WE GIVE THEM THE BANK ACCOUNT 4699 03:01:52,240 --> 03:01:52,800 HAS TO SHARE HOW THEY WILL 4700 03:01:52,800 --> 03:01:57,760 ADDRESS ACCESSIBILITY, CAUSE 4701 03:01:57,760 --> 03:01:58,360 AND ALSO USER EXPERIENCE. WE 4702 03:01:58,360 --> 03:01:58,880 WANT TO MAKE SURE WE ARE 4703 03:01:58,880 --> 03:01:59,480 CREATING TOOLS THAT CUSTOMERS 4704 03:01:59,480 --> 03:02:00,080 AND PEOPLE WILL LIVED 4705 03:02:00,080 --> 03:02:00,640 EXPERIENCES WILL ACTUALLY 4706 03:02:00,640 --> 03:02:05,960 BENEFIT FROM. 4707 03:02:05,960 --> 03:02:06,480 AND FINALLY HOW MIGHT THIS 4708 03:02:06,480 --> 03:02:13,960 PROGRAM BE MISPERCEIVED OR 4709 03:02:13,960 --> 03:02:14,600 MISUSED? WE KNOW THERE'S A LOT 4710 03:02:14,600 --> 03:02:15,240 OF MISINFORMATION ABOUT HEALTH 4711 03:02:15,240 --> 03:02:15,880 OUT THERE AND WE DO NOT WANT TO 4712 03:02:15,880 --> 03:02:16,520 BE CONTRIBUTING TO THE PROBLEM. 4713 03:02:16,520 --> 03:02:17,160 WE WANT TO THINK PROACTIVELY AT 4714 03:02:17,160 --> 03:02:17,760 THE BEGINNING OF THE PROGRAM TO 4715 03:02:17,760 --> 03:02:22,600 LIMIT THAT IS MUCH AS POSSIBLE. 4716 03:02:22,600 --> 03:02:22,920 AND SO ON THE 4717 03:02:22,920 --> 03:02:23,520 REALLY THE LIFECYCLE. 95% OF 4718 03:02:23,520 --> 03:02:24,160 WHAT THE PROGRAM MANAGERS GOING 4719 03:02:24,160 --> 03:02:30,440 TO DO. 4720 03:02:30,440 --> 03:02:31,040 SOMEWHERE ALONG THE LIFECYCLE 4721 03:02:31,040 --> 03:02:31,640 IF YOU DO START A NEW PROGRAM 4722 03:02:31,640 --> 03:02:32,200 SO YOU WILL HAVE MULTIPLE 4723 03:02:32,200 --> 03:02:32,840 PROGRAMS RUNNING AT ONCE AND IN 4724 03:02:32,840 --> 03:02:33,320 DIFFERENT STAGES OF THE 4725 03:02:33,320 --> 03:02:33,720 LIFECYCLE. 4726 03:02:33,720 --> 03:02:37,680 EVERYTHING FROM DESIGNING A 4727 03:02:37,680 --> 03:02:38,280 PROGRAM, FOR EXAMPLE IF WE HAD 4728 03:02:38,280 --> 03:02:41,560 A PROGRAM IN HIV, 4729 03:02:41,560 --> 03:02:45,160 4730 03:02:45,160 --> 03:02:49,240 4731 03:02:49,240 --> 03:02:49,800 STAKEHOLDERS LIKE YOU MAKING 4732 03:02:49,800 --> 03:02:50,360 SURE WE ARE INCLUDING YOUR 4733 03:02:50,360 --> 03:02:50,960 INSIGHTS AND WHAT IS WORKING 4734 03:02:50,960 --> 03:02:51,480 AND WHAT IS NOT IN THE 4735 03:02:51,480 --> 03:02:52,040 COMMUNITY IF WE HAVE A BIG 4736 03:02:52,040 --> 03:02:52,640 INVESTMENT IN THIS AREA. THIS 4737 03:02:52,640 --> 03:02:53,120 WILL REALLY CHANGE A 4738 03:02:53,120 --> 03:02:53,720 STATE-OF-THE-ART. WE NEED TO 4739 03:02:53,720 --> 03:02:54,360 COLLECT THOSE INSIGHTS ARE AND 4740 03:02:54,360 --> 03:02:54,800 ALSO UNDERSTAND THE 4741 03:02:54,800 --> 03:02:55,400 MARKETPLACE. IS OUR MARKET FOR 4742 03:02:55,400 --> 03:02:57,200 THIS OR NOT? IT'S OKAY IF IT 4743 03:02:57,200 --> 03:02:57,800 ISN'T THAT WE NEED TO SHIP THAT 4744 03:02:57,800 --> 03:03:02,120 MARKET AS WE MOVE FORWARD. 4745 03:03:02,120 --> 03:03:02,560 AND THEN BILLING THE 4746 03:03:02,560 --> 03:03:03,160 PERFORMANCE TEAMS AND PUTTING 4747 03:03:03,160 --> 03:03:03,680 OUT THE SOLICITATION AND 4748 03:03:03,680 --> 03:03:04,240 SELECTED THE TEAM TO DO THE 4749 03:03:04,240 --> 03:03:07,200 WORK. 4750 03:03:07,200 --> 03:03:07,800 AND THEN IT IS ACTIVE PROGRAM 4751 03:03:07,800 --> 03:03:08,400 MANAGER AND BEING THE CEO OF 4752 03:03:08,400 --> 03:03:09,080 THE PROGRAM AND MAKING SURE THE 4753 03:03:09,080 --> 03:03:09,680 TEAMS ARE WORKING TOWARDS THEIR 4754 03:03:09,680 --> 03:03:13,440 GOALS AND HELPING THEM. 4755 03:03:13,440 --> 03:03:13,920 SOMETIMES IT IS MAKING 4756 03:03:13,920 --> 03:03:14,520 INTRODUCTIONS, BRINGING IN NEW 4757 03:03:14,520 --> 03:03:15,920 PLAYERS AS NEEDED. 4758 03:03:15,920 --> 03:03:21,240 LEARNING AND GROWING. 4759 03:03:21,240 --> 03:03:21,840 WE ARE GOING TO FAIL SOMETIMES 4760 03:03:21,840 --> 03:03:22,440 AND IN SOME WAY SUCCESS EARLY 4761 03:03:22,440 --> 03:03:25,960 ON FOR US IS GOING TO LOOK LIKE 4762 03:03:25,960 --> 03:03:26,520 FAILURE BECAUSE YOU'RE NOT 4763 03:03:26,520 --> 03:03:27,120 TAKING BIG ENOUGH RISK BUT WE 4764 03:03:27,120 --> 03:03:27,680 TRANSPARENT IN PUBLIC ABOUT 4765 03:03:27,680 --> 03:03:31,200 THESE FAILURES 4766 03:03:31,200 --> 03:03:31,720 SO THE WHOLE COMMUNITY CAN 4767 03:03:31,720 --> 03:03:32,320 LEARN FROM THEN WE DON'T HAVE 4768 03:03:32,320 --> 03:03:32,920 TO REPEAT THOSE MISTAKES AND 4769 03:03:32,920 --> 03:03:37,080 LEARN FROM THEM. 4770 03:03:37,080 --> 03:03:37,560 AND COMMERCIALIZATION 4771 03:03:37,560 --> 03:03:39,440 TRANSITION. THE PROGRAM 4772 03:03:39,440 --> 03:03:40,040 MEASURES ARE ALSO RESPONSIBLE 4773 03:03:40,040 --> 03:03:40,640 TO MAKE SURE THE PROGRAM CAN 4774 03:03:40,640 --> 03:03:42,280 GRADUATE OUT OF THE AGENCY. 4775 03:03:42,280 --> 03:03:43,000 THE PROGRAM MANAGERS WILL 4776 03:03:43,000 --> 03:03:44,840 BRING THEIR OWN IDEAS 4777 03:03:44,840 --> 03:03:46,160 4778 03:03:46,160 --> 03:03:46,720 OTHER SPECIFIC PROGRAM THAT 4779 03:03:46,720 --> 03:03:47,320 THEY WANT TO FOCUS ON BUT I 4780 03:03:47,320 --> 03:03:48,920 HAVE OUTLINED FOUR INITIAL 4781 03:03:48,920 --> 03:03:55,840 FOCUS AREAS FOR ARPA-H THAT I 4782 03:03:55,840 --> 03:03:56,480 BELIEVE FURTHER INVESTMENT CAN 4783 03:03:56,480 --> 03:03:57,120 CHANGE THE STATE-OF-THE-ART IN 4784 03:03:57,120 --> 03:03:59,240 THE FIELD. 4785 03:03:59,240 --> 03:03:59,840 FIRST IS SELF SCIENCE FEATURES 4786 03:03:59,840 --> 03:04:02,760 EXPANDING WHAT IS TECHNICALLY 4787 03:04:02,760 --> 03:04:03,400 POSSIBLE. THINK HERE ABOUT THE 4788 03:04:03,400 --> 03:04:07,400 TOOLS, TECHNOLOGIES AND 4789 03:04:07,400 --> 03:04:07,920 PLATFORMS. IT IS DISEASE 4790 03:04:07,920 --> 03:04:10,400 AGNOSTIC BUT YOU MADE 4791 03:04:10,400 --> 03:04:10,840 DECIDE TO CREATE A NEW 4792 03:04:10,840 --> 03:04:11,480 CELLULAR MANUFACTURING PROBLEM 4793 03:04:11,480 --> 03:04:12,120 HE WAS SELECTED TEAM FOCUSED ON 4794 03:04:12,120 --> 03:04:14,080 CANCER. 4795 03:04:14,080 --> 03:04:14,680 YOU MAY SELECT OTHER TEAM THAT 4796 03:04:14,680 --> 03:04:15,200 IS FOCUSED ON ALZHEIMER'S 4797 03:04:15,200 --> 03:04:16,360 DISEASE. 4798 03:04:16,360 --> 03:04:16,880 AND HAVE THEM NOT COMPETE 4799 03:04:16,880 --> 03:04:19,160 AGAINST EACH OTHER. WE LIKE TO 4800 03:04:19,160 --> 03:04:23,880 THINK OF COOPETITION, WERE BOTH 4801 03:04:23,880 --> 03:04:24,480 ARE THINKING ON THE SAME GOAL 4802 03:04:24,480 --> 03:04:25,000 BUT ONE WILL ADVANCE THE 4803 03:04:25,000 --> 03:04:32,760 STATE-OF-THE-ART. 4804 03:04:32,760 --> 03:04:33,360 SCALABLE SOLUTIONS IS REACHING 4805 03:04:33,360 --> 03:04:35,400 EVERYONE CRITICALLY, BRINGING A 4806 03:04:35,400 --> 03:04:37,520 NEW THERAPY, AND THE SCALE OF 4807 03:04:37,520 --> 03:04:38,160 REACHING PEOPLE WHERE THEY ARE 4808 03:04:38,160 --> 03:04:38,800 AT BUT YOU HEARD WHEN THE LAST 4809 03:04:38,800 --> 03:04:44,080 TALKS ABOUT RURAL SETTINGS. 4810 03:04:44,080 --> 03:04:46,160 4811 03:04:46,160 --> 03:04:46,760 WEST VIRGINIA IS DIFFICULT TO 4812 03:04:46,760 --> 03:04:47,400 REACH PATIENTS AND WHAT ARE THE 4813 03:04:47,400 --> 03:04:48,000 NEW CAPABILITIES TO REACH THE 4814 03:04:48,000 --> 03:04:48,600 SCALE OF EVERYONE WHERE THEY 4815 03:04:48,600 --> 03:04:48,960 ARE AT? 4816 03:04:48,960 --> 03:04:49,480 THAT ARE MEANT TO BE THE 4817 03:04:49,480 --> 03:04:55,440 CUSTOMERS OF THESE PROGRAMS? 4818 03:04:55,440 --> 03:04:56,000 CO-ACTIVE HEALTH AND KEEPING 4819 03:04:56,000 --> 03:05:06,480 PATIENTS IN PLACE. AND THE 4820 03:05:07,920 --> 03:05:08,440 DETECTION PROBLEMS THAT WILL 4821 03:05:08,440 --> 03:05:09,000 CONTRIBUTE TO THIS GOAL AND 4822 03:05:09,000 --> 03:05:13,800 FINALLY RESILIENT SYSTEMS. AND 4823 03:05:13,800 --> 03:05:14,280 HOW TO CREATE A GREATER 4824 03:05:14,280 --> 03:05:14,840 CAPABILITY WHERE THE SUM IS 4825 03:05:14,840 --> 03:05:17,280 MORE IMPACTFUL THAN THE PARTS. 4826 03:05:17,280 --> 03:05:17,840 THIS IS ALSO THE PLACE WHERE 4827 03:05:17,840 --> 03:05:18,440 THERE ARE MANY LOW HANGING 4828 03:05:18,440 --> 03:05:21,480 FRUIT, 4829 03:05:21,480 --> 03:05:22,040 DIGITAL SOLUTIONS IF WE CAN 4830 03:05:22,040 --> 03:05:24,480 GET SOME OF THOSE 4831 03:05:24,480 --> 03:05:25,000 TO BE ABLE TO SPEAK TO ONE 4832 03:05:25,000 --> 03:05:25,640 ANOTHER AND SHARE DATA AND MAKE 4833 03:05:25,640 --> 03:05:26,280 IT MACHINE-READABLE 4834 03:05:26,280 --> 03:05:27,200 WE CAN REALLY IMPROVE CARE FOR 4835 03:05:27,200 --> 03:05:30,320 PATIENTS. NEXT SLIDE. 4836 03:05:30,320 --> 03:05:37,160 THIS IS REALLY UNIQUE TO ANY 4837 03:05:37,160 --> 03:05:39,400 ARPA, 4838 03:05:39,400 --> 03:05:40,000 WE ARE THE FIRST ONE WITH THE 4839 03:05:40,000 --> 03:05:40,440 PROJECT ACCELERATED 4840 03:05:40,440 --> 03:05:41,040 TRANSITIONAL OFFICE AND WE DO 4841 03:05:41,040 --> 03:05:41,640 NOT HAVE ADVANCED DEVELOPERS 4842 03:05:41,640 --> 03:05:42,320 AND THE FEDERAL GOVERNMENT 4843 03:05:42,320 --> 03:05:43,040 FOR MOST THINGS COMING OUT OF 4844 03:05:43,040 --> 03:05:44,800 AN ARPA, SO THAT MEANS WE START 4845 03:05:44,800 --> 03:05:46,720 TO PRIME THE PUMP 4846 03:05:46,720 --> 03:05:49,320 4847 03:05:49,320 --> 03:05:53,760 4848 03:05:53,760 --> 03:05:54,360 FOR TRANSITION RIGHT FROM THE 4849 03:05:54,360 --> 03:05:54,880 BEGINNING OF THE PROGRAM. 4850 03:05:54,880 --> 03:05:55,520 UNDERSTANDING HOW DO WE DESIGN 4851 03:05:55,520 --> 03:05:56,080 THESE PROGRAMS IF SOMEBODY 4852 03:05:56,080 --> 03:05:56,680 WANTS TO USE THE TOOL TO THE 4853 03:05:56,680 --> 03:05:57,520 BACK END OF THE PROGRAM, 4854 03:05:57,520 --> 03:05:58,120 ACCESSING THE MARKETS AND MAKE 4855 03:05:58,120 --> 03:05:58,760 SURE WE HAVE SOLICITATION THAT 4856 03:05:58,760 --> 03:06:01,120 IS RELEASED SUCH AS A BAA, TO 4857 03:06:01,120 --> 03:06:01,720 IDENTIFY PEOPLE WHO MIGHT WANT 4858 03:06:01,720 --> 03:06:03,800 TO BE FUNDED BY ARPA-H. 4859 03:06:03,800 --> 03:06:04,880 NOT EVERYBODY KNOWS ABOUT 4860 03:06:04,880 --> 03:06:10,560 ARPA-H YET. SO IT IS A GOOD 4861 03:06:10,560 --> 03:06:11,200 GROUP TO BE HERE TODAY TO SHARE 4862 03:06:11,200 --> 03:06:11,760 A LITTLE BIT MORE ABOUT OUR 4863 03:06:11,760 --> 03:06:14,520 ORGANIZATION. 4864 03:06:14,520 --> 03:06:15,120 WE NEED TO MAKE SURE WE HAVE A 4865 03:06:15,120 --> 03:06:15,720 BROAD REACHING WE DO NOT MISS 4866 03:06:15,720 --> 03:06:16,360 THE OPPORTUNITY TO WORK WITH A 4867 03:06:16,360 --> 03:06:16,680 GROUP 4868 03:06:16,680 --> 03:06:17,200 THAT MIGHT HAVE A REALLY 4869 03:06:17,200 --> 03:06:22,520 UNIQUE SOLUTION. 4870 03:06:22,520 --> 03:06:23,120 AND WE ARE GOING TO DO VENTURE 4871 03:06:23,120 --> 03:06:23,680 CAPITAL STYLE DUE DILIGENCE 4872 03:06:23,680 --> 03:06:26,440 WHETHER TECHNICAL DILIGENCE, 4873 03:06:26,440 --> 03:06:27,080 MANAGEMENT DILIGENCE AND WE ARE 4874 03:06:27,080 --> 03:06:27,720 GOING TO LEAN ON THIS OFFICE TO 4875 03:06:27,720 --> 03:06:31,920 HELP US DO THAT. 4876 03:06:31,920 --> 03:06:32,440 WE KNOW THAT IS GOING TO 4877 03:06:32,440 --> 03:06:33,080 HAPPEN AT THE BACK END OF THESE 4878 03:06:33,080 --> 03:06:33,720 PROGRAMS ANYWAY SO WE MIGHT AS 4879 03:06:33,720 --> 03:06:37,040 WELL BE HELPING THESE TEAMS 4880 03:06:37,040 --> 03:06:37,600 FROM THE VERY BEGINNING AND 4881 03:06:37,600 --> 03:06:38,240 THEN WE WILL ASSESS PERFORMANC, 4882 03:06:38,240 --> 03:06:44,600 UNDERSTAND MVPS BEFORE WE 4883 03:06:44,600 --> 03:06:45,240 ITERATE IN THE WRITTEN SESSION 4884 03:06:45,240 --> 03:06:45,840 WILL START TO ADOPT A LOT OF 4885 03:06:45,840 --> 03:06:46,480 THE OTHER TOOLS IN THE FEDERAL 4886 03:06:46,480 --> 03:06:49,040 TOOLKIT LIKE THE SBARS, ETC., 4887 03:06:49,040 --> 03:06:56,280 AS WE MOVE FORWARD. 4888 03:06:56,280 --> 03:06:59,600 SO WE ARE STILL FAIRLY EARLY 4889 03:06:59,600 --> 03:07:00,200 DAY. I WOULD LIKE TO HIRE 20 4890 03:07:00,200 --> 03:07:00,840 PROGRAM MANAGERS THIS YEAR AS I 4891 03:07:00,840 --> 03:07:01,480 MENTIONED AND WE WILL START TO 4892 03:07:01,480 --> 03:07:02,080 SEE THE FIRST PROGRAM MANAGERS 4893 03:07:02,080 --> 03:07:02,720 COMING ON IN THE NEXT FEW WEEKS 4894 03:07:02,720 --> 03:07:03,360 AND AT WHAT I WOULD ASK YOU AND 4895 03:07:03,360 --> 03:07:04,560 YOUR COMMUNITY, IF YOU ARE 4896 03:07:04,560 --> 03:07:05,160 REALLY PASSIONATE ABOUT WHAT 4897 03:07:05,160 --> 03:07:06,480 YOU DO AND YOU WANT TO SEE 4898 03:07:06,480 --> 03:07:11,640 ARPA-H WORKING IN THE FIELD, 4899 03:07:11,640 --> 03:07:12,200 THE BEST THING YOU CAN DO IS 4900 03:07:12,200 --> 03:07:12,800 THINK ABOUT ONE OR TWO PEOPLE 4901 03:07:12,800 --> 03:07:13,400 IN YOUR NETWORK-- OR MAYBE IT 4902 03:07:13,400 --> 03:07:16,200 IS YOU-- THAT WANT TO COME ON 4903 03:07:16,200 --> 03:07:16,760 AND BE A CHAMPION FOR THIS 4904 03:07:16,760 --> 03:07:17,360 EFFORT AND SOLVE ONE OF THESE 4905 03:07:17,360 --> 03:07:18,160 BIG PROBLEMS. 4906 03:07:18,160 --> 03:07:21,480 SO THESE ARE THE PROGRAM 4907 03:07:21,480 --> 03:07:22,120 MANAGERS. THEY THINK LIKE CEOS 4908 03:07:22,120 --> 03:07:24,600 AND THEY ARE DECISIVE. THERE IS 4909 03:07:24,600 --> 03:07:25,200 AN URGENCY TO THE PROBLEMS THEY 4910 03:07:25,200 --> 03:07:26,360 NEED TO SOLVE AND NOT AFRAID TO 4911 03:07:26,360 --> 03:07:27,840 FAIL. THEY ARE VERY CUSTOMER 4912 03:07:27,840 --> 03:07:28,440 CENTRIC. THEY KNOW THE PROGRAMS 4913 03:07:28,440 --> 03:07:32,840 BELONG TO ARPA-H AND THEY WANT 4914 03:07:32,840 --> 03:07:33,400 TO GET IT OUT THERE TO THE 4915 03:07:33,400 --> 03:07:34,440 AMERICAN PEOPLE AND THIS COULD 4916 03:07:34,440 --> 03:07:34,960 BE FOLKS IN ALL DIFFERENT 4917 03:07:34,960 --> 03:07:36,680 STAGES OF THEIR CAREERS. IT 4918 03:07:36,680 --> 03:07:40,240 COULD BE EARLY-STAGE AND 4919 03:07:40,240 --> 03:07:40,880 UNBIASED, FRESH WITH IDEAS AND 4920 03:07:40,880 --> 03:07:41,520 MAYBE MORE MIDDLE CAREER STATUS 4921 03:07:41,520 --> 03:07:46,760 QUO CHALLENGER. THIS WAS ME. I 4922 03:07:46,760 --> 03:07:47,400 HAD A BLOCKER, AND SOME OF THE 4923 03:07:47,400 --> 03:07:47,960 WORK THAT I WAS DOING AND I 4924 03:07:47,960 --> 03:07:54,640 CAME TO ARPA-H TO GET A BIG 4925 03:07:54,640 --> 03:07:55,280 BANK ACCOUNT TO TRY TO UNBLOCK 4926 03:07:55,280 --> 03:07:55,920 AT WHICH WE WERE ABLE TO DO FOR 4927 03:07:55,920 --> 03:07:56,840 SAFER, MOST EFFECTIVE GENETIC 4928 03:07:56,840 --> 03:08:00,920 TECHNOLOGIES. 4929 03:08:00,920 --> 03:08:01,480 AND THEN THE CAREER FOLKS WHO 4930 03:08:01,480 --> 03:08:04,280 ARE NOT AFRAID TO TAKE RISKS. 4931 03:08:04,280 --> 03:08:04,880 THIS MIGHT BE THE LAST STOP IN 4932 03:08:04,880 --> 03:08:09,520 GOVERNMENT BEFORE THE RETIRE. 4933 03:08:09,520 --> 03:08:10,120 SO THIS IS A GREAT WAY TO HAVE 4934 03:08:10,120 --> 03:08:10,760 SOMEONE WHO REALLY UNDERSTANDS 4935 03:08:10,760 --> 03:08:11,360 THE PROBLEM AND TRY TO SOLVE 4936 03:08:11,360 --> 03:08:15,480 IT. NEXT SLIDE. 4937 03:08:15,480 --> 03:08:16,080 A COUPLE OF QUICK THINGS ABOUT 4938 03:08:16,080 --> 03:08:19,040 BECOMING A PROGRAM MANAGER. 4939 03:08:19,040 --> 03:08:21,760 I MENTIONED THAT IT IS A TERM 4940 03:08:21,760 --> 03:08:22,360 APPOINTMENT, THREE YEARS WITH 4941 03:08:22,360 --> 03:08:22,960 AN ADDITIONAL THREE YEARS AND 4942 03:08:22,960 --> 03:08:24,600 CAN OFFER COMPETITIVE SALARY. 4943 03:08:24,600 --> 03:08:25,200 IT CAN BE A DIRECT GOVERNMENT 4944 03:08:25,200 --> 03:08:26,360 HIGHER OR WHAT IS CALLED AN 4945 03:08:26,360 --> 03:08:30,560 IPA, SO WE CAN BRING FOLKS ON 4946 03:08:30,560 --> 03:08:31,200 LOAN FROM A UNIVERSITY SO THEY 4947 03:08:31,200 --> 03:08:32,600 DO NOT LOSE THERE'S LOTS. 4948 03:08:32,600 --> 03:08:37,120 BUT THEY WILL BE EMPLOYED FOR 4949 03:08:37,120 --> 03:08:37,720 ARPA-H DURING THEIR TIME HERE 4950 03:08:37,720 --> 03:08:38,240 AND THAT IS IMPORTANT TO 4951 03:08:38,240 --> 03:08:41,880 UNDERSTAND 4952 03:08:41,880 --> 03:08:42,480 THE APPLICATION PROCESS. IS 4953 03:08:42,480 --> 03:08:43,320 PRETTY SIMPLE BUT IT IS INTENSE. 4954 03:08:43,320 --> 03:08:44,880 IT STARTS WITH MAKING CONTACT, 4955 03:08:44,880 --> 03:08:49,920 A COVER LETTER, CV, BUT THE BIG 4956 03:08:49,920 --> 03:08:50,560 PROBLEM HELP THAT YOU WANT TO 4957 03:08:50,560 --> 03:08:52,840 SOLVE ARTICULATED THROUGH THE 4958 03:08:52,840 --> 03:08:53,440 QUESTIONS AND WE WILL HAVE A 4959 03:08:53,440 --> 03:08:55,480 CONVERSATION WITH YOU. 4960 03:08:55,480 --> 03:08:56,080 LEARN A LITTLE BIT MORE ABOUT 4961 03:08:56,080 --> 03:08:56,880 YOU AND WHAT YOU WOULD WANT TO 4962 03:08:56,880 --> 03:08:58,440 COME TO ARPA-H AND THE CONCEPT 4963 03:08:58,440 --> 03:09:01,760 THAT YOU WANT TO PURSUE. 4964 03:09:01,760 --> 03:09:02,360 AND THAT IF IT IS LOOKING GOOD 4965 03:09:02,360 --> 03:09:08,640 WE WILL HELP YOU SHAPE THE IDEA 4966 03:09:08,640 --> 03:09:10,960 AND THEN 4967 03:09:10,960 --> 03:09:11,560 HELP YOU PITCH THE CONCEPT OF 4968 03:09:11,560 --> 03:09:12,160 YOUR SELECTED INDIVIDUAL HAVE 4969 03:09:12,160 --> 03:09:16,120 ABOUT 3 TO 4 MONTHS 4970 03:09:16,120 --> 03:09:16,680 TO LAUNCH THE PROGRAM AND 4971 03:09:16,680 --> 03:09:17,280 START WORKING IN EARNEST ON THE 4972 03:09:17,280 --> 03:09:17,920 EFFORT WITH THE TEAMS THAT THEY 4973 03:09:17,920 --> 03:09:18,280 FUND. 4974 03:09:18,280 --> 03:09:23,320 LAST, I WANT TO SAY THAT FOR 4975 03:09:23,320 --> 03:09:27,360 A SUCCESS IS REAL WORLD IMPACT. 4976 03:09:27,360 --> 03:09:34,280 WE WANT REAL PEOPLE TO 4977 03:09:34,280 --> 03:09:34,800 WANT TO USE THE TOOLS AND 4978 03:09:34,800 --> 03:09:35,400 ENTHUSIASTICALLY ADOPT THEM. 4979 03:09:35,400 --> 03:09:36,040 AND SHOW PROOF OF CONCEPT OR WE 4980 03:09:36,040 --> 03:09:37,000 CAN TAKE SOMETHING THAT SEEMED 4981 03:09:37,000 --> 03:09:37,600 IMPOSSIBLE, AND SHOW THEY CAN 4982 03:09:37,600 --> 03:09:38,200 ACTUALLY BE DONE AND TO DO THIS 4983 03:09:38,200 --> 03:09:43,480 AGAIN IN AN EQUITABLE WAY FOR 4984 03:09:43,480 --> 03:09:44,040 OTHER COMMUNITIES THAT NEED 4985 03:09:44,040 --> 03:09:44,640 THEM AND THE BEST VEHICLES TO 4986 03:09:44,640 --> 03:09:46,560 NEW THEM OTHER COOPERATIVE 4987 03:09:46,560 --> 03:09:47,120 AGREEMENTS, CONTEXT ANOTHER 4988 03:09:47,120 --> 03:09:48,680 TRANSACTIONAL AUTHORITIES. 4989 03:09:48,680 --> 03:09:49,120 SO A QUICK LOOK AT THE 4990 03:09:49,120 --> 03:09:52,480 MILESTONES THAT WE PICKED. WE 4991 03:09:52,480 --> 03:10:02,880 ARE REALLY A STARTUP. 4992 03:10:08,640 --> 03:10:09,240 AS A STARTUP, WE LAUNCHED OUR 4993 03:10:09,240 --> 03:10:13,720 WEBSITE ABOUT A MONTH AGO, 4994 03:10:13,720 --> 03:10:14,280 THE FIRST PROGRAMS WILL COME 4995 03:10:14,280 --> 03:10:14,920 UP THIS SUMMER AND WE BUILT THE 4996 03:10:14,920 --> 03:10:15,520 BUSINESS OF THE HOUSE WE ARE 4997 03:10:15,520 --> 03:10:16,160 EXCITED TO HAVE THE CONTRACTOR 4998 03:10:16,160 --> 03:10:19,040 TEAM AND THE OTHER COMPONENTS 4999 03:10:19,040 --> 03:10:19,600 THAT NEED TO BE IN PLACE A 5000 03:10:19,600 --> 03:10:20,080 PROGRAM MANAGERS TO BE 5001 03:10:20,080 --> 03:10:20,680 SUCCESSFUL AND WE HAVE OUR 5002 03:10:20,680 --> 03:10:26,800 FIRST SOLICITATIONS OUT FOR 5003 03:10:26,800 --> 03:10:27,400 SOME OF THE PATTY OFFICE AND 5004 03:10:27,400 --> 03:10:27,840 THE PARTNERSHIP AND 5005 03:10:27,840 --> 03:10:28,400 INTERMEDIARY AGREEMENT FOR 5006 03:10:28,400 --> 03:10:33,920 TRANSITION AND TRANSITION 5007 03:10:33,920 --> 03:10:34,520 PROGRAM MANAGERS ON BOARD SO 5008 03:10:34,520 --> 03:10:35,160 SERIOUSLY TO TAKE THAT. I SPENT 5009 03:10:35,160 --> 03:10:38,560 A LOT OF MY TIME IN THE FIRST 5010 03:10:38,560 --> 03:10:42,760 THREE MONTHS WITH CONGRESS, 5011 03:10:42,760 --> 03:10:43,360 ENJOYING BIPARTISAN SUPPORT IN 5012 03:10:43,360 --> 03:10:44,000 EVERYBODY IS TOUCHED BY HEALTH 5013 03:10:44,000 --> 03:10:44,600 AND FRUSTRATED ABOUT HOW LONG 5014 03:10:44,600 --> 03:10:45,120 IT TAKES TO GET SOLUTIONS 5015 03:10:45,120 --> 03:10:47,920 FORWARD. 5016 03:10:47,920 --> 03:10:48,520 THEY REALLY WANT TO HELP US BE 5017 03:10:48,520 --> 03:10:51,160 SUCCESSFUL AND WE WERE THRILLED 5018 03:10:51,160 --> 03:10:51,760 BY THE AUTHORITY THEY GAVE US 5019 03:10:51,760 --> 03:10:54,800 TO HELP US DO THAT. 5020 03:10:54,800 --> 03:10:55,360 THIS IS A PICTURE OF MYSELF 5021 03:10:55,360 --> 03:10:58,000 AND THE FDA COMMISSIONER, WE 5022 03:10:58,000 --> 03:11:02,200 WERE AT J.P. MORGAN EARLIER 5023 03:11:02,200 --> 03:11:02,840 THIS YEAR WE WERE TALKING ABOUT 5024 03:11:02,840 --> 03:11:03,480 ONE OF THE SPECIAL SUPERPOWERS 5025 03:11:03,480 --> 03:11:07,360 THAT ARPA-H THROUGH OUR 5026 03:11:07,360 --> 03:11:09,760 AUTHORITY IS WE CAN 5027 03:11:09,760 --> 03:11:10,360 DIRECTLY REIMBURSE THE FDA FOR 5028 03:11:10,360 --> 03:11:15,880 SERVICES PROVIDED 5029 03:11:15,880 --> 03:11:16,400 AND THERE'S NOT A LOT OF 5030 03:11:16,400 --> 03:11:17,920 GUIDANCE BEYOND THAT. 5031 03:11:17,920 --> 03:11:18,400 HOW CAN WE USE THIS TO 5032 03:11:18,400 --> 03:11:19,880 INCENTIVIZE INDUSTRY TO WORK 5033 03:11:19,880 --> 03:11:24,040 WITH ARPA-H? 5034 03:11:24,040 --> 03:11:24,600 THIS IS SOMETHING WE KNOW IS 5035 03:11:24,600 --> 03:11:25,200 GOING TO BE REALLY ATTRACTIVE 5036 03:11:25,200 --> 03:11:31,840 TO HAVE INDUSTRY 5037 03:11:31,840 --> 03:11:32,400 WORK WITH US SO MORE TO COME 5038 03:11:32,400 --> 03:11:33,000 THERE BUT WOULD LOVE TO HEAR 5039 03:11:33,000 --> 03:11:33,600 YOUR THOUGHTS AND SOME OF THE 5040 03:11:33,600 --> 03:11:34,200 REVELATORY CHALLENGES YOU ARE 5041 03:11:34,200 --> 03:11:35,440 FACING AS WELL. 5042 03:11:35,440 --> 03:11:36,000 WITH THAT I AM HAPPY TO STOP 5043 03:11:36,000 --> 03:11:38,880 AND TAKE ANY QUESTIONS 5044 03:11:38,880 --> 03:11:39,480 FROM THIS GROUP I THINK I HAVE 5045 03:11:39,480 --> 03:11:43,640 ABOUT FIVE MINUTES REMAINING. 5046 03:11:43,640 --> 03:11:44,200 THANK YOU AGAIN FOR THE TIME 5047 03:11:44,200 --> 03:11:44,800 AND REALLY IS AN HONOR TO BE 5048 03:11:44,800 --> 03:11:45,520 ABLE TO PRESENT THIS GROUP. 5049 03:11:45,520 --> 03:11:51,280 >>CHAIR TOLBERT: THANK YOU DR. 5050 03:11:51,280 --> 03:11:53,040 WEGRZYN FOR AN EXCITING 5051 03:11:53,040 --> 03:11:54,360 PRESENTATION, AND YOUR 5052 03:11:54,360 --> 03:11:56,560 ENTHUSIASM FOR ARPA-H REALLY 5053 03:11:56,560 --> 03:12:01,800 POURED OUT. APPRECIATE THAT. 5054 03:12:01,800 --> 03:12:02,400 ACTUALLY I WANTED TO MAYBE GET 5055 03:12:02,400 --> 03:12:06,400 A LEAD IN QUESTION. IT KIND OF 5056 03:12:06,400 --> 03:12:09,400 RELATES TO THIS ORGANIZATION 5057 03:12:09,400 --> 03:12:10,040 MODEL THAT YOU PUT IN PLACE FOR 5058 03:12:10,040 --> 03:12:10,720 THE PROGRAM MANAGERS, AND THE 5059 03:12:10,720 --> 03:12:13,600 TURN OVER. AND WE HEARD 5060 03:12:13,600 --> 03:12:19,200 EARLIER IN OUR CONVERSATION 5061 03:12:19,200 --> 03:12:19,800 TODAY ABOUT THE IMPORTANCE OF 5062 03:12:19,800 --> 03:12:20,320 INCLUSION AND COMMUNITY 5063 03:12:20,320 --> 03:12:21,960 ENGAGEMENT. THE QUESTION IS 5064 03:12:21,960 --> 03:12:27,680 HOW DO YOU BALANCE EQUITY, 5065 03:12:27,680 --> 03:12:32,160 INCLUSION, WITH HIGH RISK 5066 03:12:32,160 --> 03:12:32,760 PROJECTS, AND PROGRAM MANAGER 5067 03:12:32,760 --> 03:12:37,880 FOR TURNOVER FREQUENTLY? 5068 03:12:37,880 --> 03:12:48,280 >>REALLY, I SHARED THAT WE 5069 03:12:48,280 --> 03:12:48,920 WON'T GIVE A PROGRAM MANAGER A 5070 03:12:48,920 --> 03:12:49,520 BANK ACCOUNT TO HAVE A CLEAR 5071 03:12:49,520 --> 03:12:52,760 PLAN ON HOW THEY WILL ADDRESS 5072 03:12:52,760 --> 03:12:53,360 THAT. WHEN A PROGRAM MANAGER 5073 03:12:53,360 --> 03:12:53,800 MAKES A BROAD AGENCY 5074 03:12:53,800 --> 03:12:55,440 ANNOUNCEMENT IT WOULD MAKE 5075 03:12:55,440 --> 03:12:56,080 INSTRUCTION TO THE TEAM THAT WE 5076 03:12:56,080 --> 03:13:02,400 WILL NOT FUND YOU AS YOU 5077 03:13:02,400 --> 03:13:02,960 PROPOSE, SAY CLINICAL TRIAL 5078 03:13:02,960 --> 03:13:03,480 THAT IS EXEMPLARY OF THE 5079 03:13:03,480 --> 03:13:04,000 POPULATION THAT IS MOST 5080 03:13:04,000 --> 03:13:06,520 IMPACTED BY THIS DISEASE. HOW 5081 03:13:06,520 --> 03:13:07,160 WILL YOU DO THAT? SO BRING THAT 5082 03:13:07,160 --> 03:13:11,280 TO THE SOLVERS. WE LOOK FOR 5083 03:13:11,280 --> 03:13:11,880 CREATIVE SOLUTIONS FROM THOSE 5084 03:13:11,880 --> 03:13:12,440 COMMITTEES THAT WE CAN MAKE 5085 03:13:12,440 --> 03:13:14,760 THAT AS A REAL GUIDELINE. 5086 03:13:14,760 --> 03:13:15,360 YOU WILL NOT GET THIS FUNDING 5087 03:13:15,360 --> 03:13:15,920 UNLESS YOU ACTUALLY ADDRESS 5088 03:13:15,920 --> 03:13:18,600 THIS CRITERIA. THAT IS 5089 03:13:18,600 --> 03:13:19,240 SOMETHING WE ARE TAKING REALLY 5090 03:13:19,240 --> 03:13:19,920 SERIOUSLY AS PART OF THIS. 5091 03:13:19,920 --> 03:13:29,360 >>CHAIR TOLBERT: THANK YOU. 5092 03:13:29,360 --> 03:13:29,960 >> THANK YOU FOR THAT THAT IS 5093 03:13:29,960 --> 03:13:30,600 AN EXCITING INITIATIVE AND ALL 5094 03:13:30,600 --> 03:13:31,200 OF US ARE LOOKING FORWARD TO 5095 03:13:31,200 --> 03:13:31,920 HELPING YOU SUCCEED ANYWAY WE 5096 03:13:31,920 --> 03:13:39,840 CAN. I WANTED TO GET YOUR 5097 03:13:39,840 --> 03:13:40,600 THOUGHTS TO WHAT YOU THINK ARE 5098 03:13:40,600 --> 03:13:47,760 ACHIEVABLE TRANSFORMATIONAL 5099 03:13:47,760 --> 03:13:48,400 GOALS IN A LESS THAN THREE YEAR 5100 03:13:48,400 --> 03:13:48,920 TIMELINE FOR MY MEDICAL 5101 03:13:48,920 --> 03:13:49,520 PROBLEMS THAT HAVE A 10 OR 15 5102 03:13:49,520 --> 03:13:55,480 YEAR TIMELINE? WHEN IT COMES 5103 03:13:55,480 --> 03:13:56,080 TO DESIGNING A NEW CHIP OR A 5104 03:13:56,080 --> 03:13:58,760 NEW TECHNOLOGY A LOT OF THE 5105 03:13:58,760 --> 03:14:01,640 ADVANCES CAN BE CATEGORICAL. 5106 03:14:01,640 --> 03:14:02,200 YOU JUST BROKE THROUGH THE 5107 03:14:02,200 --> 03:14:04,960 BARRIER AND WHEN IT COMES TO 5108 03:14:04,960 --> 03:14:08,840 BIOLOGY, IS MORE SORT OF NOT AS 5109 03:14:08,840 --> 03:14:09,480 CLEAR WHAT THE 10 YEAR TIMELINE 5110 03:14:09,480 --> 03:14:13,320 WOULD BE. YOU MAKE THESE 5111 03:14:13,320 --> 03:14:13,920 INFERENCES ABOUT THE IMPACT. 5112 03:14:13,920 --> 03:14:17,560 AND STUDY SECTIONS AS YOU KNOW 5113 03:14:17,560 --> 03:14:19,280 , KIND OF TAKE YOU AT YOUR 5114 03:14:19,280 --> 03:14:19,800 WORD THAT THIS IS WORTH 5115 03:14:19,800 --> 03:14:20,400 ADDRESSING SO WE ARE GOING TO 5116 03:14:20,400 --> 03:14:20,920 GIVE YOU THE OPPORTUNITY 5117 03:14:20,920 --> 03:14:27,080 BECAUSE WE ALL SAY IN THE 5118 03:14:27,080 --> 03:14:27,720 GRANTS THAT WE WILL ADVANCE TO 5119 03:14:27,720 --> 03:14:28,360 CURE OR TRANSFORM HEALTH AND DO 5120 03:14:28,360 --> 03:14:29,960 ALL THE THINGS THAT LONG-TERM 5121 03:14:29,960 --> 03:14:30,520 OBJECTIVES THAT COULD BE 5122 03:14:30,520 --> 03:14:34,760 REPHRASED SUCH AS ARPA-H. HI DO 5123 03:14:34,760 --> 03:14:35,400 YOU DEFINE THE FOR THE PROGRAM 5124 03:14:35,400 --> 03:14:38,360 OFFICER? 5125 03:14:38,360 --> 03:14:38,960 IF PROGRAM OFFICERS ARE MAKING 5126 03:14:38,960 --> 03:14:39,560 THAT DETERMINATION, THE OTHER 5127 03:14:39,560 --> 03:14:41,760 ONES BASED 5128 03:14:41,760 --> 03:14:42,360 IN THE NETWORK INCLUDE THE CAN 5129 03:14:42,360 --> 03:14:43,960 APPROACH AND REACH OUT TO. 5130 03:14:43,960 --> 03:14:49,360 AND THAT IT IS TIED TO THE 5131 03:14:49,360 --> 03:14:49,880 NETWORK ITSELF AND SO I'M 5132 03:14:49,880 --> 03:14:51,400 TRYING TO RECONCILE HOW YOU, 5133 03:14:51,400 --> 03:14:55,920 WHAT YOUR THOUGHTS ARE. 5134 03:14:55,920 --> 03:15:01,960 >>SO WE ARE NOT RESTRICTED TO 5135 03:15:01,960 --> 03:15:02,480 ANY KIND OF TECHNOLOGY 5136 03:15:02,480 --> 03:15:03,080 READINESS LEVEL SO IT CAN BE 5137 03:15:03,080 --> 03:15:08,560 ANYTHING, 1 THROUGH 9. 1 IS 5138 03:15:08,560 --> 03:15:12,080 PRUITT THE BENCHTOP AND 9 IS 5139 03:15:12,080 --> 03:15:15,600 GET THIS ON THE SHELF AT CVS. 5140 03:15:15,600 --> 03:15:16,200 WE CAN FIND ANYTHING IN THAT 5141 03:15:16,200 --> 03:15:16,760 SPECTRUM AND WHAT IS REALLY 5142 03:15:16,760 --> 03:15:17,680 IMPORTANT I THINK, SOMETIMES TO 5143 03:15:17,680 --> 03:15:28,200 GET FROM 1 TO 9 WILL TAKE 15 5144 03:15:30,920 --> 03:15:31,480 YEARS AND THAT THREE YEARS THAT 5145 03:15:31,480 --> 03:15:36,560 I TALKED ABOUT WILL BE 15 YEARS 5146 03:15:36,560 --> 03:15:37,160 BUT IT DOES NOT MEAN THAT EVERY 5147 03:15:37,160 --> 03:15:37,760 PERSON HAS TO END AT THE VERY 5148 03:15:37,760 --> 03:15:40,880 HIGH TECHNOLOGY LEVEL. AS AN 5149 03:15:40,880 --> 03:15:42,880 EXAMPLE WHAT ARE THE PROGRAMS 5150 03:15:42,880 --> 03:15:43,480 AT DARPA STARTED FOR YOU CAN 5151 03:15:43,480 --> 03:15:50,040 FERMENT A MOLECULE TO MAKE IN 5152 03:15:50,040 --> 03:15:50,600 MEDICINE. IT TOOK ABOUT TWO 5153 03:15:50,600 --> 03:15:51,240 YEARS TO DO THAT EVERY TIME WE 5154 03:15:51,240 --> 03:15:51,840 SAID DO IT A THOUSAND TIMES AND 5155 03:15:51,840 --> 03:15:54,680 WE KNOW YOU CAN'T DO THAT WITH 5156 03:15:54,680 --> 03:15:55,280 FORCE, HAVE TO FUNDAMENTALLY 5157 03:15:55,280 --> 03:15:55,840 CHANGE YOU DO THAT AND WE 5158 03:15:55,840 --> 03:15:56,440 PROVED THAT WAS POSSIBLE AND 5159 03:15:56,440 --> 03:16:03,080 INDUSTRY PICKED IT UP. IT IS 5160 03:16:03,080 --> 03:16:03,720 NOT MEANT TO FUND THE ENTIRE 15 5161 03:16:03,720 --> 03:16:04,320 YEARS. IT IS MEANT TO FUND THE 5162 03:16:04,320 --> 03:16:07,040 SPARK. 5163 03:16:07,040 --> 03:16:07,640 WHEN I WAS AT DARPA I WAS PART 5164 03:16:07,640 --> 03:16:15,360 OF THE TEAM THAT FOUNDED 5165 03:16:15,360 --> 03:16:15,960 MODERNA WHEN THERE WERE FOUR 5166 03:16:15,960 --> 03:16:19,520 PEOPLE. AND THEN IT WAS LEFT 5167 03:16:19,520 --> 03:16:23,560 UP TO THE REST OF -- AND HERE 5168 03:16:23,560 --> 03:16:29,880 WE ARE 10 YEARS LATER, AND I 5169 03:16:29,880 --> 03:16:30,480 WOULD ARGUE MOST OF US HAVE IT 5170 03:16:30,480 --> 03:16:31,080 IN OUR ARM RIGHT NOW. THIS IS 5171 03:16:31,080 --> 03:16:31,680 THE KIND OF SPARK THAT WAS 5172 03:16:31,680 --> 03:16:33,400 INTENDED AND YOU MENTIONED A 5173 03:16:33,400 --> 03:16:34,000 NETWORK. IT IS CERTAINLY NOT 5174 03:16:34,000 --> 03:16:34,640 NETWORK BIASED BUT WE KNOW THAT 5175 03:16:34,640 --> 03:16:41,840 WILL HAPPEN. PART OF THIS 5176 03:16:41,840 --> 03:16:42,480 PATIO OFFICES TO TRY TO REMOVE 5177 03:16:42,480 --> 03:16:43,080 THAT BIAS. SO THERE'S A FEW 5178 03:16:43,080 --> 03:16:46,280 WAYS YOU CAN DO THAT. WE NEED 5179 03:16:46,280 --> 03:16:46,920 TO MAKE SURE WE TALK TO ALL THE 5180 03:16:46,920 --> 03:16:47,560 RIGHT STAKEHOLDERS THAT NEED TO 5181 03:16:47,560 --> 03:16:51,600 BE AT THE TABLE. WE ALSO WANT 5182 03:16:51,600 --> 03:16:56,960 TO BE WHERE WE SHARE IN BROAD 5183 03:16:56,960 --> 03:16:57,600 AGENCY ANNOUNCEMENT DO WE NEED 5184 03:16:57,600 --> 03:16:58,200 TO MAKE SURE THEY GET BLASTED 5185 03:16:58,200 --> 03:16:59,720 12 COMMUNITIES THAT WOULD HAVE 5186 03:16:59,720 --> 03:17:00,360 RESPOND, AND BRING NEW PLAYERS 5187 03:17:00,360 --> 03:17:06,520 TO THE TABLE IN FACT IF I HAVE 5188 03:17:06,520 --> 03:17:07,040 A CONNECTION WITH SOME 5189 03:17:07,040 --> 03:17:07,640 ORGANIZATION, I WOULD HAVE AN 5190 03:17:07,640 --> 03:17:08,200 ORGANIZATIONAL CONFLICT OF 5191 03:17:08,200 --> 03:17:08,840 INTEREST THAT WOULD NOT BE ABLE 5192 03:17:08,840 --> 03:17:16,520 TO FUND THEM. TO YOUR POINT WE 5193 03:17:16,520 --> 03:17:17,160 NEED TO BE VERY PROACTIVE ABOUT 5194 03:17:17,160 --> 03:17:17,760 NOT FUNDING THE USUAL SUSPECTS 5195 03:17:17,760 --> 03:17:18,480 IF YOU WILL AND THAT WORK. 5196 03:17:18,480 --> 03:17:20,640 >>CHAIR TOLBERT: WANT TO ALLOW 5197 03:17:20,640 --> 03:17:21,200 ONE MORE QUESTION FROM DR. 5198 03:17:21,200 --> 03:17:25,520 GANDHI. 5199 03:17:25,520 --> 03:17:26,080 >>I AM REALLY SORRY, MY HAND 5200 03:17:26,080 --> 03:17:32,240 IS NOT SHOW UP WELL ON ZOOM. I 5201 03:17:32,240 --> 03:17:32,840 REALLY WANTED TO COMMEND JUDY 5202 03:17:32,840 --> 03:17:41,240 AND TED. I THINK IS THE DUTY OF 5203 03:17:41,240 --> 03:17:41,800 PUBLIC HEALTH THAT WE CAN'T 5204 03:17:41,800 --> 03:17:42,400 ELIMINATE MAYBE EVERY SINGLE 5205 03:17:42,400 --> 03:17:42,840 RISK, BUT TO SHARE 5206 03:17:42,840 --> 03:17:43,320 DECISION-MAKING ABOUT 5207 03:17:43,320 --> 03:17:49,720 BREAST-FEEDING WITH WOMEN. IS 5208 03:17:49,720 --> 03:17:50,360 LONG IN COMING AND NOTHING WILL 5209 03:17:50,360 --> 03:17:50,840 NOT BE EVER BE ABLE TO 5210 03:17:50,840 --> 03:17:51,440 ELIMINATE THE RISK IN PUBLIC 5211 03:17:51,440 --> 03:17:52,000 HEALTH BUT IT IS A DECISION 5212 03:17:52,000 --> 03:17:53,360 WITH THE PATIENT. AND IT 5213 03:17:53,360 --> 03:17:54,000 REALLY HELPED ME AS SOMEONE WHO 5214 03:17:54,000 --> 03:17:54,960 PROVIDES CARE FOR WOMEN HAVE 5215 03:17:54,960 --> 03:17:57,600 THIS CHANGE MADE. 5216 03:17:57,600 --> 03:17:58,440 THE SECOND IS THAT THE 5217 03:17:58,440 --> 03:18:01,640 LONG-ACTING AWARDS PRESENTED AT 5218 03:18:01,640 --> 03:18:03,640 CROY (PHONETIC), TO TELL YOU 5219 03:18:03,640 --> 03:18:04,200 WHAT HAS BEEN SPURRED ABOUT 5220 03:18:04,200 --> 03:18:09,880 THAT THE ECTG PUTTING A 5221 03:18:09,880 --> 03:18:10,360 REQUEST TO ME AND OTHER 5222 03:18:10,360 --> 03:18:10,960 STAKEHOLDERS TO SEE WHO COULD 5223 03:18:10,960 --> 03:18:12,600 DO LARGER STUDY ACROSS ECTG OF 5224 03:18:12,600 --> 03:18:23,120 LONG ACTING -- -- IN PATIENTS 5225 03:18:23,800 --> 03:18:24,360 AND IT LOOKS LIKE IT IS GOING 5226 03:18:24,360 --> 03:18:25,960 TO GO FORWARD IT AND IT WILL BE 5227 03:18:25,960 --> 03:18:26,480 GREAT TO HAVE A MULTISITE 5228 03:18:26,480 --> 03:18:27,000 STUDY. IT WOULD TAKE SOME 5229 03:18:27,000 --> 03:18:29,600 BOLDNESS TO DO IT IN ONE PLACE 5230 03:18:29,600 --> 03:18:30,200 BUT WE NEED TO GENERALIZE THE 5231 03:18:30,200 --> 03:18:30,800 ABILITY OF MULTIPLE SITES TO 5232 03:18:30,800 --> 03:18:31,440 GET IT ON THE GUIDELINES. 5233 03:18:31,440 --> 03:18:33,600 >>CHAIR TOLBERT: THANK YOU DR. 5234 03:18:33,600 --> 03:18:36,680 GANDHI. AND THANK YOU AGAIN DR. 5235 03:18:36,680 --> 03:18:42,320 WEGRZYN, AND WHEN YOU VISIT 5236 03:18:42,320 --> 03:18:42,880 ORAC YOU CAN GET SWEPT INTO 5237 03:18:42,880 --> 03:18:45,280 ONGOING CONVERSATIONS. SO WE 5238 03:18:45,280 --> 03:18:45,880 ARE GOING TO TAKE A BREAK NOW 5239 03:18:45,880 --> 03:18:56,360 FOR 1 5 MINUTES. I WOULD 5240 03:18:57,240 --> 03:18:57,800 ENCOURAGE EVERYONE TO TURN YOUR 5241 03:18:57,800 --> 03:18:58,440 CAMERAS OFF AND YOUR MIC AND WE 5242 03:18:58,440 --> 03:18:58,960 WILL SEE YOU BACK IN 15 5243 03:18:58,960 --> 03:19:01,280 MINUTES. 5244 03:19:01,280 --> 03:19:03,640 WELCOME BACK, WE HAVE 5245 03:19:03,640 --> 03:19:05,640 THE BRIEF UPDATES FROM THE 5246 03:19:05,640 --> 03:19:12,760 COMMITTEES. 5247 03:19:12,760 --> 03:19:18,480 I WOULD LIKE TO INVITE DR. 5248 03:19:18,480 --> 03:19:26,480 GUNDY, MARGUERITA LIGHTFOOT, AND 5249 03:19:26,480 --> 03:19:28,080 GEETANJALI BANSAI WITH THE 5250 03:19:28,080 --> 03:19:30,480 NATIONAL ADVISORY MENTAL HEALTH 5251 03:19:30,480 --> 03:19:33,760 COUNCIL, NATIONAL ADVISORY ON 5252 03:19:33,760 --> 03:19:40,080 DRUG ABUSE, ARAC AND AIDS 5253 03:19:40,080 --> 03:19:43,440 EXECUTIVE COMMITTEE. 5254 03:19:43,440 --> 03:19:44,920 MONICA SERVES AS DIVISION CHIEF 5255 03:19:44,920 --> 03:19:51,920 OF THE DIVISION OF HIV, 5256 03:19:51,920 --> 03:19:56,600 INFECTIOUS DISEASES AT USF, AND 5257 03:19:56,600 --> 03:19:58,480 DR. MARGUERITA LIGHTFOOT IS WELL 5258 03:19:58,480 --> 03:19:59,680 KNOWN TO THE OARAC. 5259 03:19:59,680 --> 03:20:01,760 CHIEF OF THE DIVISION OF 5260 03:20:01,760 --> 03:20:04,800 PREVENTION SCIENCE AND DIRECTOR 5261 03:20:04,800 --> 03:20:09,400 OF THE CENTER FOR PREVENT 5262 03:20:09,400 --> 03:20:14,480 STUDIES, AT THE PREVENTION 5263 03:20:14,480 --> 03:20:16,080 PRESEARCH CENTER. 5264 03:20:16,080 --> 03:20:22,880 AND DR. OAT SERVES AS THE 5265 03:20:22,880 --> 03:20:33,360 DIRECTOR OF THE GLADSTONE 5266 03:20:38,560 --> 03:20:49,000 INSTITUTE AND DR. DR. DB, I'M 5267 03:20:57,080 --> 03:20:58,480 SORRY, I HAD AN A LITTLE TROUBLE 5268 03:20:58,480 --> 03:20:59,520 WITH MY VOICE. 5269 03:20:59,520 --> 03:21:02,760 I WILL HAND IT OVER TO DR. GUNDY 5270 03:21:02,760 --> 03:21:02,920 NOW. 5271 03:21:02,920 --> 03:21:03,880 >>THANK YOU SO MUCH. 5272 03:21:03,880 --> 03:21:06,400 I AM WONDERING IF I CAN SHARE 5273 03:21:06,400 --> 03:21:08,840 THEM MYSELF, IF YOU WANT, I CAN 5274 03:21:08,840 --> 03:21:12,440 KEEP ON SAYING, NEXT SLIDE. 5275 03:21:12,440 --> 03:21:20,440 WHATEVER YOU LIKE. 5276 03:21:20,440 --> 03:21:21,120 NEXT SLIDE. 5277 03:21:21,120 --> 03:21:23,840 WE ARE GOING TO, I HAD TO GO 5278 03:21:23,840 --> 03:21:26,480 FAST, I HAVE A LOT OF SLIDE, I 5279 03:21:26,480 --> 03:21:29,880 AM JUST GOING TO SKIP SOME OF 5280 03:21:29,880 --> 03:21:30,400 THIS. 5281 03:21:30,400 --> 03:21:32,680 WE HAD AN AMAZING COUNCIL. 5282 03:21:32,680 --> 03:21:34,240 THE DIRECTORS REPORT. 5283 03:21:34,240 --> 03:21:38,400 IT WAS MORE OF AN OVERVIEW ON 5284 03:21:38,400 --> 03:21:42,920 THE VACCINE RESEARCH PROGRAM. 5285 03:21:42,920 --> 03:21:44,400 THERAPEUTICS, PREVENTION 5286 03:21:44,400 --> 03:21:49,200 SCIENCE, WHAT CAN WE LEARN FROM 5287 03:21:49,200 --> 03:21:52,880 COVID FOR FOR HIV, AND IF WE GO 5288 03:21:52,880 --> 03:21:54,400 TO THE NEXT SLIDE, THE 5289 03:21:54,400 --> 03:21:56,520 DIRECTOR'S REPORT, WE TALKED 5290 03:21:56,520 --> 03:21:58,760 ABOUT THIS. 5291 03:21:58,760 --> 03:22:09,280 WE HAVE BEEN FORTUNATE, THERE 5292 03:22:09,920 --> 03:22:12,680 WAS A LOT OF CONSTERNATION ON 5293 03:22:12,680 --> 03:22:14,240 THE CALL. 5294 03:22:14,240 --> 03:22:17,240 THE ADVISORY COUNCIL WAS THE 5295 03:22:17,240 --> 03:22:19,000 PANDEMIC INITIATIVE, NOT 5296 03:22:19,000 --> 03:22:20,480 APPROVED BY CONGRESS. 5297 03:22:20,480 --> 03:22:23,320 THAT CONSTERNATION LEAD TO REAL 5298 03:22:23,320 --> 03:22:25,200 QUESTIONS ABOUT HOW OTHER 5299 03:22:25,200 --> 03:22:29,360 FUNDING CAN GO TOWARD PANDEMIC 5300 03:22:29,360 --> 03:22:29,840 PREPAREDNESS. 5301 03:22:29,840 --> 03:22:30,080 NEXT. 5302 03:22:30,080 --> 03:22:32,400 THEN WE TALKED ABOUT A MINUTE, 5303 03:22:32,400 --> 03:22:34,720 ON HOW INCREDIBLE NIH HAS BEEN 5304 03:22:34,720 --> 03:22:37,800 DURING THE COVID PANDEMIC TO 5305 03:22:37,800 --> 03:22:39,120 CONTRIBUTE TO RESEARCH AND 5306 03:22:39,120 --> 03:22:41,840 PROBABLY HASN'T BEEN RECOGNIZED 5307 03:22:41,840 --> 03:22:43,480 ENOUGH, THAT NOT ONLY DID THEY 5308 03:22:43,480 --> 03:22:46,080 CONTRIBUTE TO ALL OF THE VACCINE 5309 03:22:46,080 --> 03:22:47,960 TRIALS IN SOME WAY, AND THE 5310 03:22:47,960 --> 03:22:49,040 RESEARCH CENTER HELPED TO 5311 03:22:49,040 --> 03:22:53,560 DEVELOP THE MRNA, THE 5312 03:22:53,560 --> 03:22:54,200 THERAPEUTIC CONTRIBUTIONS FROM 5313 03:22:54,200 --> 03:23:00,640 THE NIH, THEY WERE THROUGH THE 5314 03:23:00,640 --> 03:23:02,480 ACTIVE TRIALS. 5315 03:23:02,480 --> 03:23:04,160 HARNESSING THE NIH NETWORKS TO 5316 03:23:04,160 --> 03:23:07,520 LOOK AT ALL OF THE TREATMENTS 5317 03:23:07,520 --> 03:23:10,920 FOR COVID WAS ONE OF THE 5318 03:23:10,920 --> 03:23:13,040 GREATEST STRENGTHS THEY HAD TO 5319 03:23:13,040 --> 03:23:14,480 PLAY IN THIS SLIDE. 5320 03:23:14,480 --> 03:23:17,720 I THINK I WOULD GO TO THE NEXT 5321 03:23:17,720 --> 03:23:19,560 SLIDE, THAT SHOWS WHAT WE ARE 5322 03:23:19,560 --> 03:23:21,440 DOING NOW IN TERMS OF 5323 03:23:21,440 --> 03:23:22,560 THERAPEUTIC TRIALS. 5324 03:23:22,560 --> 03:23:26,520 THE NEXT THERAPY TO LOOK AT IS 5325 03:23:26,520 --> 03:23:29,800 THE PROJECT, PROBABLY THE LAST 5326 03:23:29,800 --> 03:23:31,080 ONE THROUGH THE EMERGENCY PHASE 5327 03:23:31,080 --> 03:23:37,480 TO ADD FUNDING TO LOOK AT AN 5328 03:23:37,480 --> 03:23:38,760 IMPORTANT FOR THE TREATMENT OF 5329 03:23:38,760 --> 03:23:39,440 COVID. 5330 03:23:39,440 --> 03:23:45,280 NEXT, I WOULD REFER EVERYONE TO 5331 03:23:45,280 --> 03:23:53,920 THIS SCIENCE ARTICLE WRITTEN BY 5332 03:23:53,920 --> 03:23:55,560 FRANNIS COLLINS. 5333 03:23:55,560 --> 03:23:55,760 NEXT. 5334 03:23:55,760 --> 03:23:57,120 GOING TO VACCINE RESEARCH. 5335 03:23:57,120 --> 03:24:02,480 AND THERAPEUTICS. 5336 03:24:02,480 --> 03:24:05,960 THE VACCINE RESEARCH PROGRAM FOR 5337 03:24:05,960 --> 03:24:10,320 HIV, WE ALL KNOW IT WAS PUT OUT 5338 03:24:10,320 --> 03:24:13,520 IN PRESS RELEASE. 5339 03:24:13,520 --> 03:24:18,320 IT WAS KNOW AN EFFECTIVE 5340 03:24:18,320 --> 03:24:18,560 VACCINE. 5341 03:24:18,560 --> 03:24:28,760 NEXT, SLIDE. 5342 03:24:31,120 --> 03:24:34,480 TO TAKE ANTIBODY, RAISED TO HIGH 5343 03:24:34,480 --> 03:24:34,720 LEVELS. 5344 03:24:34,720 --> 03:24:38,400 IT IS SO PROMISING IN TERMS OF A 5345 03:24:38,400 --> 03:24:44,440 PROFOUND UMMUNE -- IMMUNE 5346 03:24:44,440 --> 03:24:45,040 RESPONSE. 5347 03:24:45,040 --> 03:24:48,680 NEXT SLIDE SHOWS US. 5348 03:24:48,680 --> 03:24:50,240 THERAPEUTIC PROGRAM THAT IS 5349 03:24:50,240 --> 03:24:52,080 WEIGHTED AS IT SHOULD BE TOWARD 5350 03:24:52,080 --> 03:24:55,600 CLINICAL TRIALS, HOW MUCH IS 5351 03:24:55,600 --> 03:25:04,080 GOING IN IN THE NEXT SLIDE, 5352 03:25:04,080 --> 03:25:04,320 PLEASE. 5353 03:25:04,320 --> 03:25:08,920 WHAT WE TALKED ABOUT ON THE 5354 03:25:08,920 --> 03:25:10,800 SESSION THERE IS A VERY BIG 5355 03:25:10,800 --> 03:25:14,480 FOCUS ON NEW AND IMPROVED, LONG 5356 03:25:14,480 --> 03:25:17,240 ACTING TREATMENTS FOR THE NEXT 5357 03:25:17,240 --> 03:25:19,120 PHASE OF THE TREATMENT. 5358 03:25:19,120 --> 03:25:20,960 AND NOT ONLY THROUGH 5359 03:25:20,960 --> 03:25:24,320 DEMONSTRATIONAL PROJECTS, I 5360 03:25:24,320 --> 03:25:26,480 THINK IMPORTANTLY, THROUGH THE 5361 03:25:26,480 --> 03:25:30,480 CLINICAL TRIALS NETWORKS AS WE 5362 03:25:30,480 --> 03:25:31,440 TALKED ABOUT. 5363 03:25:31,440 --> 03:25:35,160 THEN END WITH THE LAST PART, WAS 5364 03:25:35,160 --> 03:25:38,240 TALKING ABOUT THE PREVENTION 5365 03:25:38,240 --> 03:25:38,520 SCIENCES. 5366 03:25:38,520 --> 03:25:42,440 THE NEXT SLIDE SHOWS THE 5367 03:25:42,440 --> 03:25:42,760 PREVENTION. 5368 03:25:42,760 --> 03:25:44,600 I THOUGHT IT WAS A GREAT SLIDE 5369 03:25:44,600 --> 03:25:46,080 TO SHOW WHAT THE PROGRAM IS 5370 03:25:46,080 --> 03:25:47,360 INVOLVED IN. 5371 03:25:47,360 --> 03:25:48,640 IT IS SO DIVERSE. 5372 03:25:48,640 --> 03:25:51,160 ALL THE WAY FROM EVOLVING 5373 03:25:51,160 --> 03:25:53,960 RESEARCH, AND INFANTS AND 5374 03:25:53,960 --> 03:25:55,480 CHILDREN, TO IMPROVING 5375 03:25:55,480 --> 03:25:57,920 ENGAGEMENT IN KEY POPULATIONS, 5376 03:25:57,920 --> 03:26:01,160 ALL THE PRIORITIES, YES, FLKS 5377 03:26:01,160 --> 03:26:01,520 SLIDE. 5378 03:26:01,520 --> 03:26:06,360 AND SO, I THINK THE ONES THE 5379 03:26:06,360 --> 03:26:07,120 PREVENTION SCIENCE PROGRAM 5380 03:26:07,120 --> 03:26:09,000 HIGHLIGHTED FOR US, ARE THE 5381 03:26:09,000 --> 03:26:12,440 HIGHLIGHTS WE TALKED ABOUT THE 5382 03:26:12,440 --> 03:26:19,440 CALL. 5383 03:26:19,440 --> 03:26:24,720 THE REGULARATORY APPROVAL FOR 5384 03:26:24,720 --> 03:26:25,320 CHILDREN. 5385 03:26:25,320 --> 03:26:27,600 AND THE ANTIBODIES, AND THE 5386 03:26:27,600 --> 03:26:30,400 LACTATING MOTHERS. 5387 03:26:30,400 --> 03:26:37,320 A FEW MORE R APP S, REALLY, 5388 03:26:37,320 --> 03:26:40,360 LOOKING, 52% OF CHILDREN HAVE 5389 03:26:40,360 --> 03:26:48,440 ACCESS TO THE STATISTICS FROM 5390 03:26:48,440 --> 03:26:51,120 THE ENDAFR REPORT. 5391 03:26:51,120 --> 03:26:55,000 NEED TO WORK MORE ON PEDIATRIC 5392 03:26:55,000 --> 03:26:58,840 FORMULATIONS ON MEDICATIONS. 5393 03:26:58,840 --> 03:27:00,040 BIOLOGY, CURE AND PREVENTION. 5394 03:27:00,040 --> 03:27:02,120 YOU CAN SEE HOW THEY ARE 5395 03:27:02,120 --> 03:27:02,440 OVERLAPPING. 5396 03:27:02,440 --> 03:27:05,200 THE NEXT SLIDE, ALL THE 5397 03:27:05,200 --> 03:27:08,360 INITIATIVES FOR STRUCTURAL 5398 03:27:08,360 --> 03:27:09,120 BIOLOGY. 5399 03:27:09,120 --> 03:27:10,120 INCLUDING A PROGRAM HERE, AND 5400 03:27:10,120 --> 03:27:13,640 THE NEXT SLIDE, THE CURE 5401 03:27:13,640 --> 03:27:13,960 INITIATIVES. 5402 03:27:13,960 --> 03:27:17,160 THROUGH THE DIFFERENT 5403 03:27:17,160 --> 03:27:20,280 COLLABORATIONS. 5404 03:27:20,280 --> 03:27:22,080 REALLY, ABLAZING CURE PROGRAMS 5405 03:27:22,080 --> 03:27:26,080 ALL OVER THE COUNTRY. 5406 03:27:26,080 --> 03:27:29,320 AND THE NEXT SLIDE, SHOWS 5407 03:27:29,320 --> 03:27:31,640 THROUGH THE BASIC SCIENCE 5408 03:27:31,640 --> 03:27:34,080 PROGRAM. 5409 03:27:34,080 --> 03:27:37,760 EHE MONEY, HAS BEEN GOING OUT. 5410 03:27:37,760 --> 03:27:39,520 AND THEN END WITH THE NEXT 5411 03:27:39,520 --> 03:27:39,720 SLIDE. 5412 03:27:39,720 --> 03:27:40,840 NEXT SLIDE. 5413 03:27:40,840 --> 03:27:42,920 THIS IS WHAT I TOOK FROM WHAT 5414 03:27:42,920 --> 03:27:47,080 WORKED DURING COVID FOR US. 5415 03:27:47,080 --> 03:27:51,400 KIND OF RAPID TRIAL DESIGNS, 5416 03:27:51,400 --> 03:27:53,920 USING THE FRAMEWORK, AND WHAT 5417 03:27:53,920 --> 03:27:55,000 DIDN'T WORK. 5418 03:27:55,000 --> 03:27:59,120 REGULATORY TIMELINES DELAYED IN 5419 03:27:59,120 --> 03:28:00,680 OTHER COUNTRIES. 5420 03:28:00,680 --> 03:28:04,080 COMPLEX TRAVEL DESIGNS DIDN'T 5421 03:28:04,080 --> 03:28:04,280 WORK. 5422 03:28:04,280 --> 03:28:07,520 WE NEEDED TO USE REAL WORLD 5423 03:28:07,520 --> 03:28:10,800 EVIDENCE AND HARNESS THAT TO GET 5424 03:28:10,800 --> 03:28:12,120 THE INFORMATION OUT THERE. IT 5425 03:28:12,120 --> 03:28:15,440 WAS ONE OF THE BEST AND MOST 5426 03:28:15,440 --> 03:28:18,120 COMPREHENSIVE MEETINGS I 5427 03:28:18,120 --> 03:28:18,440 EXPERIENCED. 5428 03:28:18,440 --> 03:28:24,480 >>THANKS YOU DR. GANDHI. 5429 03:28:24,480 --> 03:28:28,080 MARGUERITA LIGHTFOOT. 5430 03:28:28,080 --> 03:28:33,520 I AM HERE TO REPORT IMH. 5431 03:28:33,520 --> 03:28:36,040 IN TERMS OF THE APPROPRIATIONS 5432 03:28:36,040 --> 03:28:40,080 AND BUDGE FOR NIMH HAS BEEN 5433 03:28:40,080 --> 03:28:42,360 INCREASING CLOUDS. 5434 03:28:42,360 --> 03:28:44,600 AND EXPANSION OF BUDGET TO 5435 03:28:44,600 --> 03:28:46,800 ADDRESS COVID 19 AND MENTAL 5436 03:28:46,800 --> 03:28:48,800 HEALTH, THAT WILL BE ON-GOING. 5437 03:28:48,800 --> 03:28:51,680 THE DIRECTOR TOLD US ABOUT THE 5438 03:28:51,680 --> 03:28:57,000 NEW INITIATIVES AT NIMH IS PART 5439 03:28:57,000 --> 03:28:59,040 OF. 5440 03:28:59,040 --> 03:29:05,000 HHS RELEASED ROAD MAP FOR 5441 03:29:05,000 --> 03:29:07,000 BEHAVIORAL INTERIGRATION. 5442 03:29:07,000 --> 03:29:09,680 IN THE FIRST, THE PRESIDENT'S 5443 03:29:09,680 --> 03:29:13,000 FIRST STATE OF THE UNION TALKED 5444 03:29:13,000 --> 03:29:23,560 ABOUT THE PROVIDING SUPPORT, AND 5445 03:29:25,040 --> 03:29:28,280 NIMH IS IT WILLY INVOLVED IN 5446 03:29:28,280 --> 03:29:28,480 THAT. 5447 03:29:28,480 --> 03:29:31,640 MEMBERSHIP OF US KNOW CONFUSING 5448 03:29:31,640 --> 03:29:34,280 DATA SHARI REQUIREMENTS ARE 5449 03:29:34,280 --> 03:29:37,800 REQUIRED FOR GRANT PROPOSALS, I 5450 03:29:37,800 --> 03:29:43,520 AM TAKE A UNIQUE PROSPECTIVE. 5451 03:29:43,520 --> 03:29:47,120 DURING REVIEW, REVIEWERS ARE 5452 03:29:47,120 --> 03:29:51,600 COMMENTS ON THE DATA SHARING 5453 03:29:51,600 --> 03:29:53,040 REQUIREMENTS. 5454 03:29:53,040 --> 03:29:58,560 ANY DATEDA SHARING PROVIDED BY 5455 03:29:58,560 --> 03:30:00,920 THE INVESTIGATORS WAS 5456 03:30:00,920 --> 03:30:02,040 INADEQUATE, IT WON'T KEEP THE 5457 03:30:02,040 --> 03:30:05,280 GRANT FROM BEING FUNDED AT NIMH. 5458 03:30:05,280 --> 03:30:08,600 THEY HAVE A TEAM THAT WILL BE 5459 03:30:08,600 --> 03:30:10,920 WORKING WITH ADVISORY TO BRING 5460 03:30:10,920 --> 03:30:12,760 UP TO SPEED PLANS IN THE GRANTS 5461 03:30:12,760 --> 03:30:15,920 THAT WERE NOT REVIEWED WELL. 5462 03:30:15,920 --> 03:30:19,560 I AM ANXIOUS, SPENDING A LOT OF 5463 03:30:19,560 --> 03:30:25,000 TIME AND EFFORT IN WORK FIRST 5464 03:30:25,000 --> 03:30:26,280 DEVELOPMENT. 5465 03:30:26,280 --> 03:30:27,680 WORK FIRST DEVELOPMENT, 5466 03:30:27,680 --> 03:30:30,400 PARTICIPATING IN TWO PROGRAMS, 5467 03:30:30,400 --> 03:30:34,360 ONE IS THE SUPMRIMENT FOR -- 5468 03:30:34,360 --> 03:30:41,240 SUPPLEMENT FOR DEI MEMBER, THIS 5469 03:30:41,240 --> 03:30:46,520 IS THE SUPPLEMENTS WILL BE 5470 03:30:46,520 --> 03:30:50,320 AVAILABLE FOR ALL GRANT TYPES, 5471 03:30:50,320 --> 03:30:53,080 INCLUDING CURRENT DEVELOPMENT 5472 03:30:53,080 --> 03:30:55,640 GRANTS, COOPERATIVE AGREEMENTS 5473 03:30:55,640 --> 03:30:59,240 AND RESEARCH, THEY WILL PROVIDE 5474 03:30:59,240 --> 03:31:00,960 UP TO 250,000 IN DIRECT COST TO 5475 03:31:00,960 --> 03:31:02,040 THE PARENT GRANT. 5476 03:31:02,040 --> 03:31:04,000 THE OTHER ONE, RESEARCH 5477 03:31:04,000 --> 03:31:06,320 OPPORTUNITIES FOR NEW AND 5478 03:31:06,320 --> 03:31:08,360 AT-RISK INVESTIGATORS TO PROMOTE 5479 03:31:08,360 --> 03:31:12,160 WORK TOWARD DIVERSITY IS 5480 03:31:12,160 --> 03:31:22,600 INTENDED TO SUPPORT NEW 5481 03:31:23,440 --> 03:31:24,480 INVESTIGATORS, AND AT-RISK MEANS 5482 03:31:24,480 --> 03:31:29,720 A PI, ON A SUBSTANTIAL RESEARCH 5483 03:31:29,720 --> 03:31:32,000 AWARD, A LESSER SUCCESS IN 5484 03:31:32,000 --> 03:31:35,360 SECURING THE NEXT GRANT IN THE 5485 03:31:35,360 --> 03:31:39,800 CURRENT FISCAL YEAR,TYPICALLY, 5486 03:31:39,800 --> 03:31:43,400 THESE ARE GOING TO BE FOLKS 5487 03:31:43,400 --> 03:31:45,440 LOOKING AT, WITHOUT GETTING THAT 5488 03:31:45,440 --> 03:31:47,720 NEXT GRANT. 5489 03:31:47,720 --> 03:31:54,800 AND OF NOTE, THE NIMH STJIC 5490 03:31:54,800 --> 03:31:55,080 FRAMEWORK. 5491 03:31:55,080 --> 03:31:58,760 AND THE NEXT SLIDE, PLEASE. 5492 03:31:58,760 --> 03:32:00,800 WE HEARD ABOUT A PRESENTATION 5493 03:32:00,800 --> 03:32:05,000 ABOUT THE GLOBAL MENTAL HEALTH 5494 03:32:05,000 --> 03:32:06,400 RESEARCH CENTER THAT IS 5495 03:32:06,400 --> 03:32:09,000 HAPPENING BEEN FORMED AT NIMH, 5496 03:32:09,000 --> 03:32:14,040 THE IDEA BEHIND THE CENTER IS TO 5497 03:32:14,040 --> 03:32:18,840 WORK WITH LMICs TO EMMRIMENT AND 5498 03:32:18,840 --> 03:32:22,280 ADOPT AND SCALE UP 5499 03:32:22,280 --> 03:32:24,920 EVIDENCE-BASED MENTAL HEALTH 5500 03:32:24,920 --> 03:32:25,840 INTERVENTIONS, AND THE FOCUS OF 5501 03:32:25,840 --> 03:32:29,000 THIS GROUP IS LOOKING AT THE 5502 03:32:29,000 --> 03:32:32,600 POTENTIAL FOR MULTIDIRECTIONAL 5503 03:32:32,600 --> 03:32:33,360 EXCHANGE. 5504 03:32:33,360 --> 03:32:36,160 ADAPTATION, RECIPROCAL LEARNING 5505 03:32:36,160 --> 03:32:40,280 BETWEEN LMICs, AND THE 5506 03:32:40,280 --> 03:32:40,600 INVESTIGATORS. 5507 03:32:40,600 --> 03:32:42,960 SOME OF THE LESSONS LEARNED FROM 5508 03:32:42,960 --> 03:32:46,480 THE WORK THAT HAS HAPPENED SO 5509 03:32:46,480 --> 03:32:49,240 FAR, BY THE CENTER, IS THAT 5510 03:32:49,240 --> 03:32:53,280 GROUP LEARNING IS POWERFUL. 5511 03:32:53,280 --> 03:32:55,640 CROSS SECTION, MULTISECTORED 5512 03:32:55,640 --> 03:32:58,960 GROUPS TOGETHER TO THINK ABOUT 5513 03:32:58,960 --> 03:33:00,960 HOW WE SCALE UP INTERVENTIONS 5514 03:33:00,960 --> 03:33:04,080 FOR MENTAL HEALTH. 5515 03:33:04,080 --> 03:33:06,240 IN THE U.S., DISTRESS IS 5516 03:33:06,240 --> 03:33:07,560 INCREASING GLOBALLY. 5517 03:33:07,560 --> 03:33:09,680 USING AN IMPLEMENTATION SCIENCE, 5518 03:33:09,680 --> 03:33:11,360 AND EFFORTS FORWARD THAT IS 5519 03:33:11,360 --> 03:33:12,960 SOMETHING LOOKED AT HERE. 5520 03:33:12,960 --> 03:33:15,480 THERE ARE A NUMBER OF RESEARCH 5521 03:33:15,480 --> 03:33:17,640 PARTNERSHIPS FOR SCALING UP 5522 03:33:17,640 --> 03:33:20,560 LMICs, ACROSS THE COUNTRY. 5523 03:33:20,560 --> 03:33:24,320 SO, THEY ARE IN SOUTH AFRICA, 5524 03:33:24,320 --> 03:33:28,640 PERU, LIBERIA, AFGHANISTAN, I 5525 03:33:28,640 --> 03:33:31,880 WON'T CATCH ALL OF THEM. 5526 03:33:31,880 --> 03:33:36,320 IT IS A REFLECT OF GLOBAL REACH. 5527 03:33:36,320 --> 03:33:38,520 NEXT SLIDE, PLEASE. 5528 03:33:38,520 --> 03:33:41,600 WE DID HEAR FROM THE DIVISION 5529 03:33:41,600 --> 03:33:46,280 FOR AIDS RESEARCH NIMH. 5530 03:33:46,280 --> 03:33:50,000 THEY HAD CONCEPT CLEARANCE 5531 03:33:50,000 --> 03:33:52,040 REVIEWED BY THE COUNCIL MEMBERS, 5532 03:33:52,040 --> 03:33:54,360 AND SUPPORTED BY COUNCIL MEMBERS 5533 03:33:54,360 --> 03:33:57,680 AS WELL. THERE WAS SUPPORT, IT 5534 03:33:57,680 --> 03:34:02,000 WAS CALLED RECIPROCAL 5535 03:34:02,000 --> 03:34:02,600 INFORMATION. 5536 03:34:02,600 --> 03:34:11,800 AND CENTRAL NERVOUS SYSTEM 5537 03:34:11,800 --> 03:34:15,640 NEUROPATHOGEN SIS AND CURE. 5538 03:34:15,640 --> 03:34:18,400 GOAL IS TO ENCOURAGE RESEARCH 5539 03:34:18,400 --> 03:34:24,160 USING NOVEL CNS CELL SYSTEMS, 5540 03:34:24,160 --> 03:34:26,640 ERADICATING, AND UNDERSTANDING 5541 03:34:26,640 --> 03:34:37,000 THE MECHANISMS IN AIDS RESEARCH. 5542 03:34:37,000 --> 03:34:41,320 THE OTHER PARTS OF THE RATIONAL 5543 03:34:41,320 --> 03:34:45,840 FOR THIS CONCEPT CLEARANCE, HIV 5544 03:34:45,840 --> 03:34:50,520 CONTINUES TO BE OBSERVED IN 5545 03:34:50,520 --> 03:34:58,200 PATIENTS, AS WE ALL KNOWS, 5546 03:34:58,200 --> 03:35:02,760 RESIDUAL LEVELS OF AND 5547 03:35:02,760 --> 03:35:07,240 PERSISTENT LEVELS OF 5548 03:35:07,240 --> 03:35:09,680 INFLAMMATION, AND PERSISTENCE 5549 03:35:09,680 --> 03:35:11,040 CONTINUES TO EXIST. 5550 03:35:11,040 --> 03:35:13,520 HOPEFULLY, TO BE ABLE TO ADDRESS 5551 03:35:13,520 --> 03:35:13,720 THAT. 5552 03:35:13,720 --> 03:35:15,000 NEXT SLIDE, PLEASE. 5553 03:35:15,000 --> 03:35:18,520 I THINK THAT MIGHT BE IT. 5554 03:35:18,520 --> 03:35:22,600 THANK YOU. 5555 03:35:22,600 --> 03:35:25,440 THANK YOU DR. OAT, OVER TO YOU. 5556 03:35:25,440 --> 03:35:30,320 I AM A NEW MEMBER, I HAD MY 5557 03:35:30,320 --> 03:35:31,920 FIRST MEETING FEBRUARY 8th, 5558 03:35:31,920 --> 03:35:33,880 INTERESTING AND PRODUCTIVE 5559 03:35:33,880 --> 03:35:34,640 MEETING. 5560 03:35:34,640 --> 03:35:42,640 IT WAS CENTERED A LOT AROUND THE 5561 03:35:42,640 --> 03:35:45,000 FENTANYL CRISIS. 5562 03:35:45,000 --> 03:35:46,680 WANTED TO BRING TO YOU, TWO 5563 03:35:46,680 --> 03:35:48,560 PAPERS, TWO CONCEPTS THAT I 5564 03:35:48,560 --> 03:35:53,600 SHOULD HIGHLIGHT WITH YOU, THAT 5565 03:35:53,600 --> 03:35:56,600 IN THE HIV AREA. 5566 03:35:56,600 --> 03:36:03,280 THE FIRST ONE, THE RECENT 5567 03:36:03,280 --> 03:36:07,360 MOLECULAR CELL, RESEARCH AND 5568 03:36:07,360 --> 03:36:12,560 FOCUS AT NIGHTA WITH THE BRAIN. 5569 03:36:12,560 --> 03:36:15,720 HIV AND SUBSTANCE ABUSE OR 5570 03:36:15,720 --> 03:36:16,880 SUBSTANCE ABUSE DISORDERS. 5571 03:36:16,880 --> 03:36:20,600 THIS PAPER HAS DONE AN AMAZING 5572 03:36:20,600 --> 03:36:24,840 JOB, USING SOPHISTICATED GENOME 5573 03:36:24,840 --> 03:36:28,320 ANALYSIS TECHNOLOGIES, STARTING 5574 03:36:28,320 --> 03:36:36,600 FROM SINGULAR NUCLEUS, HIGH-C, 5575 03:36:36,600 --> 03:36:41,560 AND SEQUENCES, TO FRONTAL CORTEX 5576 03:36:41,560 --> 03:36:49,000 SAMPLES WITH INSEF LIGHTS OR 5577 03:36:49,000 --> 03:36:57,760 WITHOUT ENCEPHALITTIS. 5578 03:36:57,760 --> 03:37:00,960 AND INTERESTING OBSERVATIONS 5579 03:37:00,960 --> 03:37:02,360 WERE MADE. 5580 03:37:02,360 --> 03:37:10,560 THROUGH 3-D. REMODELLING HERE. 5581 03:37:10,560 --> 03:37:13,920 AT VERY SPECIFIC SET OF NURRAL 5582 03:37:13,920 --> 03:37:18,120 GENES WERE FOUND REPRESSED, AND 5583 03:37:18,120 --> 03:37:24,960 SHOWN THAT ENCEPHALITIS G NO 5584 03:37:24,960 --> 03:37:26,520 CONFIGURATION, AND STIMULATED 5585 03:37:26,520 --> 03:37:28,880 GENE EXPRESSION. 5586 03:37:28,880 --> 03:37:31,560 THERE IS ALSO CLEAR EVIDENCE 5587 03:37:31,560 --> 03:37:36,960 THAT HIV TARGETS GENOMIC 5588 03:37:36,960 --> 03:37:40,760 REGIONS, AND HIV IS TRANSCRIBED 5589 03:37:40,760 --> 03:37:44,640 IN IT WAS CLEAR THAT DURING 5590 03:37:44,640 --> 03:37:47,000 ENCEPHALITIS EXPRESSION OF HIV 5591 03:37:47,000 --> 03:37:47,920 IS ENHANCED. 5592 03:37:47,920 --> 03:37:49,240 THE NEXT SLIDE, PLEASE. 5593 03:37:49,240 --> 03:37:53,160 THE SECOND PAPER IS FOCUSED ON 5594 03:37:53,160 --> 03:38:00,120 THE SECOND AREA OF FOCUS. 5595 03:38:00,120 --> 03:38:03,680 HOW CAN LATENCY BE ADDRESSED, 5596 03:38:03,680 --> 03:38:05,760 BETTER UNDERSTOOD, AND 5597 03:38:05,760 --> 03:38:08,640 THERAPEUTICALLY REVERSED OR 5598 03:38:08,640 --> 03:38:08,920 ENFORCED. 5599 03:38:08,920 --> 03:38:13,000 THIS IS A STUDY FROM THE EMER 5600 03:38:13,000 --> 03:38:17,560 MAN LAB, THAT PERFORMED A SCREEN 5601 03:38:17,560 --> 03:38:22,560 IN CELLS, PROVIRUS, TO IDENTIFY 5602 03:38:22,560 --> 03:38:25,000 FACTORS THAT REPRESS THE SCREEN 5603 03:38:25,000 --> 03:38:28,320 WAS DONE WITH THIS TO REACTIVATE 5604 03:38:28,320 --> 03:38:29,000 THE VIRUS. 5605 03:38:29,000 --> 03:38:33,720 TO IDENTIFY FACTORS THAT WOULD 5606 03:38:33,720 --> 03:38:36,920 ENHANCE OR BLOCK THE 5607 03:38:36,920 --> 03:38:37,280 REACTIVATION. 5608 03:38:37,280 --> 03:38:44,640 YOU MIGHT ASK WHY ANOTHER, 5609 03:38:44,640 --> 03:38:47,400 HIGHLY CURATED DIET ENA, FOCUSED 5610 03:38:47,400 --> 03:38:51,680 ON GENETICS, SO THAT OTHER 5611 03:38:51,680 --> 03:38:56,120 PATHWAYS, THAT CAN OVERSHADOW 5612 03:38:56,120 --> 03:38:58,040 QUESTION HOW IS THE VIRUS 5613 03:38:58,040 --> 03:38:58,440 REGULATED. 5614 03:38:58,440 --> 03:39:02,640 I AM NOT ADDRESSED IN THIS. 5615 03:39:02,640 --> 03:39:04,960 AND BURYING OTHERWISE 5616 03:39:04,960 --> 03:39:07,000 INTERESTING HITS. 5617 03:39:07,000 --> 03:39:10,960 THEY CAME BACK TO AN ALREADY 5618 03:39:10,960 --> 03:39:15,600 KNOWN FACTOR, THE TRANSFER, A 5619 03:39:15,600 --> 03:39:19,000 SUBSET OF THIS IN A FACTOR 5620 03:39:19,000 --> 03:39:22,160 HIGHLIGHTED HERE ON THE SCREEN. 5621 03:39:22,160 --> 03:39:24,240 THAT SEEMED TO BE IMPORTANT IN 5622 03:39:24,240 --> 03:39:26,520 PRECESSING HIV, IT IS AN 5623 03:39:26,520 --> 03:39:29,000 INTERESTING CONCEPT. 5624 03:39:29,000 --> 03:39:33,240 THE CONCEPT THAT ASSETALATION IN 5625 03:39:33,240 --> 03:39:36,080 HIV LATENCY IS CLEARLY 5626 03:39:36,080 --> 03:39:37,080 ASSOCIATED WITH REPRESSION. 5627 03:39:37,080 --> 03:39:40,920 THAT IS VERY INTERESTING. 5628 03:39:40,920 --> 03:39:44,160 NEXT SLIDE, PLEASE. 5629 03:39:44,160 --> 03:39:48,760 THE 2025 CONCEPT HAS BEEN 5630 03:39:48,760 --> 03:39:49,040 FINALIZED. 5631 03:39:49,040 --> 03:39:49,400 LISTED HERE. 5632 03:39:49,400 --> 03:39:52,040 I WILL LET YOU GO THROUGH THEM. 5633 03:39:52,040 --> 03:40:01,000 I WANT TO FOCUS ON THE TWO 5634 03:40:01,000 --> 03:40:01,640 HIGHLIGHTS HERE. 5635 03:40:01,640 --> 03:40:11,760 HIV AND ADDICTIVE DRUGS, AND 5636 03:40:11,760 --> 03:40:13,400 MITHE FOCUS HERE IS ON THE 5637 03:40:13,400 --> 03:40:13,600 BRAIN. 5638 03:40:13,600 --> 03:40:16,920 IN THE FIRST INITIATIVE, IT 5639 03:40:16,920 --> 03:40:19,880 REALLY IS LOOKING IN THE 5640 03:40:19,880 --> 03:40:24,720 COMBINATION OF THE NEUROAND THE 5641 03:40:24,720 --> 03:40:25,760 CENTRAL NERVOUS SYSTEM AND THE 5642 03:40:25,760 --> 03:40:28,280 HUMAN SYSTEM, I WANT TO 5643 03:40:28,280 --> 03:40:30,720 HIGHLIGHT ONE SENTENCE HERE IN 5644 03:40:30,720 --> 03:40:34,320 THE LOWER PART, STUDIES 5645 03:40:34,320 --> 03:40:36,440 INVESTIGATIONING THE NEUROIMMUNE 5646 03:40:36,440 --> 03:40:41,200 CROSS TALK, AND NEUROCOGNITION, 5647 03:40:41,200 --> 03:40:51,720 BEHAVIOR AND SUBSAN ANTONIO USE, 5648 03:40:52,200 --> 03:40:53,880 THE IMMUNE SYSTEM AND THE 5649 03:40:53,880 --> 03:40:54,760 CENTRAL NERVE SYSTEM IS 5650 03:40:54,760 --> 03:40:56,640 INTERESTING TO SEE HOW IT THEN 5651 03:40:56,640 --> 03:40:59,080 CHANGES BEHAVIOR, AND IT CHANGES 5652 03:40:59,080 --> 03:41:01,000 HIV INFECTION. 5653 03:41:01,000 --> 03:41:04,760 THE OTHER THE NEXT ONE, PLEASE. 5654 03:41:04,760 --> 03:41:06,440 IT IS ALSO VERY MUCH FOCUSED ON 5655 03:41:06,440 --> 03:41:09,000 THE BRAIN. 5656 03:41:09,000 --> 03:41:16,680 HERE, IT IS CLEAR THAT 5657 03:41:16,680 --> 03:41:18,760 MICROGLIAL, BETWEEN HIV AND 5658 03:41:18,760 --> 03:41:20,960 SUBSTANCE ABUSE DISORDER, IT IS 5659 03:41:20,960 --> 03:41:24,760 A CONVERGENCE POINT, IN THE WAY 5660 03:41:24,760 --> 03:41:28,960 THAT THESE CELLS PLAY AN 5661 03:41:28,960 --> 03:41:34,120 ENORMOUS ROLE HAR VESING IT, 5662 03:41:34,120 --> 03:41:36,800 SUBSTANCE DISORDERS AFFECTING 5663 03:41:36,800 --> 03:41:38,480 THE BEHAVIOR AND CHANGES 5664 03:41:38,480 --> 03:41:39,440 PATHWAYS IN THE BRAIN. 5665 03:41:39,440 --> 03:41:43,120 THIS IS AN INITIATIVE THAT IS 5666 03:41:43,120 --> 03:41:50,640 SEEKING PROFILING OF THE 5667 03:41:50,640 --> 03:41:54,520 MICROGLIAL CELLS, MODIFYICATIONS 5668 03:41:54,520 --> 03:41:56,960 TO SEE HOW THEY BEHAVE AND LOOK 5669 03:41:56,960 --> 03:41:58,520 IN DISEASE AND HEALTH. 5670 03:41:58,520 --> 03:42:02,520 THE FOCUS HERE IS REALLY NOT ON 5671 03:42:02,520 --> 03:42:04,920 ISOLATED CELLS, BUT ON BRAIN 5672 03:42:04,920 --> 03:42:07,200 REGIONS, AND SPECIFIC BRAIN 5673 03:42:07,200 --> 03:42:11,080 REGIONS, AND IT IS ENCOURAGED TO 5674 03:42:11,080 --> 03:42:14,520 USE HUMAN OR ANIMAL MODELS TO 5675 03:42:14,520 --> 03:42:21,280 LOOK AT MICRO GLIAL, RATHER THAN 5676 03:42:21,280 --> 03:42:23,360 IN AN ISOLATED MODEL. 5677 03:42:23,360 --> 03:42:25,000 I HAND IT OVER TO THE NEXT 5678 03:42:25,000 --> 03:42:25,520 SPEAKER. 5679 03:42:25,520 --> 03:42:28,200 >>THANK YOU. 5680 03:42:28,200 --> 03:42:35,040 OVER TO YOU NOW, DR. GEETANJALI 5681 03:42:35,040 --> 03:42:36,960 BANSAI. 5682 03:42:36,960 --> 03:42:44,600 >>CLEARED CONCEPTS, NEXT SLIDE, 5683 03:42:44,600 --> 03:42:49,000 PLEASE. 5684 03:42:49,000 --> 03:42:51,680 THIS IS A SUMMARY, WITH A TOTAL 5685 03:42:51,680 --> 03:42:56,640 OF 17 NEW, AND REISSUED 5686 03:42:56,640 --> 03:43:01,160 CONCEPTS. 5687 03:43:01,160 --> 03:43:03,080 NATIONAL INSTITUTION OF MINORITY 5688 03:43:03,080 --> 03:43:05,760 HEALTH HAS TWO NEW CONCEPTS, 5689 03:43:05,760 --> 03:43:08,160 FOCUSING ON HEALTH DISPARITIES, 5690 03:43:08,160 --> 03:43:12,480 WITH THOSE LIVING WITH HIV, 5691 03:43:12,480 --> 03:43:23,040 HOUSING AND FOUR NEW CONCEPTS, 5692 03:43:25,040 --> 03:43:27,720 ONE FOCUSES ON THE DELIVERY 5693 03:43:27,720 --> 03:43:29,080 TREATMENT FOR TREATMENT, A 5694 03:43:29,080 --> 03:43:32,840 SECOND CONCEPT IS THE RAPID 5695 03:43:32,840 --> 03:43:36,040 DIAGNOSTICS, SELF MONITORING, 5696 03:43:36,040 --> 03:43:43,680 AND ANOTHER ONE, HEP TITUS B, C, 5697 03:43:43,680 --> 03:43:44,160 AND HIV. 5698 03:43:44,160 --> 03:43:47,760 AND HCV CURE. 5699 03:43:47,760 --> 03:43:51,920 THE NEXT SLIDE, PLEASE. 5700 03:43:51,920 --> 03:43:53,200 NATIONAL INSTITUTION ON DRUG 5701 03:43:53,200 --> 03:43:56,640 ABUSE NEW CONCEPTS LISTED HERE. 5702 03:43:56,640 --> 03:43:59,800 ALREADY PRESENTED TODAY. 5703 03:43:59,800 --> 03:44:10,000 NEXT SLIDE. 5704 03:44:20,000 --> 03:44:29,000 A NEW CONCEPT ON THE HIV, AND 5705 03:44:29,000 --> 03:44:31,800 OROPHAR LANGIAL CANCER. 5706 03:44:31,800 --> 03:44:34,880 NATIONAL INSTITUTE OF MENTAL 5707 03:44:34,880 --> 03:44:43,840 HEALTH, REVIEWED IN A 5708 03:44:43,840 --> 03:44:44,200 PRESENTATION. 5709 03:44:44,200 --> 03:44:48,320 NEXT SLIDE, PLEASE. 5710 03:44:48,320 --> 03:44:50,640 NATIONAL INSTITUTE OF DRUG ABU, 5711 03:44:50,640 --> 03:44:54,400 SIX CONCEPTS LISTED HERE. 5712 03:44:54,400 --> 03:44:58,480 NEXT SLIDE. 5713 03:44:58,480 --> 03:45:00,120 NATIONAL INSTITUTE ON ALCOHOL 5714 03:45:00,120 --> 03:45:03,640 ABUSE AND ALCOHOLISM, REISSUED 5715 03:45:03,640 --> 03:45:08,640 TWO CONCEPTS THE REFRESH YOUR 5716 03:45:08,640 --> 03:45:11,360 RECOLLECTIONS O1, AND REFRESH 5717 03:45:11,360 --> 03:45:12,960 YOUR RECOLLECTIONS 34. 5718 03:45:12,960 --> 03:45:16,840 THE INCIDENCE OF NEW INFECTIONS. 5719 03:45:16,840 --> 03:45:19,840 NEXT SLIDE, PLEASE. 5720 03:45:19,840 --> 03:45:24,160 THE OFFICE OF RESEARCH AND 5721 03:45:24,160 --> 03:45:31,720 INFRASTRUCTURE PROGRAMS. 5722 03:45:31,720 --> 03:45:37,640 IMPORTANTLY, USING THE ORIP 5723 03:45:37,640 --> 03:45:38,400 ISSUE 5724 03:45:38,400 --> 03:45:40,960 ISSUED APPLICATIONS FROM 5725 03:45:40,960 --> 03:45:43,440 RESEARCH INSTITUTIONS TO SEEK 5726 03:45:43,440 --> 03:45:45,960 FUNDS TO DEVELOP RESEARCH 5727 03:45:45,960 --> 03:45:47,120 FACILITIEDS THAT SUPPORT HIV 5728 03:45:47,120 --> 03:45:51,960 RESEARCH, IN THE AREAS OF 5729 03:45:51,960 --> 03:45:56,640 BASICALLY SOCIAL, AND BEHAVIORAL 5730 03:45:56,640 --> 03:45:57,800 RESEARCH. 5731 03:45:57,800 --> 03:46:01,320 UNDER SERVED POPULATIONS, AND 5732 03:46:01,320 --> 03:46:01,960 INSTITUTIONAL DEVELOPMENT OR 5733 03:46:01,960 --> 03:46:05,400 IDEA ELIGIBLE STATES, THE 5734 03:46:05,400 --> 03:46:11,640 FACILITIES HIV RESEARCH. 5735 03:46:11,640 --> 03:46:18,680 WE WILL STOP HERE. 5736 03:46:18,680 --> 03:46:19,880 COLLEAGUES, WE HAVE ABOUT A 5737 03:46:19,880 --> 03:46:23,680 MINUTE FOR ANY QUESTIONS OR 5738 03:46:23,680 --> 03:46:28,800 COMMENTS. 5739 03:46:28,800 --> 03:46:35,000 FROM THE LAST PRESENTERS. 5740 03:46:35,000 --> 03:46:36,440 SEEING NO HANDS. 5741 03:46:36,440 --> 03:46:40,200 WE WILL MOVE ON AND THE AGENDA, 5742 03:46:40,200 --> 03:46:42,840 WE ARE IN THE HOME STRETCH HERE. 5743 03:46:42,840 --> 03:46:45,680 THE NEXT PART OF THE AGENDA, WE 5744 03:46:45,680 --> 03:46:48,560 WILL HEAR FROM THE HIV CLINICAL 5745 03:46:48,560 --> 03:46:49,480 GUIDELINES WORKING GROUPS. 5746 03:46:49,480 --> 03:46:51,680 BOTH GUIDELINES AND PANEL 5747 03:46:51,680 --> 03:46:53,240 UPDATES, WE WILL HAVE TWO 5748 03:46:53,240 --> 03:46:56,640 PRESENTERS, THE FIRST PRESENTER 5749 03:46:56,640 --> 03:47:00,400 IS DR. GULICK, WELL KNOWN 5750 03:47:00,400 --> 03:47:04,200 COLLEAGUE AND FORMER ESHG CHAIR. 5751 03:47:04,200 --> 03:47:09,440 HERE IS THE ROCHEL SUBDIVISION 5752 03:47:09,440 --> 03:47:16,720 OF INFECTIOUS DISEASES, WEILL 5753 03:47:16,720 --> 03:47:20,640 MEDICAL COLLEAGUE OF CORNELL 5754 03:47:20,640 --> 03:47:26,360 UNIVERSITY. 5755 03:47:26,360 --> 03:47:30,080 H.P.T. NETWORKS, OUR SECOND 5756 03:47:30,080 --> 03:47:36,080 PRESENTER IS DR. MASUR, CHIEF OF 5757 03:47:36,080 --> 03:47:36,960 THE CRITICAL CARE MEDICINE 5758 03:47:36,960 --> 03:47:45,200 DEPARTMENT NIH, GUIDELINES FOR 5759 03:47:45,200 --> 03:47:48,160 OPPORTUNISTIC INFECTIONS IN ALL 5760 03:47:48,160 --> 03:47:50,320 THES AND ADOLESCENTS. 5761 03:47:50,320 --> 03:47:53,120 PAST PRESIDENT OF IDSA. 5762 03:47:53,120 --> 03:47:55,160 WE WILL START WITH DR. GULICK, 5763 03:47:55,160 --> 03:47:57,560 OVER TO YOU. 5764 03:47:57,560 --> 03:47:59,080 >>THANK YOU. 5765 03:47:59,080 --> 03:48:03,160 DR. TOL BERT. 5766 03:48:03,160 --> 03:48:05,720 GREETINGS TO THE ESHG, PLEASURE 5767 03:48:05,720 --> 03:48:09,360 TO SEE YOU ON ZOOM. 5768 03:48:09,360 --> 03:48:10,400 OVERVIEW ON THE CLINICAL 5769 03:48:10,400 --> 03:48:12,160 PRACTICE GUIDELINES PROCESSES. 5770 03:48:12,160 --> 03:48:19,640 WHY IS THAT? NEXT SLIDE. 5771 03:48:19,640 --> 03:48:21,840 WELL, BECAUSE THE HIV CLINICAL 5772 03:48:21,840 --> 03:48:22,480 GUIDELINES, AND THERE ARE FIVE 5773 03:48:22,480 --> 03:48:27,000 OF THEM, ARE WORKING GROUPS OF 5774 03:48:27,000 --> 03:48:28,960 OARAC. 5775 03:48:28,960 --> 03:48:31,160 FEDERALLY APPROVED CLINICAL 5776 03:48:31,160 --> 03:48:32,240 PRACTICE GUIDELINES FOR HIV 5777 03:48:32,240 --> 03:48:32,440 AIDS. 5778 03:48:32,440 --> 03:48:33,720 YOU KNOW THEM WELL. 5779 03:48:33,720 --> 03:48:35,320 THEY ARE LISTED HERE. 5780 03:48:35,320 --> 03:48:42,400 LEFT TO RIGHT, THE ADULT AND 5781 03:48:42,400 --> 03:48:46,120 ADOLESCENT GUIDELINES, AND ADULT 5782 03:48:46,120 --> 03:48:51,360 AND ADOLESCENT OPPORTUNISTIC 5783 03:48:51,360 --> 03:48:58,320 INFECTIONS, PED AT RICK ARV, AND 5784 03:48:58,320 --> 03:49:00,880 PEDIATIC OPPORTUNISTIC 5785 03:49:00,880 --> 03:49:04,960 GUIDELINES, AND THERE ARE THE 5786 03:49:04,960 --> 03:49:06,680 PERNATAL CLINICAL GUIDELINES, 5787 03:49:06,680 --> 03:49:09,720 THEY ARE ALL AVAILABLE AT 5788 03:49:09,720 --> 03:49:12,320 CLINICAL INFO HIV.GOV. 5789 03:49:12,320 --> 03:49:14,280 OF THE FIVE, THE ONES THAT I 5790 03:49:14,280 --> 03:49:17,960 KNOW THE BEST ARE THE GUIDELINES 5791 03:49:17,960 --> 03:49:26,640 FOR THE ANTIRETROVIRAL AGENTS IN 5792 03:49:26,640 --> 03:49:32,040 ADULTS AND ADOLESCENTS WITH HIV. 5793 03:49:32,040 --> 03:49:36,360 I WILL FOCUS ON THE ADULT 5794 03:49:36,360 --> 03:49:36,680 GUIDELINES. 5795 03:49:36,680 --> 03:49:38,640 WHAT ABOUT THE HISTORY OF THE 5796 03:49:38,640 --> 03:49:42,760 GUIDELINES, WHERE DID THAT 5797 03:49:42,760 --> 03:49:46,080 KIFRESHMAN? IN 1996, THE PANEL 5798 03:49:46,080 --> 03:49:52,800 WAS FIRST COCONVENED BY DHHS AND 5799 03:49:52,800 --> 03:49:55,000 THE CASER FOUNDATION, CONCEIVED 5800 03:49:55,000 --> 03:49:56,360 AS A PRIVATE PARTNERSHIP. 5801 03:49:56,360 --> 03:50:02,240 WHY DID WE NEED THIS? 1996 WAS 5802 03:50:02,240 --> 03:50:05,880 A BANNER YEAR IN HIV, THAT WAS 5803 03:50:05,880 --> 03:50:09,920 THE YEAR THEY APPROVED THREE 5804 03:50:09,920 --> 03:50:11,400 INHIBITERS. 5805 03:50:11,400 --> 03:50:19,480 IT WAS FELT THAT THEY NIGHEDED 5806 03:50:19,480 --> 03:50:20,640 GLIDANCE. 5807 03:50:20,640 --> 03:50:26,640 THE GOAL WAS TO PROVIDE 5808 03:50:26,640 --> 03:50:29,000 GUIDANCE. 5809 03:50:29,000 --> 03:50:32,320 NEXT, THE FIRST GUIDELINES WERE 5810 03:50:32,320 --> 03:50:35,640 PUBLISHED AFTER THE PANEL MET IN 5811 03:50:35,640 --> 03:50:38,240 THE MMWR. 5812 03:50:38,240 --> 03:50:41,240 THEY WERE RELATIVELY SHORT, AND 5813 03:50:41,240 --> 03:50:42,560 GAVE DIRECT INFORMATION TO 5814 03:50:42,560 --> 03:50:46,120 PRACTICING CLINICIANS AS TO HOW 5815 03:50:46,120 --> 03:50:49,880 TO USE ART. 5816 03:50:49,880 --> 03:50:53,080 LATER, FAST FORWARDING, 2005, 5817 03:50:53,080 --> 03:50:56,560 THE GUIDELINES BECAME A WORKING 5818 03:50:56,560 --> 03:50:58,600 GROUP OF THE OFFICE OF AIDS 5819 03:50:58,600 --> 03:51:00,920 RESEARCH ADVISORY COUNCIL, THAT 5820 03:51:00,920 --> 03:51:02,800 IS YOU ALL. 5821 03:51:02,800 --> 03:51:04,360 WE CURRENTLY GOT UPDATE EACH OF 5822 03:51:04,360 --> 03:51:06,840 THE FIVE SETS OF GUIDELINES, 5823 03:51:06,840 --> 03:51:08,640 ONCE OR TWICE A YEAR, DEPENDING 5824 03:51:08,640 --> 03:51:10,280 ON THE NEED. 5825 03:51:10,280 --> 03:51:10,680 NEXT. 5826 03:51:10,680 --> 03:51:12,440 HERE IS THE PANEL STRUCTURE, 5827 03:51:12,440 --> 03:51:19,080 THERE ARE TWO CO-CHAIRS, CLIP 5828 03:51:19,080 --> 03:51:24,160 LANE FROM NIH, I AM THE ACADEMIC 5829 03:51:24,160 --> 03:51:28,000 CHAIR, AND THE EXECUTIVE 5830 03:51:28,000 --> 03:51:28,280 SECRETARY. 5831 03:51:28,280 --> 03:51:31,240 THERE ARE FIVE MEMBERS FROM 5832 03:51:31,240 --> 03:51:34,800 PARTS OF HHS, REPRESENTATIVE 5833 03:51:34,800 --> 03:51:40,640 FROM THE CDC, AND HIH, HRSA. 5834 03:51:40,640 --> 03:51:43,600 THERE ARE 38 SCIENTIST MEMBERS 5835 03:51:43,600 --> 03:51:45,000 FROM ACADEMIC CONSTITUTION 5836 03:51:45,000 --> 03:51:45,880 INSTITUTIONS ACROSS THE UNITED 5837 03:51:45,880 --> 03:51:48,960 STATES, AND ADDITIONALLY, THERE 5838 03:51:48,960 --> 03:51:52,240 ARE FIVE COMMUNITY MEMBERS. 5839 03:51:52,240 --> 03:51:55,960 WE HAVE THREE NONVOTING 5840 03:51:55,960 --> 03:52:00,040 OBSERVERS FROM OTHER GUIDELINE 5841 03:52:00,040 --> 03:52:02,640 PANELS, PERRYINATELY, AS WELL AS 5842 03:52:02,640 --> 03:52:06,360 A CLINICAL PHARMACIST. 5843 03:52:06,360 --> 03:52:10,240 THE XSHT EASE FOR THE 5844 03:52:10,240 --> 03:52:13,800 GUIDELINES, SPANS AM MULTIPLE 5845 03:52:13,800 --> 03:52:17,000 AREAS, EXPERTISE AND 5846 03:52:17,000 --> 03:52:21,680 ADOLESCENTS, VIRAL HEP TITUS, 5847 03:52:21,680 --> 03:52:25,160 BIOSTATISTICS, IMMUNOLOGY, 5848 03:52:25,160 --> 03:52:35,480 SUBSTANCE USE, TRANSGENDER CAR, 5849 03:52:35,480 --> 03:52:41,200 COMORBIB IDS, AND COST 5850 03:52:41,200 --> 03:52:41,520 EFFECTIVENESS. 5851 03:52:41,520 --> 03:52:48,720 THREE NONVOTING OBSERVERS, THREE 5852 03:52:48,720 --> 03:52:50,680 NONMEMBER CULTANTS, ONE IS AN 5853 03:52:50,680 --> 03:52:54,800 EXPERT IN HIV AND TREATMENT. 5854 03:52:54,800 --> 03:52:56,960 THE FLAUN HHS MEMBERS ARE 5855 03:52:56,960 --> 03:52:58,360 SELECTED THROUGH OPEN 5856 03:52:58,360 --> 03:53:00,600 APPLICATIONS, THAT WOULD BE THE 5857 03:53:00,600 --> 03:53:02,480 38 CLINICAL AND SCIENTIFIC 5858 03:53:02,480 --> 03:53:02,720 MEMBERS. 5859 03:53:02,720 --> 03:53:06,520 THEY EACH SERVE A FOUR-YEAR 5860 03:53:06,520 --> 03:53:08,960 TERM, HAVE THE OPTION TO REVIEW 5861 03:53:08,960 --> 03:53:11,440 IT ONE TIME. 5862 03:53:11,440 --> 03:53:15,000 NEXT, WE HAVE AND IN OUR 5863 03:53:15,000 --> 03:53:18,800 STRUCTURE, 21 WRITING TAMS, 5864 03:53:18,800 --> 03:53:23,440 FOCUSED ON DIFFERENT AREAS OF 5865 03:53:23,440 --> 03:53:23,960 IMP SYSTEM. 5866 03:53:23,960 --> 03:53:25,360 4 TO 12 MEMBERS. 5867 03:53:25,360 --> 03:53:29,000 THAT IS WHERE THE WORK OF THE 5868 03:53:29,000 --> 03:53:31,880 GUIDELINES IS DONE. 5869 03:53:31,880 --> 03:53:34,120 THIS WILL SHOW YOU HOW WE 5870 03:53:34,120 --> 03:53:35,840 DEVELOP AND REVISE THE 5871 03:53:35,840 --> 03:53:36,760 GUIDELINES, NEXT, THE FIRST 5872 03:53:36,760 --> 03:53:39,160 THING WE DO IS REVIEW THE 5873 03:53:39,160 --> 03:53:41,440 LITERATURE, THE PUBLISHED 5874 03:53:41,440 --> 03:53:42,960 LITERATURE, ABSTRUCTS PRESENTED 5875 03:53:42,960 --> 03:53:45,520 AT CONFERENCES, THESE DAYS, 5876 03:53:45,520 --> 03:53:48,760 PRESS RELEASES AND PRE-PRINTS 5877 03:53:48,760 --> 03:53:52,120 ARE PART OF THE BODY OF LANGUAGE 5878 03:53:52,120 --> 03:53:58,040 THAT WE REGALLY, NEW SECTIONS OF 5879 03:53:58,040 --> 03:53:58,960 THE GUIDELINES. 5880 03:53:58,960 --> 03:54:02,080 ONE OF THOSE WRITING SCHEMES, 5881 03:54:02,080 --> 03:54:07,080 FOCUSES ON THE DRAFTS, 5882 03:54:07,080 --> 03:54:08,520 CIRCULATES TAKES COMMENTS TO 5883 03:54:08,520 --> 03:54:11,920 DRAFT A NEW SEKSZ OR UPDATED 5884 03:54:11,920 --> 03:54:12,760 SECTION OF THE GUIDELINE. 5885 03:54:12,760 --> 03:54:14,560 MOST OF THE WORK IS DONE WITHIN 5886 03:54:14,560 --> 03:54:16,840 THE SUBTEAM. 5887 03:54:16,840 --> 03:54:18,960 ULTIMATELY, THEY PRODUCE A FINAL 5888 03:54:18,960 --> 03:54:20,520 DRAFT, WHICH GOES TO THE FULL 5889 03:54:20,520 --> 03:54:25,000 PANEL AND PRESENTED AT ONE OF 5890 03:54:25,000 --> 03:54:29,000 OUR MONTHLY CONFERENCE CALLS. 5891 03:54:29,000 --> 03:54:32,280 THE ENTIRE PANEL HAS THE RIGHT 5892 03:54:32,280 --> 03:54:33,520 TO GIVE FEEDBACK ON AN 5893 03:54:33,520 --> 03:54:35,880 INDIVIDUAL SECTION, AND THE TEAM 5894 03:54:35,880 --> 03:54:38,320 WILL REVISE THE SECTION BASED ON 5895 03:54:38,320 --> 03:54:41,600 THE COMMENTS, THE PANEL VOTES 5896 03:54:41,600 --> 03:54:44,680 FOR EACH NEW RECOMMENDATION, AND 5897 03:54:44,680 --> 03:54:50,440 BASED ON THAT, THE TEAM WILL 5898 03:54:50,440 --> 03:54:54,560 INCORPORATE COMPLENTS AND THE 5899 03:54:54,560 --> 03:54:56,520 VOTE WILL FULLY PROVE THE 5900 03:54:56,520 --> 03:54:57,200 SECTION TO MOVE FORWARD 5901 03:54:57,200 --> 03:55:03,440 >>THE NEXT STEPS, SUBMIT TO HIV 5902 03:55:03,440 --> 03:55:05,320 INFO, AND ULTIMATELY, THE SECOND 5903 03:55:05,320 --> 03:55:13,320 IS REVIEWED BY THE EXECUTIVE 5904 03:55:13,320 --> 03:55:17,360 SECRETARY TO FINALIZE IT. 5905 03:55:17,360 --> 03:55:20,400 IT WOULD BE PUBLIC. 5906 03:55:20,400 --> 03:55:24,000 IMPORTANT TO KNOW THAT ALL OF 5907 03:55:24,000 --> 03:55:25,920 OUR TEAMS WORK SIMULTANEOUSLY. 5908 03:55:25,920 --> 03:55:28,840 FROM START TO COMPLETION OF A 5909 03:55:28,840 --> 03:55:32,480 REVIG, CAN TAKE BETWEEN 4 AND 9 5910 03:55:32,480 --> 03:55:35,040 MONTHS, WE TYPICALLY, UPDATE THE 5911 03:55:35,040 --> 03:55:38,720 RELEASE ABOUT ONCE A YEAR FOR A 5912 03:55:38,720 --> 03:55:42,440 NEW VERSION OF THE GUIDELINES. 5913 03:55:42,440 --> 03:55:43,880 NEXT. 5914 03:55:43,880 --> 03:55:44,080 NEXT. 5915 03:55:44,080 --> 03:55:46,360 SO, HERE ARE THE CURRENT 5916 03:55:46,360 --> 03:55:48,120 GUIDELINES, SECTIONS, WHAT IS 5917 03:55:48,120 --> 03:55:51,320 NEW, THE BASELINE EVALUATION. 5918 03:55:51,320 --> 03:55:55,080 LAB TESTING, TREATMENT GOALS, 5919 03:55:55,080 --> 03:55:56,960 INITIATION OF ART, WHAT IS TO 5920 03:55:56,960 --> 03:55:59,280 START. 5921 03:55:59,280 --> 03:56:02,120 WHAT NOT TO USE. 5922 03:56:02,120 --> 03:56:11,120 MANAGEMENT AND THEN, 5923 03:56:11,120 --> 03:56:13,880 CO-INFECTION, OLDER PEOPLE, 5924 03:56:13,880 --> 03:56:18,280 SUBSTANCE USE, TRANSGENDER AND 5925 03:56:18,280 --> 03:56:18,880 WOMEN. 5926 03:56:18,880 --> 03:56:24,960 A FEW LAST SECONDS, ART AND 5927 03:56:24,960 --> 03:56:28,960 CO-INFECTIONS, LIMITATIONS TO 5928 03:56:28,960 --> 03:56:39,520 ARC, A HELPFUL SECTION ON RENAL 5929 03:56:43,240 --> 03:56:44,680 DOSING TABLES. 5930 03:56:44,680 --> 03:56:46,920 WE HAVE THE TUNGZ TO MAKE 5931 03:56:46,920 --> 03:56:52,080 INTERMITEN RELEASES, IF THERE IS 5932 03:56:52,080 --> 03:56:53,840 RAPID COMMUNICATION THAT NEEDS 5933 03:56:53,840 --> 03:56:56,920 TO BE PROVIDED TO PROVIDERS 5934 03:56:56,920 --> 03:56:58,920 ACROSS THE U.S. 5935 03:56:58,920 --> 03:57:09,440 AN UNDER THE TIME OF CONCEPTION, 5936 03:57:12,920 --> 03:57:14,280 RERAYING IT THIS INFORMATION TO 5937 03:57:14,280 --> 03:57:14,840 U.S. PROVIDERS. 5938 03:57:14,840 --> 03:57:17,000 YOU CAN SEE THE TITLES THERE. 5939 03:57:17,000 --> 03:57:20,680 THE OTHER THING THAT WE CAN DO 5940 03:57:20,680 --> 03:57:26,080 IS OFFER SPECIFIC GUIDANCE. 5941 03:57:26,080 --> 03:57:29,200 HOW DO YOU MANAGE PEOPLE LIVING 5942 03:57:29,200 --> 03:57:36,880 WITH HIV DURING A DISASTER, WE 5943 03:57:36,880 --> 03:57:41,000 CAME UP FOR FORMAL GIANS FOR 5944 03:57:41,000 --> 03:57:47,040 CARING FOR THOSE PEOPLE LIVING 5945 03:57:47,040 --> 03:57:48,960 WITH HIV. 5946 03:57:48,960 --> 03:57:57,720 THESE ARE POPULAR GUIDELINES 5947 03:57:57,720 --> 03:58:08,280 FROM AROUND THE WORLD, THESE ARE 5948 03:58:10,400 --> 03:58:20,960 RECENT, YOU CAN SEE 6, 6 5949 03:58:25,040 --> 03:58:28,120 SEVEN,000, THE AUSTRALIANS USE 5950 03:58:28,120 --> 03:58:31,080 THEIR GUIDELINES, AND ANNOTATE 5951 03:58:31,080 --> 03:58:32,160 THEM FOR THEIR USE. 5952 03:58:32,160 --> 03:58:34,920 OF ALL THE GUIDELINES AROUND THE 5953 03:58:34,920 --> 03:58:37,720 WORLD, THEY CHOSE US, WHICH WE 5954 03:58:37,720 --> 03:58:38,680 ARE PROUD OF. 5955 03:58:38,680 --> 03:58:42,360 WE COMMUTE WITH THEM. 5956 03:58:42,360 --> 03:58:43,680 THANKS ON OARAC FOR SUPPORTING 5957 03:58:43,680 --> 03:58:47,080 US OVER THE MANY YEARS, OF 5958 03:58:47,080 --> 03:58:49,400 COURSE, THE OFFICE OF AIDS 5959 03:58:49,400 --> 03:58:52,800 RESEARCH, AND MY COACH, AND 5960 03:58:52,800 --> 03:58:56,680 SECOND AND MY LAST SLIDE LISTS 5961 03:58:56,680 --> 03:59:02,680 THE NUMBERS. 5962 03:59:02,680 --> 03:59:06,680 CAN YOU SEE, WE HAVE BROUGHT 5963 03:59:06,680 --> 03:59:07,840 REPRESENTATION FROM ACADEMIC 5964 03:59:07,840 --> 03:59:10,080 CENTERS ACROSS THE COUNTRY, AND 5965 03:59:10,080 --> 03:59:13,560 THE FOUR COMMUNITY MEMBERS, FROM 5966 03:59:13,560 --> 03:59:16,960 LOS ANGELES, THE DISTRICT OF 5967 03:59:16,960 --> 03:59:19,560 COLUMBUSIA, SAN DIEGO AND I WILL 5968 03:59:19,560 --> 03:59:22,320 STOP THERE, THANKS FOR YOUR 5969 03:59:22,320 --> 03:59:22,600 ATTENTION. 5970 03:59:22,600 --> 03:59:28,520 >>WE WILL MOVE ON TO DR. 5971 03:59:28,520 --> 03:59:28,880 MASURE. 5972 03:59:28,880 --> 03:59:32,640 >>THANKS. 5973 03:59:32,640 --> 03:59:37,360 THANK YOU FOR THE OPPORTUNITY TO 5974 03:59:37,360 --> 03:59:40,960 PRESENT THE GUIDELINES, HOW 5975 03:59:40,960 --> 03:59:50,280 ABOUT PROCESS IS SIMILAR, NOT 5976 03:59:50,280 --> 03:59:50,560 IDENTICAL. 5977 03:59:50,560 --> 03:59:53,320 OURS ARE A LITTLE DIFFERENT 5978 03:59:53,320 --> 03:59:53,600 STRUCTURE. 5979 03:59:53,600 --> 03:59:56,920 WE DO THIS JOINTLY WITH THE 5980 03:59:56,920 --> 03:59:58,200 INFECTIOUS DISEASE SOCIETY, AND 5981 03:59:58,200 --> 04:00:03,040 WITH CDC, SO THAT OUR CO-CHAIRS, 5982 04:00:03,040 --> 04:00:07,680 IN ADDITION TO ME, CONNIE 5983 04:00:07,680 --> 04:00:10,640 BENSON, JOHN BROOKS FROM CDC, 5984 04:00:10,640 --> 04:00:15,320 AND ALICE POW, ONE OF THE 5985 04:00:15,320 --> 04:00:19,200 CO-CHAIRS AS WELL. WE ARE 5986 04:00:19,200 --> 04:00:23,720 CONCERNED WITH HOW MUCH USE THE 5987 04:00:23,720 --> 04:00:26,640 GUIDELINES HAVE. 5988 04:00:26,640 --> 04:00:28,920 WE WILL LIKE TO RECOGNIZE THOSE 5989 04:00:28,920 --> 04:00:30,680 WHO USE IT WISELY. 5990 04:00:30,680 --> 04:00:36,280 THESE GUYS ARE FREQUENTLY 5991 04:00:36,280 --> 04:00:38,240 ACCESS, WHILE THE GUIDELINES 5992 04:00:38,240 --> 04:00:42,400 DON'T ACCESS AS OFTEN AS THE A 5993 04:00:42,400 --> 04:00:44,320 ART GUIDELINE, 5,000 STAGE 5994 04:00:44,320 --> 04:00:47,320 VIEWS, THESE ARE LARGELY IN THE 5995 04:00:47,320 --> 04:00:48,960 UNITED STATES, NOT EXACTLY, THE 5996 04:00:48,960 --> 04:00:53,080 GUIDELINES ARE FOCUSED ON THE 5997 04:00:53,080 --> 04:00:57,320 U.S., THAT IS WHAT WE ARE CONS 5998 04:00:57,320 --> 04:00:59,680 CONSTITUTED WITH, WE DO THINK 5999 04:00:59,680 --> 04:01:03,160 THEY HAVE WIDE INFLUENCE. 6000 04:01:03,160 --> 04:01:08,040 FLKS SLIDE. 6001 04:01:08,040 --> 04:01:10,280 IF YOU LOOK AT WHAT SECTIONS ARE 6002 04:01:10,280 --> 04:01:12,960 BEING USED, 29 DIFFERENT 6003 04:01:12,960 --> 04:01:16,720 CHAPTERS ON INDIVIDUAL PASSAGES, 6004 04:01:16,720 --> 04:01:20,520 GROUPS OF PASSAGES, IT IS ALWAYS 6005 04:01:20,520 --> 04:01:22,320 INTERESTING TO SEE WHAT SECTIONS 6006 04:01:22,320 --> 04:01:32,960 ARE USE ARES A OUR USERS ARE 6007 04:01:36,400 --> 04:01:37,960 LOOKING AT. 6008 04:01:37,960 --> 04:01:42,400 MAINTAIN ON THE LESS USED 6009 04:01:42,400 --> 04:01:44,640 SECTIONINGS, THOSE ARE THE ONES, 6010 04:01:44,640 --> 04:01:48,960 WHEN YOU GET A CASE OF HIV THAT 6011 04:01:48,960 --> 04:01:51,280 IS WHEN YOU ARE MOST DESPERATE 6012 04:01:51,280 --> 04:01:54,920 FOR SOMETHING UP TO DATE AND 6013 04:01:54,920 --> 04:01:55,200 RELEVANT. 6014 04:01:55,200 --> 04:01:59,200 EVEN THE LESS USE. 6015 04:01:59,200 --> 04:02:00,960 NEXT SLIDE. 6016 04:02:00,960 --> 04:02:04,240 WE UPDATE THESE, MOST RECENTLY, 6017 04:02:04,240 --> 04:02:08,280 UPDATED THE HEP-C VIRUS SECTION. 6018 04:02:08,280 --> 04:02:12,040 OUR SECTION GROUPS MEET AS A 6019 04:02:12,040 --> 04:02:12,360 GROUP. 6020 04:02:12,360 --> 04:02:17,440 WE ASK THEM WHAT IT NEEDS TO BE 6021 04:02:17,440 --> 04:02:20,600 UPDATED. 6022 04:02:20,600 --> 04:02:22,480 WE PUBLISH UPDATES THROUGHOUT 6023 04:02:22,480 --> 04:02:23,400 THE YEAR. 6024 04:02:23,400 --> 04:02:24,600 NEXT SLIDE. 6025 04:02:24,600 --> 04:02:26,680 SOME OF THE ADMINISTRATIVE 6026 04:02:26,680 --> 04:02:28,960 CHANGES WE ARE MAKING WE LOOK TO 6027 04:02:28,960 --> 04:02:32,960 SEE, ARE THEY READABLE? ARE 6028 04:02:32,960 --> 04:02:37,680 THEY EASY TO ACCESS? WHAT DO 6029 04:02:37,680 --> 04:02:40,800 THE PARTNER OTHERS WANT. 6030 04:02:40,800 --> 04:02:43,800 TO BE MORE INVOLVED, LOOKING AT 6031 04:02:43,800 --> 04:02:45,040 THE CONTENT. 6032 04:02:45,040 --> 04:02:48,960 THEY GIVE US USEFUL FEEDBACK. 6033 04:02:48,960 --> 04:02:53,120 THEIR FEEDBACK OR SESSION CDC 6034 04:02:53,120 --> 04:02:54,480 ALSO DOES THIS. 6035 04:02:54,480 --> 04:02:59,080 WE ARE IN THE PROCESS OF WORKING 6036 04:02:59,080 --> 04:03:00,960 WITH OUR SUBJECT GROUP, SIMPLIFY 6037 04:03:00,960 --> 04:03:08,640 THE TABLES TO MAKE THEM MORE 6038 04:03:08,640 --> 04:03:11,560 READABLE. 6039 04:03:11,560 --> 04:03:14,640 WE HAVE A SECTION REVIEW GROUP, 6040 04:03:14,640 --> 04:03:16,640 WHO READ EACH GROUP AND MAKE 6041 04:03:16,640 --> 04:03:17,520 SESSIONS AS TO WHETHER OR NOT 6042 04:03:17,520 --> 04:03:20,640 THE SECTIONS ARE CLEAR, 6043 04:03:20,640 --> 04:03:22,080 PRACTICAL AND CONFORM TO WHAT 6044 04:03:22,080 --> 04:03:26,160 PEOPLE ARE ACTUALLY DOING. 6045 04:03:26,160 --> 04:03:26,840 NEXT SLIDE. 6046 04:03:26,840 --> 04:03:28,560 THIS IS AN EXAMPLE. 6047 04:03:28,560 --> 04:03:32,120 RECENTLY, WE Z DVEN UPDATES, WE 6048 04:03:32,120 --> 04:03:34,480 CHANGED OVER TABLES, IN THE NEAR 6049 04:03:34,480 --> 04:03:36,920 FUTURE, WE ARE MAKING MORE 6050 04:03:36,920 --> 04:03:40,040 CHANGES, THEY WILL BE ROLLED OUT 6051 04:03:40,040 --> 04:03:40,800 PERIODICALLY THROUGHOUT THE 6052 04:03:40,800 --> 04:03:41,000 YEAR. 6053 04:03:41,000 --> 04:03:44,960 THAT COMPLETES THIS UPDATE. 6054 04:03:44,960 --> 04:03:51,000 AGAIN, WE VALUE FOR OAR, AND 6055 04:03:51,000 --> 04:03:53,080 HAVING UPTO DATE INFORMATION WE 6056 04:03:53,080 --> 04:03:56,960 ARE ABLE TO UPDATE MORE 6057 04:03:56,960 --> 04:04:03,320 FREQUENTLY THAN BOOKS AND 6058 04:04:03,320 --> 04:04:03,560 SOURCES. 6059 04:04:03,560 --> 04:04:08,320 WE ARE HAPPY THEY GET USED. 6060 04:04:08,320 --> 04:04:10,040 THANK YOU VERY MUCH. 6061 04:04:10,040 --> 04:04:14,360 >>WE Z QUITE A BIT OF TIME LEFT 6062 04:04:14,360 --> 04:04:20,480 FOR SOME GOOD Q AND A. 6063 04:04:20,480 --> 04:04:22,640 >>THANK YOU FOR THOSE 6064 04:04:22,640 --> 04:04:24,680 PRESENTATIONS, THANK YOU FOR ALL 6065 04:04:24,680 --> 04:04:28,600 THE WORK YOU DO, PUTTING THE 6066 04:04:28,600 --> 04:04:29,160 GUIDELINES TOGETHER. 6067 04:04:29,160 --> 04:04:34,720 IT IS AN UNVALUABLE RESOURCE. 6068 04:04:34,720 --> 04:04:37,480 GET YOUR INSIGHTS, WHETHER OR 6069 04:04:37,480 --> 04:04:40,320 NOT YOU HAVE CONSIDERED MAKING 6070 04:04:40,320 --> 04:04:43,120 GUIDELINES FOR CARING FOR 6071 04:04:43,120 --> 04:04:45,000 PERSONS IN HIV TRIALS. 6072 04:04:45,000 --> 04:04:47,760 WE FIND THAT AT LEAST IN THE 6073 04:04:47,760 --> 04:04:51,800 CONTEXT OF TRIAL RECRUITMENT, 6074 04:04:51,800 --> 04:04:53,000 RECURRENT EXPERIENCES THAT WE 6075 04:04:53,000 --> 04:04:55,400 HAVE TO EDUCATE THE PROVIDERS 6076 04:04:55,400 --> 04:04:59,680 ABOUT MAKING THEM COMFORTABLE, 6077 04:04:59,680 --> 04:05:05,680 SO THEY ALLOW THEIR PATIENTS TO 6078 04:05:05,680 --> 04:05:08,960 PARTICIPATE OF RESEARCHERS, 6079 04:05:08,960 --> 04:05:11,480 COMFORTABLE WITH THIS NOTION. 6080 04:05:11,480 --> 04:05:13,000 THERE IS THE CENTER CITY AND 6081 04:05:13,000 --> 04:05:16,040 OUTSIDE PROVIDERS, MORE FOREIGN 6082 04:05:16,040 --> 04:05:17,840 TO THIS. 6083 04:05:17,840 --> 04:05:23,760 HOW DO WE GET MORE WOMEN 6084 04:05:23,760 --> 04:05:24,040 INVOLVED. 6085 04:05:24,040 --> 04:05:26,000 PROVIDERS, SOMETIMES NOW PART OF 6086 04:05:26,000 --> 04:05:28,560 THE ACADEMIC CENTER, THEY ARE 6087 04:05:28,560 --> 04:05:30,520 LESS VERSED IN THE RESEARCH 6088 04:05:30,520 --> 04:05:30,760 PROCESS. 6089 04:05:30,760 --> 04:05:33,760 WHEN WE APPROACH THEM, THE 6090 04:05:33,760 --> 04:05:35,720 PARTICIPANT, MANY TIMES THEY SAY 6091 04:05:35,720 --> 04:05:37,120 ABSOLUTELY, TALK TO THE PROVIDER 6092 04:05:37,120 --> 04:05:41,480 AND SAY, YOU KNOW, IT IS A RISK, 6093 04:05:41,480 --> 04:05:43,240 WHATEVER. 6094 04:05:43,240 --> 04:05:44,520 THE DISCUSSION ENDS. 6095 04:05:44,520 --> 04:05:47,800 THERE MAY BE AN OPPORTUNITY TO 6096 04:05:47,800 --> 04:05:51,040 AT LEAST DISCUSSION IF THERE IS 6097 04:05:51,040 --> 04:05:54,560 VALUE TO CREATING A RESOURCE 6098 04:05:54,560 --> 04:05:56,320 THAT COULD MAYBE FACILITATE THIS 6099 04:05:56,320 --> 04:05:57,920 DISCUSSION OR EDUCATION. 6100 04:05:57,920 --> 04:06:00,840 I AM NOT SAYING, MAYBE YOU HAVE 6101 04:06:00,840 --> 04:06:04,800 IT, I AM INTRODUCING AT LEAST A 6102 04:06:04,800 --> 04:06:07,120 GAP THAT WE FACED OFTEN, I AM 6103 04:06:07,120 --> 04:06:11,680 SURE YOU ARE AWARE OF IT AS 6104 04:06:11,680 --> 04:06:12,040 WELL. 6105 04:06:12,040 --> 04:06:15,560 COULD THIS TOOL BE SOMETHING IN 6106 04:06:15,560 --> 04:06:19,080 THE TOOL KIT WE COULD CONSIDER. 6107 04:06:19,080 --> 04:06:20,680 >>TRIP AND I WOULD BE 6108 04:06:20,680 --> 04:06:23,160 INTERESTED TO SEE IF WE HAVE 6109 04:06:23,160 --> 04:06:27,960 IDENTICAL OR PARALLEL VIEWS. 6110 04:06:27,960 --> 04:06:30,440 THE ONLY GUIDELINES THAT I AM 6111 04:06:30,440 --> 04:06:33,320 AWARE OF HAS BEEN WILLING TO DO. 6112 04:06:33,320 --> 04:06:38,640 THEY ARE SO TIME INTENSITY, AND 6113 04:06:38,640 --> 04:06:40,240 IT IS NOT EXACTLY OUR MISSION. 6114 04:06:40,240 --> 04:06:42,480 YOU COULD ARGUE THAT IT IS 6115 04:06:42,480 --> 04:06:43,840 IMPORTANT THAT WE COMMUNICATE. 6116 04:06:43,840 --> 04:06:49,560 THE ONLY THINGS WE DO, IS HIV 6117 04:06:49,560 --> 04:06:52,360 GUIDELINES AND SO VID. 6118 04:06:52,360 --> 04:06:56,280 WE HAVE TRIED TO THE FOCUS 6119 04:06:56,280 --> 04:06:59,880 GUIDELINE, TO FOCUS ON THE 6120 04:06:59,880 --> 04:07:00,800 MISSION. 6121 04:07:00,800 --> 04:07:02,440 TO UPDATE, THERE ARE MANY THINGS 6122 04:07:02,440 --> 04:07:03,080 WE CAN DO. 6123 04:07:03,080 --> 04:07:06,760 THE QUESTION IS, IS THAT AN 6124 04:07:06,760 --> 04:07:09,360 INVESTMENT THEY WANT TO MAKE? 6125 04:07:09,360 --> 04:07:14,880 IS THAT OUR ROLE? THESE ARE 6126 04:07:14,880 --> 04:07:20,680 ENORMOUSLY TIME CONSUMING. 6127 04:07:20,680 --> 04:07:28,240 THE QUESTION HOW WOULD YOU 6128 04:07:28,240 --> 04:07:30,120 ANSWER THAT 6129 04:07:30,120 --> 04:07:32,640 >>I AGREE WITH YOU, NOT 6130 04:07:32,640 --> 04:07:32,960 SURPRISINGLY. 6131 04:07:32,960 --> 04:07:35,680 THAT IS A GREAT POINT. 6132 04:07:35,680 --> 04:07:40,840 IN CLINICAL TRIALS, HOW DO WE 6133 04:07:40,840 --> 04:07:42,000 EDUCATE COMMUNITY PROVIDERS 6134 04:07:42,000 --> 04:07:44,080 ABOUT CLINICAL TRIALS, WHAT THEY 6135 04:07:44,080 --> 04:07:48,640 MIGHT DO FOR US. 6136 04:07:48,640 --> 04:07:53,080 AS HENRY MENTIONED, IT MAY BE 6137 04:07:53,080 --> 04:08:00,520 OUT OF -- IN THE GUIDELINES, WE 6138 04:08:00,520 --> 04:08:03,480 INCORPORATE THE RESULT. 6139 04:08:03,480 --> 04:08:08,680 WHEN WE GIVE RESULTS, UNANSWER 6140 04:08:08,680 --> 04:08:13,600 ED THE NEXT STEP, CLARIFYING, 6141 04:08:13,600 --> 04:08:16,320 WHAT ARE CLINICAL TRIALS, WHAT 6142 04:08:16,320 --> 04:08:19,160 CAN THEY DO FOR YOU, THAT MAY BE 6143 04:08:19,160 --> 04:08:20,000 BEYOND OUR PERVIEW. 6144 04:08:20,000 --> 04:08:23,960 OTHER GROUPS MAY BE THINKING 6145 04:08:23,960 --> 04:08:28,040 ABOUT THIS. 6146 04:08:28,040 --> 04:08:31,280 >>LET ME MAKE A POINT FROM 6147 04:08:31,280 --> 04:08:32,280 SOMEONE WILL RESPOND. 6148 04:08:32,280 --> 04:08:36,480 FOR THE INDIVIDUAL PANELS. 6149 04:08:36,480 --> 04:08:38,240 I AGREE WHAT YOU ARE PROPOSING 6150 04:08:38,240 --> 04:08:39,240 IS IMPORTANT. 6151 04:08:39,240 --> 04:08:42,480 THESE PANELS TAKE AING HUGE 6152 04:08:42,480 --> 04:08:44,680 AMOUNT OF INPUT FROM VOLUNTEERS, 6153 04:08:44,680 --> 04:08:49,000 RIGHT NOW, ESPECIALLY IN COVID, 6154 04:08:49,000 --> 04:08:51,200 THE VOLUNTEERS, IT IS REMARKABLE 6155 04:08:51,200 --> 04:08:53,040 HOW MUCH TIME THEY ARE WILLING 6156 04:08:53,040 --> 04:08:56,080 TO VOLUNTEER. 6157 04:08:56,080 --> 04:09:00,840 I ACCEPT IT WOULD BE WITHOUT 6158 04:09:00,840 --> 04:09:10,040 CREATING DIFFERENT PANELS. 6159 04:09:10,040 --> 04:09:11,760 I DON'T KNOW IF ANYONE ELSE 6160 04:09:11,760 --> 04:09:14,480 WOULD LIKE TO MAKE A COMMENT OR 6161 04:09:14,480 --> 04:09:16,640 RATHER THAN MAKE A COMMENT ON 6162 04:09:16,640 --> 04:09:24,520 THAT MAUREEN? I THINK YOU ARE 6163 04:09:24,520 --> 04:09:30,520 ON MUTE. 6164 04:09:30,520 --> 04:09:34,760 >>BUT I SAID ALL THE GOOD 6165 04:09:34,760 --> 04:09:35,160 STUFF. 6166 04:09:35,160 --> 04:09:38,080 I WAS THANKING TRIP AND HENRY. 6167 04:09:38,080 --> 04:09:39,400 GOOD TO SEE THEM. 6168 04:09:39,400 --> 04:09:42,560 WE ARE IN LISTENING MODE, HENRY, 6169 04:09:42,560 --> 04:09:46,320 IN TERMS OF GETTING INPUT TO 6170 04:09:46,320 --> 04:09:49,440 THIS IDEA FROM THE OARAC FLBS 6171 04:09:49,440 --> 04:09:50,440 AND CONSIDER WHAT FURTHER WHAT 6172 04:09:50,440 --> 04:09:51,560 WE SHOULD DO ABOUT IT. 6173 04:09:51,560 --> 04:09:55,360 I WOULD LIKE TO HEAR WHAT OUR 6174 04:09:55,360 --> 04:09:56,640 OARAC NUMBERS IN GENERAL THINK 6175 04:09:56,640 --> 04:09:57,400 ABOUT IT. 6176 04:09:57,400 --> 04:10:01,040 I THINK THERE ARE TWO QUESTIONS, 6177 04:10:01,040 --> 04:10:05,640 IS THIS WORTHWHILE, AND IS THIS 6178 04:10:05,640 --> 04:10:08,680 AN INTERESTING LINK BETWEEN 6179 04:10:08,680 --> 04:10:11,280 CRITICAL CARE AND RESEARCH TO 6180 04:10:11,280 --> 04:10:12,680 DEVELOP CLINICAL CARE. 6181 04:10:12,680 --> 04:10:14,680 AND THE PRODUCTS THAT ARE PUT 6182 04:10:14,680 --> 04:10:18,000 INTO CLINICAL CARE F SO, HOW 6183 04:10:18,000 --> 04:10:22,760 COULD THIS BE? I THINK IT IS A 6184 04:10:22,760 --> 04:10:27,280 TWO-PART QUESTION. 6185 04:10:27,280 --> 04:10:28,560 THANKS. 6186 04:10:28,560 --> 04:10:32,680 >>I WILL PASS IT OVER TO MARY, 6187 04:10:32,680 --> 04:10:32,920 BRIEFLY. 6188 04:10:32,920 --> 04:10:34,840 >>THANK YOU DOCTOR, I WANTED TO 6189 04:10:34,840 --> 04:10:39,080 MAKE SURE WE WERE ALL AWARE THAT 6190 04:10:39,080 --> 04:10:42,080 DR. RONALD WILCOX ARE WITH US, 6191 04:10:42,080 --> 04:10:44,680 AND DR. ROHAN, THEY ARE MEMBER 6192 04:10:44,680 --> 04:10:47,360 OF THE PEDIATRIC PANEL. 6193 04:10:47,360 --> 04:10:50,680 WE WERE JOINED BY THE PRENATAL 6194 04:10:50,680 --> 04:10:51,200 PANEL. 6195 04:10:51,200 --> 04:10:53,960 IF THERE ARE QUESTIONS REGARDING 6196 04:10:53,960 --> 04:10:57,560 THE FEEDING GUIDELINES MENTIONED 6197 04:10:57,560 --> 04:10:58,720 EARLIER, FEEL FREE TO ASK THEM 6198 04:10:58,720 --> 04:10:59,760 AS WELL. 6199 04:10:59,760 --> 04:11:02,120 >>THANK YOU. 6200 04:11:02,120 --> 04:11:08,600 >>DR. MILLER? 6201 04:11:08,600 --> 04:11:12,960 >>I JUST WANTED TO THANK TRIP, 6202 04:11:12,960 --> 04:11:19,320 AND HENRY FOR THE PRESENTATIONS, 6203 04:11:19,320 --> 04:11:20,560 HAVING SPENT TIME TALKING ABOUT 6204 04:11:20,560 --> 04:11:22,920 THE GUIDELINES, NOT JUST FOR THE 6205 04:11:22,920 --> 04:11:25,120 CARE OF PATIENTS BUT ACCESS TO 6206 04:11:25,120 --> 04:11:28,960 THE CARE THEY NEED IN TERMS OF 6207 04:11:28,960 --> 04:11:31,760 SUPPORTING REIMBURSEMENT AMONG 6208 04:11:31,760 --> 04:11:33,800 THE COMPLICATED REIMBURSEMENT 6209 04:11:33,800 --> 04:11:36,400 PARTIES THAT WE HAVE HERE IN THE 6210 04:11:36,400 --> 04:11:36,600 U.S. 6211 04:11:36,600 --> 04:11:42,120 IN JUST FOR THE REMINDER HOW 6212 04:11:42,120 --> 04:11:44,440 SPECIAL THE NIH TREATMENT PANEL 6213 04:11:44,440 --> 04:11:44,680 IS. 6214 04:11:44,680 --> 04:11:46,880 I DON'T BELIEVE IT EXISTS IN 6215 04:11:46,880 --> 04:11:48,360 THAT FORM FOR ANY OTHER DISEASE. 6216 04:11:48,360 --> 04:11:50,040 I MAY BE WRONG. 6217 04:11:50,040 --> 04:11:54,920 TO HAVE A FEDERALLY APPROVED NIH 6218 04:11:54,920 --> 04:11:56,440 GUIDELINES PANEL, THAT INCLUDES, 6219 04:11:56,440 --> 04:12:00,960 ALL THE AGENCIES, I THINK IT IS 6220 04:12:00,960 --> 04:12:03,240 UNIQUE. 6221 04:12:03,240 --> 04:12:05,200 PLEASE CORRECT ME IF I AM WRONG. 6222 04:12:05,200 --> 04:12:06,520 TO ACKNOWLEDGE, NOT JUST THE 6223 04:12:06,520 --> 04:12:08,960 AMOUNT OF TIME IT TAKES ON THE 6224 04:12:08,960 --> 04:12:11,920 PARTICIPANTS AND PANEL MEMBERS, 6225 04:12:11,920 --> 04:12:13,920 BUT ALSO, ON THE LEADERSHIP ON 6226 04:12:13,920 --> 04:12:17,120 PEOPLE LIKE YOU AND ALICE. 6227 04:12:17,120 --> 04:12:20,160 IT MADE ME WANT TO THANK 6228 04:12:20,160 --> 04:12:23,640 EVERYBODY FOR THEIR EFFORTS. 6229 04:12:23,640 --> 04:12:26,760 THE CLINICAL TRIAL QUESTION, I 6230 04:12:26,760 --> 04:12:30,040 REALLY THINK THAT THAT MAYBE 6231 04:12:30,040 --> 04:12:31,800 POINTING OUT WHAT CLINICAL 6232 04:12:31,800 --> 04:12:35,040 TRIALS ARE, AND WHAT MIGHT COME 6233 04:12:35,040 --> 04:12:36,360 UP IN FUTURE TREATMENT OPTIONS 6234 04:12:36,360 --> 04:12:39,040 MIGHT BE GOOD. 6235 04:12:39,040 --> 04:12:41,840 THE ONE AREA WHERE SOME OF THE 6236 04:12:41,840 --> 04:12:43,840 CLINICAL PAIR, AND DEVELOPMENT 6237 04:12:43,840 --> 04:12:51,640 OVERLAPS A BIT IS IN EXPAND ED 6238 04:12:51,640 --> 04:12:53,080 AND COMPATIBLE USE. 6239 04:12:53,080 --> 04:12:58,680 AS A CLINICAL CARE PROCESS, NOT 6240 04:12:58,680 --> 04:13:01,920 SO MUCH A RESEARCH PROCESS. 6241 04:13:01,920 --> 04:13:05,200 I DON'T KNOW IF THE GUIDELINES 6242 04:13:05,200 --> 04:13:08,920 HAVE EVER GOTTEN INTO YOU KNOW, 6243 04:13:08,920 --> 04:13:14,960 THE ISSUE OF COMPASSIONATE USE 6244 04:13:14,960 --> 04:13:15,320 APPLICATIONS. 6245 04:13:15,320 --> 04:13:21,280 OR EXPANDED ACCESS PROGRAMS. 6246 04:13:21,280 --> 04:13:22,280 >>>WE HAVE FEATURED INFORMATION 6247 04:13:22,280 --> 04:13:24,240 ON THEM IN THE PAST. 6248 04:13:24,240 --> 04:13:25,440 AGAIN, WE LOOK FOR INFORMATION 6249 04:13:25,440 --> 04:13:31,040 THAT IS USEFUL TO PROVIDERS. 6250 04:13:31,040 --> 04:13:32,720 PROVIDERS HAVE A HARD TIME 6251 04:13:32,720 --> 04:13:33,880 FINDING THE INFORMATION THAT YOU 6252 04:13:33,880 --> 04:13:34,120 MENTIONED. 6253 04:13:34,120 --> 04:13:37,800 IT IS MORE OF AN ISSUE IN THE 6254 04:13:37,800 --> 04:13:41,680 PAST THAN IT IS NOW. 6255 04:13:41,680 --> 04:13:43,520 >>WE APPRECIATE WHAT YOU SAID 6256 04:13:43,520 --> 04:13:48,280 ABOUT THE AMOUNT OF TIME IT 6257 04:13:48,280 --> 04:13:48,600 TAKES. 6258 04:13:48,600 --> 04:13:49,960 THE QUESTION WE DEAL WITH IN ALL 6259 04:13:49,960 --> 04:13:51,600 OF OUR LIVES, WHAT DO WE HAVE 6260 04:13:51,600 --> 04:13:53,560 THE TIME TO DO WELL, IF WE 6261 04:13:53,560 --> 04:13:55,640 EXPAND TO DO THAT, CAN WE DO 6262 04:13:55,640 --> 04:14:00,960 THAT WELL? THAT IS A CONSTANT 6263 04:14:00,960 --> 04:14:05,080 STRUGGLE. 6264 04:14:05,080 --> 04:14:10,720 >>I HEAR YOU. 6265 04:14:10,720 --> 04:14:14,600 >>JUST ECHOING WHAT MARY, IF 6266 04:14:14,600 --> 04:14:18,000 THERE ARE ANY QUESTIONS OR 6267 04:14:18,000 --> 04:14:18,760 COMMENTS, FROM THE ADVISORY AS 6268 04:14:18,760 --> 04:14:25,680 IT RELATES TO THE FEEDING 6269 04:14:25,680 --> 04:14:26,640 GUIDELINES, THAT WE DIDN'T HAVE 6270 04:14:26,640 --> 04:14:29,480 TIME FOR, WE CAN OPEN IT FOR 6271 04:14:29,480 --> 04:14:30,680 DISCUSSION NOW. 6272 04:14:30,680 --> 04:14:31,000 LUIS. 6273 04:14:31,000 --> 04:14:32,040 >>A QUICK ONE. 6274 04:14:32,040 --> 04:14:33,800 WE HAVE A COUPLE OF EMPTY SAYS, 6275 04:14:33,800 --> 04:14:36,480 HAVE YOU BEEN ABLE TO EVALUATE 6276 04:14:36,480 --> 04:14:40,960 THE READS FROM THE U.S. VERSUS 6277 04:14:40,960 --> 04:14:44,440 INTERNATIONAL? OTHER CONDITIONS 6278 04:14:44,440 --> 04:14:45,560 RAISED THE QUESTION. 6279 04:14:45,560 --> 04:14:51,920 YOU ARE SERVING A BROADER 6280 04:14:51,920 --> 04:14:52,400 AUDIENCE. 6281 04:14:52,400 --> 04:14:53,440 >>WE HAVE. 6282 04:14:53,440 --> 04:14:56,800 THE U.S. IS THE NUMBER ONE USER 6283 04:14:56,800 --> 04:14:59,680 OF OUR GUIDELINES. 6284 04:14:59,680 --> 04:15:01,600 THERE ARE USERS FROM AROUND THE 6285 04:15:01,600 --> 04:15:01,800 WORLD. 6286 04:15:01,800 --> 04:15:04,600 NO QUESTION. 6287 04:15:04,600 --> 04:15:07,320 HENRY, YOU CAN PROBABLY COMMENT 6288 04:15:07,320 --> 04:15:09,000 ON THE FACT THAT YOUNGER 6289 04:15:09,000 --> 04:15:11,280 PROVIDERS HAVE NOT SEEN A CASE 6290 04:15:11,280 --> 04:15:12,880 BEFORE, MAKING THE GUIDELINES 6291 04:15:12,880 --> 04:15:14,320 RELEVANT ALL OVER AGAIN. 6292 04:15:14,320 --> 04:15:18,320 >>IT IS TRUE, I MEAN, WE THINK 6293 04:15:18,320 --> 04:15:20,720 THAT AS OLDER PROVIDERS, WE HAVE 6294 04:15:20,720 --> 04:15:24,360 SEEN MANY OF THE DISEASES. 6295 04:15:24,360 --> 04:15:29,000 TRIP SAYS, THERE ARE PEOPLE WHO 6296 04:15:29,000 --> 04:15:34,200 NEED TO LOOK AT -- MAKING IT 6297 04:15:34,200 --> 04:15:35,560 INTERNATIONAL, IS A COMPLEX 6298 04:15:35,560 --> 04:15:35,880 ISSUE. 6299 04:15:35,880 --> 04:15:39,040 FOR A U.S. GOVERNMENT AGENCY, WE 6300 04:15:39,040 --> 04:15:41,480 HAVE TO BE CAREFUL ABOUT NOT 6301 04:15:41,480 --> 04:15:43,960 TREADING ON OTHERS' TOES WHEN WE 6302 04:15:43,960 --> 04:15:45,200 DON'T KNOW THE SITUATIONS IN 6303 04:15:45,200 --> 04:15:47,920 OTHER COUNTRIES. 6304 04:15:47,920 --> 04:15:49,120 IT IS DIFFICULT TO DEAL WITH 6305 04:15:49,120 --> 04:15:51,720 ALL THE COUNTRIES OUT THERE, TO 6306 04:15:51,720 --> 04:15:53,720 SAY SOMETHING IRRELEVANT. 6307 04:15:53,720 --> 04:15:56,680 WE HAVE LARGELY U.S. PROVIDERS. 6308 04:15:56,680 --> 04:15:59,200 UNLESS WE ASK FOR A 6309 04:15:59,200 --> 04:16:01,000 COLLABORATIVE AGREEMENT WITH 6310 04:16:01,000 --> 04:16:04,960 OTHER COUNTRIES, AND PUT THEM ON 6311 04:16:04,960 --> 04:16:07,840 HERE, IT IS HARD TO GIVE 6312 04:16:07,840 --> 04:16:11,240 GUIDANCE FOR OTHER PLACES. 6313 04:16:11,240 --> 04:16:14,040 IT WOULD MAKE THEM TREMENDOUSLY 6314 04:16:14,040 --> 04:16:14,720 MORE. 6315 04:16:14,720 --> 04:16:17,240 >>I WASN'T SUGGESTING THAT A 6316 04:16:17,240 --> 04:16:18,480 GLOBAL GUIDELINES, I WAS TRYING 6317 04:16:18,480 --> 04:16:21,880 TO GET A SENSE AS TO YOUR 6318 04:16:21,880 --> 04:16:22,120 AUDIENCE. 6319 04:16:22,120 --> 04:16:25,880 AS TO WHO ACCESSES. 6320 04:16:25,880 --> 04:16:32,000 HOW MUCH IS U.S. VERSUS 6321 04:16:32,000 --> 04:16:32,360 INTERNATIONAL. 6322 04:16:32,360 --> 04:16:34,080 >>THAT IS AN IMPORTANT ISSUE. 6323 04:16:34,080 --> 04:16:36,400 ALEX POWELL LOOKS AT THIS 6324 04:16:36,400 --> 04:16:39,440 CAREFULLY FOR ALL THE 6325 04:16:39,440 --> 04:16:41,440 GUIDELINES. 6326 04:16:41,440 --> 04:16:43,640 >>MAYBE YOU CAN JUMP IN QUICKLY 6327 04:16:43,640 --> 04:16:46,160 TO MENTION THAT WE DO LOOK AT 6328 04:16:46,160 --> 04:16:49,200 THE METRIC FORS PAGE VIEWS AND 6329 04:16:49,200 --> 04:16:50,480 DIFFERENT VIEWS BY LOCATION. 6330 04:16:50,480 --> 04:16:52,680 WE HAVE THAT DATA. 6331 04:16:52,680 --> 04:16:54,880 WE WOULD BE HAPPY TO SHARE WITH 6332 04:16:54,880 --> 04:16:55,040 YOU. 6333 04:16:55,040 --> 04:16:58,120 IT DOES BARE ON THE TYPE OF GIAN 6334 04:16:58,120 --> 04:16:59,480 ARE YOU LOOKING AT. 6335 04:16:59,480 --> 04:17:04,960 NATIONAL GUIDELINES FOR ARVs, 6336 04:17:04,960 --> 04:17:05,760 MORE PREVALENT. 6337 04:17:05,760 --> 04:17:08,720 WE DO HAVE A NUMBER OF 6338 04:17:08,720 --> 04:17:11,360 INTERNATIONAL HITS, IF YOU WILL 6339 04:17:11,360 --> 04:17:13,000 FOR THE OI GUIDELINES. 6340 04:17:13,000 --> 04:17:16,960 WE DO FOR ALL OF THEM. 6341 04:17:16,960 --> 04:17:24,280 THOSE IN PARTICULAR. 6342 04:17:24,280 --> 04:17:26,640 >>THAT IS AN INTERESTING 6343 04:17:26,640 --> 04:17:27,840 QUESTION ABOUT THE INTERNATIONAL 6344 04:17:27,840 --> 04:17:28,040 VIEWS. 6345 04:17:28,040 --> 04:17:30,720 I THINK NAWOULD BE INTERESTING 6346 04:17:30,720 --> 04:17:34,920 TO SEE WHAT DETAILS ON THAT. 6347 04:17:34,920 --> 04:17:38,720 AND I JUST, AGAIN, GOING BACK TO 6348 04:17:38,720 --> 04:17:42,200 THE WORKSHOP, THAT IS STILL 6349 04:17:42,200 --> 04:17:44,960 FRESH IN MY MIND. 6350 04:17:44,960 --> 04:17:47,120 THE ISSUE OF FACILITATING. 6351 04:17:47,120 --> 04:17:52,000 I AM NOT SAYING ABOUT ANY OF HER 6352 04:17:52,000 --> 04:17:55,760 PEOPLE INVOLVED, IT MAY MAKE AN 6353 04:17:55,760 --> 04:17:58,120 INTERESTING, YOU KNOW, THESIS 6354 04:17:58,120 --> 04:18:00,960 FOR A STUDENT. 6355 04:18:00,960 --> 04:18:04,720 TO HOOK AT WHAT MEKS TENT THE 6356 04:18:04,720 --> 04:18:08,400 GUIDELINES HAVE BY THIS PANEL. 6357 04:18:08,400 --> 04:18:18,960 BY THIS FEDERAL -- AS A RESEARCH 6358 04:18:26,520 --> 04:18:26,720 TOPIC. 6359 04:18:26,720 --> 04:18:31,320 BRAIN STORMING HERE ABOUT IT. 6360 04:18:31,320 --> 04:18:34,480 WE SAY THE HELP. 6361 04:18:34,480 --> 04:18:36,760 HCB, I THINK IT BECAME CLEAR, I 6362 04:18:36,760 --> 04:18:39,760 WONDER IF IT WOULD BE AN 6363 04:18:39,760 --> 04:18:42,960 INTERESTING RESEARCH TOPIC FOR A 6364 04:18:42,960 --> 04:18:52,640 STUDENT AT SOME POINT. 6365 04:18:52,640 --> 04:18:56,840 >>THANK YOU AGAIN, FOR THE 6366 04:18:56,840 --> 04:19:04,160 IDEA. 6367 04:19:04,160 --> 04:19:09,840 I THINK OUR COLLEAGUES, I WANT 6368 04:19:09,840 --> 04:19:14,720 TO MAKE SURE, WE HAVE ABOUT 10 6369 04:19:14,720 --> 04:19:16,080 MINUTES LEFT IN THE SCHEDULE IF 6370 04:19:16,080 --> 04:19:17,560 THERE ARE ANY OTHER THOUGHTS AND 6371 04:19:17,560 --> 04:19:19,360 COMMENTS WE CAN MAKE. 6372 04:19:19,360 --> 04:19:20,720 HANDS ARE GOING UP. 6373 04:19:20,720 --> 04:19:24,320 I AM GOING TO GO WITH DR. METTA 6374 04:19:24,320 --> 04:19:27,520 FIRST, AND WE WILL COME BACK TO 6375 04:19:27,520 --> 04:19:27,680 YOU. 6376 04:19:27,680 --> 04:19:30,040 >>I AM GOING TO GO BACK TO THE 6377 04:19:30,040 --> 04:19:31,640 COMMENT I WANTED TO MAKE 6378 04:19:31,640 --> 04:19:33,000 EARLIER, THANK YOU FOR THE 6379 04:19:33,000 --> 04:19:35,000 PRESENTATIONS TODAY. 6380 04:19:35,000 --> 04:19:36,960 MY COMMENT AND QUESTION WAS FOR 6381 04:19:36,960 --> 04:19:38,440 DR. MILLER'S PRESENTATION. 6382 04:19:38,440 --> 04:19:41,800 I WAS EXCITED TO SEE ALL OF THE 6383 04:19:41,800 --> 04:19:42,800 PRESENTATIONS, IN PARTICULAR, 6384 04:19:42,800 --> 04:19:46,720 THIS ONE, IT HIGHLIGHTED THE 6385 04:19:46,720 --> 04:19:48,960 SYSTEMATIC INCLUSION OF THOSE 6386 04:19:48,960 --> 04:19:53,320 WHO INJECT AND DRUGS, PREVENTION 6387 04:19:53,320 --> 04:19:55,640 TRIALS, RAISED AT CROIX THIS 6388 04:19:55,640 --> 04:19:55,960 YEAR. 6389 04:19:55,960 --> 04:19:58,120 PEOPLE WHO USED INJECT DRUGS 6390 04:19:58,120 --> 04:20:01,560 WERE NOT INCLUDED IN THE 6391 04:20:01,560 --> 04:20:02,640 LONG-ACTING PREP TRIALS. 6392 04:20:02,640 --> 04:20:04,960 WE DON'T HAVE THAT EVIDENCE 6393 04:20:04,960 --> 04:20:05,160 BASE. 6394 04:20:05,160 --> 04:20:08,280 YOU HAVE EXCELLENT 6395 04:20:08,280 --> 04:20:10,720 RECOMMENDATIONS AND GREAT 6396 04:20:10,720 --> 04:20:12,320 EXAMPLES I WORRY WE KEEP MAKING 6397 04:20:12,320 --> 04:20:14,320 THE SAME MISTAKES IN THE EARLY 6398 04:20:14,320 --> 04:20:16,480 FACES, IN TERMS OF SAFETY, AND 6399 04:20:16,480 --> 04:20:17,480 THE EARLY TRIALS. 6400 04:20:17,480 --> 04:20:20,080 HOW DO WE, AS NEW INNOVATIONS 6401 04:20:20,080 --> 04:20:23,480 COME DOWN THE PIKE, A DIFFICULT 6402 04:20:23,480 --> 04:20:28,960 QUESTION, ENSURE THAT 6403 04:20:28,960 --> 04:20:35,840 POPULATIONS, INCLUDE PEOPLE WHO 6404 04:20:35,840 --> 04:20:37,000 STAND TO BENEFIT FROM THE 6405 04:20:37,000 --> 04:20:38,520 INTERVENTIONS. 6406 04:20:38,520 --> 04:20:39,560 >> YOU ARE SO RIGHT. 6407 04:20:39,560 --> 04:20:45,880 THANK YOU FOR RAISING THAT. 6408 04:20:45,880 --> 04:20:47,760 PREVENTION AND PARTIES ARE 6409 04:20:47,760 --> 04:20:53,080 STARTING TO OVERLAP A LOT MORE. 6410 04:20:53,080 --> 04:20:54,960 OBVIOUSLY, THEY ARE SEPARATE IN 6411 04:20:54,960 --> 04:20:56,960 MANY WAYS, I THINK WHEN PEOPLE 6412 04:20:56,960 --> 04:21:00,960 DO TREATMENTS AND TRIALS -- YOU 6413 04:21:00,960 --> 04:21:04,920 KNOW, THERE WAS A TRIAL IN 6414 04:21:04,920 --> 04:21:08,720 THAILAND THAT WAS FOR INJECTION 6415 04:21:08,720 --> 04:21:11,720 DRUG USERS. 6416 04:21:11,720 --> 04:21:19,680 >>IT WAS ORAL PREP. 6417 04:21:19,680 --> 04:21:22,920 MOST OF WHAT THEY FOCUS ON, IS 6418 04:21:22,920 --> 04:21:26,680 THERE HIGH ENOUGH INCIDENTS, TO 6419 04:21:26,680 --> 04:21:36,960 SEE A DECREASE. 6420 04:21:38,360 --> 04:21:41,000 THEY ARE NOT UNIFORM. 6421 04:21:41,000 --> 04:21:43,240 THEY MIGHT BE INJECTING, MAYBE 6422 04:21:43,240 --> 04:21:44,360 FOR WOMEN, IN DIFFERENT 6423 04:21:44,360 --> 04:21:44,640 SETTINGS. 6424 04:21:44,640 --> 04:21:46,840 I THINK THAT IS WHY SOME OF THE 6425 04:21:46,840 --> 04:21:48,760 RURAL SETTINGS, WHERE YOU SEE 6426 04:21:48,760 --> 04:21:52,480 THE HOT SPOTS OF HIV INCIDENTS, 6427 04:21:52,480 --> 04:21:53,880 DON'T -- IT WOULD BE SO 6428 04:21:53,880 --> 04:21:56,400 IMPORTANT TO STUDY AND PREP AS 6429 04:21:56,400 --> 04:21:56,600 WELL. 6430 04:21:56,600 --> 04:22:00,400 I THINK THAT IT IS THE LONG 6431 04:22:00,400 --> 04:22:02,720 ACTING MOLECULE, USE IT FOR 6432 04:22:02,720 --> 04:22:03,840 PREVENTION OR TREATMENT. 6433 04:22:03,840 --> 04:22:05,720 THERE SHOULD BE MORE OVERLAP 6434 04:22:05,720 --> 04:22:08,200 THERE, AND LESSONS LEARNED ON 6435 04:22:08,200 --> 04:22:08,960 THE SAFETY SIDE. 6436 04:22:08,960 --> 04:22:11,440 IN BOTH PROGRAMS. 6437 04:22:11,440 --> 04:22:12,560 I SO AGREE WITH YOU. 6438 04:22:12,560 --> 04:22:15,840 WE NEED TO TALK WITH THE 6439 04:22:15,840 --> 04:22:17,400 SPONSORS AND THE COMMITTEES 6440 04:22:17,400 --> 04:22:20,160 ABOUT HOW TO INCREASE DIVERSITY 6441 04:22:20,160 --> 04:22:30,120 AND INCUBATION TRIALS. 6442 04:22:30,120 --> 04:22:33,280 >>I WILL GO TO JONATHAN NEXT. 6443 04:22:33,280 --> 04:22:34,360 >>CAN YOU HEAR ME OKAY? 6444 04:22:34,360 --> 04:22:35,960 >>WE CAN. 6445 04:22:35,960 --> 04:22:39,600 >>I WILL SAY THAT THE VIDEO 6446 04:22:39,600 --> 04:22:42,040 GREMLIN TOOK OVER MY CAMERA. 6447 04:22:42,040 --> 04:22:43,920 I DIDN'T WANT TO SIGN OUT AND 6448 04:22:43,920 --> 04:22:45,080 MISS SOMETHING, AND SIGN BACK 6449 04:22:45,080 --> 04:22:45,600 IN. 6450 04:22:45,600 --> 04:22:48,000 OTHERWISE, I WOULD BE SHOWING MY 6451 04:22:48,000 --> 04:22:49,240 FACE. 6452 04:22:49,240 --> 04:22:51,680 THIS HAS BEEN A GREAT MEETING. 6453 04:22:51,680 --> 04:22:53,120 I WANTED TO APPRECIATE ALL THE 6454 04:22:53,120 --> 04:22:54,680 COMMENTS FROM FOLKS, ONE 6455 04:22:54,680 --> 04:22:56,960 QUESTION, I THINK FOR THE GROUP. 6456 04:22:56,960 --> 04:22:58,320 MAYBE FOR ONE IN PARTICULAR. 6457 04:22:58,320 --> 04:23:00,800 A LOT OF WHAT WE HAVE BEEN 6458 04:23:00,800 --> 04:23:02,520 BRINGING UP IN THE CONCEPT, HOW 6459 04:23:02,520 --> 04:23:07,960 DO WE DO A BETTER JOB WITH 6460 04:23:07,960 --> 04:23:10,000 HOLISTIC AND APPROACHES, AND 6461 04:23:10,000 --> 04:23:12,480 ACROSS BARRIERS, SOME OF IT 6462 04:23:12,480 --> 04:23:19,440 RELATES TO POPULATIONS, WOMEN, 6463 04:23:19,440 --> 04:23:21,880 OR TRANSGENDER GROUPS WHO USE 6464 04:23:21,880 --> 04:23:22,080 DRUGS. 6465 04:23:22,080 --> 04:23:24,840 I WANT TO CARE FOR SOMEONE'S 6466 04:23:24,840 --> 04:23:27,960 HIV, BUT THOSE LIVING WITH HIV. 6467 04:23:27,960 --> 04:23:29,560 I THINK THAT BROAD PICTURE I HAD 6468 04:23:29,560 --> 04:23:35,160 IS HOW DO WE DO THAT? IS ON. 6469 04:23:35,160 --> 04:23:36,960 AR CAPABLE OF SUPPORTING AND 6470 04:23:36,960 --> 04:23:40,960 USING RESOURCES FOR THOSE KINDS 6471 04:23:40,960 --> 04:23:45,560 OF CROSS-DISEASE APPROACHES, OR 6472 04:23:45,560 --> 04:23:48,200 DO THEY FEEL LIMITED BY LAW NOT 6473 04:23:48,200 --> 04:23:50,720 TO USE THEM? SOMETHING WE HAVE 6474 04:23:50,720 --> 04:23:52,560 BEEN THINKING ABOUT AS BEING AN 6475 04:23:52,560 --> 04:23:56,720 OPTION AT THE CDC, A LOT OF OUR 6476 04:23:56,720 --> 04:24:00,960 INFECES ARE CHRONIC INFECTIOUS 6477 04:24:00,960 --> 04:24:06,080 DISEASES, THE DIAGNOSIS IS OFTEN 6478 04:24:06,080 --> 04:24:08,520 DELAYED, AND PROBABLY BETWEEN 6479 04:24:08,520 --> 04:24:15,760 HIV, 15%, HEP C, 14%, HEP C, OR 6480 04:24:15,760 --> 04:24:18,280 PEOPLE WHO DON'T KNOW THEIR 6481 04:24:18,280 --> 04:24:18,920 STATUS. 6482 04:24:18,920 --> 04:24:19,560 GET TESTED. 6483 04:24:19,560 --> 04:24:22,520 IT IS AN EXTRA STEP THAT WILL 6484 04:24:22,520 --> 04:24:24,440 PREVENT IT FROM OCCURRING. 6485 04:24:24,440 --> 04:24:28,960 IF THERE IS A SYSTEM IN PLACE, 6486 04:24:28,960 --> 04:24:31,840 FOR ANTIBODIES OR BOTH, I WENT 6487 04:24:31,840 --> 04:24:34,320 TO THE DOCTOR, IN THE ER. 6488 04:24:34,320 --> 04:24:38,320 THEY ORDERED 90/20, AND 20 6489 04:24:38,320 --> 04:24:40,320 PICKING UP CHRONIC INFECTIONS, 6490 04:24:40,320 --> 04:24:50,760 WE WOULD GREATLY BENEFIT. 6491 04:24:51,880 --> 04:24:53,760 IT WOULDN'T BE HIV-SPECIFIC. 6492 04:24:53,760 --> 04:24:56,160 I WONDER IF THERE IS A SCOPE FOR 6493 04:24:56,160 --> 04:25:00,960 THAT OR DO CHANGES NEED TO BE 6494 04:25:00,960 --> 04:25:08,160 MADE? MARR EEP, I BELIEVE THE 6495 04:25:08,160 --> 04:25:09,880 QUESTION WAS TO YOU. 6496 04:25:09,880 --> 04:25:11,880 I WILL GIVE YOU AN OPPORTUNITY 6497 04:25:11,880 --> 04:25:15,360 TO COMMENT IF YOU HAVE ONE. 6498 04:25:15,360 --> 04:25:17,200 >>YOU ALWAYS ASK THE GREAT 6499 04:25:17,200 --> 04:25:18,240 QUESTIONS. 6500 04:25:18,240 --> 04:25:20,920 I THINK WHAT YOU ARE TALKING 6501 04:25:20,920 --> 04:25:26,160 ABOUT IN TERMS OF LOOKING AT 6502 04:25:26,160 --> 04:25:31,640 ISSUES MORE THAN JUST HIV, IN 6503 04:25:31,640 --> 04:25:32,760 CONSIDERABLE PROPOEGZ WITH 6504 04:25:32,760 --> 04:25:36,960 PEOPLE WHO HAVE HIV WHO HAVE 6505 04:25:36,960 --> 04:25:43,680 OTHER CONDITIONS, COLON 6506 04:25:43,680 --> 04:25:48,720 INFECTIONS OR COMORBIDITIES, IS 6507 04:25:48,720 --> 04:25:50,400 IT SCIENTIFICALLY JUSTIFIABLE AS 6508 04:25:50,400 --> 04:25:52,520 PART OF IT, I WOULD SAY YES, 6509 04:25:52,520 --> 04:25:56,120 DEPENDING ON HOW THE TERMS AND 6510 04:25:56,120 --> 04:25:59,440 THE QUESTIONS ARE DEVELOPED. 6511 04:25:59,440 --> 04:26:02,280 FOR THE FUNDING AND THE SUPPORT. 6512 04:26:02,280 --> 04:26:08,760 THERE IS A LOT OF WAYS TO LOOK 6513 04:26:08,760 --> 04:26:10,840 AT PREVENTION AND PARTICULARLY 6514 04:26:10,840 --> 04:26:13,640 TREATMENT OF PEOPLE WITH HIV, 6515 04:26:13,640 --> 04:26:17,680 AND THEIR COMORBIDITIES AND 6516 04:26:17,680 --> 04:26:20,760 COINFECTIONS ANDANCEULARY ISSUES 6517 04:26:20,760 --> 04:26:24,560 THAT CAN COMPLICATE THEIR CARE 6518 04:26:24,560 --> 04:26:26,320 AND TREATMENT. 6519 04:26:26,320 --> 04:26:32,360 IT IS NOT NECESSARILY EXCLUSIVE. 6520 04:26:32,360 --> 04:26:33,520 THE RECURRING PROBLEM OR 6521 04:26:33,520 --> 04:26:35,000 CHALLENGE, IT WAS A PROBLEM 6522 04:26:35,000 --> 04:26:36,400 BEFORE I WAS THE DIRECTOR. 6523 04:26:36,400 --> 04:26:38,800 IT IS HOW DO YOU DEFINE THESE 6524 04:26:38,800 --> 04:26:41,840 AREAS? IT IS SOMETHING THAT WE 6525 04:26:41,840 --> 04:26:43,680 GRAPPLE WITH. 6526 04:26:43,680 --> 04:26:46,440 IF THERE WERE LIMITLESS FUNDS, 6527 04:26:46,440 --> 04:26:50,760 THERE COULD BE LIMITLESS WAYS. 6528 04:26:50,760 --> 04:26:53,680 ON THE INCREASING INVOLVE, HOW 6529 04:26:53,680 --> 04:26:55,880 WE DEPLOY THE RESOURCES, THE ONE 6530 04:26:55,880 --> 04:26:57,360 OF THE QUESTIONS THAT YOU 6531 04:26:57,360 --> 04:27:01,200 GRAPPLE WITH, IT MAY BE A GOOD 6532 04:27:01,200 --> 04:27:03,800 QUESTION FOR OARAC IN THE 6533 04:27:03,800 --> 04:27:06,520 FUTURE, HOW MANY DEGREES ARE 6534 04:27:06,520 --> 04:27:08,800 THERE, IMPORTANT SCIENCE, NOT 6535 04:27:08,800 --> 04:27:19,240 INTIMATELY RELATED TO HIV. 6536 04:27:20,200 --> 04:27:21,520 >>I AM APPRECIATING YOUR 6537 04:27:21,520 --> 04:27:21,840 EXPERIENCE. 6538 04:27:21,840 --> 04:27:32,320 >>THANK YOU FOR THE QUESTION. 6539 04:27:33,040 --> 04:27:36,960 >>WHAT IS THE POSITION OF THE 6540 04:27:36,960 --> 04:27:38,760 COMMITTEE, PRIMARILY FOR THE 6541 04:27:38,760 --> 04:27:41,280 SUPPRESSED, THERE HAS BEEN A LOT 6542 04:27:41,280 --> 04:27:43,640 OF DISCUSSION ABOUT THE 6543 04:27:43,640 --> 04:27:45,840 POPULATIONS WHO THE GAIN WILL 6544 04:27:45,840 --> 04:27:48,600 MOST MAY NOT HAVE SUSTAINED 6545 04:27:48,600 --> 04:27:50,240 SUPPRESSION, AND HAVE THIS FOR 6546 04:27:50,240 --> 04:27:51,440 AN ALTERNATIVE. 6547 04:27:51,440 --> 04:27:52,600 I DON'T KNOW WHAT THE GUIDELINES 6548 04:27:52,600 --> 04:27:53,720 COULD CHANGE. 6549 04:27:53,720 --> 04:27:56,480 THERE MAY BE A GAP BETWEEN 6550 04:27:56,480 --> 04:27:58,840 PROVIDERS LOOKING FOR THIS 6551 04:27:58,840 --> 04:28:01,560 OPTION, AND THE INDICATION 6552 04:28:01,560 --> 04:28:05,000 COMING OUT FOR IT. 6553 04:28:05,000 --> 04:28:08,120 DOES THE GUIDANCE COMMITTEE TAKE 6554 04:28:08,120 --> 04:28:09,840 A POSITION? 6555 04:28:09,840 --> 04:28:13,560 >>WE, LIKE PRACTICING 6556 04:28:13,560 --> 04:28:15,960 PHYSICIANS, CAN INCLUDE OFF 6557 04:28:15,960 --> 04:28:19,560 LABEL -- WE ARE NOT BOUND BY THE 6558 04:28:19,560 --> 04:28:21,160 FDA, WE WOULD CONSIDER THEM 6559 04:28:21,160 --> 04:28:21,680 CAREFULLY. 6560 04:28:21,680 --> 04:28:24,800 MORE IMPORTANTLY, WE ARE LOOKING 6561 04:28:24,800 --> 04:28:29,000 FOR DATA TO SUPPORT OUR 6562 04:28:29,000 --> 04:28:29,360 RECOMMENDATIONS. 6563 04:28:29,360 --> 04:28:32,800 ANEC DOTTA DATA IS JUST THAT. 6564 04:28:32,800 --> 04:28:35,240 WE ARE LOOKING FOR MORE DATA TO 6565 04:28:35,240 --> 04:28:36,800 SUPPORT RECOMMENDATIONS. 6566 04:28:36,800 --> 04:28:40,040 YES, THERE ARE TIMES THAT WE 6567 04:28:40,040 --> 04:28:42,880 HAVE MADE A RECOMMENDATION THAT 6568 04:28:42,880 --> 04:28:46,440 IS OFF LABEL USE OF THE 6569 04:28:46,440 --> 04:28:46,840 MEDICATION. 6570 04:28:46,840 --> 04:28:55,000 >>THANK YOU. 6571 04:28:55,000 --> 04:28:57,960 MONICA, THE LAST QUESTION. 6572 04:28:57,960 --> 04:29:01,000 >>JUST TO RESPOND. 6573 04:29:01,000 --> 04:29:03,520 WHAT IS CONSIDERED ANECDOTAL AND 6574 04:29:03,520 --> 04:29:05,040 A PROJECT THAT IS ENOUGH? DO 6575 04:29:05,040 --> 04:29:09,320 YOU HAVE A NUMBER IN MIND THAT 6576 04:29:09,320 --> 04:29:13,000 PEOPLE FLEEDED TO TREAT, 133 6577 04:29:13,000 --> 04:29:18,480 PEOPLE, WELL, NOW WE HAVE MORE. 6578 04:29:18,480 --> 04:29:25,000 WHAT IS IT IS BEING REVIEWED AS 6579 04:29:25,000 --> 04:29:28,960 A MANUSCRIPT, I KNOW THAT IS 6580 04:29:28,960 --> 04:29:31,320 SMALL, SO, ABOUT 57 PEOPLE. 6581 04:29:31,320 --> 04:29:34,480 WHAT KIND OF NUMBERS, IS THAT 6582 04:29:34,480 --> 04:29:36,440 SOMETHING YOU HAVE TO MEET AND 6583 04:29:36,440 --> 04:29:36,680 DISCUSS. 6584 04:29:36,680 --> 04:29:38,800 WHAT DATA WOULD IT TAKE FOR THE 6585 04:29:38,800 --> 04:29:42,520 GUIDELINES TO SAY, NOT A GRADE A 6586 04:29:42,520 --> 04:29:44,800 RECOMMENDATION, BUT SOMETHING 6587 04:29:44,800 --> 04:29:47,280 THAT PEOPLE ARE TRYING, EASIER 6588 04:29:47,280 --> 04:29:50,800 FOR THEM TO GET EXPERIENCE TO DO 6589 04:29:50,800 --> 04:29:52,960 THAT, THE GUIDELINES COMMITTEE 6590 04:29:52,960 --> 04:29:53,600 STATEMENT ABOUT IT. 6591 04:29:53,600 --> 04:29:56,800 >>WE LOOK AT THE TOTALITY OF 6592 04:29:56,800 --> 04:29:59,400 THE DATA, AND THE HIGHEST LEVEL, 6593 04:29:59,400 --> 04:30:04,840 OF COURSE, A RANDOMIZED CLINICAL 6594 04:30:04,840 --> 04:30:08,080 TRIAL, DONE AT MULTIPLY PEL 6595 04:30:08,080 --> 04:30:11,080 INSTITUTIONS, AND SHOWS A 6596 04:30:11,080 --> 04:30:15,320 RESULT, TWO AT MULTIPLE U.S. 6597 04:30:15,320 --> 04:30:15,640 INSTITUTIONS. 6598 04:30:15,640 --> 04:30:18,040 WE HEAR CASE REPORTS, AND LEVIEW 6599 04:30:18,040 --> 04:30:19,360 THE DATA. 6600 04:30:19,360 --> 04:30:21,840 CLEARLY, SOME DATA ARE STRONGER 6601 04:30:21,840 --> 04:30:23,880 THAN OTHERS, AND MORE 6602 04:30:23,880 --> 04:30:26,760 INFLUENTIAL FOR GUIDELINES. 6603 04:30:26,760 --> 04:30:29,760 A SINGLE CENTER REPORT OF A 6604 04:30:29,760 --> 04:30:32,160 GROUP OF PATIENTS, WEST COAST 6605 04:30:32,160 --> 04:30:35,040 CITY THAT HAS A GOOD RESULT, 6606 04:30:35,040 --> 04:30:36,680 CERTAINLY IS SOMETHING TO 6607 04:30:36,680 --> 04:30:36,920 DISCUSS. 6608 04:30:36,920 --> 04:30:38,800 WHETHER IT IS POWERFUL ENOUGH TO 6609 04:30:38,800 --> 04:30:42,360 CHANGE GUIDELINES MERITS 6610 04:30:42,360 --> 04:30:42,680 DISCUSSIONS. 6611 04:30:42,680 --> 04:30:50,520 >>THANK YOU. 6612 04:30:50,520 --> 04:30:54,960 >>>THIS, THIS TURNED INTO A 6613 04:30:54,960 --> 04:30:56,800 REALLY RICH DISCUSSION. 6614 04:30:56,800 --> 04:30:58,480 WE WILL MOVE ALONG NOW IN THE 6615 04:30:58,480 --> 04:31:02,000 AGENDA, THIS IS THE TIME THAT WE 6616 04:31:02,000 --> 04:31:04,840 A LOT FOR PUBLIC COMMENT. 6617 04:31:04,840 --> 04:31:07,080 MARY, DO YOU -- DID YOU RECEIVE 6618 04:31:07,080 --> 04:31:08,640 ANY PUBLIC COMMENTS? 6619 04:31:08,640 --> 04:31:10,000 >>AS A MATTER OF FACT, WE DO 6620 04:31:10,000 --> 04:31:10,800 HAVE ONE. 6621 04:31:10,800 --> 04:31:13,000 I WILL GO AHEAD AND SHARE THAT 6622 04:31:13,000 --> 04:31:14,800 WITH YOU NOW. 6623 04:31:14,800 --> 04:31:21,000 THIS IS FROM MR. JULES LEIN, 6624 04:31:21,000 --> 04:31:28,960 NATIONAL AIDS ADVOCACY. 6625 04:31:28,960 --> 04:31:31,600 THANKS FOR LISTENING TO THE 6626 04:31:31,600 --> 04:31:33,760 CONCERNS VOICED AROUND HIS 6627 04:31:33,760 --> 04:31:34,000 PROBLEM. 6628 04:31:34,000 --> 04:31:36,760 HE KNOWS THERE ARE CONCERNS THAT 6629 04:31:36,760 --> 04:31:38,800 REMAIN ON THE MAT. 6630 04:31:38,800 --> 04:31:42,000 MR. LEVIN STATES THAT AGING WITH 6631 04:31:42,000 --> 04:31:45,320 HIV IS A MAJOR PROBLEM FOR 6632 04:31:45,320 --> 04:31:48,000 PERSONS WITH HIV OVER 50, AND 6633 04:31:48,000 --> 04:31:49,400 PARTICULARLY THOSE OVER THE AGE 6634 04:31:49,400 --> 04:31:50,160 OF 65. 6635 04:31:50,160 --> 04:31:53,680 HE KNOWS THAT FOR OLDER PERSONS 6636 04:31:53,680 --> 04:31:57,840 WITH HIV, THEY MAY SUFFER FROM 6637 04:31:57,840 --> 04:32:02,480 EARLIER ON-SET AND 6638 04:32:02,480 --> 04:32:05,080 COMORBIDITIES, AND MULTIPLE 6639 04:32:05,080 --> 04:32:07,440 COMORBIDITIES. 6640 04:32:07,440 --> 04:32:11,520 HE KNOWS THAT ALZHEIMER'S RISK 6641 04:32:11,520 --> 04:32:14,800 MAY BE INCREASED. 6642 04:32:14,800 --> 04:32:18,640 PEOPLE OVER 65 WITH UNSET CARE 6643 04:32:18,640 --> 04:32:22,320 NEEDS, THE NEED FOR GERIATRIC 6644 04:32:22,320 --> 04:32:23,800 SCREENINGS ARE NOT PERFORMED 6645 04:32:23,800 --> 04:32:26,800 OFTEN IN HIV CLINICS, AND HIV 6646 04:32:26,800 --> 04:32:30,000 CARE IS NOT OFTEN PROVIDED IN 6647 04:32:30,000 --> 04:32:32,800 GERIATRIC CLINICS. 6648 04:32:32,800 --> 04:32:35,600 THESE ISSUES CAN RESULT IN 6649 04:32:35,600 --> 04:32:38,160 IMPAIRMENT AND PREMATURE DEATH. 6650 04:32:38,160 --> 04:32:43,400 HE ACKNOWLEDGES THE BROAD 6651 04:32:43,400 --> 04:32:48,640 NIHESTS, AND EMPHASISES THE NEED 6652 04:32:48,640 --> 04:32:49,200 TO GO BEYOND SCIENCE. 6653 04:32:49,200 --> 04:32:53,120 INNOVATIVE RESEARCH TO, SUPPORT 6654 04:32:53,120 --> 04:32:57,000 THE CLINICAL CARE OF EARLY WITH 6655 04:32:57,000 --> 04:32:58,080 HIV. 6656 04:32:58,080 --> 04:33:01,560 HE STATES THAT HIV ADVOCACY 6657 04:33:01,560 --> 04:33:04,840 COMMUNITY HAS BEEN DISCUSSING 6658 04:33:04,840 --> 04:33:07,320 THIS, HAVING DIRECT DISCUSSIONS 6659 04:33:07,320 --> 04:33:09,520 WITH THE OARAC, AND HE NOTES 6660 04:33:09,520 --> 04:33:14,800 THAT HE AND OTHER ADVOCATES 6661 04:33:14,800 --> 04:33:19,080 WOULD LIKE TO PARTICIPATE IN 6662 04:33:19,080 --> 04:33:22,240 WHAT WAS DISCUSSED EARLIER 6663 04:33:22,240 --> 04:33:22,440 TODAY. 6664 04:33:22,440 --> 04:33:27,040 AND WITHIN THE ACTG, AND 6665 04:33:27,040 --> 04:33:29,000 ADVOCATES FOR 34R EDUCATION 6666 04:33:29,000 --> 04:33:32,800 THROUGH THE NETWORK. 6667 04:33:32,800 --> 04:33:37,560 THE ACTG FUNDING, AND ATTENTION 6668 04:33:37,560 --> 04:33:40,720 TO PROVIDE QUALITY CARE FOR 6669 04:33:40,720 --> 04:33:48,960 THOSE WHO ARE PERNATALLY 6670 04:33:48,960 --> 04:33:49,200 INFECTED. 6671 04:33:49,200 --> 04:33:52,160 THAT CLON CLUDES THE PUBLIC 6672 04:33:52,160 --> 04:33:52,400 COMMENT. 6673 04:33:52,400 --> 04:33:54,800 I WOULD LIKE TO THANK A MOMENT 6674 04:33:54,800 --> 04:33:56,680 TO THANK YOU AS THE CHAIR, THIS 6675 04:33:56,680 --> 04:33:58,360 IS YOUR LAST MEETING AS CHAIR. 6676 04:33:58,360 --> 04:34:00,440 WE HOPE TO HAVE YOU BACK IN 6677 04:34:00,440 --> 04:34:01,880 OTHER CAPACITIES IN THE FUTURE. 6678 04:34:01,880 --> 04:34:05,000 IT HAS BEEN MY PLEASURE TO WORK 6679 04:34:05,000 --> 04:34:05,920 WITH YOU. 6680 04:34:05,920 --> 04:34:06,680 THANK YOU. 6681 04:34:06,680 --> 04:34:08,600 >>THANK YOU, MARY. 6682 04:34:08,600 --> 04:34:11,720 BEFORE I HAND IT OVER TO 6683 04:34:11,720 --> 04:34:12,920 MAUREEN, I WOULD LIKE TO SAY 6684 04:34:12,920 --> 04:34:16,960 THAT THE PAST TWO YEARS HAVE 6685 04:34:16,960 --> 04:34:22,000 BEEN QUITE YOU KNOW, A LEARNING 6686 04:34:22,000 --> 04:34:23,200 EXPERIENCE FOR ME. 6687 04:34:23,200 --> 04:34:25,640 SOMEONE COMING IN WHO IS A BASIC 6688 04:34:25,640 --> 04:34:27,400 SCIENTIST TO THINKS OF THE 6689 04:34:27,400 --> 04:34:31,520 MOLECULES OF THE VIRUS, HOW TO 6690 04:34:31,520 --> 04:34:33,640 SLOW DOWN PROGRESSION AND 6691 04:34:33,640 --> 04:34:34,840 MOLECULAR LEVEL. 6692 04:34:34,840 --> 04:34:38,800 I GAINED A LOT FROM SERVING AS 6693 04:34:38,800 --> 04:34:41,000 CHAIR OF THE OARAC FOR THE PAST 6694 04:34:41,000 --> 04:34:43,280 TWO YEARS, AND I WANT TO END ON, 6695 04:34:43,280 --> 04:34:46,440 ONE OF THE THINGS THAT I LEARNED 6696 04:34:46,440 --> 04:34:49,560 AND APPRECIATED IS THAT YOU 6697 04:34:49,560 --> 04:34:56,000 KNOW, THE COOPERATION, AND 6698 04:34:56,000 --> 04:35:01,000 CONVERANCE AND CLINICAL TRIALS, 6699 04:35:01,000 --> 04:35:05,360 PUBLIC ENCOURAGEMENT, I HAVE 6700 04:35:05,360 --> 04:35:06,920 HEARD A LOT ABOUT IT OVER THE 6701 04:35:06,920 --> 04:35:10,200 LAST TWO YEARS, IT HAS BEEN 6702 04:35:10,200 --> 04:35:10,480 GREAT. 6703 04:35:10,480 --> 04:35:12,440 I WILL CAST IT OVER TO MAUREEN. 6704 04:35:12,440 --> 04:35:16,360 >>OKAY, WELL, THANK YOU VERY 6705 04:35:16,360 --> 04:35:20,680 MUCH TO EVERYONE, BLANTON, I 6706 04:35:20,680 --> 04:35:24,960 WANT TO SAY AWE FEW WORDS ABOUT 6707 04:35:24,960 --> 04:35:26,760 YOUR TENURE AS OARAC CHAIRS, YOU 6708 04:35:26,760 --> 04:35:29,960 ARE UNIQUE, IN THE SENSE THAT 6709 04:35:29,960 --> 04:35:34,000 YOU ARE THE FIRST CHAIR TO HAVE 6710 04:35:34,000 --> 04:35:36,440 TO RUN VIRTUALLY THROUGH THE 6711 04:35:36,440 --> 04:35:38,800 ENTIRE TIME OF YOUR TENU, 6712 04:35:38,800 --> 04:35:43,440 VIRTUAL MEETINGS, YOU WE HAVE 6713 04:35:43,440 --> 04:35:44,080 NEVER DONE BEFORE. 6714 04:35:44,080 --> 04:35:48,280 YOU HAVE BEEN INCREDIBLY 6715 04:35:48,280 --> 04:35:53,080 TALENTED IN HOW YOU CAN. 6716 04:35:53,080 --> 04:35:57,240 UDOS TO YOU FOR A FANTASTIC JOB 6717 04:35:57,240 --> 04:35:57,720 AS CHAIR. 6718 04:35:57,720 --> 04:36:05,560 OF THE OARAC, AND ALL THE NEW 6719 04:36:05,560 --> 04:36:07,800 POSITION WITH THE HOWARD HUGHES 6720 04:36:07,800 --> 04:36:08,800 INSTITUTE. 6721 04:36:08,800 --> 04:36:13,120 I SHOULD POINT OUT THAT WE HAD 6722 04:36:13,120 --> 04:36:19,280 TRIP GULICK TODAY, AND JEN, THEY 6723 04:36:19,280 --> 04:36:21,080 HAVE ALL BEEN CHAIR. 6724 04:36:21,080 --> 04:36:24,720 YOU NEVER ESCAPE, ONCE YOU HAVE 6725 04:36:24,720 --> 04:36:34,520 COME IN TO THAT CATEGORY. 6726 04:36:34,520 --> 04:36:37,400 I AM GLAD YOU WILL SPEND PART OF 6727 04:36:37,400 --> 04:36:41,000 YOUR TIME IN D.C., WE HAVE 6728 04:36:41,000 --> 04:36:41,840 LUNCH. 6729 04:36:41,840 --> 04:36:44,800 I AM EXCITED LOOKING TO THE JUNE 6730 04:36:44,800 --> 04:36:45,040 MEETING. 6731 04:36:45,040 --> 04:36:47,640 HOPEFULLY, WE CAN PULL OFF AT 6732 04:36:47,640 --> 04:36:49,000 LEAST A HYBRID. 6733 04:36:49,000 --> 04:36:51,320 AND HAVE SOME OF YOU COME INTO 6734 04:36:51,320 --> 04:36:53,080 TOWN. 6735 04:36:53,080 --> 04:36:56,640 IF NOT A LOT OF YOU. 6736 04:36:56,640 --> 04:36:58,720 I CAN'T SAY SAFE TRAVELS, SINCE 6737 04:36:58,720 --> 04:37:01,560 YOU ARE PROBABLY ALL IN YOUR 6738 04:37:01,560 --> 04:37:04,360 HOMES AT BEST. 6739 04:37:04,360 --> 04:37:06,560 WE DO THANK YOU VERY MUCH AND 6740 04:37:06,560 --> 04:37:10,360 APPRECIATE ALL OF THE INPUT, AND 6741 04:37:10,360 --> 04:37:11,200 CONTINUED CONVERSATION. 6742 04:37:11,200 --> 04:37:12,720 NO REASON WHY WE CAN'T TALK TO 6743 04:37:12,720 --> 04:37:14,800 EACH OTHER IN BETWEEN TIMES. 6744 04:37:14,800 --> 04:37:16,440 IF YOU HAVE AN IDEA. 6745 04:37:16,440 --> 04:37:18,840 POP IT ALONG. 6746 04:37:18,840 --> 04:37:20,800 IF WE NEED TO GET INFORMATION 6747 04:37:20,800 --> 04:37:23,280 QUICKLY, WE HAVE A HUGE RESOURCE 6748 04:37:23,280 --> 04:37:25,600 IN THE PEOPLE ON THE COMMITTEE. 6749 04:37:25,600 --> 04:37:27,880 AND ALL OF THE DIFFERENT 6750 04:37:27,880 --> 04:37:28,920 CAPACITIES IN WHICH YOU 6751 04:37:28,920 --> 04:37:29,440 FUNCTION. 6752 04:37:29,440 --> 04:37:39,960 THANK YOU AND HAVE A GREAT DAY.